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Hearing loss affects 278 million people world wide and is one of the most significant 
health problems. Deafness can be acquired due to environmental insults including 
injuries and infections. Additionally, about 50 % of hearing loss is genetic and 
scientists have identified nearly 100 genes implicated in deafness, while many more 
remain to be identified. This book brings together different topics on our current 
understanding of hearing loss. 
The first section on “Hearing” presents a brief overview about normal hearing as well 
as the technology and instruments involved in its measurement including audiometry 
and auditory brainstem response as well as methods to record otoacoustic emissions. 
Scientists have also investigated the listening scores of audio signals and the 
psychological impressions related to speech audibility. In the last chapter in this 
section, the suitability of the Mongolian gerbil is discussed, particularly as a model of 
structural and functional aspects of age-dependent hearing loss in humans. 
The section on “Childhood Hearing loss” provides an overview of parental practices 
and behaviours related to children with and without hearing loss. The results 
indicated that the interactions established between mothers and children favour the 
acquisition and maintenance of social skills. Additionally, early detection of hearing 
loss and prompt intervention gives children with deafness a chance to develop spoken 
language comparable to those with normal hearing. 
“Injuries & traumas” as cause of hearing loss are the focus of the third chapter in this 
book. This section includes a report on head injuries in India and the ensuing hearing 
loss. Symptoms of hearing loss were found in 10% of the patients with head trauma. 
Sensorineural hearing loss was the most common finding in the affected individuals.   
Additionally, perforation of the tympanic membrane is reported as a common finding 
in Nigeria due to trauma to the ear. The next two chapters explore the role of ototoxic 
agents such as solvents, pesticides and metals, and their interaction with noise in 
causing hearing loss. Research conducted in human subjects exposed to these 
chemicals indicates that these agents cause auditory dysfunction. The combined 
influence of noise and chemical pollutants on hearing loss confirmed the existence of 
an interaction between physical and chemical factors which influence the alteration of 
auditory function.  
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The “Genetics” of hearing loss is discussed in a series of review articles in the next 
section. An overview is provided of different genes involved in nonsyndromic and 
syndromic hearing loss and reflects the unparalleled heterogeneity of deafness genes. 
Different modes of inheritance of deafness are also discussed. The genetics of 
recessively inherited, moderate to severe and progressive hearing loss in humans is 
covered in detail. Strategies are described about identification of modifiers of deafness 
genes. Common craniofacial abnormalities inherited together with hearing loss are 
discussed in the next chapter. The genes involved in causing Usher syndrome as well 
as different mouse models for each of these genes are also comprehensively reviewed.  
The last section of the book presents the “Treatment” of hearing loss for both genetic 
and acquired cases of deafness. Cochlear implants are now accepted as the standard of 
care for children with severe to profound hearing loss. They have allowed many 
children to attend regular schools, and to develop their language, social and academic 
skills to levels that exceed those for their peers with severe to profound hearing loss 
using hearing aids.  The efficacy of corticosteroid treatment through the eardrum and 
into the middle ear to treat various otologic disorders, such as Meniere’s disease and 
sudden sensorineural hearing loss is also reviewed. The last chapter discusses an 
ancient Chinese technique of acupuncture for treatment of sudden sensorineural 
hearing loss. The authors’ experimentally demonstrate improvement of the hearing 
loss in more than 20% of the individuals who underwent the treatment. Acupuncture 
has gained scientific ground after it was experimentally demonstrated that during this 
process adenosine is released and improves different symptoms in patients. Exactly 
how acupuncture may help in treating hearing loss remains to be determined.  
It is hoped that the research and the reviews on various aspects of hearing loss 
described in this book will be of benefit to different students and the researchers 
working actively in this field. The coming years will see accelerated discoveries in 
many research areas discussed in this book, particularly in genetics of deafness due to 
the use of massively parallel sequencing technologies to identify disease genes. 
Therapies based on genetic findings for treatment of hearing loss may also become 
possible in future. 
Ms. Martina Blecic, the publishing process manager, Ms Ana Pantar, editor relations 
consultant and Ms Nina Dundovic, the technical editor contributed to editing of this 
book. 
Sadaf Naz 
School of Biological Sciences, 
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Technology for Hearing Evaluation 
Josefina Gutierrez 
National Rehabilitation Institute 
Mexico 
1. Introduction 
The hearing system is composed of several components that, by means of a physiological 
process, break down the broad spectrum of frequencies and intensities of sounds from the  
environment (speech, music, signals and noise) into frequency components and temporal 
patterns. These acoustic signals are transmitted to the temporal lobes of the Central Nervous 
System by electric stimuli to generate the neural message (Salesa et al., 2005). The hearing 
process utilizes acoustic, mechanical and electrical principles, and in addition analyzes 
sound waves, removes noise and compares these with signals that have been previously 
registered in the memory of the subject. In this manner, we are able to know when a person 
is speaking, when we are hearing a musical note from a violin or a flute, or when a bird is 
singing. 
The auditory system possesses a wide dynamic range for perceiving sounds; humans with 
normal hearing detect tonal frequencies from 20 Hz to 20 kHz. Acoustic intensity is 
proportional to sound vibration amplitude. Commonly, sound intensity is measured in 
terms of decibels as dB = 10 log(I/I0), where I0 is the reference intensity, or equivalently for 
acoustic pressure, dB = 20 log(P/P0), where P0 is the reference pressure (in Pa). Tonality 
represents the number of vibrations in time and is measured in cycles/sec or Hz. Timbre 
characterizes all of the harmonics overheard in a clear sound, allowing differentiation 
between two sounds with the same tonality and intensity. 
The dynamic range at 2-4 kHz, the span between threshold and pain, is approximately 120 
dB. The minimum threshold for sound occurs between 2 and 5 kHz and is approximately 
20μPa. At the low end of the auditory spectrum, the threshold is 80 dB higher, while at the 
high end, it is 70 dB higher. Intensity differences of 1 dB can be detected, while frequency 
differences of 2-3 Hz can be detected at frequencies below 3 kHz (Aitkin, 1990).  
Sounds are normally transmitted both by Air conduction (AC), and by Bone conduction 
(BC). Conduction of sound starts in the pinna or auricle and passes through the external 
auditory canal on its way to the eardrum, where sounds are amplified to frequencies 
ranging from 5,000-6,000 Hz at 20 dB. Later, the pressure and strength of the sound wave 
vibration that reaches the tympanic membrane, particularly of low frequencies of up to 1,500 
Hz, are amplified in the middle ear. The acoustic vibration of the sound is thus transformed 
into a mechanical vibration to be transmitted to the organ of Corti, located in the cochlear 
duct. The cochlea is a hydromechanical frequency analyzer whose major role is to turn the 
acoustic signal into a frequency map through which each frequency is assigned to certain 
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groups of receptor cells and their nerve fibers. The cochlear nerve innervates the organ of 
Corti; it possesses myelinized efferent fibers that carry spatial orientation information from 
the cochlea to the brain. Efferent signals are amplified and transmitted, frequency 
discrimination is increased, acoustic otoemissions originate, and mechanical changes 
produced in the liquid medium of the sound waves are detected (Steele et al., 2000). 
Hearing loss can occur at any age. Otorhinolaryngologists, surgeons, and audiologists with 
assistance technology are readily able to identify different degrees of hearing loss. Children 
and adults experiencing significant hearing loss suffer specific problems and may need 
special assistance. Early identification of hearing loss and its treatment is essential for 
successful speech development, the child’s intellectual growth and the adult’s social 
integration. 
Hearing impairment is caused by either loss in sensitivity (loss in perceived loudness), loss 
in the ability to discriminate different speech sounds, or both. Loss of loudness may be due 
to either increased mechanical impedance between the outer and inner ear or reduced 
sensitivity of the sensory hearing organ. Loss of the discrimination ability is basically 
associated with damage to the sensory organ, although other neural structures at higher 
levels may also be involved. 
2. Audiologic evaluation technology 
Several subjective and objective methods to assess hearing disorders are available, 
depending on the individual’s age, hearing level and condition type. Among other things, 
evaluation must be conducted for cochlear integrity, acoustic impedance, and screening of 
hearing of newborns and infants.  
With ever changing technology and new methodologies in healthcare, available for 
addressing the specific needs of adult and pediatric populations, hearing technology 
represents not only devices for clinicians’ practice, but also devices to meet the high level of 
need for diagnostic techniques, audiologic rehabilitation, treatment methodologies, and 
special issues in researching the needs of patients (Montano & Spitzer, 2009).  
2.1 Subjective evaluation (technology) 
Subjective hearing tests (Miller, 2006) are available for performing a rough estimate of the 
grade of hearing loss. These tests do not provide a quantitative report of the patient’s 
hearing status, but rather comprise a method with practical clinical value for exploring the 
cochlea in order to determine location rather than intensity of the damage; results must be 
evaluated in conjunction with quantitative hearing evaluation. These include the following: 
2.1.1 Acumeter 
Instrumental acumetry (see Figure 1), which employs the diapason to assess hearing acuity, 
guarantees limited precision (Marullo et al., 1967). This instrument “tuning fork“produces 
sounds with frequencies between 16 and 4,096 Hz from octave to octave. This is a U-shaped 
acoustic resonator that resonates at a specific constant on a frequency-related scale when set 
to vibrate by striking it against a surface or with an object emitting a pure tone. There are 
three mean tests: 
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The Schwabach test determines BC duration. The instrument is placed on the antero-
superior region of the mastoid. Normal duration is 20 sec. The Schwabach test makes a 
comparison between bone conduction of the patient and the examiner. The diapason is 
placed between the patient and examiner and a sound is created. If the patient can no longer 
hear the sound even though the examiner can hear it, it is indicative of sensory neural loss; if 
the examiner stops hearing the sound and the patient continues to hear it, it suggests  
conductive loss. However, this test is completely dependent on the hearing powers of the 
examiner. In conduction hypoacusis – the duration is prolonged, while in sensory neural 
hypoacusis, the duration is shortened. 
The Weber test utilizes the low frequency of the instrument (126 Hz), which is placed on 
vertex. Normally the vibration is heard equally in both ears. This is a common medical test 
conducted in the physician´s office in which a comparison is made between two hearings. In 
the first, the base of the tuning fork is applied to the bone and hearing is elicited after this. 
When the sound is completely inaudible, the vibrating top is brought near the external ear 
canal. If there is a positive value, it is considered that there is an air-bone gap due to which 
there is a conductive loss.  
The Rinne test employs the diapason as initially placed near the ear to explore aerial 
conduction and after that, on the mastoid to explore bone conduction. Normally, air 
conduction is better than bone conduction. With BC/AC=½, the Rinne test is normally 
positive. In this test, a 512 Hz tuning fork is placed on the forehead of the patient. An 
ipsilateral conductive hearing loss is occurred if the sound appears to be louder on one side 
than on the other. A contralateral sensorineural hearing loss may also be determined by use 
of this test. 
 
Fig. 1. Set of tuning fork 
2.1.2 Speech perception test 
This test uses words that the subject hears through headphones and he/she is required to 
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adult and pediatric populations. It is categorized according to whether the words are aimed 
at evaluating detection level ability, syllable, phoneme, word, or sentence perception 
(Australian Hearing Group, 2001). Additionally, it is designed to provide a useful overview 
of the key features (e.g., target hearing-impaired group, clinical application) of each of the 
tests and thereby assists the Audiologist in selecting the appropriate speech perception 
test/s for the individual patient and the specific clinical situation. 
2.1.3 Acoustic reflex test 
The acoustic reflex test measures the contraction of the stapedius, a tiny muscle in the 
middle ear, in response to loud sounds, which occurs under normal conditions when a 
sufficiently intense sound is presented to the auditory pathway. This muscle contraction 
causes a stiffening of the ossicular chain, which alters the compliance of the middle ear 
system. When stimulus presentation and measurement are effected on the same ear by 
means of the probe tone, this acoustical reflex is referred to as an ipsilateral acoustic reflex. 
When stimulus presentation and measurement are effected on opposite ears, the reflex is 
referred to as a contralateral acoustic reflex. 
Stimulus tones of varying intensities of 500, 1000, 2000 or 4000 Hz are presented as short 
bursts. If a change in compliance greater than 0.05ml is detected, a reflex is considered to be 
present. Because this is an extremely small compliance change, any movement of the probe 
during the test may produce an artifact (false response). The test result is recorded as 
Pass/No Response in graphic form (MAICO, 2007). The level of loudness aids in identifying 
the location of the problem along the auditory pathway. 
2.1.4 Scope evaluation 
Scope evaluation utilizes a light emitted by an otoscope. The examiner is able to look into 
the outer and middle ear through a lens on the rear of the instrument and to screen for 
disease including otitis or infection during regular clinical check-ups. Figure 2 depicts the  
 
Fig. 2. Welch-Allyn handle otoscope 
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Welch-Allyn otoscope (Golfain et al., 2008), which is a small hand-held instrument. It has a 
light that is directed through a funnel-like tip to illuminate the ear canal for examination. 
The funnel-like tip is called speculum. The specula are disposable and come in sizes for 
average adult ear canals. The otoscope is powered by a rechargeable battery located in the 
handle; the handle is detachable and can be plugged into a standard wall outlet for recharging. 
2.2 Objective evaluation (technology) 
Diagnostic equipment can help to identify different degrees of hearing loss in a more 
quantitative fashion. There are several techniques that are implemented in medical 
equipment for screening of hearing. The most widely used initial screen involves a pure-
tone, air-conduction hearing test or audiometry, followed by tympanometry, otoacoustic 
emissions, multilingual speech audiometry, and stem cell evoked potentials. 
Hearing testing is conducted in the audiometry testing chamber; a special sound booth is 
built into this room, which must be constructed based on testing guidance described in the 
ASTM E336 “Standard Test Method for measurement of Airborne Sound Insulation in 
Buildings” (ASTM E336–10, 2011). This triangular-shaped booth is designed to ensure that 
the sound levels inside are sufficiently quiet to permit accurate hearing-threshold 
measurements. In addition to the sound booth, the examination room possesses several 
other features designed to reduce sound levels in the room further, as shown in Figure 3. 
These include sound dampening materials on the interior walls of the examination room 
and a rubber seal on the exterior door. 
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The testing suite consists of two adjoining rooms: one of single-wall construction, and the 
other, of double-wall construction. The double portion of the suite is the subject of the noise 
reduction test that includes the following: 1) generating a high-volume controlled sound 
field outside the testing chamber; 2) measuring the sound pressure level at the outer wall; 3) 
measuring the attenuated sound-pressure level of the controlled sound field inside the test 
chamber, and 4) subtracting internal from the external sound-pressure levels while making 
corrections for the interior ambient sound pressure level (Acoustic Systems MD, 2000). 
2.2.1 Pure-tone audiometry and logoaudiometry 
The Audiometry study is used to diagnose the degree and type of hearing loss by 
determining the faintest tones that a person can hear at selected pitches; the measuring 
equipment utilized is called audiometer. This device emits a pure tone by means of a fixed-
frequency oscillator calibrated at the decibel hearing level (National Health and Nutrition 
Examination Survey, 2003); frequencies (125-8000 Hz) and intensities (0-110 dB) which can 
be varied. This unit is controlled by a microprocessor that is sometimes available as a 
handheld Windows-driven instrument and possesses high accuracy and efficiency 
(Khandpur, 2005). Such systems can be also employed with bone vibrators to test 
conductive hearing mechanisms. A pair of headphones is attached, and a test subject 
feedback button indicates when the subject has heard the sound. On the one hand, 
audiometry measures hearing thresholds and oral audiometry or logoaudiometry (Aguilera 
et al., 1997), considered to be a subjective evaluation, is defined by the capacity to evaluate 
the human speech understanding consists of supplying the patient with words at different 
energies that aid in recognizing acoustical features and in providing clues concerning the 
etiology of the hearing loss. On the other hand, audiometry includes supraliminal tests such 
as SISI, Fowler, Tone Decay, or Békésy, to suggest the sensorineural damage (Ghani, 2005). 
Figures 4 and 5 ilustrate the SISI and Békésy tests. 
 
Fig. 4. A patient’s SISI Graph with score value (Gutierrez et al., 2009) 
 




Fig. 5. A patient’s Békésy test (Gutierrez et al., 2009) 
Generally, an audiometric system controlled by a microprocessor (Penhaker & Kijonka, 
2011) is composed of two channels: one for test ear stimulus, and other as a non-test ear 
masker, as shown in the block diagram of Figure 6. 
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An audiogram is a chart that depicts the results of the audiometric study; on the x-axis, 
frequencies are represented in Hz, and on the y-axis, the patient’s hearing ability is 
expressed in dB. Two charts are usually employed: one for the right ear, and one for the left. 
The right ear is graphed with a circle in red color, the blue color plot the left ear with an X. 
Symbols and notes should correspond to the recommendations and standards of the 
American Speech Language Hearing Association (ASHA). 
ASHA guidelines for manual pure-tone threshold audiometry (Campbell et al., 2010); these 
guidelines contain procedures for performing a hearing diagnosis and for monitoring 
standard pure-tone threshold and include manual air-conduction and bone-conduction, 
masking. From the inception of modern audiometric technology, staff at the Department of 
Audiology at the Massachusetts Eye and Ear Infirmary began using an extension of the 
standard symbols for designating "response at limit" and responses found using speakers 
(Halpin, 2007). These symbols represent new exploratory developments and are not part of 
the ASHA standard symbol. 
The NOAH-3™ System (Hearing Instrument Manufacturers’ Software Association, 2000)  is 
a database that integrates software applications from the several manufacturers of audiologic 
devices, including Madsen™ (Madsen Electronics, 2004), Amplaid™, Interacustic™, Benson 
Medical™ . The main purpose of NOAH is to control data exchange from an audiometer to a 
personal computer, among other applications. The transmitted information is introduced into 
a database that is manipulated and processed to obtain audiograms, tables, measurements, 
and statistics, as well as to save and print the patient’s study. 
 
Fig. 7. Overview Producer-Consumer Architecture for the Audiometer Interface. 
The NOAH-3™ System does not work with certain special tests (SISI, Békésy) and some 
audiometers, for example, Madsen™ (Gutiérrez et al., 2009), and it is not possible to transfer 
data for processing or printing these special tests. When the audiometer is turned off, or 
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when new patient data is introduced, the information of the previous test is lost. There is no 
database and the hardcopy audiograms are not designed for long term storage because the 
audiometer has a thermal printer. 
This limitation is a problem for the specialist, because he/she needs to store the patient’s test 
data so that this information can be used in clinical and research audiometric protocols. 
Some authors (Gutiérrez et al., 2009) have described the design and implementation of a 
communication and graphical module for transmitting, processing, printing, and storing the 
patient’s special audiometric studies as a substitute for the NOAH-3™ System (see Figure 7). 
2.2.2 Tympanometry 
The Impedance Audiometry or most commonly used Tympanometry, is a magnitude that 
examines the condition of the middle ear, the status and mobility of the eardrum (tympanic 
membrane). The equipment produces variations of air pressure in the ear canal by means of 
a probe measuring the middle ear’s acoustic resistance. The secondary purpose of this 
examination is to evaluate the acoustic reflex pathway which includes the 7th and 8th 
cranial nerves and the brain stem. Furthermore, tympanometry permits a distinction 
between sensorineural and conductive hearing loss when results are not apparent via Weber 
and Rinne testing. It is also helpful in the diagnosis of otitis media by demonstrating the 
presence of middle-ear effusion. When sound impacts on the eardrum, part of the sound is 
absorbed and sent via the middle to the inner ear, while the remaining part of the sound is 
reflected. When the eardrum is inflamed over a long period of time, it can become stiff and 
heavy and the majority of the sound is reflected; therefore less sound reach the inner ear. 
Among other things, tympanometery assesses cochlear integrity and evaluates acoustic 
impedance, i.e., the degree of difficulty that the middle ear and ossicles encounter for the 
passage of sounds, as a result of the mass, stiffness and ossicular disruption of the auditory 
system. If there is fluid behind the ear-drum, it will not move back and forth from its resting 
position when pressure is applied. Tympanometry is thus affected by the mass, mobility, 
and resistance systems of the external and middle-ear cavities. 
The instrument, or tympanometer, applies air pressure to the eardrum and measures the 
reflected sound. Inside the instrument’s probe, a small loudspeaker is installed that emits a 
tone, typically at 226 Hz, through a tube into the auditory canal in front of the eardrum. The 
canal’s air pressure is altered between +200 and -400 decapascals (dapa), at which the sound 
strikes the tympanic membrane, causing middle-ear vibration, which in turn results in the 
perception of hearing. Some of this sound is reflected back and picked up by another tube, 
which is connected to the microphone inside the probe that receives the sound. Together 
with a third tube, all three are inserted nearly into the eardrum and are made airtight 
against outside pressure by the ear tip. A manometer and a pump, which can produce both 
positive and negative pressure, are connected to tube C. Less sound is reflected into the 
microphone when the eardrum is stiff and the eardrum transmits the majority of the sound 
via the middle to the inner ear. Highest compliance is normally reached with air pressure 
that corresponds to the outside pressure. During tympanometric measurement, a 
continuous change in positive and negative pressure is produced by the instrument’s pump 
in the outer middle auditory canal. This test should not be performed in infants below 7 
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Normally, air pressure in the ear canal is the same as ambient pressure. Also, under normal 
conditions, air pressure in the middle ear is approximately the same as ambient pressure 
because the Eustachian tube opens periodically to ventilate the middle ear and to equalize 
pressure. In a healthy individual, maximum sound is transmitted through the middle ear 
when ambient-air pressure in the ear canal is equal to the pressure in the middle ear.  
The general term employed to describe how energy is transmitted through the middle ear is 
admittance. The impedanciometer measures reflected sound and expresses it in ml as 
admittance to or compliance with the pressure in daPa, plotting the results on a chart known 
as a tympanogram, which is illustrated in Figure 8. The maximum compliance occurs when 
the pressure of the external auditory canal and the middle ear becomes equal. It is only at 
this pressure that maximal acoustic transmission takes place through the middle ear. Thus, 
the compliance peak indicates the pressure of the middle ear, implying the efficacy of the 
Eustachian tube function. The height of the compliance peak indicates the mobility/ 
stiffness of the tympanic membrane or of the middle-ear cavity. 
 
Fig. 8. Tympanogram of a normal subject, their canal’s air pressure is altered between +200 
and -400 dapa at 226Hz. 
This test is not a hearing evaluation, but is rather a measure of energy transmission through 
the middle ear. It should not be used to assess hearing sensitivity and the results of this test 
should always be viewed in conjunction with pure-tone audiometry. Figure 9 presents the 
block diagram of a portable, hand-held tympanometer. Manufacturers, such as Welch Allyn, 
 
Technology for Hearing Evaluation 
 
13 
have marketed the invention registered by Heller et al, (Heller et al., 1987). This instrument 
has the capacity has the capacity of performing the test and of displaying and storing data. 
 
Fig. 9. General block diagram of a hand-held tympanometer. 
2.2.3 Otoacoustic emissions  
Otoacoustic Emissions (OAE) may occur spontaneously or may be evoked by acoustic 
stimulation, appearing to originate from within the cochlea and propagating through 
middle ear structures to the external auditory meatus. OAE are acoustic energy leakages 
from the biochemical reactions (echoes) of a healthy cochlea that possess a latency of 2-20 
msec. If an emission by the cochlea is present, it is likely that hearing is normal at that 
frequency; those with a hearing loss greater than 25–30 dB usually do not produce these soft 
sounds. Auditory neuropathy may have OAE even though the hearing loss may be 
profound. 
To measure OAE, the equipment produces a quiet, clicking sound that is emitted by the 
loudspeaker and OEA is measured with a small probe inserted into the ear canal; recording 
of the response signal is captured with the aid of a sensitive microphone (Choi, 2011). A 
number of response epochs must be averaged to improve the signal-to noise ratio (SNR) and 
produce a clear waveform. Mathematical methods are used for evaluation of the signal, such 
as Fast Fourier (FF) and Wigner-Ville transforms (WVT), Digital filtering, and Correlation 
analysis (CA) (Buller, 1997), or Hilbert–Huang transform (HT) for detection of OAE and 
Time–Frequency Mapping (Janušauskas et al., 2006). The measuring system employed to 
detect otoacoustic emissions consists of the following several parts, as illustrated in Figure 
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preamplifier and amplifier signal; an Analog-to-digital converter (ADC), and Digital Signal 
Processing (DSP) based on a central processing unit that provides ultra-fast calculation, such 
as filtering, averaging, FF, WVT, CA or HT in order to obtain otoacoustic emissions 
response. Additionally, the equipment must be accompanied by the printing and displaying 
module. 
Because the subject being tested is not required to respond, this is an ideal test method for 
neonates and infants or for those who cannot be evaluated using conventional techniques 
(Buz & Bower, 2009). OAE are valuable in testing for ototoxicity, detecting blockage in the 
outer ear canal, as well as the presence of middle-ear fluid and damage to the cochlea outer 
hair cells. 
 
Fig. 10. Block Diagram of the measuring system used to detect OAE 
2.2.4 Stem cell evoked potentials 
The Vestibular Evoked Myogenic Potential is a test that is frequently performed on patients 
experiencing dizziness or balance problems. It evaluates additional portions of the inner ear 
providing a more complete evaluation of the vestibular system which controls balance. 
Electrodes are placed on the patients head and neck and a loud sound is delivered through 
inserted earphones. This test is very useful to screen infants and children under 5 years of 
age for hearing loss. 
Auditory Brainstem Response is an electrical potentials activity in the brain that occurs in 
response to a sound. The test provides information on the cochlea and brain pathways for 
hearing. Three small disk electrodes are pasted onto the head and neck, and brain wave 
activity is recorded while the patient listens to a clicking sound. Soft headphones are placed 
into the patient’s ears and quiet clicking sounds are played through the earphones.  
Depending on the amount of time elapsing between the "click" stimulus and the auditory 
evoked response, potentials are classified as early (0-10 msec), middle (11-50 msec), or late 
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(51-500 msec).  Early potentials reflect electrical activity at the cochlea, eighth cranial nerve, 
and brain-stem levels, while later potentials reflect cortical activity. In order to separate 
evoked potentials from background noise, a system computer, as shown in Figure 11 
(Nicolet™ EMG/PE), analyzes how well the ears respond to the sound by averaging 
auditory evoked responses at 1,000 to 2,000 clicks at least. Early evoked responses may be 
analyzed to estimate the magnitude of hearing loss and to differentiate among cochlear, 
eighth nerve, and brainstem lesions. 
 
Fig. 11. Evoked Potential/EMG measuring system  
For purposes of neonatal screening, only limited auditory evoked potentials or limited 
evoked otoacoustic emissions are considered medically necessary. Neonates who fail this 
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auditory evoked responses at 1,000 to 2,000 clicks at least. Early evoked responses may be 
analyzed to estimate the magnitude of hearing loss and to differentiate among cochlear, 
eighth nerve, and brainstem lesions. 
 
Fig. 11. Evoked Potential/EMG measuring system  
For purposes of neonatal screening, only limited auditory evoked potentials or limited 
evoked otoacoustic emissions are considered medically necessary. Neonates who fail this 





comprehensive otoacoustic emissions. Comprehensive auditory evoked response testing 
and comprehensive otoacoustic emissions are considered experimental and investigational 
for neonatal screening because there is a lack of evidence of the value of comprehensive 
testing in limited auditory evoked potentials or limited otoacoustic emissions for this 
indication. 
2.2.5 Videonystagmography 
This technique is used to evaluate the function of the vestibular system; the inner-ear 
portion may be the cause of any balance or dizziness problems. The instrument records eye 
movements, most notably involuntary eye movements called nystagmus. Eye movements 
are recorded by using infrared goggles. There are three evaluations, including: 1) following 
a light as it moves in different ways; 2) lying flat on the examination table and the subject’s 
moving his/her head left or right, and 3) stimulating the vestibular system with warm and 
cool air or water.  
2.3 Hearing assistance technology 
Hearing loss can be categorized according to which part of the auditory system is damaged, 
the degree or severity of impairment and the configuration or pattern of injury across tones. 
There are three basic types of hearing loss: conductive hearing loss, sensorineural loss, and 
mixed hearing loss. Each of these should be approach with assistive devices, such as hearing 
aids and cochlear implants, so that individual best adapt to managing conversations and 
take charge of their communication. 
2.3.1 Hearing aids 
From; tremendous advances in technology of amplification have occurred from the days 
that ear trumpets and animal horns were used to help to transmit sounds into the ear. A 
hearing aid is an electroacoustic device that typically fits in or behind the wearer’s ear. It is 
designed to amplify and modulate sound in order to direct the flow of sound into the ear 
canal, thus enhancing sound quality (Killion, 1997). Hearing aids differ in design, size, ease 
of handling, volume control, amount of amplification, and the availability of special features 
such as digitized processing. Their basic functional parts include a microphone to pick up 
sound and an associated preamplifier, an automatic gain control circuit, a set of active 
filters, a mixer and power amplifier to make the sound louder, and an output transducer or 
receiver (a miniature loudspeaker that can be made in integrated form with a field-effect 
transistor preamplifier) to deliver the amplified sound into the ear. All electronic circuitry is 
packaged in housing works on a battery. The use of multiple channels in this design 
provides different compression characteristics for different frequency ranges. Typically, 
crossover frequencies of the channels and compression characteristics can be adjusted with 
potentiometers or digital control. 
Conventional analog hearing aids are designed for a particular frequency and utilize a fixed 
or dedicated directional microphone. Although some adjustments are necessary, the aid 
essentially amplifies all sounds (speech and noise) in the same manner. The directional 
microphone mode, amplifies sounds from in front more than sounds from other directions. 
(Berger, 1984). 
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Analog programmable hearing aids have a microchip that is programed for different 
listening environments. Program settings depend on the individual’s hearing-loss profile, 
understanding of speech, and range of tolerance for louder sounds (Walden & Walden, 
2004). Even with the improvement that analog programmable offer, 25.3% of analog hearing 
aid users reported that they have a hard time listening in presence of high background 
noise. Approximately 1% of the users reported difficulty in using the telephone. Examples of 
environments include quiet conversation in the home, noisy situations such as at a 
restaurant, or in large areas such as a theater. 
In 1996, the Digital signal processing (DSP) chip was introduced into digital programmable 
hearing aids (Phillips et al., 2007). These hearing aids use digitized sound-processing 
algorithms to convert sound waves into digital signals. Key benefits of these include 
improvement in programmability, greater precision in fitting, management of loudness 
discomfort, control of acoustic feedback, and noise reduction. A processor chip in the aid 
analyzes the signals to determine whether the sound is noise or speech. It then makes 
modifications to provide a clear, amplified, distortion-free signal (Clopton & Spelman, 
2000). 
Digital hearing aids are usually self-adjusting. The digital processing allows for more 
flexibility in programming the aid. Thus, the sound transmitted matches the patient’s 
specific hearing-loss pattern. This digital technology is more expensive than that of the 
conventional analog, but it offers many advantages: these generally have a longer life span 
and may provide better hearing in different listening situations. Some aids can store several 
programs, i.e., when the listening environment changes, it is possible to change the hearing 
aid settings. This is usually done by pushing a button on the hearing aid or by using a 
remote control to switch channels. The aid can be reprogrammed by the Audiologist if the 
user’s hearing or hearing needs change.  
Of all of the advances in hearing aid technology in the last several years, perhaps the 
greatest has been the performance of directional microphones. The use of DSP in hearing 
aids has opened the door to the many different types of algorithms used in directional 
microphones. Digital technology offers many options, including automatic, automatic 
adaptive, multiband automatic adaptive, and, most recently, asymmetric directionality 
(Kerckhoff, 2008). Each of these options possesses benefits, but some also have limitations 
and may not prove to be as beneficial to the patient as advertised by hearing aid 
manufacturers. 
Directional microphones were developed in an attempt to improve SNR performance. These 
microphones can employ different types of polar patterns, some of which have multiple 
nulls. The fixed directional microphone contains two sound ports and operates by 
acoustically delaying the signal entering the back microphone port and subtracting this from 
the signal entering the front port. This creates a null at an azimuth, corresponding to the 
location where the microphone is least sensitive, and which can be plotted graphically on a 
polar pattern (Chung, 2004). These patterns are predetermined; thus, the location of sound 
attenuation always remains the same. Therefore, if the interfering sound is located directly 
behind the patient, this design acts to attenuate the input level to the hearing aid at the 180° 
null. If, however, the offending sound arrives from behind but not directly at, 180°, the 
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Several studies have reported the effectiveness of fixed directional microphones in 
improving SNR for the hearing aid user by at least 5 dB, (Bilsen et al., 1993). Gravel, Fausel, 
and Liskow (Gravel et al., 1999) found that children listening with dual microphones 
achieved a mean improvement of 4.7 dB in SNR when compared with the omnidirectional 
condition. 
Automatic directional microphones were subsequently developed so that patients would 
not have to bother with manually changing the hearing aid program or setting to the 
directional microphone mode. Automatic directional microphones utilize an algorithm in 
which the microphones switch automatically between omnidirectional and directional. 
Input level, signal location, and SNR are factors that contribute to determining when the 
microphones switch (Preves & Banerjee, 2008).  
The automatic microphone feature works well for patients who do not want to be concerned 
with manual switching between omnidirectional and directional modes. However, 
automatic switching can be problematic for patients when the microphone switches but the 
patient does not prefer switching, or if the switching takes place too rapidly and amplifies 
unwanted sounds such as a cough or a dog barking (Preves & Banerjee, 2008). The other 
limitation with automatic directional microphones is that the null is fixed when in the 
hearing aid is in directional mode. Depending on the location of the noise source and the 
azimuth of the null in the microphone, there is the possibility that the noise source may not 
be maximally attenuated. 
Although directional microphones have been shown to be successful in the laboratory, there 
is no guarantee that this success will be achieved in real-life situations for all hearing aid 
users, due to the difficulty that some persons have in manipulating the hearing aid’s 
controls. 
There are four hearing aids styles or configurations. These include the following: the In-the-
canal (ITC) style; the In-the-ear (ITE) hearing instruments, which are very easy to operate 
even if the user has poor dexterity; the behind-the-ear (BTE) style, which is extremely 
flexible for all hearing loss types, and the Completely-in-the-canal (CIC) style, as depicted in 
Table 1 (Miller,2006). 
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Table 1. Styles of Hearing Aids 
There are many manufactures of hearing aids such as Viennatone™, Hansaton™, 
Bernafon™, Oticon™, Siemens™, Sonic™, Unitron™, and Phonak™. According to the Food 
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and Drug Administration (FDA), the manufacture and sale of hearing aids must meet the 
following requirements: 
1. Dispensers must obtain a written statement from the patient, signed by a licensed 
physician;  
2. A patient aged 18 years or older can sign a waiver for a medical examination, but 
dispensers must avoid encouraging the patient to waive the medical evaluation 
requirement; 
3. Dispensers must advise patients who appear to have a hearing problem to consult a 
physician promptly, and 
4. FDA regulations also require that an instruction brochure be provided with the hearing 
aid that illustrates and describes its operation, use, and care. 
The FDA Web site that provides standards for hearing aids is at 
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/Detail.CFM?STANDAR
D_IDENTIFICATION_ NO=14730 
Recent developments in the access to newer forms of wireless transmission and 
improvements in coupling this technology with hearing aids not only enhance patients’ 
abilities to use telephones or other external devices, but also allow improvement in SNR 
performance for better speech recognition through noise reduction algorithms. 
2.3.2 Cochlear implants 
A cochlear implant is a prosthetic inner-ear replacement that provides direct electrical 
stimulation to the inner ear’s auditory nerve, allowing for perception of the sensation of 
sound. These devices are used for patients with severe-to-profound hearing sensorineural 
loss who cannot be helped with hearing aids. These implants can benefit patients with bone-
conduction thresholds as poor as 65 dB HL. Because of this damage, sound cannot reach the 
auditory nerve. With a cochlear implant, the damaged hair cells are bypassed and the 
auditory nerve is electronically stimulated directly (Spitzer, 2010).  
Part of the cochlear implant is surgically implanted into the mastoid bone behind the target 
ear with a titanium screw (osseointegrated material), and a tiny electrode array is inserted 
into the cochlea at set intervals depending on the number of channels or number of 
frequency bands to excite (Medical Advisory Secretariat, 2002). The other part of the device 
is external and includes a microphone, a speech processor, and a transmitter coil.  
The signal from the microphone is sent to the speech processor, which comes in two 
designs. It may be either a BTE model Nucleus Freedom™, which looks like a hearing aid, 
or a Body-worn device (BWD) that it attached to the belt, for example, the Cordelle II 
(European Assistive Technology Information Network, 2010), manufactured by Cochlear 
Deutschland GmbH & Co. KG, as shown in Table 2.  
The microphone looks like a BTE hearing aid. It picks up sounds—just as a hearing aid 
microphone does—and sends these to the speech processor. The speech processor is a 
computer that analyzes and digitizes the sound signals and sends them to a transmitter 
worn on the head just behind the ear. The transmitter sends the coded signals to a receiver 
implanted immediately under the skin. The internal or implanted parts include a receiver 
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coded electrical signals from the transmitter and delivers them to the array of electrodes that 
have been surgically inserted into the cochlea. The electrodes stimulate the fibers of the 
auditory nerve and sound sensations are perceived. Figure 12 depicts a series of stages of 
the speech processor of a typical cochlear implant and the associated processing waveforms 
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Fig. 12. Block Diagram of a typical cochlear implant and processing waveforms  
2.4 Hearing Assistive Technology Systems 
Other devices are employed to assist individuals with hearing impairment who have not 
previously experienced benefit with hearing aids or cochlear implants alone. Hearing 
assistive technology systems (HATS) are devices that can help patients function better in 
their day-to-day listening and communication situations. HATS can be used with or without 
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hearing aids or cochlear implants to make hearing easier—and thereby reduce stress and 
fatigue. HATS must be directed toward resolving any one of the following situations: 
distance; noise, or reverberation that can create listening problems (Medical Services 
Advisory Committee, 2010). 
2.4.1 FM systems 
FM systems operate on special frequencies. A receiver worn around the neck transmits 
sound to the hearing aid. The sound comes from a transmitter microphone used by a 
speaker, although in many public places, the transmitter is built into the general sound 
system. 
Because of their flexibility, mobility, and sturdiness, these systems are among the most 
commonly used HATS. Studies have shown that FM systems have the best results when 
implementation is carried out early in the amplification-fitting or cochlear-implant process. 
Also, infrared wireless headset are available for television listening and interface. However, 
there are other systems, denominated sound-field systems, which assist listening for all of 
the children in the classroom. The teacher speaks into a microphone transmitter and his/her 
voice is projected through speakers mounted around the classroom. 
2.4.2 High-frequency hearing loss 
Newer devices, such as the BAHA™ system manufactured by Entific Medical (Medical 
Advisory Secretariat, 2002) have been developed for patients diagnosed with unilateral 
profound sensorineural hearing loss, also referred to as single-sided deafness. Other devices 
have been designed for patients exhibiting severe high-frequency transposition hearing loss 
and comprise self-learning features on hearing aids and cochlear implants that allow 
integrate of actual measurements. Finally, an infrared wireless headset is used with 
television for listening at a higher volume than others sitting in the same room. Bluetooth 
interface allows persons to hear telephone conversations more easily, amplifying any 
devices that employ this technology. 
3. Conclusion 
The present section provided a brief guide on equipment for diagnosis of deafness and 
hearing assistive technology. 
Although, audiology equipment for evoked potentials and otoacoustic emissions provides 
highly relevant information deriving from hearing damage, in future, new technological 
developments should be directed toward improving the hearing test. The research will 
continue to study algorithms for more accurate, physically realistic modeling of the cochlea, 
which should assist in the process of diagnosing local inner-ear problems. 
Audiometers, Tympanometers and other electronic equipment for hearing diagnosis must 
be designed taking into account specific data formats, communication protocols and 
interoperability standards, as such HL7 (Health Level Seven) to send data from audiology 
equipment to electronic medical record, then it is possible to share and use data for research 
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Potential areas for improving hearing aids and cochlear implants include frequency 
response by analyzing sound across several bands, enhancing the signal-to-noise ratio with 
adaptive filtering, installing additional detectors for monitoring the environment. 
Subsequently applying average algorithms to turn the acoustic signal into a frequency map 
and for the application of noise reduction while maintaining high gain in bands in which 
speech is detected., will improve speech understanding in noise. 
For patient with nerve deafness, one goal is to restore hearing with cochlear electrode 
implants in order to stimulate the nerve endings directly. However, despite electrode 
stimulation of nerves at the correct place along the cochlea, the perception of high frequency 
has not been achieved to date. 
Finally, the research on FM and infrared systems, Bluetooth adaptors, and other novel 
communication techniques and devices continues for helping patient to achieve greater 
comfort, higher satisfaction-of-fit and less fatigue, when he/she is exposed to a noisy 
environment  
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1. Introduction 
Hearing loss affects all demographics regardless of geographical location or age. In a similar 
fashion to how hearing loss can isolate post-lingualy deaf adults, hearing loss in the 
pediatric population has profound detrimental effects despite the richness of the deaf 
culture. A complete discussion of the adverse effects of hearing loss must include discussion 
of this important component of the deaf and hearing impaired population. The World 
Health Organization defines “disabling hearing impairment” in children under the age of 15 
years as an unaided hearing threshold level in the better ear of 31 dB HL or more using pure 
tone averages at 0.5, 1, 2 and 4 kHz. The prevalence of childhood hearing loss is 1.2 to 1.7 
cases per 1000 live births and the prevalence increases up to 6 years of age as a result of 
meningitis, delayed onset of genetic hearing loss, or delayed diagnosis (Kral & O'Donoghue, 
2010). In the majority of cases of childhood  hearing loss is congenital with a smaller 
proportion being progressive or acquired (A. Davis & Wood, 1992; A. Davis et al., 1997).The 
prevalence is greater still in developing countries because of lack of immunization, exposure 
to ototoxic drugs, and consanguinity (Kral & O'Donoghue, 2010). Profound hearing loss 
(hearing loss > 90 dB) has far-reaching, lifelong consequences in children (Kral & O'Donoghue, 
2010). Andrej et al. report that there can be a restriction in learning and literacy as a result of 
the lack of development of spoken language with its impact on daily communication (Kral & 
O'Donoghue, 2010; Marschark & Wauters, 2008). This in turn has been shown to substantially 
compromise educational achievement and employment opportunity later in life (Allen, 1986; 
A. Davis et al., 1997; Schroeder et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, 
Collins, & Rickards, 2004a). The detrimental effects of profound hearing loss in children are 
summarized in Table 1. Unless children are afforded opportunities to develop language, deaf 
children can fall behind their hearing peers in communication, cognition, literacy and 
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prevalence is greater still in developing countries because of lack of immunization, exposure 
to ototoxic drugs, and consanguinity (Kral & O'Donoghue, 2010). Profound hearing loss 
(hearing loss > 90 dB) has far-reaching, lifelong consequences in children (Kral & O'Donoghue, 
2010). Andrej et al. report that there can be a restriction in learning and literacy as a result of 
the lack of development of spoken language with its impact on daily communication (Kral & 
O'Donoghue, 2010; Marschark & Wauters, 2008). This in turn has been shown to substantially 
compromise educational achievement and employment opportunity later in life (Allen, 1986; 
A. Davis et al., 1997; Schroeder et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, 
Collins, & Rickards, 2004a). The detrimental effects of profound hearing loss in children are 
summarized in Table 1. Unless children are afforded opportunities to develop language, deaf 
children can fall behind their hearing peers in communication, cognition, literacy and 





Speech and language development 
Academic achievement 
Social-emotional development 
Childhood behavioral problems 
Comprised employment opportunities in later life 
Self-perceived health status 
*(Allen, 1986; A. Davis et al., 1997; Kral & O'Donoghue, 2010; Marschark & Wauters, 2008; Schroeder 
et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, Collins, & Rickards, 2004a) 
Table 1. Detrimental Effects of Profound Hearing Loss in Childhood* 
The widespread use of universal neonatal hearing screening has been established based on 
the growing body of evidence that early detection of hearing loss leads to early aural 
rehabilitation (Kennedy, McCann, Campbell, Kimm, & Thornton, 2005). Multiple studies 
have demonstrated the deleterious effect of bilateral hearing loss on speech and language 
development (Allen, 1986; A. Davis et al., 1997; Thompson et al., 2001; Wake, Hughes, 
Poulakis, Collins, & Rickards, 2004b). However if caught early, the effects of hearing loss are 
somewhat mitigated. Yoshinaga-Itano et al. reported on the ability of early detection of 
hearing loss to improve language development as measured by standardized testing 
(Yoshinaga-Itano, Sedey, Coulter, & Mehl, 1998; Yoshinaga-Itano, 2003). Children enrolled 
into language programs at earlier ages have improved vocabulary and verbal reasoning 
skills on standardized tests at 5 years of age (Moeller, 2000) Opponents to Universal 
screening cite the great cost of such widespread screening as well as efficacy in earlier years. 
From a pragmatic, fiduciary perspective, a cost-effectiveness study has shown that as a 
result of special education needs, failure to detect severe-to-profound hearing loss can cost 
the educational system  approximately $38 000 – 240 000 (USD) per child over their 
educational lifetime (Mohr et al., 2000). It would seem then that detecting these children 
would offset a significant amount of the cost. Furthermore, in areas that have adapted a 
Universal Newborn Hearing protocol, detection of congenital hearing loss has nearly 
doubled since its introduction (Choo & Meinzen-Derr, 2010). 
It is clear that the early detection of hearing loss has strong developmental, psychosocial and 
societal implications as well. Therefore, in 2007 the American Academy of Pediatrics’ Joint 
Committee on Infant hearing endorsed the early detection of hearing loss with an aim at 
early intervention to improve linguistic competence and literary development (Busa et al., 
2007). They recommended that all infants should be screened prior to 1 month of age. 
Children identified with hearing loss by screening should have a comprehensive 
audiological assessment by 3 months of age. After audiological assessment, children with 
confirmed hearing loss should receive appropriate intervention by dedicated hearing loss 
health care and education professionals not later than 6 months of age. Children with risk 
factors for hearing loss (a summary of commonly cited risk factors can be found in Table 2.) 
should be followed by on-going surveillance starting at 2 months of age. Unfortunately in 
many centers the “lost to follow up” rates approach 40% of infants who do not pass their 
infant screening (Choo & Meinzen-Derr, 2010). All centers must work diligently to ensure 
children who fail their hearing screen are referred appropriately to maximize their potential 
and mitigate the lifelong effects of hearing loss. The following sections will provide an 
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overview of existing neonatal hearing screening tests and use of the medial olivocochlear 
system as a potential new screening method. 
 
Craniofacial syndromes: Crouzon disease, Klippel-Feil syndrome, and Goldenhar 
syndrome 
Syndromes known to be associated with sensorineural hearing loss: Brancho-oto-renal 
syndrome, Pendred syndrome, Wardenburg syndrome, Treacher-Collins, Stickler 
syndrome, Usher syndrome 
Neurodegenerative disorders: Hunter syndrome, Friedrich’s ataxia, Charcot-Marie-
Tooth syndrome 
Trauma 
Extracorporeal membrane oxygenation   
Chemotherapy 
Consanguinity 
Family history of hearing loss 
Neonatal hyperbilirubinemia 
Neonatal intensive care unit admission for > 5 days 
Infection and neonatal sepsis: CMV, measles, mumps, rubella, H influenzae type b, and 
childhood meningitis, toxoplasmosis, herpes, syphilis, bacterial meningitis 
Genetic mutations 
*(Busa et al., 2007; Manchaiah, Zhao, Danesh, & Duprey, 2011) 
Table 2. Risk factors for childhood hearing loss* 
2. Existing neonatal hearing tests 
The difficulty of testing young individuals using subjective methods has lead to the 
development of hearing testing based on objective methods such as otoacoustic emissions 
and auditory brainstem response testing (James, 2011; Thompson et al., 2001). 
2.1 Auditory evoked potentials 
Measurement of auditory evoked potentials (AEP) has been possible since the 1960s. AEPs 
represent electrical activity occurring along the length of the auditory pathway. They are 
typically described by their latency from the onset of the auditory stimulus: early (0 to 15 
milliseconds), middle (15 to 100 milliseconds) and late (100 to 500 milliseconds). Auditory 
brainstem responses (ABR) appear to be the most clinically useful early latency AEPs for 
detecting hearing loss in newborns and infants ( Hecox 1974). Hecox et al. first speculated on 
the use of Auditory Brainstem Responses (ABR) as an objective method of assessing infant 
hearing in 1974 (Hecox & Galambos, 1974). Measurement of ABR makes use of the 
summation of action potentials from the cochlear nerve to the inferior colliculus of the 
midbrain in response to a click stimulus applied to the test ear. Since that time the use of 
ABR has become a widely accepted method to assess auditory function and hearing 






Speech and language development 
Academic achievement 
Social-emotional development 
Childhood behavioral problems 
Comprised employment opportunities in later life 
Self-perceived health status 
*(Allen, 1986; A. Davis et al., 1997; Kral & O'Donoghue, 2010; Marschark & Wauters, 2008; Schroeder 
et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, Collins, & Rickards, 2004a) 
Table 1. Detrimental Effects of Profound Hearing Loss in Childhood* 
The widespread use of universal neonatal hearing screening has been established based on 
the growing body of evidence that early detection of hearing loss leads to early aural 
rehabilitation (Kennedy, McCann, Campbell, Kimm, & Thornton, 2005). Multiple studies 
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overview of existing neonatal hearing screening tests and use of the medial olivocochlear 
system as a potential new screening method. 
 
Craniofacial syndromes: Crouzon disease, Klippel-Feil syndrome, and Goldenhar 
syndrome 
Syndromes known to be associated with sensorineural hearing loss: Brancho-oto-renal 
syndrome, Pendred syndrome, Wardenburg syndrome, Treacher-Collins, Stickler 
syndrome, Usher syndrome 
Neurodegenerative disorders: Hunter syndrome, Friedrich’s ataxia, Charcot-Marie-
Tooth syndrome 
Trauma 
Extracorporeal membrane oxygenation   
Chemotherapy 
Consanguinity 
Family history of hearing loss 
Neonatal hyperbilirubinemia 
Neonatal intensive care unit admission for > 5 days 
Infection and neonatal sepsis: CMV, measles, mumps, rubella, H influenzae type b, and 
childhood meningitis, toxoplasmosis, herpes, syphilis, bacterial meningitis 
Genetic mutations 
*(Busa et al., 2007; Manchaiah, Zhao, Danesh, & Duprey, 2011) 
Table 2. Risk factors for childhood hearing loss* 
2. Existing neonatal hearing tests 
The difficulty of testing young individuals using subjective methods has lead to the 
development of hearing testing based on objective methods such as otoacoustic emissions 
and auditory brainstem response testing (James, 2011; Thompson et al., 2001). 
2.1 Auditory evoked potentials 
Measurement of auditory evoked potentials (AEP) has been possible since the 1960s. AEPs 
represent electrical activity occurring along the length of the auditory pathway. They are 
typically described by their latency from the onset of the auditory stimulus: early (0 to 15 
milliseconds), middle (15 to 100 milliseconds) and late (100 to 500 milliseconds). Auditory 
brainstem responses (ABR) appear to be the most clinically useful early latency AEPs for 
detecting hearing loss in newborns and infants ( Hecox 1974). Hecox et al. first speculated on 
the use of Auditory Brainstem Responses (ABR) as an objective method of assessing infant 
hearing in 1974 (Hecox & Galambos, 1974). Measurement of ABR makes use of the 
summation of action potentials from the cochlear nerve to the inferior colliculus of the 
midbrain in response to a click stimulus applied to the test ear. Since that time the use of 
ABR has become a widely accepted method to assess auditory function and hearing 






Screening ABR utilizes a click or tone pip stimulus presented via a headphone or a 
transducer inserted into the subject’s ear. Click stimuli are commonly used and make use of 
a broad range of frequencies (1 – 6 kHz) but do not provide information about hearing in 
lower frequencies (Jacobson & Jacobson, 2004) . If necessary, tone pips can be used to 
acquire frequency specific information (Jacobson & Jacobson, 2004). The subject is prepared 
with three surface electrodes placed on the forehead and both mastoids or earlobes. The 
electrodes detect click or tone pip-induced action potentials that are generated in the 
cochlea. The signal is transmitted from along the cochlear nerve from the cochlear nucleus to 
the inferior colliculus. The amplitude of the action potential is measured in microvolts and 
averaged. The averaged potential is then plotted against time to create a waveform with 
characteristic peaks labeled I-VII (Table 4).  Only waves I and II correspond to true action 
potentials. Waves III-VII are thought to represent post-synaptic activity in the major 
brainstem auditory centres. Given the necessity of electrode placement and duration of 
approximately 15 minutes, sedation is often required (Kral & O'Donoghue, 2010). The 
morphology and latency of the wave form is compared to a normal wave form and a pass or 
fail result is generated. The sensitivity of ABR is generally quoted as 84-100% and the 
specificity is 99.7% (A. Davis et al., 1997; Hall, Smith, & Popelka, 2004; Llanes & Chiong, 2004).  
2.2 Otoacoustic emissions 
Initially hypothesized in 1948 by the theoretical physicist Thomas Gold and later confirmed 
by Kemp in 1978, Otoacoustic emissions (OAE) now provide an important non-invasive 
method of auditory testing (Gold, 1948; Kemp, 1978b). OAEs are acoustic signals generated 
by the activity of the outer hair cells of the cochlea that occur during normal hearing. 
Control of outer hair cell activity is intimately linked with the olivocochlear pathway and 
will be discussed further in later sections. In brief, the mechanical energy generated by the 
outer hair cells propagates backward to the tympanic membrane. Movements of the 
tympanic membrane in turn produce acoustic signals that can be detected by an extremely 
sensitive microphone placed in the external ear canal. The presence of OAEs demonstrates 
the presence of functional outer hair cells suggesting the presence of a cochlea which forms 
the basis of this screening method. Testing of OAEs is simple and efficient requiring 
approximately 10 minutes. Sensitivity and specificity of OAE testing for hearing impairment 
ranges from 76.9-98% and 90% respectively (A. Davis et al., 1997; Llanes & Chiong, 2004; 
Thompson et al., 2001). 
Different types of OAE can be detected but only some are useful in hearing testing (Saurini, 
Nola, & Lendvai, 2004). Spontaneous OAEs are obtained without any acoustic simulation. 
They are narrow band signals present in 40-70% of normal ears. Evoked OAEs are 
stimulated by acoustic signals and comprise a range of subtypes. Sustained frequency OAEs 
are obtained by continuous acoustic stimuli and are found in approximately 94% of people. 
Their measurement is typically complex and is not used very often. Transient OAEs are 
stimulated by clicks or tone bursts. Distortion Product OAEs (DPOAE)  are produced in 
response to the simultaneous presentation of two stimuli and can be found in up to 98% of 
normal hearing individuals. As suggested by the name, stimuli for DPOAE consist of the 
combination of two stimuli that vary by frequency (f1 and f2) and intensity (L1 and L2). 
Varying the relationship of f1 and f2 and L1 and L2 determine the frequency response. 
Achieving an optimal response is usually obtained by setting L1 equal or greater than L2 e.g. 
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65 and 55 dBL SPL respectively are commonly used. Responses are usually the most robust 
when recorded at the frequency 2f1-f2.  Transient OAE testing applies a brief click to the test 
ear to elicit the hair cell response. As such, Transient OAE measurement lacks frequency 
specificity (Jacobson & Jacobson, 2004). Conversely, stimulus tones used in DPOAE testing 
combine frequency stimuli in a predictable way that can measure specific regions of the 
cochlea allowing frequency specific testing (Jacobson & Jacobson, 2004). While OAEs have 
been widely adapted for newborn hearing screening programs, they are still only surrogate 
markers for hearing. Their presence indicates normal function of the outer hair cell, middle 
ear and ear canal. As such, conditions such as auditory neuropathy, cochlear nerve 
hypoplasia or inner hair cell anomalies can be missed and may lead to delay in diagnosis 
and initiation of aural rehabilitation. 
 
 Advantage Disadvantage 
Otoacoustic 
Emissions 
Simple administration – 
minimal training required 
Only asses outer hair cell function 
Cost-effective Debris or fluid in the external ear 
may affect results 
Results are immediately 
available 
Failure rates are high during first 
24 hours after birth 
Average screening time is less 
than ABR 
No use in fluid filled middle ear 
 Requires quiet environment 
 Sensitivity – may fail to detect 
infants with very mild hearing 






Assess greater extent of 
auditory system 
Requires more operator 
knowledge than ABR 
Requires no interpretation by 
the screener 
ABR may be susceptible to 
electrical interference 
ABR results are less affected by 
middle ear or external ear 
debris than OAEs 
Sensitivity – may fail to detect 
Infants with very mild hearing 
loss 
Results are immediately 
available 
Requires long period of time 
May detect neural or central 
auditory pathologies 
Cost 
 May take longer in noisy 
environment 
 Patient must be sleeping 
 Potential for electrical and noise 
artifact 
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response to the simultaneous presentation of two stimuli and can be found in up to 98% of 
normal hearing individuals. As suggested by the name, stimuli for DPOAE consist of the 
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65 and 55 dBL SPL respectively are commonly used. Responses are usually the most robust 
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Wave I Action potential arising from afferent activity of cochlear nerve 
entering internal auditory canal 
Wave II Action potential arising from proximal cochlear nerve entering 
brainstem 
 
Wave III Arise from second order neurons beyond the cochlear nerve in the 
cochlear nucleus 
 
Wave IV Arise from third order neurons located in the superior olivary complex 
 
Wave V Multiple anatomic origins postulated in the vicinity of the inferior 
colliculus 
 
Wave VI Arise from medial geniculate body 
 
Wave VII Arise from medial geniculate body 
 
Table 4. Characteristic auditory brainstem response waves 
3. Auditory neuropathy spectrum disorder (ANSD) 
One disorder that continuously eludes the new born hearing screen is ANSD. ANSD 
represents a range of hearing disorders of variable severity which present with pure tone 
hearing thresholds that may be low or approach normal, but underestimate the subject’s 
perception of hearing difficulty. Included within the spectrum are inner hair cell anomalies, 
neuropathy of the auditory nerve, disruption of the olivocochlear response (OCR), and 
brainstem dysfunction that can be secondary to kernicterus (Amatuzzi et al., 2001; Berlin et 
al., 2005; Harrison, 1998; Hood & Berlin, 2001; Shapiro, 2003; Starr, Picton, Sininger, Hood, & 
Berlin, 1996; Yasunaga et al., 1999).The unifying feature of ANSD diseases are a 
characteristic finding of abnormal ABR waveforms in the presence of normal OAE and/or 
cochlear microphonic (CM). Middle ear muscle reflexes and the olivocochlear reponse are 
also absent. These findings are suggestive of persistent outer hair cell activity but lack of a 
normal afferent auditory pathway and as such would be missed by currently employed 
screening methods (Manchaiah et al., 2011). Accurate diagnosis is hampered by the lack of a 
simple commercially available test for OCR function but typically the diagnosis can be 
assumed from OAE and ABR results alone. 
Etiologies of ANSD that have been identified include polyneuropathy (especially in adults), 
perinatal anoxia and hypoxia, and hyperbilirubinaemia, congenital brain anomalies, 
ototoxic drug exposure, and genetic factors. An estimated 40% of cases have an underlying 
genetic basis, which can be inherited in both syndromic and non-syndromic conditions 
(Harrison, 2001; Manchaiah et al., 2011; Nadol Jr, 2001; Starr et al., 1996).  
Treatment options in ANSD include auditory verbal therapy, cued speech, hearing aids and 
cochlear implantation (Cone-Wesson, Rance, & Sininger, 2001; Rance & Barker, 2008a; Hood 
& Berlin, 2001). Prognostication and predicting treatment outcome is difficult and varies 
depending on origin. Some forms of neonatal ANSD can show significant spontaneous 
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improvement (Attias & Raveh, 2007; Rance & Barker, 2008b). As such determination of 
patient who will benefit from hearing aids or cochlear implantation is difficult (Raveh, 
Buller, Badrana, & Attias, 2007). The development of improved testing techniques that can 
be used to diagnose, characterize, and differentiate between the numerous diseases that 
make up this spectrum may allow patients to be treated earlier. 
4. The olivocochlear pathway  
4.1 Neuroanatomy and physiology 
Cochlear function including the sensitivity and frequency tuning of the peripheral auditory 
system is influenced by incoming acoustic stimuli but also higher cochlear function. The 
olivocochlear pathway is a neural pathway which innervates cochlear outer hair cells 
(OHC), linking the superior olivary complex to the cochlea. Further insights into this 
pathway may improve our ability to screen for various forms of hearing loss such as ANSD. 
The olivocochlear neural pathway is comprised of efferent neurons that travel from the 
superior olivary complex in the brainstem to cochlear hair cells. First described in 1946, 
Rasmussen (Rasmussen, 1946) traced the neural fibres from the floor of the fourth ventricle, 
along the inferior and superior vestibular nerves, then into the cochlear nerve in the bundle 
of Oort (the vestibulocochlear anastomosis). Later he confirmed passage of the pathway into 
the cochlea and named it the olivocochlear bundle (Rasmussen, 1953). This neural pathway, 
the olivocochlear efferent pathway, is now thought to play an important role in the 
olivocochlear reflex. There appear to be two forms of olivocochlear efferent fibres, medial 
olivocochlear (MOC) and lateral olivocochlear (LOC) efferents. The majority are the thin, 
unmyelinated fibres of the LOC system arising from the lateral superior olive and travel via 
the vestibular nerve to the cochlea where they innervate the auditory nerve supplying the 
inner hair cells (Kimura & Wersäll, 1962; Warr, 1975).  While the LOC system received 
contributions from both sides of the brainstem, the majority of fibres innervate the ipsilateral 
cochlea (Guinan Jr, 2006). Thick, myelinated neurons of the MOC pathway originate in the 
medial part of the superior olivary complex. A portion of fibres cross the midline to the 
contralateral cochlea while others project to the ipsilateral cochlea both via the vestibular 
nerves (Guinan Jr, 2006). Within the cochlea the MOC fibres innervate the outer hair cells; 
this is referred to as the medial olivocochlear system (MOCS). The MOCS is innervated by 
ascending and descending neural pathways. Descending innervations arises from the 
inferior colliculus and auditory cortex (Mulders & Robertson, 2000a; Mulders & Robertson, 
2000b).  
Ascending innervation arises predominantly from the contralateral cochlea, by way of inter-
neurons which cross the brainstem from cochlear nucleus to the olivary complex (Brown, 
Venecia, & Guinan, 2003; Morest, 1973; Ye, Machado, & Kim, 2000). The majority of MOCS 
fibres cross back over the midline to innervate the cochlea from which innervation is 
received (Azeredo et al., 1999; M. Liberman & Brown, 1986). A smaller proportion of MOCS 
fibers do not travel back across the brainstem and therefore innervate the cochlea on the 
same side. As they are stimulated by signals from the contralateral ear they provide a 
mechanism by which stimulation of one ear can influence the detection of acoustic signals 





Wave I Action potential arising from afferent activity of cochlear nerve 
entering internal auditory canal 
Wave II Action potential arising from proximal cochlear nerve entering 
brainstem 
 
Wave III Arise from second order neurons beyond the cochlear nerve in the 
cochlear nucleus 
 
Wave IV Arise from third order neurons located in the superior olivary complex 
 
Wave V Multiple anatomic origins postulated in the vicinity of the inferior 
colliculus 
 
Wave VI Arise from medial geniculate body 
 
Wave VII Arise from medial geniculate body 
 
Table 4. Characteristic auditory brainstem response waves 
3. Auditory neuropathy spectrum disorder (ANSD) 
One disorder that continuously eludes the new born hearing screen is ANSD. ANSD 
represents a range of hearing disorders of variable severity which present with pure tone 
hearing thresholds that may be low or approach normal, but underestimate the subject’s 
perception of hearing difficulty. Included within the spectrum are inner hair cell anomalies, 
neuropathy of the auditory nerve, disruption of the olivocochlear response (OCR), and 
brainstem dysfunction that can be secondary to kernicterus (Amatuzzi et al., 2001; Berlin et 
al., 2005; Harrison, 1998; Hood & Berlin, 2001; Shapiro, 2003; Starr, Picton, Sininger, Hood, & 
Berlin, 1996; Yasunaga et al., 1999).The unifying feature of ANSD diseases are a 
characteristic finding of abnormal ABR waveforms in the presence of normal OAE and/or 
cochlear microphonic (CM). Middle ear muscle reflexes and the olivocochlear reponse are 
also absent. These findings are suggestive of persistent outer hair cell activity but lack of a 
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along the inferior and superior vestibular nerves, then into the cochlear nerve in the bundle 
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4.2 Physiology of the olivocochlear pathway 
Despite decades of investigation since the discovery of the olivocochlear pathway, 
understanding of its purpose remains somewhat speculative (Rasmussen, 1946). Proposed 
roles include protection against noise-induced hearing loss, enhancement of discrimination 
of sound in noise, or a role predominantly during development of the auditory pathway 
(Micheyl, Khalfa, Perrot, & Collet, 1997; Rajan & Johnstone, 1988; Walsh, McGee, McFadden, 
& Liberman, 1998).  
There are a few studies of inter-cochlear interaction in humans which are consistent with 
MOCS functioning to reduce sensitivity of the cochlea to auditory stimuli. For example, 
contralateral pure tone stimulation causes a reduction of compound action potentials 
(Folsom & Owsley, 1987). Contralateral narrow band noise causes a ‘negativation’ of the 
summating potential response to ipsilateral tone bursts (i.e. the negative amplitude of 
summating potential increases) (Innitzer & Ehrenberger, 1977). There are indications that 
cortical function (e.g. visual or auditory attention tasks) influences olivocochlear activity via 
descending neural pathways (Froehlich, Collet, & Morgon, 1993; Maison, Durrant, 
Gallineau, Micheyl, & Collet, 2001). 
Much more information on olivocochlear function has come from electrophysiological 
studies in animal models. Various investigations have supported the conclusion that MOCS 
activity turns down the gain of the cochlear amplifier (Siegel & Kim, 1982). The cochlear 
amplifier is an active process within the cochlea in which motor activity of OHCs increases 
sensitivity of the cochlea, by amplification of the basilar membrane motion induced by 
acoustic energy. With electrical stimulation of the olivocochlear bundle (OCB) in the floor of 
4th ventricle, the amplitude of the compound action potential of the auditory nerve induced 
by auditory stimuli is reduced (Galambos, 1956; Nieder & Nieder, 1970; Wiederhold & 
Peake, 1966). In this way, the threshold of the auditory nerve can be increased by as much as 
25dB  an effect referred to as the ‘level shift’ (Galambos, 1956). By using focal simulation 
near the cell bodies of olivocochlear fibers, it has been shown that MOCS mediates this effect 
(i.e., via action on OHCs), rather than LOCS (Gifford & Guinan Jr, 1987). Electrical 
stimulation of the OCB increases the cochlear microphonic and causes a decrease in the 
electrical impedance of scala media of the guinea pig (Mountain, Daniel Geisler, & 
Hubbard, 1980). These changes are considered to be due to hyperpolarization of outer hair 
cells (Art, Fettiplace, & Fuchs, 1984; Mountain et al., 1980). Thus electrical stimulation of 
MOCS suppresses OHC activity so dampening basilar membrane motion and reducing 
cochlear amplification. This has an indirect effect on IHC activity, as demonstrated by the 
level shift. 
Contralateral acoustic stimulation (CAS) has been found to elicit similar effects to electrical 
stimulation of the MOCS. This was first reported by Fex, who found that CAS increased the 
cochlear microphonic (Fex, 1962). Recording from the round window in cats, Liberman 
showed that the compound action potential generated by ipsilateral tone pips was 
suppressed by contralateral noise or tones. Sectioning of the olivocochlear bundle in the 
floor of 4th ventricle or in the inferior vestibular nerve abolished this contralateral 
suppression effect (M. C. Liberman, 1989; Warren III & Liberman, 1989b). Such studies 
clearly show that the MOCS is stimulated by ascending signals from the auditory 
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Descending neural pathways also contribute to the MOCS. This has been shown in humans 
by increased MOCS activity when attention is focused on acoustic signals (Maison, Micheyl, 
& Collet, 2001). Animal studies have shown that electrical stimulation of the inferior 
colliculus increases MOCS activity (Mulders & Robertson, 2000a; Scates, Woods, & Azeredo, 
1999). Axonal transport studies also suggest that MOCS neurons are innervated directly by 
neurons arising in the auditory cortex (Mulders & Robertson, 2000b). Though giving insight 
into olivocochlear activity electrophysiological studies have many limitations (Collet et al., 
1990). Sectioning experiments, especially at the level of the floor of 4th ventricle, are 
imprecise and are not fully selective for efferents (though their effectiveness has been 
carefully demonstrated (M. C. Liberman, 1989; Warren III & Liberman, 1989b)). Electrical 
stimuli provide global stimulation, and in the floor of the 4th ventricle may simulate both 
crossed and uncrossed medial efferents that loop close to the midline (however, the LOCS is 
probably less easily stimulated this way as its fibers are unmyelinated). The main 
disadvantage with electrical stimulation is that it does not necessarily reflect normal 
cochlear input/output activity. Stimulation is often at supraphysiological levels, and 
provides unnatural synchronization and frequency of stimulation. Results can be 
confounded by stimulation artifact. Also neither sectioning nor electrical stimulation can be 
applied to humans, which limits extrapolation of findings from the animal models. The 
opportunity to study the MOCS non-invasively in animal models and humans was 
facilitated by the discovery of otoacoustic emissions (OAEs) (Kemp, 1978a). 
The function of the LOCS is not well understood. Some groups have proposed a role in 
providing “binaural balance” for sound localization has been proposed (Darrow, Maison, & 
Liberman, 2006; Guinan Jr, 2006). Studies to confirm this hypothesis are still needed. 
5. New technology 
5.1 Frequency specificity in the Medial Olivocochlear System (MOCS) 
It is now well established that the sensitivity and frequency tuning of the peripheral 
auditory system is influenced by the cochlear efferent neural pathways (Guinan Jr, 2006). 
Activation of the MOCS by acoustic stimulation of the contralateral ear has been shown to 
suppress sensitivity of the cochlea, for example by reduction in cochlear nerve action 
potential amplitude (Fex, 1962). It is considered that this effect is mediated by suppression 
of the cochlear amplifier effect of OHC activity (Siegel & Kim, 1982). It is likely that 
relatively specific stimulus conditions are required for efferents to play a role in hearing 
(M. C. Liberman, 1988), but despite intensive investigation, the nature of this role remains 
unclear. Further assessment of how the MOCS is activated by different stimuli should 
improve understanding of this issue (Maison, Micheyl, Andéol, Gallégo, & Collet, 2000).  
Tonotopicity of the MOCS has been clearly demonstrated in recordings from single 
olivocochlear fibers in the cat and guinea pig (Brown, 1989; Cody & Johnstone, 1982; M. 
Liberman & Brown, 1986). In these studies, efferent neural tuning curves were derived by 
measuring firing rate in response to contralateral tones of different frequency, and were 
found to have a shape and sharpness similar to cochlear afferent tuning curves. In 
addition, horseradish peroxidase injection was used to reveal the projection of some 
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neurons have a characteristic frequency (CF) similar to that measured in the cochlear 
efferent.  
Frequency specificity of MOCS activity can also be detected when recording the response of 
inner hair cells and auditory nerve fibers to acoustic stimulation. For example in cats, the 
response of single cochlear afferent fibers to tone pips is suppressed by simultaneously 
applying tone pips to the contralateral ear. This suppression is maximal when the 
contralateral tone is similar to the characteristic frequency of the afferent fiber (Murata, 
Tanahashi, Horikawa, & Funai, 1980; Warren III & Liberman, 1989a; Warren III & Liberman, 
1989b). Similarly, when recording the compound action potential induced by tone pips with 
a round window electrode, maximum suppression is induced by contralateral tone pips of 
similar frequency (M. C. Liberman, 1989).  
As OAEs are generated by OHC activity, they may provide a more direct and non-invasive 
insight into the effect of the MOCS on its target cells than neural recordings. In human 
subjects, suppression of spontaneous OAEs is maximal with a CAS tone at a frequency close 
to the spontaneous OAE  (Mott, Norton, Neely, & Bruce Warr, 1989). In addition to 
suppression, a frequency shift of spontaneous OAEs is caused by CAS and interestingly this 
is maximal with a CAS about 3/8 to 1/2 octaves below the spontaneous OAE frequency. 
OAEs evoked by tone pips can be suppressed by contralateral narrow band noise, 
suppression being maximal with CAS frequencies close to the frequency of the tone pip 
(Veuillet, Collet, & Duclaux, 1991).  
Contralateral suppression of OAEs has not been widely used to investigate MOCS 
frequency specificity in animal models. A systematic study in the barn owl produced 
frequency response functions in which DPOAE suppression was plotted as a function of 
CAS frequency (Manley, Taschenberger, & Oeckinghaus, 1999). This showed maximal 
suppression with CAS similar to primary frequencies. Extrapolation of these findings to 
other models is limited by the variability of DPOAE levels and the additional types of 
efferent fiber which are present in birds.  
The purpose of the present study was to investigate the frequency specificity of the MOCS 
in the chinchilla. In this species there has been a report of difficulty in detecting MOCS 
change in response to contralateral stimulation (Azeredo et al., 1999). On the other hand, 
electrical stimulation of the olivocochlear bundle in the floor of the fourth ventricle elicits 
OAE suppression (Siegel & Kim, 1982). In our present study, the suppressive effect on 
DPOAEs of contralateral pure tone stimuli is investigated with real-time recording of the 
DPOAE.  
5.1.1 Materials and methods 
5.1.1.1 Animals  
Ten anaesthetized adult chinchillas (Chinchilla laniger) weights 505 - 725 g were studied. 
The anesthetic regime was intra-peritoneal Ketamine 15mg/kg (Ketamine Hydrochloride 
U.S.P. 100mg/ml, Ayerst Laboratories, Ontario), Xylazine 2.5mg/kg (Xylazine 20mg/ml, 
Bayer Inc., Toronto), and Atropine 0.04mg/kg (Atropine Sulfate 0.5mg/ml, MTC 
Pharmaceuticals, Ontario). Recordings were started 15 minutes after induction of anesthesia. 
A second dose of anesthetic was given 45 minutes later (intra-peritoneal Ketamine 8mg/kg, 
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Xylazine 1.3mg/kg). Five animals were studied twice, typically with an interval of >4 weeks 
between recording sessions. Thus in total, 15 recording sessions were completed. All studies 
were approved by the local Animal Care Committee, following the guidelines of the 
Canadian Council on Animal Care. 
5.1.1.2 Real time DPOAE measurement  
DPOAEs were measured in real time with a Vivo 600 DPR device (Vivosonic Inc., Toronto, 
ON). In contrast to conventional OAE techniques which employ signal averaging to extract 
the signal from noise, this technique uses digital filtering and signal modeling. The 
continuous real-time signal is ideally suited to the detection of changes in OAE amplitude, 
such as those produced by contralateral stimuli (James et al., 2005). Primary frequencies 
were set at f2/f1= 1.22 for values of f2 between 1.6 and 8.0 kHz, with intensities of L1 = 70dB 
and L2 = 65dB. DPOAEs were measured at 2f1-f2. The OAE probe, in a conforming soft 
plastic cuff, was inserted into the external auditory meatus by straightening the soft tissues 
to allow the probe to abut the lateral aspect of the bony meatus (approximately 13mm from 
the tympanic membrane). Multiple recordings of up to three minutes duration were made in 
each session. All recordings were made in a sound-attenuating booth. The DPOAE probe 
was calibrated in the ear canal by the device and calibration confirmed in a 2ml coupler 
using an SR760 FFT Spectrum Analyzer (Stanford Research Systems, Sunnyvale, CA) and a 
precision CR: 511D Acoustic Calibrator (Cirrus Research plc, North Yorkshire, U.K.).  
5.1.1.3 Contralateral stimulus  
An intermittent pure tone stimulus was applied to the contralateral ear using an ER-2 
transducer with a foam ear-insert (Etymotic Research Inc., IL). 60 different CAS frequencies 
were tested between 0.6 – 17 kHz. Sweep direction from high to low, or low to high 
frequency of contralateral stimulation was changed between sweeps to control for any 
gradual drift in DPOAE level that might occur during a recording period. CAS intensity was 
set at 50 dB SPL as a previous study had shown the threshold for a response to be around 
30dB SPL while acoustic cross talk occurred at intensities of ≥70 dB SPL (using noise floor 
measures and recordings in cadaveric chinchilla). Stimulus duration was set at 0.5s with rise 
/ fall times of 4 ms. The interval between stimuli was long enough to allow DPOAE levels to 
return to pre-stimulus levels (typically > 300ms longer than CAS duration).  
5.1.1.4 Analysis of results  
DPOAE signals were recorded in real time, and level changes occurring in synchrony with 
contralateral stimulation were noted. Subsequent analysis was performed on the recorded 
real time trace and on averaged data, using VivoAnalysis software (Vivosonic Inc., ON), 
based on LabVIEW 5.1 data acquisition software (National Instruments, TX). Averaging was 
synchronized with the start of the CAS and was used to smooth the data and remove non-
synchronous or spontaneous variation in the DPOAE signal. Averaged data were used to 
measure the magnitude of the DPOAE response to CAS from the baseline (no contralateral 
stimulation condition) to maximum OAE change (i.e. at asymptotic level). Frequency 
response curves to indicate tuning of contralateral suppression were plotted with 
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5.1.2 Results  
DPOAEs were successfully recorded in real time in all animals. DPOAE levels were stable 
for the duration of the experiments, though they tended to fall gradually around 2 – 4 
dB/hr. Figures 1 through 5 demonstrate DPOAE suppression data progressing from the 
initial real time signal, to the averaged waveform, and finally ideal curve fitting to the 
contralateral frequency response function.  
 
Fig. 1. Typical example of contralateral suppression of real time DPOAE signals in 
chinchilla: (a) DPOAE at f2 = 4.4 kHz, contralateral acoustic stimulation = 5.9 kHz at 50dB 
SPL; (b) DPOAE at f2 = 7.7 kHz, contralateral acoustic stimulation = 8.4 kHz at 50 dB SPL. 
(Stimulus duration = 550ms, marked by horizontal black bar).  
Figure 1 shows examples of real time recordings of DPOAE suppression. Panel 1a shows 
variation in DPOAE level at f2 = 4.4 kHz over a twelve second period during six periods of 
CAS at 5.9 kHz (marked by horizontal bar). Suppression of 0.5 dB from the baseline level of 
38.8 dB SPL occurs with each CAS. In panel 1b, a DPOAE at f2 = 7.7 kHz is suppressed by 1.2 
dB by CAS of 8.4 kHz. The suppression response was sometimes smaller than the 
spontaneous signal variation so was not always readily visible in real-time. However, by 
averaging the raw real-time data in synchrony with the onset of CAS, suppression could 
usually be detected.  
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Typical examples of averaged DPOAE suppression responses are shown in figure 2. Here 
the DPOAE measured is at f2 = 4.4 kHz, with contralateral suppression stimuli between 2.8 
and 6.7 kHz. In this series, suppression is greatest (0.8 dB) with contralateral stimulations at 
4.5 kHz, but is only half this value when contralateral stimulation is at 2.8 kHz or 6.7 kHz, 
indicating the frequency dependence of DPOAE suppression.  
 
Fig. 2. Averaged DPOAE signal from 20s recording periods, synchronized with onset of 
contralateral stimulus. (DPOAE at f2 = 4.4 kHz; contralateral acoustic stimulation at 
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Fig. 3. DPOAE suppression plotted against contralateral stimulation frequency. Panels a – f 
show suppression response measured from single animal recordings at DPOAE frequencies 
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Fig. 4. Contralateral suppression frequency response curve for DPOAE of f2 = 4.4 kHz 
(marked by vertical dotted line), derived from pooling data from 8 animals. Bars show 95% 
confidence intervals.  
The frequency response function for f2 = 4.4 kHz in figure 4 was derived from 22 recordings 
in eight animals. Mean suppression was plotted against CAS frequency. The large 95% 
confidence intervals reflect the variability of response in different experiments. However, as 
in figure 3, the curve peaks near the f2 frequency (dotted line).  
In figure 3, magnitude of contralateral suppression is plotted against CAS frequency for six 
different DPOAE frequencies. The curves peak close to the f2 value (marked by the dotted 
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(marked by vertical dotted line), derived from pooling data from 8 animals. Bars show 95% 
confidence intervals.  
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in figure 3, the curve peaks near the f2 frequency (dotted line).  
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In an attempt to reduce the variability of the response between recordings and to obtain 
finer details on the shape of the frequency response, repeated measures from CAS close to f2 
were made in successive recordings in one chinchilla. The results are shown in figure 5. 
Even within this single recording period in an individual animal, variability (up to 0.15dB) 
can be seen in successive sweeps. No repeatable notches in the curve were visible.  
As illustrated in figure 5 by the continuous line, the general shape of the DPOAE 
suppression tuning can be characterized by fitting a regression curve to the data. In figure 6, 
the same regression function is plotted for four values of f2 between 3.1 – 7.7 kHz using data 
combined from multiple recordings. The responses are asymmetric with a tendency to drop 
off more steeply at values of CAS greater than f2. Small suppression responses can be 
obtained by CAS tones more than one octave lower than the f2 frequency.  
 
Fig. 5. Contralateral suppression frequency response curve for DPOAE of f2 = 4.4 kHz 
derived from one subject. Dashed line is mean value. Solid line is regression curve 
(Weibull). 
In figure 7, the suppression curves of fig. 6 are plotted on a normalized amplitude scale. The 
curves are broadly tuned and thus there is considerable overlap. The tuning of suppression 
curves for high frequency DPOAEs is narrower than at lower frequencies. The (half-
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amplitude) bandwidth values for suppression curves at 3.1, 4.4, 5.4, 6.6, and 7.7 kHz (f2) are, 
respectively, 1.7, 1.8, 1.4, 1.15, and 1.3 octaves.  
DPOAE suppression was seen in all animals with contralateral pure tone stimulation. On 
rare occasions, CAS induced an increase in DPOAE level. This occurred at f2 = 2.2 kHz in 
one chinchilla and at f2 = 6.6 and 7.7 kHz in another. The maximum response occurred with 
a contralateral tone at or just below the frequency of f2. These data were excluded from 
analysis as they may represent a different process. 
 
Fig. 6. Regression functions (Weibull) of DPOAE suppression frequency response curves for 
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Fig. 7. DPOAE suppression frequency response curves (Weibull regressions) for f2 values 
between 3.1 and 7.7 kHz, plotted on a normalized suppression scale (data from figs 4 and 6). 
5.1.3 Discussion 
This study demonstrates that suppression of DPOAEs by contralateral pure tones can be 
detected in the chinchilla with real time recording. DPOAE suppression is greatest when 
using contralateral stimulation tones close to primary tone f2. This tonotopic response is 
consistent with other investigations of frequency specificity in the MOCS pathway  (Chery-
Croze, Moulin, & Collet, 1993; Cody & Johnstone, 1982; M. C. Liberman, 1989; Murata et al., 
1980; Robertson, 1984; Robertson & Gummer, 1985; Veuillet et al., 1991; Warren III & 
Liberman, 1989a; Warren III & Liberman, 1989b). Unlike observations in human subjects, we 
did not observe any dips in fine structure DPOAEs to account for differences in the 
magnitude of suppression at different values of f2 or between chinchillas (Wagner, 
Heppelmann, Müller, Janssen, & Zenner, 2007).  
Measurement of contralateral frequency tuning of MOCS fibers has revealed narrow band 
tuning equivalent in sharpness to cochlear afferent neurons (Brown, 1989; M. Liberman & 
Brown, 1986; Robertson, 1984). The final, divergent innervation pattern of MOCS fibers at 
the OHC level appears to degrade this cochleotopicity (or frequency tuning) by a factor of 4-
5 from 0.33 octaves (the approximate bandwidth of auditory afferents) to about 1.7 octaves 
for f2 = 3.1kHz and 1.3 octaves for f2 = 7.7kHz. The difference in tuning likely rests with the 
divergent OHC innervation by the MOCS fibers. Neural tracing studies in guinea pig have 
shown MOCS fibers innervating 15 -61 OHCs (Brown, 1989). In the cat, individual cochlear 
efferents contact 23 – 84 OHCs spanning 0.55-2.8mm (M. Liberman & Brown, 1986). Thus 
although tuning in the efferent fibers themselves appears to be as sharp as afferent tuning, 
the effect of individual fibers on the organ of Corti will be much less precise.  
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MOCS frequency tuning has been assessed in the cat by recording changes in single afferent 
fiber activity during CAS. Suppression of afferent firing rate is maximal with a CAS of 
similar frequency to the characteristic frequency of the afferent fiber  (Warren III & 
Liberman, 1989a; Warren III & Liberman, 1989b)). Tuning of this form of contralateral 
suppression was asymmetric, falling off more sharply at CAS frequencies above 
characteristic frequency, and were much less sharp than afferent tuning. Tuning tended to 
be sharper at higher frequencies. These observations in the cat are consistent with the 
contralateral DPOAE suppression tuning reported here for the chinchilla, where 
bandwidths for curves at 6.6 and 7.7 kHz (f2) are 1.15 and 1.3 octaves respectively, but are 
1.7 and 1.8 octaves at 3.1 and 4.4 kHz.  
As shown by others, the primary tones used to generate DPOAE stimulate the MOCS and so 
cause ipsilateral DPOAE suppression (Guinan, Backus, Lilaonitkul, & Aharonson, 2003; M. 
C. Liberman, Puria, & Guinan Jr., 1996). It can be expected that the primary tones would 
suppress cochlear function in the contralateral ear by MOCS activation, with the same broad 
frequency tuning that we have observed. Given that the magnitude of contralateral 
suppression of DPOAE is dependent upon intensity of the contralateral stimulus (A. James, 
Mount, & Harrison, 2002), a hypothetical outcome would be a notch in the frequency 
response curve at the primary frequencies, f1 and f2. This has been observed at f1 in the barn 
owl but despite thorough investigation at one frequency (f2 = 4.4kHz, figure 5), we were 
unable to demonstrate this phenomenon in the chinchilla (Manley et al., 1999).  
As in other studies, recordings were completed under anesthesia with ketamine and 
xylazine. This does reduce the magnitude of contralateral suppression of DPOAE and other 
measures of olivocochlear function but facilitates recording by providing stable recording 
conditions, with less behavioral noise and movement artifact (Cazals & Huang, 1996; da 
Costa, Erre, de Sauvage, Popelar, & Aran, 1997; Harel, Kakigi, Hirakawa, Mount, & 
Harrison, 1997). We have not investigated the effect of anesthesia on tuning sharpness. 
As mentioned previously the exact function of the medial olivo-cochlear system remains 
speculative. Because of the predominantly inhibitory effect seen on outer hair cell function, 
improved detection of sound in noise or a protective effect have been hypothesized. Any 
role postulated for the contralateral suppression response should take into account the 
relatively slow dynamic of this reflex, being of the order of 26ms in chinchilla and 45ms in 
humans (James, Harrison, Pienkowski, Dajani, & Mount, 2005). The presence of a response 
from low intensity contralateral stimuli suggests the function of this system is less likely a 
protective one, but more to do with frequency tuning of the afferent neural responses via 
efferent effects on OHC motility. The efferent system may function as a gain control with a 
long time-constant, equalizing sensitivity between the ears. The optimal condition for 
detecting inter-aural timing or intensity differences would perhaps be when the two ears 
have equivalent function. In this respect, the medial contralateral efferent system may also 
have a role in “balancing” the ears such as to improve the accuracy of these binaural sound 
localization tasks.  
6. Conclusions 
Objective tests such as OAE and ABR are widely used in hearing screening programs and 






Fig. 7. DPOAE suppression frequency response curves (Weibull regressions) for f2 values 
between 3.1 and 7.7 kHz, plotted on a normalized suppression scale (data from figs 4 and 6). 
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6. Conclusions 
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loss. However these tests do not provide a quick and easy means for assessing hearing 
threshold at different frequencies, indeed the presence of OAE does not even guarantee the 
presence of normal hearing. An objective frequency specific test of hearing ability would 
have widespread advantages, not just for neonatal testing but in many circumstances in all 
age groups.  
In the present study we have demonstrated frequency specificity in contralateral 
suppression using a chinchilla model. The majority of studies shedding light onto the 
function of the MOCS have been derived from animal experiments. However, there is 
enough data in human studies to suggest that the human efferent system is qualitatively 
similar (Guinan Jr, 2006; James, 2006). We have shown previously that contralateral 
suppression of DPOAE can be assessed in real time in babies and adults (James et al., 2005) 
and can be used to test hearing very effectively in neonates (James, 2011). We have shown 
that this technique can distinguish between middle ear muscle reflexes and the OCR in an 
animal model (Wolter, Harrison, & James, 2011) and here show that it can be used to assess 
hearing threshold in a frequency specific manner. We envisage many clinical applications of 
this technique including the diagnosis and assessment of ANSD and more accurate hearing 
screening in neonatal and elderly populations. 
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1. Introduction
Securing good transmission characteristics for speech information and achieving a
comfortable sound environment in buildings used by a great variety of people in public
city spaces, to say nothing of spaces used for intellectual or mental work such as schools
and offices, comprise two of the most important problems of environmental design. A
common method for evaluating listening scores and psychological impressions for audio
signal has been discussed previously (Tamesue T. et al., 2003). However, this research
paid attention only to subjects in their twenties with normal hearing, and as a result the
relationships between the frequency characteristics of hearing loss due to factors such as
aging and the listening scores for audio signals and the psychological impressions related to
speech audibility were not considered. Taking this into consideration, this chapter considers
how the listening scores of audio signals and the psychological impressions for speech
audibility change while taking into account the effects of hearing loss due to factors such
as aging. Specifically, frequency filters for simulating hearing loss are first prepared. Next,
psychological listening experiments are conducted in which both the audio signal and the
noise passing through the above-mentioned filters are transmitted to subjects with normal
hearing. Using the observed experimental data, the relationships between the weight-mean
spectral distance (Tamesue T. et al., 2003) and the listening scores of the audio signals and
psychological impressions with respect to speech audibility are investigated. Next, based
on these relationships, problems associated with the prediction of listening scores and
psychological impressions with respect to speech audibility are discussed.
2. Outline of psychological listening experiment I
Psychological listening experiment I was conducted to establish the regression models of
the listening scores of the audio signal and the psychological impressions related to speech
audibility. The outline of the indoor experiment is as follows.
2.1 Location
The experiment was conducted in a simple soundproof room on campus having the following
dimensions: length 5.1 m, width 3.3 m, and height 2.2 m. The sound pressure level of the
background noise was about 37 dB. The sound pressure level in this chapter is the value
measured by a sound level meter with FLAT response. The A-weighted sound pressure level
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A total of 8 students, 7 male and 1 female, all in their 20s with normal hearing, participated in
the psychological listening experiment.
2.3 Presented sound
2.3.1 Audio signal
A monosyllable list (a list containing 50 monosyllables) from a CD originally designed for the
evaluation and fitting of hearing aids (TY-89) (Yonemoto K., 1995) was used. The maximum
band levels of speech were measured with a real-time octave-band analyzer. Maximum band
levels were adopted as the band levels of the speech peaks. The over-all sound pressure level
of the speech peaks was about 62 dB.
2.3.2 External noise
The external noise consisted of band-limited pink noise with frequency bandwidth [44, 11,300]
Hz. The sound pressure level in each subject’s ears was adjusted to 44, 47, 50, 53, 56, 59, 62,
65, 68, 71, 74, and 77 dB.
It is well known that hearing acuity declines with age. Moreover, several studies have
reported on the frequency characteristics of hearing loss associated with aging (ISO7029, 1984)
(Yokouchi Y., 1967) . Taking into account the frequency characteristics of such hearing loss
(Yokouchi Y., 1967), both the audio signal and noise were passed through frequency filters A,
B, C, and D to simulate hearing loss experienced by individuals in their 20s, 50s, 70s and 80s
based on their 20s. The frequency characteristics of the filters are shown in Figure 1. There
is a tendency for the overall sound pressure level to decrease and for the higher frequency to
attenuate in the following order: A, B, C, D.
2.4 Measurement of listening scores and psychological impressions
Both the audio signal and noise were presented to the eight subjects through two speaker
boxes to allow assessment of the listening scores of the audio signal and the psychological
impressions associated with speech audibility while listening to the audio signal. It was
confirmed prior to the experiment that there was no difference in the sound pressure levels
at the subjects’ ears. To quantify the psychological evaluation of speech audibility, various
psychological evaluation scales for audio signals were considered. For this experiment,
the seven categorized psychological impressions Ai (i = 1, 2, ..., 7) of speech audibility
(Nakajima T. et al., 1984) were adopted:
A1: Very inaudible A5: Slightly audible
A2: Quite inaudible A6: Quite audible
A3: Slightly inaudible A7: Very audible
A4: Medium
The eight subjects participated simultaneously in the psychological listening experiment.
They listened to the audio signal and completed a response sheet asking them to report exactly
what they had heard. In addition, they performed the above psychological evaluation, i.e., Ai
(i = 1, 2, ..., 7), related to speech audibility. This operation was then carried out with the same
subjects for an external noise condition as well. The subjects were given sufficient rest to avoid
fatigue.

























Fig. 1. Frequency characteristics of simulated hearing loss by filter (A: 20s, B: 50s, C: 70s, D:
80s)
3. Relationships between index and listening scores / psychological impressions
3.1 Index for evaluating listening scores and psychological impressions
In our previous research (Tamesue T. et al., 2003), the most useful indexes for evaluating
the listening scores of audio signals and psychological impressions as they relate to speech
audibility under conditions of meaningless steady noise while listening to an audio signal
were investigated. The results indicated that weighted-mean spectral distance WSPD was






ai[LS( fi)− LN( fi)] (1)
where ai denotes the weight considered to be percentages of 20 frequency bands(Kryter KD.,
1962) that contribute equally to speech intelligibility. These are included in octave bands with
center frequency fi ( f1 = 63, f2 = 125, · · · , f8 = 8000 Hz), and are shown as follows:
a1 = 0.000000 a2 = 0.000000 a3 = 0.063794 a4 = 0.140096 (2)
a5 = 0.226255 a6 = 0.319855 a7 = 0.227360 a8 = 0.022640
LS( fi) denotes the band level with center frequency fi ( f1 = 63, f2 = 125, · · · , f8 = 8000 Hz)
of the speech peaks. In this, the maximum band levels of the audio signal, measured by a
sound level meter (RION, type NL-22) along with a real-time octave-band analyzer (RION,
type NX-22RT) with FAST dynamic response for 180 seconds, are adopted as the band levels
of the speech peaks. LN( fi) denotes the band level with center frequency fi of the noise. These
band levels were measured by the real-time octave-band analyzer built into the sound level
meter with FAST dynamic response.
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3.2 Relationship between WSPD and the listening score of the audio signal
The subjects noted the monosyllables exactly as they heard them, as described in 2.4. The
number of correct answers given by each subject was assessed, with the listening score for
the audio signal being defined as the percentage of correct monosyllables from the total
(50). Using the observed data obtained during psychological listening experiment I, the
relationship between WSPD and the listening scores of the audio signal were examined. In
order to understand this relationship, the following models describing the regression between
them were adopted.
Linear function:




1 + a exp(−bx) + c (4)
Gomperz function:
y = (k − c) exp(− exp(−a(x − b))) + c (5)
In each case both the audio signal and noise passed through one of the frequency filters, A, B,
C, or D, and the relationship between WSPD and the listening score of the audio signal was
calculated. These results are shown in Figure 2. The lines in the figure indicate the regression
line as selected by AIC (Akaike H., 1974).
Here, the expressions are represented by eqn.(5). This figure reveals the following: when the
value of WSPD decreased, the listening score of the audio signal approached 0. This indicates
that when there is a larger level of hearing loss, the listening score of the audio signal clearly
decreases.
3.3 Relationship between WSPD and psychological impressions related to speech
audibility
The relationships between WSPD and the psychological impressions related to speech
audibility were investigated using frequency filters A, B, C, D in the same way as the above
investigation of the listening scores of the audio signal. Figure 3 shows the results of the
regression models represented by eqn.(5), which was found to be the most suitable. In
Figure 3, when the value of WSPD decreased, the psychological impression related to speech
audibility approached A1. This indicates that the psychological impression related to speech
audibility decreases with a reduction of hearing acuity.
4. Outline of psychological listening experiment II
Psychological listening experiment II was conducted to compare the observed values of
the listening scores of the audio signal and the psychological impressions related to speech
audibility with the predicted values. This experiment was conducted as follows.
4.1 Subjects
A total of 24 students, 20 male and 4 female, all in their 20s with normal hearing, participated
in psychological listening experiment II. These subjects were different from the subjects who
participated in psychological listening experiment I.
























Fig. 2. Relationship between the listening score of the audio signal and the weighted-mean
spectral distance (A: 20s, B: 50s, C: 70s, D: 80s)
4.2 Location
The experiment was conducted in a soundproof room on campus having the following
dimensions: length 3.0 m, width 3.0 m, and height 1.9 m. The sound pressure level of the
background noise was about 36 dB. The A-weighted sound pressure level was about 20 dB(A).
4.3 Audio signal
The same audio signal used in psychological listening experiment I
4.4 External noise
In order to best simulate an actual noise environment, various realistic external noises that
contained many frequency components were used. The following two noises were adopted
as examples of steady noise.
(a) Voice noise
A voice noise from a CD originally designed for the evaluation and fitting of hearing aids
(TY-89) was used. The sound pressure level was adjusted to 57, 62, and 67 dB.
(b) Road traffic noise
This consisted of pink noise whose power spectrum closely resembled that of actual road
traffic noise. The sound pressure level was adjusted to 57, 62, and 67 dB.
The following three noises were adopted as examples of a typical irregular fluctuating noise.
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Fig. 3. Relationship between the psychological impressions related to speech audibility and
weighted-mean spectral distance (A: 20s, B: 50s, C: 70s, D: 80s)
(c) Non-stationary road traffic noise
Actual road traffic noise under interrupted traffic flow conditions, recorded in advance for
approximately two hours at the side of a road. The equivalent continuous sound pressure
level was adjusted to 62 and 67 dB.
(d) Stationary road traffic noise
Actual road traffic noise under uninterrupted traffic flow conditions obtained from the
“Audio/Acoustics Technical CD for Professional Use.” The equivalent continuous sound
pressure level was adjusted to 62 and 67 dB.
(e) Aircraft noise
Actual aircraft noise during take off obtained from the “Audio/Acoustics Technical CD for
Professional Use.” The equivalent continuous sound pressure level was adjusted to 62 and
67 dB.
In addition, the following condition for predicting the listening score of the audio signal and
psychological impressions related to speech audibility was used.
(f) No external noise
Similar to psychological listening experiment I, both the audio signal and the noise were
passed through frequency filters A, B, C, and D.
4.5 Measurement of listening scores and psychological impressions
The specific method of measurement of the listening score of the audio signal and
psychological impressions related to speech audibility was the same as that used in
psychological listening experiment I.


















Predicted value <t̂> 
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 (a) 62 [dB]
 (a) 67 [dB]
 (b) 57 [dB]
 (b) 62 [dB]




























Predicted value <Â> 
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 (a) 67 [dB]
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(f)             
(b) Speech audibility
Fig. 4. Comparisons between the predicted and observed values (Frequency filter: A)
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(b) Speech audibility
Fig. 5. Comparisons between the predicted and observed values (Frequency filter: B)
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(b) Speech audibility
Fig. 6. Comparisons between the predicted and observed values (Frequency filter: C)
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Fig. 5. Comparisons between the predicted and observed values (Frequency filter: B)
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Fig. 6. Comparisons between the predicted and observed values (Frequency filter: C)
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(b) Speech audibility
Fig. 7. Comparisons between the predicted and observed values (Frequency filter: D)
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Fig. 8. Comparisons between the predicted and observed values
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Fig. 7. Comparisons between the predicted and observed values (Frequency filter: D)
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5. Prediction of listening scores and psychological impressions
Employing the regression model shown in Figures 2 and 3, it was predicted that the listening
scores of the audio signal and the psychological impressions related to speech audibility
would change depending on actual noise environment . The subjects were exposured to the
meaningless steady or fluctuating noise, with various power spectral level forms and sound
pressure levels.
The value of WSPD were calculated for each noise condition (a) and (b). Using Figures
2 and 3, the theoretical predicted values of the listening scores of the audio signal were
estimated for each noise condition (a) and (b). These were compared with the values obtained
directly from the recorded data in psychological listening experiment II. As an example of
the predictin results, comparisons between the predicted and observed values of the listening
score of the audio signal when using frequency filter A, which simulated the hearing loss
experienced by individuals in their 20s, are shown in Figure 4(a). It can be seen from this
figure that the predicted results are consistent with the observed values. In addition, the
results from using frequency filter B, C, and D, which simulated the hearing loss experienced
by individuals in their 50s, 70s, and 80s, are shown in Figure 5(a), Figure 6(a) and Figure 7(a).
The predicted values are in good agreement with the observed values shown in these figures,
which become smaller than those in Figure 4(a). Finally, Figure 8(a) shows the results for
all of the frequency filters (A, B, C, and D). Since the predicted values are in good agreement
with the observed values, both the validity and the applicability of the proposed method were
confirmed experimentally.
With respect to the psychological impressions associated with speech audibility, the theoretical
predicted values were calculated for each of the noise conditions (a) and (b) using the
regression models. As examples of the results, comparisons between the predicted and
observed values of the psychological impressions associated with speech audibility when
using frequency filters A, B, C, and D are shown in Figures 4(b), 5(b), 6(b) and 7(b),
respectively. In these figures, a high level of consistency can also be seen between the
predicted and observed values. Figure 8(b) shows the results for all of the frequency filters (A,
B, C, D). Since the predicted values are in good agreement with the observed values similar to
the listenig scores of audio signal, reasonable results were obtained.
Since WSPD is reflected in the mutual relationship between the spectral level of the speech
peaks and that of noise, which is limited to steady noise with no fluctuations in sound pressure
level or frequency components, it is not reasonable to evaluate the listening scores of the
audio signal or the psychological impressions related to speech audibility in an actual noise
environment where the sound pressure levels and frequency components of noise show an
irregular fluctuation over time.
Thus, here we introduce the new index as instantaneous spectral distance ISPD, which reflects
the relationship between the spectral level of the speech peaks and that of noise within a short
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where ai and LS( fi) are the same as those of eqn.(1). L
�
N( fi) denotes the band level with
center frequency fi ( f1 = 63, f2 = 125, · · · , f8 = 8000 Hz) of the noise within a short time scale,
measured with FAST dynamic response and a sampling frequency of 10 Hz.
When the sound pressure levels and frequency components of noise show an irregular
fluctuation over time, ISPD is a random variable. If regression models ft(ISPD) and
fA(ISPD) of the listening score of the audio signal and psychological impressions associated
with speech audibility (based on ISPD) and a probability density function p(ISPD) on
ISPD are known, the averages of the listening scores of the audio signal and psychological
impressions related to speech audibility can be calculated as follows:
< ∗ > =
∫
D
f∗(ISPD)p(ISPD)dISPD (D = [−40, 40] dB) (7)
where * denotes t and A in the case of the listening scores of the audio signal and psychological
impressions associated with speech audibility.
Here, the regression model to the listening score of audio signal and psychological impression
for speech audibility based on ISPD, and the probability density function of ISPD for each
noise condition were employed. From a practical point of view, ft(WSPD), shown in Figure
2, and fA(WSPD), shown in Figure 3, were adopted as ft(ISPD) and fA(ISPD).
The probability distribution was obtained for each presented sound of the psychological
listening experiment. Figures 9 and 10 show examples of the results in the case of noise (c)(62
dB) using frequency filter A, B, C, and D (which simulated the hearing loss experienced by
individuals in their 20s, 50s, 70, 80s), respectively. Comparing these figures, it can be seen that
probability distribution is translated in the direction of a higher level, and the spread of the
values of ISPD is relatively small, caused by hearing loss due to factors such as aging.
The predicted values of the listening score of the audio signal were calculated from eqn.(7)
with the probability distribution obtained for each fluctuating noise condition. As an example
of these results, comparisons between the predicted and observed values of the listening
scores of the audio signal for each of the fluctuating noise conditions (c), (d), and (e) when
using frequency filter A are shown in Figure 4(a). Even in an actual noise environment,
the predicted values are in good agreement with the observed values. The results obtained
when using frequency filter B, C, and D are shown in Figure 5(a), Figure 6(a), and Figure 7(a),
respectively. Finally, the results from using all of the frequency filters (A, B, C, D) are shown
in Figure 8(a). Since the predicted values of the listening score of audio signal by use of ISPD
are in good agreement with the observed values, both the validity and the applicability were
confirmed in fluctuating noise environment.
In addition, the predicted values of the psychological impressions associated with speech
audibility were calculated for each of the fluctuating noise conditions of (c), (d), and (e)
using eqn.(7). Comparisons between the predicted and observed values of the psychological
impression associated with speech audibility when using frequency filters A, B, C, and D are
shown in Figures 4(b), Figure 5(b), Figure 6(b), and Figure 7(b), respectively. The results from
using all of the frequency filters (A, B, C, D) are shown in Figure 8(b). Even the predicted
values of the the psychological impressions associated with speech audibility by use of ISPD
are in good agreement with the observed values. It is possible to predict a psychological
impressions associated with speech audibility as a whole over a long period of time, after a
certain amount of exposure to noise.
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the predicted values are in good agreement with the observed values. The results obtained
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Fig. 9. Probability distribution on instantaneous spectral distance ((c) 62 dB)
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Fig. 10. Probability distribution on instantaneous spectral distance ((c) 62 dB)
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6. Conclusion
This investigated how the listening scores of an audio signal and the psychological
impressions related to speech audibility when listening to the audio signal under conditions
of meaningless steady or fluctuating noise change when the frequency characteristics of
hearing loss related to aging are taken into account. Specifically, psychological listening
experiments by subjects with normal hearing were performed using artificial hearing
impairments (frequency filters) that simulated hearing loss. Using the observed data obtained
in psychological listening experiments, the relationships between WSPD and the listening
scores of an audio signal and the psychological impressions related to speech audibility were
established using regression models. Further, the effect of hearing loss due to factors such
as aging on the listening scores of the audio signal and the psychological impressions related
to speech audibility was predicted from the above relationships. Since the predicted values
are in good agreement with the observed values, both the validity and the applicability of the
proposed method were confirmed experimentally, and reasonable results were obtained.
Future studies should examine the following aspects of this research.
(1) Since the current study was limited to subjects with normal hearing who experienced
artificial hearing impairment with frequency filter-simulated hearing loss, the applicability
of the same method to situations where the subjects are actually hearing impaired persons
should be confirmed. However, comparing the available data on hearing impaired
persons with the results of our simulations of hearing impairment in this study, we
can conclude that our study provides fundamental data to aid in determining whether
the results of such psychological listening experiments conducted using normal-hearing
subjects who experience artificial hearing impairment are as valid as those conducted on
hearing-impaired subjects.
(2) Decreasing pure-tone audiometric thresholds were employed as hearing loss with
increasing age. However, it is still necessary to consider other factors, such as
loss of frequency selectivity and reduced temporal resolution in peripheral auditory
deterioration.
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1. Introduction  
Age-dependent hearing loss involves pathological changes affecting the peripheral as well 
as the central auditory system. The Mongolian Gerbil is a rodent with an average life span of 
3-4 years, which shows, in contrast to mice and rats, sensitive hearing in the frequency range 
that is important for human communication. Consequently, gerbils have been used to study 
structural and functional aspects of age-dependent hearing loss at the level of the cochlea 
and auditory brain stem nuclei. In addition, age-dependent changes in behavioural 
performance have been characterised for different auditory tasks. We have also analysed the 
effect of certain drugs on impaired temporal processing in old gerbils. The data from gerbils 
contribute to a framework that helps to better understand the mechanisms contributing to 
age-dependent hearing loss and may lead to new pharmacotherapeutic strategies for the 
treatment of age-dependent central hearing loss.  
2. Gerbils as model organism 
Like mice and rats, gerbils are small rodents. Henceforth, when we use the term gerbil, we 
refer to the species Meriones unguiculatus. The natural range of distribution of this species is 
Mongolia and the adjacent regions of Siberia and China. The first description of the species 
was by Milne Edwards in 1867 (Milne-Edwards, 1867). The history of the “laboratory gerbil” 
has been summarised by Stuermer et al. (2003). Briefly, a small group of 20 wild pairs were 
originally collected in 1935 during a Japanese expedition to Mongolia and subsequently 
bred in Japan. In 1954, eleven pairs from this Japanese colony were sent to Tumblebrook 
Farm in New York. Offspring of the Tumblebrook Farm breeding colony have subsequently 
been distributed worldwide and are used as models for different lines of research. A search 
for the term “gerbil” in combination with the terms “hearing”, “ear” and “auditory” on 
Sept. 7th 2011 in the PubMed database lists 1405 publications, illustrating that gerbils have 
become an important model in auditory research.  
The sensitivity of gerbils at low frequencies important for speech perception is similar to 
that of humans, while thresholds of rats and mice are much higher for frequencies below 4 
kHz (Fig. 1). Thus, gerbils appear to be a better model than mice and rats to study aspects of 
age-dependent hearing loss that affect communication and speech perception in older 
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The sensitivity of gerbils at low frequencies important for speech perception is similar to 
that of humans, while thresholds of rats and mice are much higher for frequencies below 4 
kHz (Fig. 1). Thus, gerbils appear to be a better model than mice and rats to study aspects of 





human subjects. Gerbils have been suggested as a particularly suitable model for research 
on diverse aspects of ageing, including audition (Cheal, 1986). Here we will review the 
studies of age-dependent changes in the auditory system of gerbils. 
 
Fig. 1. Audiograms from human, gerbil, rat and mouse  
The human audiogram (filled circles, thick continuous line; Zwicker & Fastl, 1990) shows 
the lowest thresholds at low frequencies. The gerbil audiogram (filled triangle, black 
continuous line; Ryan, 1976) is similar to the human audiogram, but the hearing range of 
gerbils extends to frequencies above 20 kHz. Compared to human and gerbil, thresholds of 
rat (open circles, thick dotted line; Kelly & Masterton, 1977) and mouse (open triangles, thin 
dotted line; Radziwon et al., 2009) are much higher for frequencies below 4 kHz.  
3. The cochlea 
Comparative studies (Webster & Plassmann, 1992) show that the low-frequency hearing in 
gerbils is associated with adaptations of the middle ear (e.g. large middle ear cavities that 
facilitate the transmission of low frequencies to the inner ear) and of the basilar membrane 
(e.g. increased width compared to other small rodents).  
3.1 Activity of single auditory nerve fibres 
Analysis of auditory nerve fibre activity provides information about sound processing in the 
cochlea. A reference species, in which auditory nerve fibre function has been studied in 
much detail, is the cat (Kiang, 1965). In a comparative analysis of gerbil auditory nerve fibre 
activity, Schmiedt (1989) demonstrated a good correspondence with data from the cat and 
suggested that this “implies the presence of fundamental mechanisms that are common to 
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mammalian auditory systems”, making the gerbil a useful model for hearing loss in ageing 
studies.  
In addition to normative data gathered using young gerbils, several studies have also 
analysed auditory nerve fibre activity in gerbils older than 1 year. In auditory nerve fibres of 
quiet aged three-year-old gerbils, Schmiedt et al. (1990) found that thresholds were elevated 
by 20-30 dB at the tip (characteristic frequency, CF) of the tuning curves, while the low 
frequency tails were much less affected, resulting in a reduced tip-to-tail ratio. Measures of 
frequency selectivity, like Q10dB and Q40dB (Hellstrom & Schmiedt, 1996), were similar for 
young and old gerbils in fibres with CFs below 4 kHz, while auditory nerve fibres with 
higher CFs were on average less sharply tuned in old gerbils. A comparison of rate-level 
functions (the discharge rate of auditory nerve fibres plotted as a function of stimulus level) 
at CF in old and young gerbils showed that these functions in old gerbils were shifted to 
higher levels, consistent with elevated thresholds of auditory nerve fibres. However, the 
slopes of functions in the dynamic range region between threshold and saturation of old 
gerbils were at least as steep as those from young gerbils. The distributions of spontaneous 
rates in large samples of auditory nerve fibres from young and old gerbils were similar for 
fibres with CFs below 6 kHz, while the proportion of low spontaneous rate fibres with CFs 
above 6 kHz was only 30% in old gerbils, compared to 60% in young gerbils (Schmiedt et al., 
1996). Fibres with low spontaneous activity typically have higher thresholds and larger 
dynamic ranges compared to fibres with high spontaneous rates (Winter et al., 1990). Thus, a 
loss of the contribution of auditory nerve fibres with low spontaneous rate may affect 
processing of supra-threshold signals and contribute to a decreased ability to understand 
speech in noise.  
3.2 The compound action potential (CAP) 
Although single-fibre recordings provide much information, the amount of data that can be 
generated in an individual gerbil, especially in aged animals, is limited. An alternative to 
evaluate the state of the cochlea is the compound action potential (CAP), an electrical signal 
that is generated by the synchronised population response of the auditory nerve fibres to the 
onset of a signal (Hellstrom & Schmiedt, 1996).  
3.2.1 CAP threshold and growth with stimulus intensity 
By plotting CAP thresholds across a range of test frequencies, Hellstrom & Schmiedt (1990) 
compared CAP audibility curves of young and old gerbils and found a varying degree of 
frequency-specific threshold elevation in old gerbils. Compared to young gerbils, the inter-
animal variability of thresholds was much higher in old gerbils for frequencies above 3 kHz. 
Below 3 kHz, old gerbils showed an average of less than 20 dB threshold elevation, while 
the difference increased at higher frequencies to more than 30 dB. The growth of the peak-
to-peak CAP amplitude with increasing level of the tone pip was considerably reduced in 
old gerbils and a quantitative analysis confirmed that the slopes of the CAP input-output 
functions were significantly reduced for test frequencies between 1 and 8 kHz. While the 
elevated CAP thresholds in old gerbils reflect the elevated thresholds at the tip of the tuning 
curve in recordings from auditory nerve fibres (Schmiedt et al., 1990), the reduced slope of 
the CAP growth functions in old gerbils was not reflected in the rate-level functions of 
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mammalian auditory systems”, making the gerbil a useful model for hearing loss in ageing 
studies.  
In addition to normative data gathered using young gerbils, several studies have also 
analysed auditory nerve fibre activity in gerbils older than 1 year. In auditory nerve fibres of 
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loss of the contribution of auditory nerve fibres with low spontaneous rate may affect 
processing of supra-threshold signals and contribute to a decreased ability to understand 
speech in noise.  
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that is generated by the synchronised population response of the auditory nerve fibres to the 
onset of a signal (Hellstrom & Schmiedt, 1996).  
3.2.1 CAP threshold and growth with stimulus intensity 
By plotting CAP thresholds across a range of test frequencies, Hellstrom & Schmiedt (1990) 
compared CAP audibility curves of young and old gerbils and found a varying degree of 
frequency-specific threshold elevation in old gerbils. Compared to young gerbils, the inter-
animal variability of thresholds was much higher in old gerbils for frequencies above 3 kHz. 
Below 3 kHz, old gerbils showed an average of less than 20 dB threshold elevation, while 
the difference increased at higher frequencies to more than 30 dB. The growth of the peak-
to-peak CAP amplitude with increasing level of the tone pip was considerably reduced in 
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functions of auditory nerve fibres did not differ between young and old gerbils, Hellstrom & 
Schmiedt (1990, 1991) argued that a loss of auditory nerve fibres and spiral ganglion cells 
and a loss of synchrony of the auditory nerve fibre population response could result in 
reduced CAP amplitudes in old gerbils.  
3.2.2 CAP measure of cochlear frequency selectivity 
CAP measurements have also been conducted to compare cochlear frequency selectivity of 
young and old gerbils (Hellstrom & Schmiedt, 1996). A forward masking paradigm was 
used to determine masked CAP tuning curves at probe frequencies between 1 and 16 kHz. 
Briefly, a probe of a given frequency was presented 10-15 dB above the CAP threshold, 
eliciting a robust CAP response. The response to the probe was masked by a 60 ms tone 
burst that was presented 5 ms before the probe. The masked CAP tuning curve was 
obtained by plotting the masker level that just suppressed the response to the probe as a 
function of masker frequency. The masked CAP tuning curves share many characteristics 
with auditory nerve fibre tuning curves. The elevation of threshold at the tip of single fibre 
tuning curves in old gerbils (Schmiedt et al., 1990), especially at higher frequencies, was also 
evident in masked CAP tuning curves. In addition, the loss of frequency selectivity in 
auditory nerve fibres with characteristic frequencies above 4 kHz in old gerbils was 
paralleled by a corresponding loss of frequency selectivity in the masked CAP tuning curves 
(Hellstrom & Schmiedt, 1996).  
3.3 Distortion product otoacoustic emissions (DPOAE) 
Distortion product otoacoustic emissions (DPOAE) characterise the function of outer hair 
cells that are the central element of the “cochlear amplifier”. They can be used to determine 
the sensitivity of the cochlea and to construct audiograms (Janssen et al., 2006). Eckrich et al. 
(2008) measured DPOAE audiograms of “laboratory” gerbils and gerbils that had been 
caught in the wild and bred for 6-7 generations in captivity. While thresholds of “wild” 
gerbils remained stable across age, thresholds of 15-28 month old, domesticated gerbils were 
increased at 2 kHz (6 dB), between 8 and 20 kHz (6-11 dB) and above 44 kHz (6-12 dB), 
when compared to the thresholds of 3 and 6 month old, domesticated gerbils. For the most 
basal test frequencies above 50 kHz, threshold elevation of more than 6 dB was present in 
the 9 and 12 month old, domesticated gerbils. Eckrich et al. (2008) suggested that elevated 
DPOAE thresholds in the older gerbils may have been caused by a loss of the endocochlear 
potential and/or a loss of outer hair cells.  
3.4 Age-dependent hair cell loss 
The loss of hair cells is one mechanism that causes hearing loss. Cytocochleograms are plots 
of the proportion of missing and abnormal hair cells as a function of the position along the 
cochlea. When the cochlear place-frequency map is known, frequency specific hearing loss 
can be directly correlated with hair cell loss. Tarnowski et al. (1991) performed such a 
comparison of cytocochleograms and CAP thresholds in 16 old gerbils raised in a low-noise 
environment. In their sample, they found a substantial inter-animal variation of threshold 
shift and hair cell loss and defined 3 groups based on the degree of hair cell loss. In 6 
animals with minimal hair cell loss (5-8%), only outer hair cells were missing, 
The Mongolian Gerbil as a Model for  
the Analysis of Peripheral and Central Age-Dependent Hearing Loss 
 
71 
predominantly in the apical turn and to a lesser degree in the extreme basal turn. This group 
of animals showed the least degree of threshold elevation (0-25 dB). Eight animals with a 
moderate degree of hair cell loss (8-14%) showed, on average, higher degrees of threshold 
shift (5-55dB). Outer hair cell loss was more pronounced at the apex, but was also present 
towards the base of the cochlea. In 2 gerbils, 41-54% of the hair cells, predominantly outer 
and to a lesser degree inner hair cells, were missing. The hair cell loss in this group was 
associated with more than 50 dB hearing loss. In addition to hair cell loss, a varying 
proportion of outer hair cells in the low-frequency (apical) region of old gerbils appeared 
grossly abnormal with a spherical shape and larger diameters. These cells were located 
between normally appearing outer hair cells. No such abnormalities were found in young 
animals. Although the degree of hair cell loss was associated with the degree of threshold 
shift in the 3 groups, the pattern of hair cell loss did not correlate with the frequency-
dependent CAP threshold shifts along the cochlea. Loss of outer hair cells at the apex was 
found without corresponding threshold shifts for frequencies below 3 kHz. Above 4 kHz, 
threshold shift was present without a loss of outer hair cells in the corresponding frequency 
region. These data demonstrate that cytocochleograms cannot predict the frequency-specific 
CAP threshold shifts in old gerbils raised in a low noise environment.  
3.5 Pathology of non-sensory cells in the organ of Corti and Reissner’s membrane 
Adams & Schulte (1997) expanded the analysis of cochlear pathology in old gerbils to the 
non-sensory cells of the organ of Corti and Reissner’s membrane. In addition to the loss and 
pathology of hair cells, they observed pathological changes to pillar cells in regions where 
outer hair cells had been lost. Compared to young gerbils, where the cells forming 
Reissner’s membrane appeared uniformly distributed, gerbils older than 2 years showed a 
formation of cell clusters mixed with regions of lower cell density. However, this 
rearrangement of cells in Reissner’s membrane appeared to not be related to hearing loss. In 
summary, Adams & Schulte (1997) emphasised the discrepancy between the frequencies 
affected by hearing loss and the position of cell pathology along the cochlea.  
3.6 Spiral ganglion cells and auditory dendrites 
Keithley et al. (1989) compared the density of spiral ganglion cells in young and old gerbils. 
The mean ganglion cell density averaged along the whole cochlea was 1106 cells/mm² for 4 
gerbils with an age of 2 months. Compared to the mean of these young gerbils, the density 
decreased to 86% and 83% in 5 animals aged 24-30 months and in 3 animals aged 36-42 
months respectively, though the difference between the young animals and the 2 groups of 
old animals was not significant in this sample. When they compared mean spiral ganglion 
cell density for separate half turns of the cochlea, a significant reduction that varied between 
16 and 55% in the two groups of old gerbils with reference to the 2 month old animals was 
only found for the most basal position (80-90% from the apical end, corresponding to 
frequencies above 20 kHz). Overall, the loss of spiral ganglion cells was limited and 
predominantly affected high frequencies.  
Based on a small sample that precluded statistical analysis, Suryadevara et al. (2001) 
suggested a slightly decreased number of auditory dendrites per inner hair cell in old 
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diameter within the osseous spiral lamina, with increasing diameter from the scala vestibuli 
to the scala tympani side. With decreasing endocochlear potential (EP) in old gerbils, this 
gradient disappeared due to fewer large diameter fibres found near scala tympani. In 
addition, the cross-sectional area of spiral ganglion cells decreased with decreasing EP. 
Thus, decreasing EP was associated with a loss or shrinkage of large diameter auditory 
nerve fibre dendrites and a reduction of the size of spiral ganglion cells.  
Rüttiger et al. (2007) found an age dependent reduction of BDNF mRNA expression in high 
frequency spiral ganglion cells. In contrast, BDNF protein expression was preserved in the 
cochlear ganglion cells of old gerbils but declined in their central and peripheral processes.  
3.7 The endocochlear potential and pathology related to endolymph homeostasis  
The sensitivity of the mechano-electrical transduction by hair cells in the mammalian 
cochlea depends on the endocochlear potential (EP) in scala media (Wangemann, 2006). The 
positive EP (80-100 mV) together with the negative intracellular potential of hair cells is the 
driving force (battery) of sensory transduction. The important contribution of the EP to the 
sensitivity of the cochlea was demonstrated in experiments, where a reduction of the 
endocochlear potential by the application of furosemide was associated with threshold shifts 
in single auditory nerve fibres in cat (Sewell, 1984).  
3.7.1 Age-dependent loss of the endocochlear potential 
Several studies in gerbils have shown that the EP, on average, declines with age and inter-
animal variability of the EP in old gerbils becomes much higher compared to young gerbils 
(Gratton et al., 1996, 1997a; Schmiedt, 1983, 1996; Schulte & Schmiedt, 1992). The EP in 
young gerbils (Schmiedt, 1983) was highest at the base, determined through the round 
window (92 mV), and slightly lower at more apical locations (76-81 mV); the reduction of 
the mean EP determined in 3 year old gerbils relative to the means obtained in young 
gerbils was more pronounced at the base (40 kHz region: 31 mV) and the apex (0.5 kHz 
region: 27 mV) as compared to the intermediate parts of the cochlea (2 kHz region: 19 mV; 
16 kHz region: 23 mV). The loss of the EP and threshold shifts in old gerbils were not related 
to each other in a direct and simple way. The pattern of CAP threshold shift from low to 
high frequencies differed from the pattern of EP loss. In addition, the plots of CAP threshold 
shift as a function of EP shift (Schmiedt, 1983) demonstrate no correlation for young and 30 
month old gerbils, despite a variation of the EP over a 40-60 mV range. Only the data from 3 
year old gerbils indicated some correlation between CAP threshold and EP, although the 
scatter in the data was large. Overall, a linear regression analysis suggested that the 
variation of EP in 3 year old gerbils accounts for 31% of the variation in CAP thresholds 
(Schmiedt, 1983). The reduction of the mean EP was not associated with a mean loss of 
potassium concentration in the endolymph of old gerbils and the “effects of age are 
primarily on EP generation, and not on the chemical potential of Ke+” between endolymph 
and perilymph (Schmiedt, 1996).  
3.7.2 Histological changes in the stria vascularis and the spiral ligament 
The stria vascularis (SV) plays a central role in the generation of the EP (Wangemann, 2006). 
Age-dependent changes in the microvasculature that might lead to ischemia and affect SV 
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function have been the focus of several studies (Gratton & Schulte, 1995; Gratton et al., 1996, 
1997b; Sakaguchi et al., 1997a, 1997b; Thomopoulos et al., 1997). Gratton & Schulte (1995) 
described small regions at the apical and basal ends of the SV that were devoid of capillaries 
in gerbils as young as 5-10 months. With increasing age, loss of capillaries progressed from 
both ends towards the middle of the cochlea. Gerbils older than 33 months showed a normal 
pattern of strial vascularisation only in the mid-region of the cochlea. In the regions of 
capillary loss, strial atrophy was observed with missing marginal cells and “clumps of 
pigment” in remaining cells. Gratton et al. (1996) found a significant correlation between the 
proportion of the SV with normal vascularisation and the EP. However, due to the large 
inter-animal variability of both parameters, the correlation coefficient indicated that SV 
pathology explained only up to 37% of the EP variation. 
In addition to loss of vascularisation and atrophy of the SV, different types of fibrocytes in 
the spiral ligament of old gerbils are also affected. Spicer & Schulte (2002) suggested that 
vacuolisation of type II fibrocytes in regions of old cochleae that show no strial atrophy can 
be regarded as an early event in the development of strial pathology. Regions with apoptotic 
or necrotic type II fibrocytes were associated with moderate degeneration of SV, while 
regions with a complete absence of type II fibrocytes showed advanced SV atrophy. Also, 
type IV and V fibrocytes showed vacuolisation in old gerbils, while type I fibrocytes did not. 
Thus, vacuolisation was found in Na,K-ATPase positive fibrocyte types II, IV and V, but not 
in negative type I fibrocytes. Unfortunately the hearing status was not known and could not 
be directly correlated with the degree of structural changes in these specimen. Based on 
their data, Spicer & Schulte (2002) put forward the hypothesis that, within the potassium 
recycling pathway, impaired secretion of potassium into the endolymph by strial marginal 
cells could reduce the flow of potassium towards the stria and lead to potassium 
accumulation and the development of vacuoles in Na,K-ATPase positive fibrocytes. They 
proposed that dysfunction of marginal cells is the first step leading to fibrocyte pathology 
and strial degeneration.  
3.7.3 Changes in enzymes regulating potassium homeostasis 
Spicer et al. (1997) compared the Na,K-ATPase-immunoreactivity (an ion exchange enzyme 
that uses ATP to pump 3 sodium ions out of the cell in exchange for 2 potassium ions that 
are pumped into the cell) in the lateral wall and SV of young and old gerbils. 
Immunostaining in cochleae of old gerbils was more variable than in young gerbils. Old 
animals showed strial atrophy and no Na,K-ATPase immunoreactivity at the apex, best 
preservation of SV and immunoreactivity in the middle, and atrophy of SV and loss of 
immunoreactivity at the base of the cochlea. Immunoreactivity in type II, IV and V 
fibrocytes of old gerbils decreased less than expression in the adjacent SV, although 
complete SV degeneration was also associated with loss of immunoreactivity in fibrocytes. 
The observation that a loss of Na,K-ATPase immunoreactivity in fibrocytes of the spiral 
ligament appeared to lag behind the loss of staining in the SV supports the suggestion that 
changes in fibrocytes occur secondarily to alterations in the SV. Sakaguchi et al. (1998) found 
that age-dependent changes in the expression of the Na-K-Cl co-transporter closely 
paralleled those reported for the Na,K-ATPase.  
Schulte & Schmiedt (1992) determined the Na,K-ATPase immunoreactive volume of the SV 
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volume showed a group of 4 old gerbils with an EP below 20 mV where the SV volume was 
reduced by more than 70%. In another group of 9 old gerbils, EP varied between 50 and 80 
mV with an associated loss of the SV volume between 20% and 70%. Thus, a reduction of the 
SV volume expressing Na,K-ATPase by up to 70% was associated with only a small loss of 
the EP. Only when the loss of Na,K-ATPase expressing SV volume increased beyond 70% 
did the EP show an abrupt break down: the EP appeared tolerant to a relatively large loss of 
Na,K-ATPase. Consistent with a mean reduction of the Na,K-ATPase immunoreactive 
volume of SV, the activity of this enzyme was reduced in the lateral wall of old as compared 
to young gerbils (Gratton et al., 1995) and a low level of Na,K-ATPase activity was 
associated with a low EP (Gratton et al., 1997b).  
Spicer & Schulte (1998) proposed a medial pathway for the recycling of potassium released 
by inner hair cells. In old gerbils, in contrast to the SV and the lateral wall, fibrocytes of the 
spiral limbus showed unaltered or upregulated Na,K-ATPase immunoreactivity. In 
addition, interdental cells remained immunoreactive in cochleae with SV atrophy. Based on 
these observations, Spicer & Schulte (1998) suggested a normal function of inner hair cells in 
old gerbils with strial atrophy (although the hearing status of the specimen they analysed 
was not known). Potassium released by inner hair cells can be recycled into the endolymph 
by the medial pathway via the remaining Na,K-ATPase immunoreactive limbal fibrocytes 
and interdental cells.  
3.8 The gerbil as a model of strial or metabolic presbyacusis  
The data discussed above describe a wide range of age-dependent pathologies of the gerbil 
cochlea. In summary, they suggest that loss of EP due to pathology of the SV and the lateral 
wall are the main factors that contribute to the threshold shifts observed in auditory nerve 
fibres and the CAP in old gerbils. This pattern resembles the category of strial atrophy in 
humans (Schuknecht & Gacek, 1993).  
The loss of sensitivity was most pronounced at the tip of single-fibre tuning curves 
(Schmiedt et al., 1990) and in masked CAP tuning curves (Hellstrom & Schmiedt, 1996) of 
old gerbils and led to a decreased tip-to-tail ratio of the tuning curves. These changes are 
similar to the effects of a reduced EP on single-fibre tuning curves in cat (Sewell, 1984). 
Consequently, Hellstrom & Schmiedt (1996) proposed that “the quiet-aged gerbil can be 
used as a model for an intact hair-cell system coupled to a chronically lowered EP”. This 
view was supported by a subsequent study where changes of cochlear function due to a 
reduction of the EP by chronic furosemide application to the round window in young 
gerbils resembled those found in quiet-aged, old gerbils (Lang et al., 2010). Schmiedt (1983) 
proposed the “dead battery theory” and reported that increasing the EP by current injection 
into scala media in an old animal with an initial EP of 41 mV was associated with increased 
CAP amplitude and a 20 dB reduction of CAP threshold.  
In summary, cochlear sensitivity in quiet-aged gerbils declines on average with a high 
degree of inter-animal variability. The loss of EP due to degeneration of the SV appears to be 
the main reason for decreased sensitivity in old gerbils, while loss of hair cells and auditory 
nerve fibres appear less important. Consequently, gerbils are a useful model of human strial 
or metabolic cochlear presbyacusis.  
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4. The auditory brainstem nuclei 
An overview of the auditory pathway is summarised in Strutz (1991) and Schwartz (1991). 
The central processes of the auditory nerve fibres enter the brain through the internal 
auditory meatus. Each fibre bifurcates when it enters the cochlear nucleus and sends an 
ascending branch to the antero-ventral (AVCN) and a descending branch through the 
postero-ventral (PVCN) to the dorsal (DCN) cochlear nucleus. All auditory nerve fibres 
terminate in the cochlear nucleus. Neurons of the ventral cochlear nucleus (VCN) 
predominantly project to the ipsi- and contra-lateral nuclei of the superior olivary complex. 
The neurons of the DCN project primarily to the contra-lateral, and to a lesser degree, to the 
ipsi-lateral inferior colliculus (IC). The medial nucleus of the trapezoid body (MNTB) 
receives input from the contra-lateral VCN and projects primarily to the ipsi-lateral medial 
(MSO) and lateral (LSO) nuclei of the superior olive. MSO and LSO also receive input from 
the ipsi- and contra-lateral VCN. MSO neurons project almost exclusively to the ipsi-lateral 
IC and send collaterals to the dorsal nucleus of the lateral lemniscus. The LSO projects to the 
ipsi- and contra-lateral IC.  
4.1 The auditory brainstem response (ABR) 
The auditory brainstem response (ABR), recorded from needle electrodes placed behind the 
ear and the vertex, reflects the synchronised neural activity to the onset of a stimulus. It is 
less invasive than single-fibre and CAP recordings for evaluating hearing status. Short tone-
pips elicit a typical ABR waveform in gerbils with peaks occurring at characteristic latencies. 
They have been termed i (1-2 ms), ii-iii (2-3.5 ms) and iv (4-5 ms) and can be homologised 
with the human ABR waves I (generated by the auditory nerve), III (generated by the 
cochlear nucleus or the MNTB) and V (generated by the lateral lemniscus and IC; Boettcher 
et al., 1993a).  
4.1.1 Age-dependent changes of ABR thresholds 
Age-related hearing loss in gerbils was first reported by Henry et al. (1980), showing 15-20 
dB threshold elevation for frequencies between 1 and 32 kHz in 2 year old as compared to 3 
month old gerbils. Mills et al. (1990) derived ABR thresholds for gerbils between 8 and 36 
months of age that were raised in a low-noise environment. Thresholds in 3 year old gerbils 
varied over a wide range; some old animals showed no or only small threshold elevation 
compared to young controls, while some old gerbils had more than 50 dB hearing loss. 
Hearing loss was less than 10 dB in a group of 19 month old gerbils, increased to 10-20 dB at 
2 years and further progressed with age. Mean threshold shift at 3 years was approximately 
20 dB for the 1-4 kHz range and 25-30 dB for higher frequencies. Threshold shift determined 
by ABR and CAP measurements in 3 year old gerbils showed a good correspondence.  
4.1.2 Age-dependent changes of ABR growth functions 
Boettcher et al. (1993a) compared wave ii-iii and wave iv ABR input-output functions of 
young and old gerbils. The plots of wave ii-iii and iv amplitude as a function of the tone pip 
level showed a reduction in old as compared to young gerbils that was not directly related 
to threshold. This was seen through the response amplitude of the best old gerbils with near 
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frequencies. The reduction in response amplitude to high stimulus levels was more 
pronounced at lower test frequencies, while ABR threshold elevation was more pronounced 
at the higher test frequencies. As a consequence of the reduced ABR response amplitudes, 
the slopes of the ABR growth functions were also reduced in old gerbils. Boettcher et al. 
(1993a) discussed that a loss of spiral ganglion cells could lead to a similar reduction in CAP 
and ABR amplitudes. However, Keithley et al. (1989) reported a significant reduction in 
spiral ganglion cell density only for the most basal portion of the cochlea (20 kHz region), 
while the reduction of ABR response amplitude in old gerbils appeared more pronounced at 
frequencies ≤ 4 kHz. In addition to ganglion cell loss, ABR response amplitude may be 
affected by a reduction of the EP or a reduction in the degree of synchronisation of the 
response across the population of auditory neurons. The reduction of ABR amplitude was 
prominent in old gerbils and largely independent of threshold elevation (Boettcher, 2002a).  
4.1.3 Age-dependent changes of ABR response latencies 
Boettcher et al. (1993b) compared wave i, ii and iv response latency between young and old 
gerbils with different degrees of threshold shift. In the group of normal hearing old gerbils, 
they found no increase in response latency. Instead, response latency appeared reduced at 8 
and 16 kHz for wave i and ii and at all frequencies for wave iv. The reduction was small for 
wave i and increased for wave iv, resulting in reduced i-iv intervals in normal hearing old as 
compared to young gerbils. In gerbils with hearing loss, ABR latencies were prolonged at 
low stimulus levels and normal at high stimulus levels for wave i and ii. Response latency 
for wave iv in old gerbils with hearing loss was increased for all stimulus levels at 1 and 2 
kHz and appeared normal at higher frequencies. Boettcher et al. (1993b) suggested that the 
decreasing latency along the auditory pathway in normal hearing old gerbils does not reflect 
changes originating in the periphery, but could rather reflect age-dependent changes in the 
central auditory system (e.g. loss of inhibition).  
4.1.4 The effect of low- and high-pass maskers on ABR thresholds 
ABR measurements have also been used to characterise masking of the response to tone 
pips by continuous low-pass (< 1 kHz) and high-pass (> 8 kHz) noise-maskers presented at 
an overall level of 80 dBSPL in young and old gerbils (Boettcher et al. 1995). Threshold shifts 
for the high-pass masker were similar for young and old gerbils. The shift of the quiet 
threshold in old gerbils was correlated with the shift of the masked threshold (relative to the 
mean quiet and masked threshold of young gerbils respectively) for 2 kHz and 4 kHz. For 
the low-pass masker, old gerbils, especially those with low ABR thresholds in the quiet 
condition, showed excessive masking compared to young gerbils. Threshold shift in old 
gerbils in the quiet condition was not correlated with the shift in the presence of the low-
pass masker. These data suggest excess upward spread of masking in old as compared to 
young gerbils: the low-pass masker affected or spread to more basal (higher frequency) 
cochlear regions in old gerbils, even when ABR thresholds in quiet were near normal.  
4.1.5 The interaction of age and acoustic trauma analysed by ABR thresholds 
The interaction of noise-induced and age-dependent hearing loss has been analysed by ABR 
threshold measurements in gerbils (Boettcher, 2002b; Mills et al., 1997). Anaesthetised 
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gerbils were exposed monaurally to a 3.5 kHz tone with 113 dBSPL for 1 hour. Pilot 
experiments had shown that this exposure was associated with a permanent threshold shift 
around 20 dB in the 4-8 kHz region (Mills et al., 1997).  
In the first study (Mills et al., 1997), pre-exposure thresholds for both ears were determined 
in 18 month old gerbils. Thresholds for the exposed and the non-exposed ears were re-
evaluated six weeks (age 19-20 months) after the exposure and at an age of 3 years. Pre-
exposure thresholds at the age of 18 months were similar for both ears. Six weeks following 
the exposure, thresholds of the unexposed ears were similar to pre-exposure thresholds 
while thresholds of the exposed ears were clearly elevated at 4 and 8 kHz. Comparing the 
pre-exposure thresholds determined at an age of 18 months and thresholds at 3 years of age 
for the unexposed ears in this sample showed a relatively small age-dependent increase of 
10-13 dB across the whole frequency range (this sample had excellent high frequency 
hearing compared to data previously presented in Mills et al., 1990). The threshold 
difference between exposed and unexposed ears was 15 and 12 dB for 4 kHz and 8 kHz 6 
weeks following exposure and decreased to 11 and 6 dB in 3 year old gerbils. The additional 
age-dependent threshold loss in the exposed ear was smaller than in the unexposed ear.  
In the second study (Boettcher, 2002b), ABR thresholds were determined for groups of 6-8 
and 34-38 month old gerbils before and 30 days following sound exposure to evaluate the 
effect of age on the susceptibility to acoustic trauma. Pre-exposure thresholds of the 17 old 
gerbils in this study were exceptionally low, and were only 5-9 dB higher than pre-exposure 
thresholds of 17 young gerbils across the frequency range tested. Threshold shift (elevation 
above pre-exposure threshold) induced by the sound exposure was very similar for both age 
groups below 16 kHz. It was 6 dB or less at 1 and 2 kHz and 15-18 dB at 4 and 8 kHz. Only 
at 16 kHz was the threshold loss in old gerbils (17dB) higher than in young (9 dB) gerbils. 
Thus, except for the high frequency region, susceptibility to acoustic trauma in relatively 
normal hearing old gerbils was not higher than in young gerbils.  
4.1.6 ABR and CAP for characterising auditory temporal resolution 
Boettcher et al. (1996) analysed the CAP and ABR responses to two successive 50 ms 
broadband noise pulses at 60 and 80 dBSPL as a function of the time interval (gap; 2, 4, 8, 16 
and 32 ms) between the two noise pulses in young and old gerbils. This design corresponds 
to the gap detection paradigm in psychoacoustic studies, where the duration of the smallest 
detectable gap is used as a measure of auditory temporal resolution. The CAP and ABR 
analysis compared the onset responses to the first and second noise pulse as a function of 
gap duration. ABR thresholds for tone pips between 1 and 16 kHz were elevated by 10-15 
dB in the group of 10 old (33-38 months) as compared to 9 young (4-8 months) gerbils, 
indicating only a moderate degree of peripheral hearing loss. Consistent with previous CAP 
(Hellstrom & Schmiedt, 1990) and ABR (Boettcher et al., 1993a) studies, the amplitudes of 
the potentials evoked by the noise bursts were reduced in old gerbils. In both age groups, 
the response amplitude to the onset of the second noise pulse decreased with decreasing 
gap duration, while the response amplitude to the first pulse was independent of gap 
duration. To compare the recovery of the response with increasing gap duration between 
the two age groups, despite the reduced response amplitude in old gerbils, the ratio of the 
response to the second burst divided by the response to the first burst was used. The ratio 
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duration. To compare the recovery of the response with increasing gap duration between 
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noise pulse for the 32 ms gap had not fully recovered and the ratio was around 0.6 in young 
and old gerbils. Recovery of ABR wave ii and iv functions with increasing gap duration was 
more complete as compared to the CAP in young and old gerbils. The comparison of 
amplitude ratio as a function of gap duration showed no clear systematic difference between 
both age groups. Thus, despite an absolute difference of response amplitude, the recovery of 
the response amplitude to the second noise burst with increasing gap duration was similar 
in young and old gerbils.  
The latency for the first noise pulse in the CAP and ABR responses was very similar in 
young and old gerbils, despite the elevated ABR thresholds to tone pips and the reduced 
response amplitudes in old gerbils. For the CAP, response latency to the second noise pulse 
was very similar in old and young gerbils and showed only a small decrease (≈ 0.1 ms) with 
increasing gap duration. In contrast to the CAP, response latency to the second noise burst 
showed a higher degree of variation with gap duration for wave ii (> 0.2 ms) and for wave 
iv (> 0.28 ms). Compared to young gerbils, the response latency of ABR wave ii was 
elevated for the 2 ms gap and that of wave iv for the 2 and 4 ms gaps in old gerbils. The 
variation of response latency as a function of gap duration did not differ between young and 
old gerbils for the CAP. Thus, while response latencies at the level of the cochlea (CAP) did 
not differ between age groups, the elevated latencies for short gaps in the ABR response 
(most pronounced for wave iv) argue for altered processing at the brainstem level that is not 
related to peripheral deficits. Boettcher et al. (1996) proposed that the latency shifts at the 
level of the brainstem without corresponding shifts in the periphery could be related to a 
loss of inhibition in the central auditory pathway of aged subjects.  
4.2 Structural changes 
“Healthy” ageing is associated with shrinkage of the brain that is predominantly due to 
shrinkage of neurons, loss of synapses, reduction of synaptic spines, reduction of the length 
of myelinated axons and, to a lesser degree, loss of neurons (Fjell & Waldhovd, 2010). The 
pattern of age-dependent structural changes varies greatly between different brain regions. 
In the following, we will present data on age-dependent changes of auditory brainstem 
nuclei in the gerbil.  
4.2.1 The cochlear nucleus (CN) 
Spongiform lesions begin to develop in the CN of young gerbils at the age of a few weeks or 
months and increase in size and number as the gerbil reaches 1-2 years of age (Czibulka & 
Schwartz, 1991; McGinn & Faddis, 1987; Ostapoff & Morrest, 1989; Statler et al., 1990). 
Lesions first become prominent in the PVCN and auditory nerve root and can spread to the 
deep layer of DCN and the caudal region of AVCN. In 1-2 year old gerbils, microcysts also 
developed in the superior olive, including LSO, the lateral lemniscus and ventral IC, while 
other non-auditory regions of the brain remained free of lesions (Ostapoff & Morest, 1989). 
Using immunostaining with antibodies against GFAP and S100, Czibulka & Schwartz (1993) 
concluded that up to 80% of the microcysts arise from astrocytes and only few lesions occur 
in dendrites or axons. In contrast, based on ultrastructural analysis and immunostaining 
with antibodies to MAP2, GFAP and S100, Faddis & McGinn (1997) concluded that their 
data “did not support a major role for astrocytes in lesion formation”, and transmission 
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electron microscopy revealed only 8% of the lesions in association with myelinated axons. 
Thus the contribution of glia and neurons to the formation of microcysts is currently not 
resolved.  
McGinn & Faddis (1987) showed that ligature of the external auditory ear canal in 12 day 
old gerbils before the onset of hearing suppressed the development of the lesions. Gerbils 
kept in acoustic isolation between 1 and 3 months of age developed fewer lesions compared 
to controls exposed to 74-80 dB ambient noise (McGinn et al., 1990). Czibulka & Schwartz 
(1991) found that the number and size of microcysts decreased between 1 and 3 years of age 
and the degree of lesions in old gerbils was related to hearing status: the number and the 
size of lesions were largest in the normal hearing old gerbils, while hearing loss was 
associated with smaller and fewer lesions. Thus, the activity of auditory nerve fibres 
terminating in the CN is an important factor for the formation of spongiform lesions and it 
has been suggested that lesions may be the result of excitotoxicity due to transmitter release 
by the auditory nerve fibres (Czibulka & Schwartz, 1991; McGinn et al., 1990; Faddis & 
McGinn, 1997). However, it remains an enigma why lesions are prominent in PVCN, yet 
typically spare AVCN, which also receives massive input from auditory nerve fibres. 
Possible functional consequences of spongiform lesions in old gerbils are not yet known.  
In addition to spongiform lesions, evidence for neuronal degeneration in the CN was 
observed by electron microscopy (Ostapoff & Morest, 1989) and through use of amino-
cupric silver impregnation (McGinn & Faddis, 1998). Czibulka & Schwartz (1991) found a 
significant reduction in the size of PVCN neurons, but no significant reduction in the 
number of neurons in the PVCN of gerbils between the age of 1 and 3 years. Ostapoff & 
Morrest (1989) argued that at most 5-6% of the PVCN neurons may be lost due to 
microcysts. Thus, these studies suggest that age is not associated with a prominent loss of 
neurons in PVCN.  
The cross sectional area of DCN, PVCN and AVCN was determined for 11 young and 18 old 
gerbils in sections at defined positions along the rostro-caudal extension of the CN (Stehle, 
2010; Gleich et al., 2007c). Comparing the group means of young and old gerbils revealed a 
significant reduction of the cross-sectional area by 12% in old as compared to young gerbils 
only for AVCN. The data showed a much higher inter-animal variability of AVCN cross-
sectional area in old as compared to young gerbils. A subgroup of 8 old gerbils had cross-
sectional areas below those from young gerbils (representing an average reduction of almost 
25%) while cross-sectional area of the other 10 old gerbils varied within the range observed 
for young gerbils. Counts of the GABA- and glycine-immunoreactive neurons in the CN 
subdivisions (Stangl et al., 2009) revealed only for the GABAergic neurons in the AVCN a 
significant reduction (mean 35%) in old as compared to young gerbils. The analysis of the 
size (cross sectional area) of inhibitory neurons as a function of age showed only for 
GABAergic cells of the PVCN a significant reduction (mean 16%) in old gerbils. These data 
demonstrate distinct and specific age-dependent changes in the CN subdivisions of the 
gerbil. The shrinkage of AVCN (presumably due to a loss of neuropil) in approximately half 
of the old gerbils was not associated with a comparable shrinkage in DCN and PVCN. A 
loss of GABAergic cells was only observed for AVCN, while the size of GABAergic cells was 
only reduced in the PVCN of old gerbils. Presently, the functional consequences of these 
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Lesions first become prominent in the PVCN and auditory nerve root and can spread to the 
deep layer of DCN and the caudal region of AVCN. In 1-2 year old gerbils, microcysts also 
developed in the superior olive, including LSO, the lateral lemniscus and ventral IC, while 
other non-auditory regions of the brain remained free of lesions (Ostapoff & Morest, 1989). 
Using immunostaining with antibodies against GFAP and S100, Czibulka & Schwartz (1993) 
concluded that up to 80% of the microcysts arise from astrocytes and only few lesions occur 
in dendrites or axons. In contrast, based on ultrastructural analysis and immunostaining 
with antibodies to MAP2, GFAP and S100, Faddis & McGinn (1997) concluded that their 
data “did not support a major role for astrocytes in lesion formation”, and transmission 
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electron microscopy revealed only 8% of the lesions in association with myelinated axons. 
Thus the contribution of glia and neurons to the formation of microcysts is currently not 
resolved.  
McGinn & Faddis (1987) showed that ligature of the external auditory ear canal in 12 day 
old gerbils before the onset of hearing suppressed the development of the lesions. Gerbils 
kept in acoustic isolation between 1 and 3 months of age developed fewer lesions compared 
to controls exposed to 74-80 dB ambient noise (McGinn et al., 1990). Czibulka & Schwartz 
(1991) found that the number and size of microcysts decreased between 1 and 3 years of age 
and the degree of lesions in old gerbils was related to hearing status: the number and the 
size of lesions were largest in the normal hearing old gerbils, while hearing loss was 
associated with smaller and fewer lesions. Thus, the activity of auditory nerve fibres 
terminating in the CN is an important factor for the formation of spongiform lesions and it 
has been suggested that lesions may be the result of excitotoxicity due to transmitter release 
by the auditory nerve fibres (Czibulka & Schwartz, 1991; McGinn et al., 1990; Faddis & 
McGinn, 1997). However, it remains an enigma why lesions are prominent in PVCN, yet 
typically spare AVCN, which also receives massive input from auditory nerve fibres. 
Possible functional consequences of spongiform lesions in old gerbils are not yet known.  
In addition to spongiform lesions, evidence for neuronal degeneration in the CN was 
observed by electron microscopy (Ostapoff & Morest, 1989) and through use of amino-
cupric silver impregnation (McGinn & Faddis, 1998). Czibulka & Schwartz (1991) found a 
significant reduction in the size of PVCN neurons, but no significant reduction in the 
number of neurons in the PVCN of gerbils between the age of 1 and 3 years. Ostapoff & 
Morrest (1989) argued that at most 5-6% of the PVCN neurons may be lost due to 
microcysts. Thus, these studies suggest that age is not associated with a prominent loss of 
neurons in PVCN.  
The cross sectional area of DCN, PVCN and AVCN was determined for 11 young and 18 old 
gerbils in sections at defined positions along the rostro-caudal extension of the CN (Stehle, 
2010; Gleich et al., 2007c). Comparing the group means of young and old gerbils revealed a 
significant reduction of the cross-sectional area by 12% in old as compared to young gerbils 
only for AVCN. The data showed a much higher inter-animal variability of AVCN cross-
sectional area in old as compared to young gerbils. A subgroup of 8 old gerbils had cross-
sectional areas below those from young gerbils (representing an average reduction of almost 
25%) while cross-sectional area of the other 10 old gerbils varied within the range observed 
for young gerbils. Counts of the GABA- and glycine-immunoreactive neurons in the CN 
subdivisions (Stangl et al., 2009) revealed only for the GABAergic neurons in the AVCN a 
significant reduction (mean 35%) in old as compared to young gerbils. The analysis of the 
size (cross sectional area) of inhibitory neurons as a function of age showed only for 
GABAergic cells of the PVCN a significant reduction (mean 16%) in old gerbils. These data 
demonstrate distinct and specific age-dependent changes in the CN subdivisions of the 
gerbil. The shrinkage of AVCN (presumably due to a loss of neuropil) in approximately half 
of the old gerbils was not associated with a comparable shrinkage in DCN and PVCN. A 
loss of GABAergic cells was only observed for AVCN, while the size of GABAergic cells was 
only reduced in the PVCN of old gerbils. Presently, the functional consequences of these 





4.2.2 The medial nucleus of the trapezoid body (MNTB) 
The neurons of the MNTB are glycinergic. They convert the excitatory input from the 
contra-lateral VCN to inhibitory glycinergic projections predominantly to MSO and LSO. A 
light microscopic analysis of glycine immunoreacted sections showed that spongiform 
lesions, like those previously described for the CN, were very prominent in the MNTB of 3 
year old gerbils, but were almost absent in 1 year old gerbils (Gleich & Strutz, 2002). Thus, 
spongiform lesions in MNTB develop with a delay of approximately 1-2 years compared to 
the CN. Spongiform lesions in old gerbils showed a gradient along the MNTB, decreasing 
from caudal towards rostral. The volume of MNTB was independent of age, as there was no 
shrinkage of the MNTB in old gerbils. In addition, there was no significant loss of 
glycinergic neurons in old as compared to young gerbils. In young and old gerbils, there 
was a systematic gradient of MNTB neuron size: MNTB neurons were largest in the ventro-
lateral and smallest in the dorso-medial part of MNTB. According to the tonotopic 
organisation of MNTB, low-frequency neurons appeared larger on average than high-
frequency neurons. Comparing soma size of young and old gerbils revealed a homogenous 
reduction of cross-sectional area by approximately 20% throughout the MNTB in old gerbils, 
without any indication that the shrinkage of neurons varied with the tonotopic organisation 
of MNTB. The reduced size of MNTB neurons in old gerbils may lead to a reduced 
glycinergic input into MSO and LSO (and other nuclei receiving input from MNTB) and 
consequently affect processing of binaural stimuli.  
4.2.3 The lateral superior olive (LSO) 
The light microscopic analysis of GABA and glycine immunostained sections through the 
LSO in gerbils revealed that this nucleus was rather resistant to age-dependent changes 
(Gleich et al., 2004). Although Ostapoff & Morest (1989) had reported the presence of 
microcysts in the LSO of 1-2 year old gerbils, we found no or only small lesions in the LSO 
of 7 gerbils over 3 years of age. Only 4 old gerbils showed more-prominent lesions that were 
mainly restricted to the medial (high frequency) limb of LSO, although all 11 old gerbils in 
this sample had prominent lesions in the MNTB. Thus, LSO appeared more resistant to the 
formation of spongiform lesions than the MNTB. Neither the rostro-caudal extension, nor 
the cross-sectional area of LSO varied with age, demonstrating that the LSO did not shrink 
in old gerbils. In addition, the number of neurons in Nissl stained sections, as well as the 
number of GABA- and glycine-immunoreactive neurons did not change with age: there was 
no loss of neurons in the LSO of old gerbils. The density of inhibitory neurons showed the 
same gradient along the tonotopic representation of the LSO in young and old gerbils: 
GABAergic and glycinergic neurons were more prominent in the low as compared to the 
high-frequency limb. The comparison of the size of inhibitory neurons revealed that the 
cross sectional area of GABAergic and glycinergic LSO neurons was not affected by age in 
the lateral low-frequency limb, while there was a significant reduction (≈ 30%) in the medial 
high-frequency limb. Overall, the LSO showed only limited age-related changes that were 
restricted to the high-frequency limb.  
4.2.4 The medial superior olive (MSO) 
The neurons of the MSO do not express GABA or glycine, but MSO was well recognised in 
sections through the gerbil brainstem that were immunostained with antibodies against 
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GABA and glycine (Dalles, 2009, Gleich, 2006; 2007). The number of MSO neurons was 
independent of age: there was no loss of MSO neurons in old gerbils. However, the cross 
sectional area of MSO neurons and the cross sectional area of MSO both decreased by 10% 
and 20% respectively in old as compared to young gerbils. The shrinkage of MSO in old 
gerbils is a combination of the shrinkage of MSO neurons and a reduction in the innervation 
density of MSO (loss of neuropil). Age-dependent structural changes in the gerbil MSO 
were quite pronounced.  
4.2.5 The inferior colliculus (IC) 
The analysis of age-dependent changes of the gerbil IC (Gleich et al., 2011) revealed a 
significant shrinkage of the IC cross-sectional area (13%) in old as compared to young 
gerbils. Although the mean number and cross-sectional areas of GABAergic cells in the IC 
were slightly smaller in old as compared to young gerbils, the difference between both 
groups was not significant in the sample of 7 young and 18 old gerbils analysed. The age- 
dependent changes in the GABAergic system of the gerbil IC appeared less pronounced 
than those previously described in rat (Caspary et al., 1995). This might be explained by 
differences in the degree of peripheral hearing loss of old rats and gerbils.  
4.2.6 Variation of age-dependent structural changes between auditory nuclei and 
potential functional consequences  
The structural changes in the different auditory nuclei discussed above (loss of neurons, 
shrinkage of neurons and shrinkage of the whole nucleus due to loss of innervation) vary 
considerably. The effect of age appeared least in DCN and LSO and most for AVCN and 
MSO. Unfortunately, the functional consequences of the age-dependent structural changes 
in a specific nucleus on auditory processing are typically not well understood except for 
MSO and LSO, where it has been shown that they process two distinct aspects of binaural 
sound analysis: MSO analyses inter-aural time differences while LSO analyses inter-aural 
level differences (see review in Irvine, 1992), two separate cues that can be used for 
localisation or lateralisation of a sound source. The limited age-dependent pathology in LSO 
and the more pronounced pathology of MSO suggest that lateralisation of a sound source in 
old gerbils should be less affected when based on inter-aural level difference and more 
affected when based on inter-aural time difference. Unfortunately, behavioural data in 
gerbils addressing this question are not available. However, Babkoff et al. (2002) showed 
that for a sample of 78 human subjects aged 21-88 years, tested by the presentation of click 
trains via head phones, lateralisation based on inter-aural level difference did not change 
with age while the inter-aural time difference for correct lateralisation increased with age. 
The correlation of the degree of age-dependent structural changes in LSO and MSO of the 
gerbil and the effect of age on lateralisation based on inter aural level- and inter aural time-
difference in humans is an example for a potential causal relationship of structural and 
functional age-dependent pathology.  
5. Psychoacoustic / behavioural measurements 
The first behavioural audiogram of the gerbil was determined by Ryan (1976) using a shock 
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GABA and glycine (Dalles, 2009, Gleich, 2006; 2007). The number of MSO neurons was 
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and 20% respectively in old as compared to young gerbils. The shrinkage of MSO in old 
gerbils is a combination of the shrinkage of MSO neurons and a reduction in the innervation 
density of MSO (loss of neuropil). Age-dependent structural changes in the gerbil MSO 
were quite pronounced.  
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significant shrinkage of the IC cross-sectional area (13%) in old as compared to young 
gerbils. Although the mean number and cross-sectional areas of GABAergic cells in the IC 
were slightly smaller in old as compared to young gerbils, the difference between both 
groups was not significant in the sample of 7 young and 18 old gerbils analysed. The age- 
dependent changes in the GABAergic system of the gerbil IC appeared less pronounced 
than those previously described in rat (Caspary et al., 1995). This might be explained by 
differences in the degree of peripheral hearing loss of old rats and gerbils.  
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considerably. The effect of age appeared least in DCN and LSO and most for AVCN and 
MSO. Unfortunately, the functional consequences of the age-dependent structural changes 
in a specific nucleus on auditory processing are typically not well understood except for 
MSO and LSO, where it has been shown that they process two distinct aspects of binaural 
sound analysis: MSO analyses inter-aural time differences while LSO analyses inter-aural 
level differences (see review in Irvine, 1992), two separate cues that can be used for 
localisation or lateralisation of a sound source. The limited age-dependent pathology in LSO 
and the more pronounced pathology of MSO suggest that lateralisation of a sound source in 
old gerbils should be less affected when based on inter-aural level difference and more 
affected when based on inter-aural time difference. Unfortunately, behavioural data in 
gerbils addressing this question are not available. However, Babkoff et al. (2002) showed 
that for a sample of 78 human subjects aged 21-88 years, tested by the presentation of click 
trains via head phones, lateralisation based on inter-aural level difference did not change 
with age while the inter-aural time difference for correct lateralisation increased with age. 
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where gerbils initiate a test trial by jumping onto an observation platform and indicate the 
perception of the test stimulus by jumping off the platform. In this procedure, correct 
responses are rewarded by a small food pellet. By repeated presentation of a fixed set of test 
stimuli, where the parameter under investigation varies over a given range (e.g. sound 
pressure level), a psychometric function is constructed by plotting the correct response 
probability as a function of the stimulus parameter. The derivation of threshold and other 
parameters from psychometric functions of gerbils are described in detail in Gleich et al. 
(2006). In addition to measuring threshold for the detection of signals in quiet, more 
complex tasks require the detection of a stimulus that deviates form a constantly and 
repeatedly presented background stimulus. This approach has been used to characterise the 
ability to discriminate between synthetic speech-like stimuli (Sinnott & Mosqueda, 2003), 
determine the minimum audible gap duration in a broadband noise pulse (Hamann et al., 
2004) and characterise forward masking (Gleich et al., 2007a) in gerbils.  
5.1 The audiogram and age-dependent threshold elevation 
Behaviourally–determined thresholds in up to 3–year-old gerbils using positive 
reinforcement (food reward; Hamann et al., 2002) resembled those previously reported by 
Ryan (1976) using shock avoidance. Behavioural thresholds of 30-36 month-old gerbils 
showed no significant elevation for broadband noise and 10 kHz and only a small degree of 
hearing loss at 2 kHz (mean 7.2 dB) compared to gerbils up to 1 year of age. Inter-animal 
variability of behavioural thresholds in gerbils older than 3 years increased and showed a 
higher mean loss. However, in clinical terms, the losses were only mild, typically less than 
40 dB (Hamann et al., 2002). This pattern differed considerably from the description of 
hearing loss based on previous CAP and ABR measurements where the mean hearing loss 
was 10-20 dB at 2 years of age and increased to 25-30 dB for frequencies above 4 kHz in 3 
year old gerbils (Hellstrom & Schmiedt, 1990; Mills et al., 1990). To address the question 
whether the different patterns of hearing loss observed by ABR and behavioural testing 
were due to methodology or the breeding line, Hamann et al. (2002) determined ABR 
thresholds in a group of 5 gerbils at the age of 28-29 months. On average, these gerbils 
showed a 14 dB hearing loss, whereas thresholds in 4 of these gerbils determined at 18 
months of age were not elevated. Based on the ABR, these 5 gerbils developed more than 10 
dB hearing loss between 18 and 28-29 months of age. Behavioural thresholds of these same 
gerbils were obtained a few months following ABR testing at an age of 31-33 months and 
were not found to be elevated compared to the behavioural thresholds of young gerbils. 
Thus, although ABR thresholds were clearly elevated in these gerbils at 28-29 months of age, 
the behavioural thresholds determined a few months later showed no hearing loss, the 
elevation of ABR thresholds in these old gerbils was not reflected in the behavioural 
thresholds. The difference between behavioural thresholds and thresholds determined by 
ABR in the frequency range of 1-8 kHz increased from 13-14 dB in young (< 12 months) to 
25-30 dB in approximately 2 year old gerbils. A similar observation was described in 
Boettcher (2002a) for humans. The difference between ABR and behavioural thresholds 
was around 8 dB at 2 and 4 kHz in a group of young human subjects and increased to 
around 20 dB in a group of old human subjects. Thus, ABR based thresholds in old 
humans and gerbils may lead to an over-estimation of threshold loss compared to pure 
tone audiometry.  
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There is not a simple, straight-forward explanation for the age–dependent, increasing 
discrepancy between behavioural and ABR thresholds (Hamann et al., 2002). One factor is a 
decreased synchronisation of the neural responses that will lead to reduced amplitudes of 
evoked potentials and reduced slopes of the CAP and ABR growth functions. In addition, a 
specific loss of auditory nerve fibres with low spontaneous activity, that typically have 
higher thresholds than those with high spontaneous activity could contribute to reduced 
amplitudes of CAP and ABR without associated elevation of threshold (Schmiedt et al., 
1996; Lin et al., 2011). The advanced age-dependent cochlear pathologies discussed above 
(see heading 3) will eventually lead to behavioural manifestation of hearing loss.  
5.2 Temporal integration 
Thresholds for tones increased by more than 10 dB in both normal hearing, young gerbils 
and old gerbils, as signal duration was reduced from 300 to 10 ms (Gleich et al., 2007b). Like 
in humans and other species, temporal integration was reduced in gerbils with hearing loss 
and varied as a function of threshold elevation.  
In the presence of fixed-level modulated and un-modulated speech like maskers, threshold 
shift due to the masker was inversely related to threshold in quiet: sensitive gerbils showed 
more masking compared to gerbils with slightly elevated thresholds. Consequently, the 
temporal integration functions (plots of the masked threshold as a function of duration) 
became very similar for all 13 gerbils with an age varying between 7 and 43 months and the 
functions were independent of peripheral hearing. Compared to the unmodulated masker, 
thresholds for short signals (10 and 30 ms) showed slightly more masking , while those for 
long signals (300 and 1000 ms) showed slightly less masking in the presence of the 
modulated masker, suggesting that long signals can be detected in the troughs while 
detection of short signals interferes with the peaks of the modulated masker. These data 
suggest that temporal integration in normal hearing gerbils is not affected by age.  
5.3 Gap detection 
The gap detection paradigm determines the minimum duration for the detection of a short 
period of silence (gap) embedded in a broadband noise pulse. It has been widely used to 
characterise the temporal resolution of the auditory system. By selecting old human subjects 
with no or minimal peripheral hearing loss (determined by pure tone audiometry), Snell 
(1997) demonstrated that mean gap detection thresholds increased with age even in the 
absence of peripheral hearing loss: some old subjects showed impaired performance, while 
others retained good temporal resolution, resulting in an increased inter-individual 
variability of gap detection thresholds in old human subjects. Very similar results were 
obtained in gerbils (Hamann et al., 2004). When tested with a noise carrier presented 30 dB 
above the threshold for the carrier, the minimum audible gap in young gerbils was below 4 
ms, while approximately 50% of the old gerbils had gap detection thresholds above 4 ms. 
The variation of the threshold for the noise carrier explained less than 20% of the variation 
of the gap detection threshold in gerbils. This suggests that peripheral hearing loss was not 
the dominant cause of impaired temporal resolution. These data point to central auditory 
processing deficits that result in increased gap detection thresholds in normal hearing old 
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The Mongolian Gerbil as a Model for  
the Analysis of Peripheral and Central Age-Dependent Hearing Loss 
 
83 
There is not a simple, straight-forward explanation for the age–dependent, increasing 
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al., 1996). The similarity of age-dependent changes in gap detection by humans and gerbils 
emphasises the usefulness of the gerbil model for the analysis of impaired auditory 
temporal processing.  
5.4 Forward masking 
Forward masking is a phenomenon through which threshold for a probe that follows a 
signal (masker) is elevated (masked) and recovers with time (≈ 100 ms) following the end of 
the masker. Increased masking and delayed recovery from preceding acoustic stimulation 
interferes with the detection of fluctuations and transients in sound signals and might 
contribute to age-dependent impairment of speech perception. In the analysis of the effect of 
age on forward masking in gerbils (Gleich et al., 2007a) a 2.85 kHz masker presented at 40 
dBSPL and repeated continuously every 1.6 seconds served as a constant background signal. 
Animals had to detect trials where a short 2.85 kHz probe signal (20 ms) was presented 2.5 
ms after the end of the masker. In addition to the masked threshold, the threshold for the 
probe signal without a masker was determined to characterise peripheral hearing. In a 
sample of 15 gerbils between 5 and 36 months of age, threshold for the probe in quiet was 
independent of age (mean 12 dBSPL). These animals showed no sign of peripheral hearing 
loss. In contrast, the masked thresholds of these gerbils increased from around 33 dB SPL at 
1 year of age to 48 dBSPL at an age of 3 years. The efficacy of the masker increased by 15 dB 
between 1 and 3 years of age. The increased degree of forward masking in old gerbils in the 
absence of elevated thresholds in the condition without a masker suggests a deficit in 
central, rather than peripheral, auditory processing. An analysis of forward masking using 
ABR in humans also demonstrated increased forward masking in old subjects with normal 
audiometric thresholds and led to the conclusion that this was likely due to changes in 
central auditory processing (Walton et al., 1999). Thus, gerbils appear to be a useful model 
for the analysis of the interaction of age and forward masking.  
5.5 Auditory spatial resolution 
Age-dependent structural changes in auditory nuclei involved in binaural processing have 
been discussed above (see headings 4.2.3-4.2.5). Consistent with the pathology in MNTB, 
MSO and LSO, auditory spatial resolution was impaired in old gerbils (Maier et al., 2008). 
The minimum resolvable angle in a sound lateralisation task showed a higher degree of 
inter-animal variability in old (32 to 51 months), as compared to young (3-8 months), gerbils. 
The angle for pure tones (0.5 and 8 kHz) and narrowband noise centred at 0.5 and 2 kHz 
was ≈ 50-60° in old gerbils, approximately twice the angle found in young gerbils. Maier et 
al. (2008) suggest that spongiform lesions in the VCN compromise the excitatory input, 
while pathology of the MNTB affects the inhibitory input to LSO and MSO and contribute to 
impaired auditory spatial resolution in old gerbils.  
5.6 Pharmacotherapy 
The available data indicate that ageing is associated with a loss of inhibition in the central 
auditory pathway, which could contribute to impaired auditory temporal processing 
(Caspary et al., 2008). Age-dependent changes in neurotransmitter systems might be 
influenced by pharmacotherapy and the similarity of age-dependent deficits between 
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humans and gerbils with respect to gap detection and forward masking makes the gerbil an 
ideal model to test the effect of candidate substances on performance. Some anti-convulsive 
drugs in the context of epilepsy were designed to interact with the GABA system.  
For our first study, we chose to analyse the effect of Sabril® (vigabatrin) on gap detection 
(Gleich et al., 2003). Vigabatrin blocks the GABA converting enzyme GABA transaminase 
and consequently leads to elevated levels of GABA in the brain. The effect of vigabatrin at a 
dose of 50 mg/kg/day was dependent on the initial gap detection threshold. Performance 
in gerbils with initially low gap detection thresholds were not systematically affected by the 
drug, while those with initially elevated gap detection thresholds improved and normalised 
to a level comparable to sensitive animals. The beneficial effect of vigabatrin on impaired 
gap detection was reversible, with gap detection thresholds increasing after the end of the 
treatment. These data clearly demonstrate the potential use of pharmacotherapy for the 
treatment of impaired auditory temporal resolution. Unfortunately, severe side effects on 
the visual system prevent the therapeutic use of vigabatrin for the treatment of hearing loss.  
In a subsequent study, we evaluated the effect of gabapentin on gap detection and forward 
masking in gerbils, since other studies suggested beneficial effects of gabapentin for certain 
forms of tinnitus (Gleich & Strutz, 2011). Gabapentin was initially designed as a GABA 
analogue for the treatment of epilepsy and is also used for the treatment of neuropathic 
pain. In gerbils, gabapentin had no beneficial effect on impaired gap detection or on 
elevated masked thresholds. Unexpectedly, the data showed that gapapentin at a dose of 
350 mg/kg/day increased masked thresholds in young gerbils, while it had no significant 
effect in old gerbils that had elevated masked thresholds before gabapentin treatment. The 
lack of a beneficial effect on impaired gap detection and increased forward masking in old 
gerbils could be due to an insufficient effect of gabapentin on the GABA system, while the 
increased masked thresholds of young gerbils during gabapentin treatment might be related 
to its interaction with voltage-gated calcium channels.  
6. Conclusion  
At the level of the cochlea, pathology begins to affect the marginal cells of the stria 
vascularis and eventually leads to a reduction of the endocochlear potential in old gerbils. 
Loss of hair cells and loss of auditory nerve fibres and spiral ganglion cells are not major 
contributors to age-dependent peripheral hearing loss. Consequently, gerbils can be 
regarded as a good model for strial or metabolic presbyacusis.  
Behavioural and evoked potential (CAP, ABR) measures of auditory sensitivity are useful to 
characterise hearing status; however, the degree of age-dependent threshold elevation 
depends on the method used: the discrepancy between thresholds determined 
psychoacoustically and by evoked potentials increases with age; evoked potentials indicate 
more threshold loss than behavioural methods in old gerbils and old humans.  
Auditory nuclei in the ascending auditory pathway of gerbils show specific and distinct age-
dependent structural changes, where some nuclei appear more affected than others. 
Structural changes in nuclei involved in binaural processing are associated with impaired 
auditory spatial resolution in old gerbils. For LSO and MSO, the degree of age-dependent 
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humans and gerbils with respect to gap detection and forward masking makes the gerbil an 
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drugs in the context of epilepsy were designed to interact with the GABA system.  
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(Gleich et al., 2003). Vigabatrin blocks the GABA converting enzyme GABA transaminase 
and consequently leads to elevated levels of GABA in the brain. The effect of vigabatrin at a 
dose of 50 mg/kg/day was dependent on the initial gap detection threshold. Performance 
in gerbils with initially low gap detection thresholds were not systematically affected by the 
drug, while those with initially elevated gap detection thresholds improved and normalised 
to a level comparable to sensitive animals. The beneficial effect of vigabatrin on impaired 
gap detection was reversible, with gap detection thresholds increasing after the end of the 
treatment. These data clearly demonstrate the potential use of pharmacotherapy for the 
treatment of impaired auditory temporal resolution. Unfortunately, severe side effects on 
the visual system prevent the therapeutic use of vigabatrin for the treatment of hearing loss.  
In a subsequent study, we evaluated the effect of gabapentin on gap detection and forward 
masking in gerbils, since other studies suggested beneficial effects of gabapentin for certain 
forms of tinnitus (Gleich & Strutz, 2011). Gabapentin was initially designed as a GABA 
analogue for the treatment of epilepsy and is also used for the treatment of neuropathic 
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350 mg/kg/day increased masked thresholds in young gerbils, while it had no significant 
effect in old gerbils that had elevated masked thresholds before gabapentin treatment. The 
lack of a beneficial effect on impaired gap detection and increased forward masking in old 
gerbils could be due to an insufficient effect of gabapentin on the GABA system, while the 
increased masked thresholds of young gerbils during gabapentin treatment might be related 
to its interaction with voltage-gated calcium channels.  
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At the level of the cochlea, pathology begins to affect the marginal cells of the stria 
vascularis and eventually leads to a reduction of the endocochlear potential in old gerbils. 
Loss of hair cells and loss of auditory nerve fibres and spiral ganglion cells are not major 
contributors to age-dependent peripheral hearing loss. Consequently, gerbils can be 
regarded as a good model for strial or metabolic presbyacusis.  
Behavioural and evoked potential (CAP, ABR) measures of auditory sensitivity are useful to 
characterise hearing status; however, the degree of age-dependent threshold elevation 
depends on the method used: the discrepancy between thresholds determined 
psychoacoustically and by evoked potentials increases with age; evoked potentials indicate 
more threshold loss than behavioural methods in old gerbils and old humans.  
Auditory nuclei in the ascending auditory pathway of gerbils show specific and distinct age-
dependent structural changes, where some nuclei appear more affected than others. 
Structural changes in nuclei involved in binaural processing are associated with impaired 
auditory spatial resolution in old gerbils. For LSO and MSO, the degree of age-dependent 





in sound lateralisation tasks, which are based on inter-aural level and inter-aural time 
difference cues. This suggests a causal relationship between structural and functional age-
dependent changes.  
The age-dependent decline of auditory temporal resolution determined by gap detection 
and forward masking in gerbils and humans is very similar and probably due to loss of 
inhibition or age-dependent disturbance of neurotransmitter balance in the auditory 
pathway. Augmentation of the GABA system by vigabatrin was effective in the treatment of 
impaired gap detection in gerbils and demonstrates that pharmacotherapy of central 
auditory processing deficits appears feasible, in principle. The challenge is to identify 
appropriate substances that act on the disturbed neurotransmitter balance in advanced age. 
The available data show that the gerbil is a suitable model to evaluate the efficacy of 
potential therapies for the treatment of impaired central auditory processing.  
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1. Introduction 
The present chapter presents an empirical study of parental practices and behaviors related 
to children with and without hearing loss. Studies of families of children with hearing loss, 
as well as aspects related to the influence of parental practices upon the behavior of children 
give support to the present research. 
1.1 Families of children with hearing loss 
People with communication disorders caused by hearing loss may present complex 
manifestations involving linguistic, cognitive, behavioral, psychological and social 
alterations. The causes can be isolated or associated to clinical aspects of different 
neurological or genetic problems. Children with hearing loss (HL) may be considered as a 
high risk population due to the presence of indicators such as:  language delay, which 
involve communication skills, low academic progress and social emotional level (Calderon, 
2000). The presence of such impairments may cause some difficulties concerning the 
development of the children and the relationship with their parents.   
Some preventive measures should be taken more actively including the primary ones which 
reduce the birth incidence of children with hearing loss and secondary ones that help in its 
early detection. (Gatto & Tochetto, 2007).  
In addition to hearing screening programs researchers emphasize the importance of training 
health professionals to guide parents on how to communicate with their children. The need 
to decide beforehand (without having enough knowledge of their benefits) the 
communication form that is to be used with their children possibly is a stress trigger which 
may influence the quality of the interaction between parents and children. (Gravel & 
O´Gara, 2003). Early identification of hearing loss and the consequent counseling services 
available in the community may help parents establish effective relationships with their 
children (Marchesi, 1996), and if followed by intervention allows fast access to available 
technologies (Smith, 2008). If this happens before six months of age, the life of the child will 
be positively affected, increasing the prognosis of better school performance (Smith, 2008; 
Marscharck, 2001; Yoshinaga-Itano & Sedey, 2000). 
In the Brazilian culture parents emphatically employ verbal behavior to interact with the 
children from an early age. This type of behavior provides no positive effect for children 
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with hearing loss.  Parents tend to reduce this and other types of communicative behaviors 
towards their deaf children as soon as they find out their children cannot hear them. A 
study was conducted with 19 parents in order to check feelings and expectations towards 
children with hearing loss. The results showed communication problems because the 
parents took a long time to make use of other communication means to facilitate the 
relationship between them (Boscolo & Santos, 2005). 
In a literature review about family relationships and presence of children with hearing loss, 
it was observed that mothers were less equalitarian and spontaneous with deaf children 
than with the other children. They were also more restricting and controlling (Brito & 
Dessen, 1999). The relationship of the fathers with the children with hearing loss tended to 
be somewhat absent. The mothers assumed the care of the children and, consequently, their 
education (Brito, 1997). Fathers participated less intensively on the development of the 
children using more rational justifications, culturally more accepted, as the necessity of 
being absent due to work. However, fathers tend to present the same anguish and anxiety 
feelings reported by mothers (Canho, Neme & Yamada, 2006). The authors suggest 
intervention procedures geared towards the fathers in order to make them active 
participants in the upbringing of the children. In the Brazilian culture, the mother is 
responsible for taking care of the house, raising the children, including the ones with no 
disorder (Oliveira, Simionato, Negrelli & Marcon, 2004; Guarinello, 2004; Dias, Rocha, 
Pedroso & Caporali, 2005). 
The authors above focus on the important role familiar interactions have for the 
development of deaf children. They represent opportunities for both of them to learn how to 
communicate with each other.   
The early use of bimodal communication (oral and gestures), may prevent problems and 
promote mutually satisfactory interactions between parents and deaf children (Oliveira, 
Simionato, Negrelli & Marcon, 2004; Guarinello, 2004; Dias, Rocha, Pedroso & Caporali, 
2005). Thus, interventions with children with hearing loss must also focus on their families. 
The use of sign language by the family helps these children to interact with the surrounding 
world, favoring satisfactory and appropriate relationships (Negrelli & Marcon, 2006; 
Lacerda, 2003). 
Deaf children with deaf parents who learned the sign language during childhood had better 
school performance than deaf children with hearing parents. Deaf children learned to read 
and write two years before those with hearing parents (Marscharck, 1993).  Nevertheless, 
90% of the children with hearing loss have hearing parents. This fact may lead to super 
protective practices due to communication problems (Gargiulo, 2003). 
Hearing parents expect their children to speak. They take longer to understand that other 
forms of communication are possible. Such communication difficulties between them may 
cause social skills deficits in the children (Boscolo & Santos, 2005).  
Social skill may lead to a better development and help preventing behavioral problems. 
They may also aid the children to interact positively with people, increasing the possibility 
of social support as well as being able to solve problems. 
Apart from hearing loss, studies have reported an inverse relation between social skills 
repertoire and behavior problems (Cia & Barham, 2009). Nevertheless, there is an 
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assumption that children with hearing loss have a lack of social skills and more behavior 
problems, as compared to hearing children.  
A review of Brazilian papers published between 1995 and 2005 has identified the 
relationship between parents and children with hearing loss (Bisol, Simioni & Sperb, 2008). 
However there are no reports comparing positive and negative practices of parents. There 
are no studies comparing those conducted in clinical and nonclinical groups. 
One study compared parental educational practices of hearing families with deaf children, 
and hearing families with hearing children. The results obtained showed that parents of 
children with hearing loss (HL) expressed less feelings and opinions, and did not play very 
much with their children. The positive practices were most frequent among parents of 
hearing children. Nonetheless, the study did not control other important variables as the 
presence or absence of behavior problems in the children (Rodrigues et al. 2010). 
1.2 Parental educational practices of mothers of children with hearing loss 
Behavioral evaluation of children and parental educational practices are important and 
necessary to identify the difficulties and the resources they present. It permits the 
elaboration of behavioral diagnosis and effective interventions with the children or with 
their parents/caretakers. Evaluation procedures include: spontaneous report during the 
interview, oriented instruments (scales, inventory) and direct observation in a natural or 
structured environment. However, it is important to investigate parental practices and 
behavior of children through validated instruments. In this study a validated inventory 
Roteiro de Entrevista de Habilidades Sociais Educativas Parentais (RE-HSE-P) (Interview 
Guide of Parental Educational Social Skills  - Bolsoni-Silva, Loureiro & Marturano, 2011)1 
was used. It evaluates positive and negative parental educational practices, as well as 
behavior problems and social skills of children reported by the mothers. 
Behavior problems are classified as internalizing (isolation, depression, anxiety and somatic 
complaints) and externalizing behaviors (impulsiveness, aggression, agitation, challenging 
and anti-social characteristics) (Achenbach & Edelbrock, 1979). In any of the situations if 
they occur for at least six months they can be considered as emotional disorders 
(internalizing) or as disruptive behavior (externalizing) according to DSM-IV (APA, 2006). 
The externalizing behaviors are characterized by improper expression usually towards other 
people, with a tendency to harm them (Kazdin & Weisz, 2003). On the other hand, 
internalizing behaviors refer to harmful actions towards the person himself. However, in 
both cases they are considered inadequate for infantile social skills. 
Infantile social skills have been reviewed by Calderella (Caldarella & Merrell, 1997). They 
identified a diversity of infantile social skills, as follows: 1)  peers relationship skills (greeting, 
praising, helping, negotiating, inviting friends to play); 2) self-control skills (controlling 
humor, dealing with criticism); 3) academic skills (removing doubts, following teacher’s 
instructions, working independently); 4) adaptability skills (following rules and instructions, 
                                                 
1  This study kept the original denomination for RE-HSE-P. The corresponding name in English is 
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assumption that children with hearing loss have a lack of social skills and more behavior 
problems, as compared to hearing children.  
A review of Brazilian papers published between 1995 and 2005 has identified the 
relationship between parents and children with hearing loss (Bisol, Simioni & Sperb, 2008). 
However there are no reports comparing positive and negative practices of parents. There 
are no studies comparing those conducted in clinical and nonclinical groups. 
One study compared parental educational practices of hearing families with deaf children, 
and hearing families with hearing children. The results obtained showed that parents of 
children with hearing loss (HL) expressed less feelings and opinions, and did not play very 
much with their children. The positive practices were most frequent among parents of 
hearing children. Nonetheless, the study did not control other important variables as the 
presence or absence of behavior problems in the children (Rodrigues et al. 2010). 
1.2 Parental educational practices of mothers of children with hearing loss 
Behavioral evaluation of children and parental educational practices are important and 
necessary to identify the difficulties and the resources they present. It permits the 
elaboration of behavioral diagnosis and effective interventions with the children or with 
their parents/caretakers. Evaluation procedures include: spontaneous report during the 
interview, oriented instruments (scales, inventory) and direct observation in a natural or 
structured environment. However, it is important to investigate parental practices and 
behavior of children through validated instruments. In this study a validated inventory 
Roteiro de Entrevista de Habilidades Sociais Educativas Parentais (RE-HSE-P) (Interview 
Guide of Parental Educational Social Skills  - Bolsoni-Silva, Loureiro & Marturano, 2011)1 
was used. It evaluates positive and negative parental educational practices, as well as 
behavior problems and social skills of children reported by the mothers. 
Behavior problems are classified as internalizing (isolation, depression, anxiety and somatic 
complaints) and externalizing behaviors (impulsiveness, aggression, agitation, challenging 
and anti-social characteristics) (Achenbach & Edelbrock, 1979). In any of the situations if 
they occur for at least six months they can be considered as emotional disorders 
(internalizing) or as disruptive behavior (externalizing) according to DSM-IV (APA, 2006). 
The externalizing behaviors are characterized by improper expression usually towards other 
people, with a tendency to harm them (Kazdin & Weisz, 2003). On the other hand, 
internalizing behaviors refer to harmful actions towards the person himself. However, in 
both cases they are considered inadequate for infantile social skills. 
Infantile social skills have been reviewed by Calderella (Caldarella & Merrell, 1997). They 
identified a diversity of infantile social skills, as follows: 1)  peers relationship skills (greeting, 
praising, helping, negotiating, inviting friends to play); 2) self-control skills (controlling 
humor, dealing with criticism); 3) academic skills (removing doubts, following teacher’s 
instructions, working independently); 4) adaptability skills (following rules and instructions, 
                                                 
1  This study kept the original denomination for RE-HSE-P. The corresponding name in English is 





using free time properly, answering requests); 5) assertive skills (starting conversation, 
accepting invitations, replying greetings).  Nonetheless, other components of the children 
social skills may be present, such as: emotional expressiveness, civility, empathy, 
interpersonal problems solution, ability to make friends and social academic skills (Del 
Prette & Del Prette, 2006).   
In a study with 48 preschoolers (24 with behavioral problem and 24 without), behavioral 
categories for the infantile social skills were suggested from evaluations of mothers and 
teachers. They were classified as: (a) Social availability and cooperation: Child makes 
requests, tries to help, asks questions, greets people, praises people, takes initiatives; (b) 
Expression of feelings and coping: expresses properly: thoughts, concerns and needs, 
shows distress, gives opinions, claims personal rights, is usually in a good mood and 
negotiates; (c) Positive social interaction: communicates in a positive manner, makes 
friends, plays with them, has nonverbal interaction (Bolsoni-Silva, Marturano, Pereira & 
Manfrinato, 2006). 
Positive parental practices may avoid the appearance and/or the maintenance of difficulties 
in interactions established between parents and children. On the other hand, negative 
practices may increase the probability of their occurrences (Patterson, Reid & Dishion, 2002).  
Positive educational practices include positive monitoring and moral behavior. Positive 
monitoring comprises the appropriate employment of attention and to grant privileges. 
Moral behavior implies promoting favorable conditions to the development of virtues and 
cultural values (empathy, notion of justice, responsibility, and work). Negative educational 
practices comprise negligence, permissiveness, negative monitoring, inconsistent 
punishment and physical abuse (Gomide, 2006).  
Parental social educational skills constitute important behaviors to guarantee a positive 
parental practice. In order to study the parents-children interaction as parental educational 
social  skills (ESS-P); such skills were classified as: communication (talking, asking) 
expression of feelings and coping (expressing positive and negative feelings, opinions, 
demonstrating concern, playing) and establishing limits (identifying and reinforcing socially 
skilful and nonskilful behaviors, setting rules, being consistent, agreeing with the spouse, 
fulfilling promises, identifying mistakes and apologizing) (Bolsoni-Silva, Loureiro & 
Marturano, 2011). 
The interview guide (RE-HSE-P) was elaborated based on the propositions of authors 
involved in the social skills field (Del Prette & Del Prette, 1999; Caballo, 1991) and 
researchers involved in the study of parental practices (Patterson, Reid & Dishion, 2002; 
Reid, Webster-Stratton & Hammond, 2003). Authors of the Behavior Analysis field were 
consulted especially concerning the application of functional analyses in clinical practice 
(Goldiamond, 1974/2002; Meyer, Oshiro, Mayer, & Starling, 2008). The RE-HSE-P was 
validated and it has been employed in characterization studies (Bolsoni-Silva & Marturano, 
2008) and as a pre and post-test measure at interventions (Bolsoni-Silva & Marturano, 2010) 
being effective in differentiating groups with and without problems. It has also being used 
in the identification of behavioral patterns of parents and children after intervention, by 
functional analysis. 
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The term functional analysis contains different definitions (Meyer, Oshiro, Mayer, & 
Starling, 2008) and it was elaborated from the Experimental Analysis of Behavior. For the 
clinical context it reinforces the relevance of evaluating several behaviors and multiple 
causes, considering antecedent variables (environment), response (reported or observed 
behavior) and consequent (events which occur after the answers). Considering parents-
children interactions the consequent variables constitute the children’s behaviors towards 
the parents’ behavior and vice-versa (Goldiamond, 1974/2002). 
In order to compare the parental educational social skills of two groups of mothers (one of 
children with hearing loss, and the other with hearing children without any behavior 
problems or other disorder) the RE-HSE-P was employed.  
Differences were found between the clinical and nonclinical population, in relation to 
parental educational social skills (ESS-P), the infantile social skills, and the contextual 
variables. There were no differences between the groups in relation to negative practices 
and behavior problems. However, there were no evaluations for the sub-categories of the 
following behaviors: communication, expressiveness and the establishment of limits 
(Bolsoni-Silva, Loureiro & Marturano, 2011). Describing them may help in the identification 
of behavior which can be focus of rapid interventions without neglecting other needs of the 
studied population. Therefore, additional analyses must be performed comparing the 
interactions established between parents and children from the hearing loss (HL) group and 
from the nonclinical group. 
The present study aims at comparing the quality of interactions established between parents 
and children, considering two groups: Clinical Group x Nonclinical Group (normative). 
Specific objectives were to describe and compare behaviors denominated as positive 
parental practices (Parental Educational Social Skills - ESS-P), negative parental practices 
(aggressiveness and no assertiveness), infantile social skills, and behavior problems. 
2. Method 
2.1 Participants      
A total of 52 mothers took part in this study whose children presented hearing loss (n = 27) 
(HL Group) or children who were part of a normative/nonclinical sample (n = 26) 
(Normative Group). The children with hearing loss (HL) used Hearing Aids (HA - AASI 
Aparelho de Amplificação Sonora Individual) and had hearing parents. They were 
identified at CEDALVI/HRAC/USP (Center of Hearing, Language and Vision Disorders, in 
the Hospital for the Rehabilitation of Craniofacial Anomalies, at University of São Paulo, 
Bauru, São Paulo, Brazil). The normative/nonclinical sample (n = 26) comprised two 
studies: the first evaluated the effectiveness of an intervention procedure (Bolsoni-Silva, 
Salina, Versuti & Rosin-Pinola, 2008) and  the other evaluated the parental practices of 
separated/divorced mothers (Boas & Bolsoni-Silva, 2010). 
2.2 Inventory 
The Roteiro de Entrevista de Habilidades Sociais Educativas Parentais (Interview Guide of 
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was used. It evaluates the occurrence and the quality of social skills applicable to 
educational practices and behavior of children, contingent to: starting conversation, asking 
questions in general (Communication), expressing positive and negative feelings and 
opinions (Expressiveness), affection, situations and strategies used to establish limits, identify 
children’s behavior, what he/she likes and dislikes, accomplish promises (Limits 
Establishment). In total the inventory comprises 70 items and comprehends alpha of 0.846. 
They are organized into two factors: positive and negative interaction characteristics. The 
positive interactions are: educational social skills and infantile social skills. The negative 
ones are: negative practices and behavior problems. 
2.3 Data collection procedures 
Data from HL and normative groups were collected in the clinics. For the normative group 
the data were collected in their houses and/or at the children’s schools. After the consent of 
the respondent the mothers signed an Informed Consent. The interviews were conducted 
according to a specific set of procedures. The answers were recorded for further 
categorization. 
2.4 Treatment procedures and data analysis 
Data were computed according to the given information and organized into previously 
reported categories. Comparisons were made between hearing loss and normative groups (t 
Student Test).  
3. Results 
The results were synthesized according to three broad categories of RE-HSE-P: 
Communication, Expressiveness and Limits Establishment. 
Figures 1 and 2 present, respectively, the results of the participant’s mothers behavior of 
“talking” and “asking” which are part of the communication category. Asterisks in the figures 
correspond to the items with statistically significant differences. The bars identify the clinical 
group and the lines the nonclinical group. 
Analyzing the answers to the question “Do you talk to your child?”, “What subjects do you 
discuss?” (Figures 1 and 2), it was observed that both groups talked to their children in order 
to teach them what is correct or incorrect, mainly concerning externalizing behaviors 
(especially disobedience and aggressiveness). Notwithstanding, the nonclinical group more 
frequently than the clinical group talked about different subjects (clinical average 0.63, SD = 
0.88; nonclinical average= 1.42, SD = 1,.5; p = 0.029), and in different periods of the day 
(clinical average = 0.26, SD = 0.45;  nonclinical average = 0.70, SD = 2.11; p = 0.002). The 
children without hearing loss acted positively during these periods. They demonstrated 
socially skilful behaviors, such as: talking, keeping eye contact, giving attention to the 
mothers (nonclinical average = 1.81, SD = 1.09). The clinical group also demonstrated social 
skills (clinical average = 0.89, SD = 0.95), but with a statistically significant difference in 
inferiority (p = 0.001). Both groups sometimes answered with nonskilful behaviors 
(problems concerning externalizing or internalizing behaviors) during conversations,, with 
no statistical difference between the groups. 
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Fig. 1. Average frequency of antecedent variables and behavior of children when the mother 
talks to them.2 
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When the answer included “different periods of the day” to the question “When”, the 
mothers reported the following: on the way to school, at night, after arriving from school, 
during the day, during hygiene care, in all the situations, on vacation, on weekends, late 
afternoon, at time to get up, during meal times, during homework time, on the traffic, 
arriving from a trip, arriving from work, when they were together, when going to bed.  
As an answer to the question “Which subject?” mothers reported “different subjects” as 
follows: everyday life, leisure time, usefulness of objects (for instance: pans, brooms), 
meaning of concepts and objects, something that the child saw, a party, food, animals, plays, 
cars, father-mother relationship (marriage and separation), drugs, private events involving 
the mother and the child, personal hygiene, their own body, infantile books, soap operas/ 
cartoons/television programs, the mother’s job, wishes and interest of the child, the future 
of the family and/or the child, offer help to the child, dangers facing the world, members of 
the family, which clothes to wear, religion, health, violence and other questions asked by the 
child. 
About the interactions established for the mothers’ questions the groups did not present 
differences. Both talked during different situations and sometimes the children answered in 
a socially skilful manner, and sometimes not. 
Expressiveness corresponds to a category of parental educational practice and behavior of the 
children corresponding to four questions of the RE-HSE-P: “Do you express positive feelings 
towards your child?”, “Do you express negative feelings towards your child?”,  Do you 
express your opinions to your child?”, “Do you caress your child?”. After each of these 
questions the respondent was required to talk about the quality of the interventions 
established between parents and children. The answers to these questions were analyzed 
and according to the occasions in which they occurred, were denominated as context 
variables. The obtained categories were as follows: in several situations, the mother’s 
personal problems, treating the environment carelessly, after calling the attention of the 
child, due to his/her behavior, before something interesting that the child has done, during 
leisure time and when the child was not feeling well. Another set of categories refers to 
features of mothers’ behavior, present in two classifications of ESSP-P:  1. Communicates and 
expresses feelings and coping and, 2. Negative educational practice (beating, shouting). 
The last set of categories refers to features of the children’s behavior contingent to the 
mother’s, described as skilful behavior and behavior problem (internalizing and 
externalizing). The results of the questions about “positive feelings” are demonstrated in 
Figure 3. 
The ESS-P “Communication to express positive feelings” refers to the parents’ behavior of 
expressing tenderness in relation to the child or the child’s appropriate behavior. The ESS-P 
“Expresses feelings and coping” refers to:  touches the child, plays, hugs and kisses. The 
comparison between groups shows that the clinical group expresses feelings less in a 
“communicating” way than the nonclinical group (clinical = 1.15, SD = 0.71; nonclinical 
average = 2.31, SD = 1.59; p = 0.002). The groups equally “express feelings and coping”.  
Figure 4 presents “Tenderness expression” for each group. It can be observed that the 
groups express tenderness towards good behaviors equally in leisure situations and when 
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0.19; nonclinical average = 0.35, SD = 0.63; p = 0.023). In these situations, the mothers of 
children without any deficiency are significantly more dedicated (clinical average = 0.04, SD 
= 0.19; nonclinical average = 0.35, SD = 0.63; p = 0.023) and as consequence, their children 
correspond more intensely to the expression of tenderness (clinical average = 0.04, SD = 0.19; 
nonclinical average = 0.35, SD = 0.63; p = 0.003). 
 
Fig. 3. Average frequency of how mothers express positive feelings to the children. 
Figure 5 shows that both groups express opinions about different subjects. Nonetheless, the 
children from the nonclinical group behaved more frequently according to the category 
“Expression of feelings and coping” (clinical average = 0.48, SD = 0.51; nonclinical average = 
1.15, SD = 1.00; p = 0.004). Some examples of how the child behaves are: hugs, accept the 
adults’ opinion, thanks, gives support to parents when they are sad, gives his/her opinion, 
and explain his/herself. 
Figure 6 presents the context and the mothers’ and children’s behaviors when mothers 
expressed negative feelings. Both groups expressed these feelings when they had personal 
problems, when were in dangerous environments, faced optimal behaviors of children, 
discussed several subjects and also after reprimands. Nonetheless, the nonclinical group 
used more negative educational practices (clinical average = 0.30, SD = 0.54; nonclinical 
average = 1.50, SD = 1.53; p = 0.004) in addition, these children expressed affection in these 
moments more frequently (clinical average = 1.11, SD = 0.89; nonclinical average = 2.08, SD 
= 1.62; p = 0.004). 
The following examples can be considered as negative practices: verbal and/or non verbal 
threatening (deprive of privileges, beating), punishment (grounding), tightening the arm of 
the child,  beating, shouting, fighting, getting nervous, calling names, talking a lot, saying 
“no” without explaining the reason, saying that will exchange the children for other ones, 
accusing/criticizing the spouse’s behavior, cheating, imitating the incorrect behavior of the 
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Fig. 5. Mean frequency of antecedent variables when mothers expressed opinions and 
behaviors of children in these interactions. 
Establishment of limits consisted in another category of educational practices and children’s 
behaviors corresponding to four questions of the RE-HSE-P:  “Why does it become important to 
establish limits?”, “What do you do to establish them?”, “Does your child do things that you like?”, 
“Does your child do things that you do not like?” After each of these questions the respondent is 
required to talk about the quality of the interactions established regarding the occasions in 
which they occurred, the type of the mother’s behavior, and the child’s behavior in relation 
to the mother’s. The answers from the analyses of content according to RE-HSE-P, were 
classified into three subcategories: (a) context variables: facing the obedience of the child,  
teaching what is correct and incorrect, having control of the behavior of the child,  
protecting the health of the child, and in leisure environment; (b) mother’s behaviors: b1) 
communicates and expresses feelings and coping and, b2) makes uses of negative practices 
(beating, shouting, being quiet/not doing anything) and, (c) children’s behavior: skilful and 
behavior problems (internalizing and externalizing). 
Figure 7 describes the results of the identification of appropriate behaviors and mothers-
children interactions in these situations. Both groups consider as appropriate the obedience 
of the children, but the nonclinical group statistically highlights the expression of affection 
of the children (clinical average = 0.41, SD = 0.50; nonclinical average = 0.88, SD = 0.86; p = 
0.019). Both groups use few negative practices, but do not report positive practices. Possibly 
in these situations even if the mothers identify the proper behavior they do not reinforce it.  
The children from both groups demonstrate behaviors corresponding to “expressing 
feelings and coping”. 
Figure 8 presents the interactions involved when the child demonstrates behaviors that 
mothers disapprove. Both groups do not like it when children are disobedient or when they 
are aggressive. Equally, in these occasions, the groups show behaviors considered as 
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Fig. 7. Behaviors that mothers approve, maternal behaviors, and children’s reactions.  
disappointed), especially the clinical group (clinical average = 2.04, SD = 0.59; nonclinical 
average = 1.38, SD = 1.10; p = 0.011). Children from both groups obey in the same degree , 
present internalizing or externalizing behaviors, though, the children with deficiency 
apologize or give explanations more frequently (clinical average = 0.15, SD = 0.36; 
nonclinical average = 0.81, SD = 1.02; p = 0.004). 
Figure 9 describes the reasons given by the mothers to establish limits, their behaviors and 
the behaviors of their children. It can be observed that mothers from both groups consider 
important the use of limits establishment to teach children how to behave correctly and 
safely according to social standards during meals and plays. 
However, the nonclinical group, more than the hearing loss group, emphasizes intensely 
that it is important to establish limits in order to have control over the child’s behavior 
(clinical average = 0.22, SD = 0.42; nonclinical average = 1.35, SD = 1.32; p = 0.000), to teach 
social relationship rules (clinical average = 0.07, SD = 0.27; nonclinical average = 0.46, SD = 
0.86; p = 0.036) and when the child treats their belongings and the environment carelessly 
(clinical average = 0.37, SD = 0.63; nonclinical average = 0.92, SD = 1.16; p = 0.039).  
Mothers of both groups reported that they demonstrated behaviors denominated as positive 
and negative educational practices, and informed that they felt fine behaving this way. 
Likewise, in these situations, the children demonstrated behaviors considered as problems, 
such as disobedience and aggressiveness.  
Figure 10 shows global results comparing both groups. In Figure 10 it can be observed that 
mothers of the nonclinical group reported that they behaved in a social skilful way 
(clinical average = 6.07, SD = 2.05; nonclinical average = 10.31, SD = 3.78; p = 0.000) as did 
their children (clinical average = 5.70, SD = 2.30; nonclinical average = 11.00, SD = 4.72; p 
= 0.000). 
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Fig. 9. Frequency of previous situations, maternal behaviors, and reactions of children 
before setting limits. 
 




Fig. 10. Categories totals of RE-HSE-P. 
4. Conclusion  
The quality of interactions established between mothers and children with hearing loss were 
positively correlated with the social skills of the children and with the context variables. The 
results indicated that the interactions established between mothers and children favor the 
acquisition and maintenance of the social skills repertoire. For the hearing loss group both 
mothers and children presented a poor social skills repertoire in comparison to the 
normative group. 
As for Communication, the HL group, when compared to the normative group reported 
talking to their children less frequently about subjects of their interests and in fewer social 
contexts. In these occasions the HL children presented poor social skills behavior. 
Regarding Expressiveness, it was observed that the mothers of the normative group 
expressed affection and praised more frequently than those from the HL group. The 
children who belonged to the normative group again presented more social skills than HL 
group. On the other hand, mothers from the HL group used less punishing strategies for 
education when compared to the normative group. 
For Limits Establishment, it was observed that mothers of children with hearing loss 
identified fewer approved behaviors when compared to the normative group, and children 
were less obedient.  
When parents establish limits children of the normative group apologize and/or offer 
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Parents establish limits in order to teach their children society rules, and also to deal with 
children carelessness behaviors towards their own belongings and those at home. The 
mothers of the normative group recognized mostly that they acted incorrectly concerning 
the children education, qualifying “incorrect behavior” as beating and shouting (negative 
practices). 
A hypothesis for the differences between the clinical and nonclinical groups could be related 
to the absence of oral expression of children with hearing loss. The mothers can 
communicate with their children, but, as the children do not have access to the spoken 
content it impairs the acquisition and maintenance of the social skills repertoire. The 
intervention programs which advise families on how to interact with their children must 
consider this aspect and propose an additional training, in order to guarantee more 
communication between parents and children. The results seem to suggest super protection 
(Gargiulo, 2003) from the mothers of children with hearing loss, considering that they 
establish few limits for the behavior of their children. The hypothesis of the study was 
partially confirmed. Children with hearing loss and their mothers reported fewer social 
skills. However, they did not present more behavioral problems than the normative 
population. 
The results also showed a connection between positive parental practices and infantile social 
skills. It was observed the reduced use of negative practices and absence of behavior 
problems (Patterson, Reid & Dishion, 2001). The nonclinical group reported statistically 
lower incidence of negative practices. In both groups there was low occurrence of negative 
practices and behavior problems. 
The RE-HSE-P (Bolsoni-Silva, Loureiro & Marturano, 2011) was useful to add some 
knowledge about interactions between mothers and children with hearing loss. In regard to 
social skills it has also favored the identification of behavioral patterns, specific for this 
population that indicated more behavioral deficits. 
The results also emphasized the fact that many times mothers of children with hearing loss 
behaved just like the mothers in the nonclinical population. Some of the similar practices 
were: talking about several subjects, expressing affection, establishing limits, and facing 
behaviors that they did not approve. Children from the HL group also demonstrated social 
skills. Both parents and children need to have their social skills repertoire improved , but it 
becomes necessary to consider behaviors which are already present on their repertoires 
(Goldiamond, 1974/2002). 
The externalizing and internalizing behaviors which were reported by the hearing loss 
group are insufficient to consider that the children have disruptive problems (APA, 2006). In 
addition, both groups present interactions which are classified as behavior problems. They 
could be avoided if the mothers learned how to reinforce (praise, thank) the good behaviors. 
Studies about social educational skills show that talking to the children about several 
subjects, especially the ones of their interest in different situations promoted social skills and 
reduced the probability of behavior problems (Bolsoni-Silva, Loureiro, & Marturano, 2011). 
In the present research such behaviors were less frequently observed during interactions 
with hearing loss children, which possibly favors the children’s poor repertoire of social 
skills. 
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These results are in accordance to the field literature which affirms that for this population 
there is a great difficulty in communicating (Boscolo & Santos, 2005). Other authors have 
also found out that mothers of children with hearing loss are less spontaneous than with 
normative children (Brito & Dessen, 1999). Additionally,  mothers of children with hearing 
loss are less involved in their development, being more concerned in taking basic care rather 
than talking to them (Canho, Neme & Yamada, 2006). However, the results of the present 
research do not prove that low repertoire of social skills is associated to behavior problems, 
a finding in agreement with some other studies (Cia & Barham, 2009; Gargiulo, 2003). 
For efficiently talking to children with hearing loss mothers are required to know sign 
language.  Due to its additional cost they avoid learning it, impairing the promotion of 
better interactions and consequently the development of children’s social skills (Lacerda, 
2003; Negrelli & Marcon, 2006). Affection expressing behaviors are also less frequent in the 
clinical group.  Children tend to see their mothers as models. When they are not affectionate 
they favor this deficit in their children. 
In relation to limits establishments it can be observed that mothers of children with hearing 
loss used fewer negative practices than the normative population. Considering the results 
expressed in Figure 8 it can be observed that children from both groups disobey; that is a 
reason for mothers to establish limits.  It can also be noticed that the mothers talk to their 
children with hearing loss who on their turn obey and justify themselves when behaving 
improperly. 
Overall, the results of the present research confirm the findings of previous studies, 
concerning educational practices (little communication and little affection expressions) with 
children social skills deficits (Rodrigues, Carrara, Palamin & Bolsoni-Silva, 2010; Bolsoni-
Silva, Rodrigues, Abramides, Souza & Loureiro, 2010). 
Mothers of children with hearing loss are less equalitarian and spontaneous than with other 
children, besides being more restricting and controlling (Brito & Dessen, 1999). Data from 
the present research do not allow affirming about different practices, considering siblings 
with or without hearing loss. The results show that the mothers of children with hearing 
loss seem to establish limits in a skilful manner (talking) and that their children obey and 
express themselves similarly to the normative population. 
Intervention procedures with this population should teach the importance of affection and 
communication, not only for the care, or to determine limits, but also in other situations of 
interest for the child. It is important to teach the social skills repertoires. The more skilful the 
mothers, the more skilful the children will be (Bolsoni-Silva, Loureiro & Marturano, 2011). 
Skilful behavior is not always easy to achieve considering that mothers are frequently 
overloaded with chores. The Brazilian literature has pointed to the cultural aspect present 
on interactions between parents and children, in which the interaction of mother-children 
are the most studied, indicating aspects in their practices as more restricting and controlling, 
associated to anxiety and anguish patterns (Brito & Dessen, 1999; Oliveira, Simionato, 
Negrelli & Marcon, 2004; Guarinello, 2004; Dias, Rocha, Pedroso &  Caporali, 2005). 
Nevertheless, studies with fathers have not been frequently developed (Brito, 1997; Canho, 
Neme e Yamada, 2006), taking into consideration its important role on the children’s 
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improving the interaction between father and child (Marchesi, 1996; Bisol, Simioni, and 
Sperb, 2008; Smith, 2008). 
In conclusion, studies comprising children with hearing loss and their families have shown 
the necessity of preventive actions and early identification of the child’s condition. This 
permits parents orientation, the involvement into alternative forms of communication with 
their children insuring their development, and reducing the possibility of behavior 
problems. However, it is mandatory for the parents to develop educational practices such 
as: expression of feelings, establishment of limits, in addition to praising and reinforcing 
their children’s appropriate behaviors. 
Studies concerning the interaction between the dyads father-child and mother-child 
specially with hearing loss are necessary and urgent. It’s important to give special attention 
to children since preschool up to school age creating a fertile and promising situation for 
optimal parents-children interactions and thus promoting the development of the child with 
hearing loss. 
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improving the interaction between father and child (Marchesi, 1996; Bisol, Simioni, and 
Sperb, 2008; Smith, 2008). 
In conclusion, studies comprising children with hearing loss and their families have shown 
the necessity of preventive actions and early identification of the child’s condition. This 
permits parents orientation, the involvement into alternative forms of communication with 
their children insuring their development, and reducing the possibility of behavior 
problems. However, it is mandatory for the parents to develop educational practices such 
as: expression of feelings, establishment of limits, in addition to praising and reinforcing 
their children’s appropriate behaviors. 
Studies concerning the interaction between the dyads father-child and mother-child 
specially with hearing loss are necessary and urgent. It’s important to give special attention 
to children since preschool up to school age creating a fertile and promising situation for 
optimal parents-children interactions and thus promoting the development of the child with 
hearing loss. 
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Early intervention is defined as “a set of services for children six years of age or younger 
who are at risk of or who currently have developmental delays or social emotional 
problems” (Guralnick, 2005, as cited in Mahoney & Wiggers, 2007). The underlying premise 
for early intervention is that children's developmental or social-emotional problems can be 
either prevented or remediated through specialized services and activities designed to 
maximize their developmental learning (Bailey, et. al., 1998; Baguley, et al., 2000; 
Bluebanning , et. al., 2004). Early intervention is grounded in the conviction that the first five 
years of life are a span during which there is unique opportunity to prevent or reverse 
children's developmental problems. The rapid brain growth that occurs at this time of 
children's lives is believed to be associated with critical periods during which children are 
uniquely prepared to benefit from developmental stimulation that is matched to their 
individualized needs and abilities (Mahoney & Wiggers, 2007; Ryugo, Limb & Redd, 2000). 
In other words there are clearly defined times when the physiological readiness of the 
organism must coincide with the occurrence of specific externally derived experiences 
(Ryugo, Limb & Redd, 2000). 
Many early intervention programs, particularly programs for children up to age three, 
provide comprehensive services to families, including social support, service coordination 
as well as information about child's development (Brown & Arehart, 2000; Brown & Nott, 
2005; Mahoney & Wiggers, 2007). Generally it is believed that services that reduce the 
burdens and stressors families experience can make it easier for parents to focus on the 
needs and care of their children (Bailey, et. al., 1998; Childress, 2004; Dunst, 2002; 
Kratochwill, et. al., 2007; Odom & Wolery, 2003). It is also argued that parents must play an 
active role in their children's development. The argument rests on research results which 
indicate effectiveness of early intervention services is related to the effect they have on the 
way parents care for or interact with their children (Bailey, et. al., 1998; Clark, 2007; Kaiser & 
Hancock, 2003; Mahoney, 2009; Rice & Lenihan, 2005). Therefore it is suggested that 
professionals who work in early intervention services should collaborate with parents 
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Like other areas of special education the necessity for early identification and intervention 
for language development of children with a hearing loss has long been realized and 
auditory oral/verbal programs have offered intervention for parents to development of 
spoken language of their children. However progress in universal newborn hearing 
screening has altered the age range that professionals used to work with. They have to deal 
much younger children than the past. The advancement in hearing technology has increased 
the hearing capacity of these young children. Digital hearing aids and cochlear implants 
provide richer stimuli than ever. Therefore it seems necessary to reconsider the intervention 
approaches regarding the age of these children and the new role of the professional. 
In this chapter the basic issues on the early management of a hearing loss and the rationale 
of family based services will be described, the professional’s role as a partner with parents 
in early intervention for babies with a hearing loss will be discussed and the factors which 
facilitate language development and their use in intervention process will be summarized. 
2. Early identification of a hearing loss 
Hearing loss which occurs congenitally or early in life prevents language development in its 
normal discourse since hearing is our primary sense to acquire spoken language. Therefore 
some steps should be taken to help babies with hearing loss to achieve speech and language 
skills.  
It has been widely acknowledged that children born with a hearing loss can acquire and 
develop spoken language if they are identified and fitted with appropriate hearing 
technology early in their lives and receive quality intervention services (Clark, 2007; Cole & 
Flexer, 2007; DesJardin, et. al., 2006; Estabrooks, 2006). Younger the age of diagnosis and 
intervention, better the development of spoken language (White, 2006; Yosinago-Itano & 
Apuzzo, 1998; Yosinago-Itano & Sedey, 2000). For this reason, it is aimed to identify and fit 
the hearing aids within the first 3 months of life and to start the intervention program no 
later than 6 months of age. 
Technology for automated hearing screening with otoacoustic emissions (OAE) and with 
auditory brainstem responses (ABR) permits fast, accurate and cost-effective identification 
of  hearing loss in infants within hours after their birth. During the last two decades 
universal newborn hearing screening (UNHS) were supported as official policy in most 
developed countries (Department of Public Health, 2009; NDCS; 2004). It is also steadily 
expanding in developing countries; giving way to early identification and management of 
any kind of a hearing loss in infants and young children throughout the world.  
Early identification and fitting of hearing aids/cochlear implant provide opportunities to 
stimulate auditory pathways during the critical periods of language acquisition and enables  
normal development of language. Although it is flawed, sensory stimulation which is 
provided through the hearing aids or cochlear implants supports  the development of the 
neural network within the auditory system (Ryugo, et.al., 2000). On the other hand, a 
language enhancing environment should also be created to make maximum use of the 
sensory stimulation since learning is  required for language acquisition (Clark, 2007; Cole & 
Flexer, 2007; Lieven, 1994; Otto, 2006 ; Sokolov & Snow, 1994). 
In course of language development the first two years of life are seen to be critical.  
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3. Language development in infancy  
Language development is one of the most remarkable achievements in childhood. Sometime 
during their second year most children begin to talk and apparently little time is required in  
using language to address their needs and carry on social interactions. During the last 50 
years language acquisition has been studied with respect to what is learned, when it is 
learned and what factors or variables seem to explain the process of acquisition. While no 
single theory provides complete and irrefutable explanation of language acquisition, each 
theory contributes significant ideas and concepts which over time has clarified the 
awareness of the ways language is acquired (Bloom, 1993; Otto, 2006; Pine, 1994; Rice, 1996).  
Theories which try to explain the language acquisition can be summarized under four broad 
categories. The nativist and the cognitive developmentalist perspectives emphasize the 
contributions of “nature” whereas the behaviourist and interactionist perspectives focus 
more on “nurture”.  
Nativist perspective emphasizes inborn or innate human capabilities as being responsible for 
language acquisition. Linguist Noam Chomsky is the major theorist associated with the 
nativist perspective. He contends that all people inherently have the capacity to acquire 
language due to cognitive structures that process language differently from other stimuli 
(Otto, 2006). A major focus of the nativist perspective is on the acquisition of syntactic 
knowledge. Semantic knowledge is also considered with respect to its relation to syntax 
(Pool, 2005). Chomsky proposes that universal grammar which is “the system of  principles, 
conditions and rules that are elements or properties of all human languages” (Chomsky, 
1975, as cited in Otto, 2006). As evidence of the universality and instinctive nature of 
language it is argued that no mute civilizations have ever been discovered throughout 
history.  Since language exists in every culture it is concluded that it must arise from human 
biological instinct rather than from the existence of the culture (Otto, 2006). 
Cognitive developmental perspective is based on the work of Jean Piaget (Baldwin, 2005). 
The emphasis of this perspective is that language is acquired as maturation occurs and 
cognitive competencies develop. While the nativist perspective emphasizes the inborn 
language mechanism, the cognitive developmental perspective assumes that cognitive 
development is a prerequisite and foundation for language learning. This perspective 
proposes that language is learned using the same learning mechanisms that the child uses 
for other learning. Thus there is no unique language mechanism. The close relation between 
the cognitive development and language is based on the belief that, for language to develop, 
specific cognitive growth must occur first (Baldwin, 2005; Bloom, 1995). 
Behaviourist perspective states that learning occurs due to associations established among 
stimuli, responses and events that occur after the response behaviour. Language is learned 
as a result of these associations. The child is considered to be a “blank slate” and 
reinforcement of a child's verbal and nonverbal responses to language directed at him is 
responsible for language learning. Thus language is “taught” through situations in which 
children are encouraged to imitate other's speech and to develop associations between 
verbal stimuli and objects. Reinforcement often takes the form of attention, repetition and 
approval. This kind of learning is called operant conditioning. The use of the word 
“operant” acknowledges the child's active role in the learning process. It occurs when 
environmental consequences occur that are contingent on the specific behaviour. For 
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infant, show signs of delight and say “Oh, you said ma-ma”. This positive response from the 
parent increases the chances the infant will repeat these sounds. Likewise, speech that elicits 
no response or ignored is less likely to be repeated (Otto, 2006). 
Interactionist approach contends that children acquire language through their attempts to 
communicate with the world around them. Sociocultural interaction has the primary role 
and therefore is the main focus of this perspective. Language is acquired by individuals out 
of a need to function in society and an accompanying need for knowledge of how language 
functions in that society (Halliday, 1996). The primary role of social interaction in language 
acquisition is based on the observation that children acquire an awareness of specific 
communicative functions or intentions (such as indicating, requesting and labelling) before 
they are able to express themselves linguistically. This can be seen in the joint attention and 
verbal turn taking that often occurs between prelinguistic infants and their parents or 
caregivers (Bruner, 1983; 1990). These early understandings of how language functions 
provide a foundation on which the linguistic competencies are acquired. Environmental 
supports for language acquisition can be observed in the interaction patterns found in 
conversations such as listening, responding to what was said, repeating for clarification and 
asking questions (Cole & Flexer, 2007). Another important aspect of this approach is its focus 
on the language as process of acquisition rather than the language as product (Otto, 2006). 
Overall the outcomes of research which has different theoretical backgrounds indicates that 
there is remarkable similarity in the general acquisition sequence for language skills across 
language and cultures although there is considerable individual variability in language 
learning strategies and rate of acquisition (Lieven, 1994; Pine, 1994). It is clear that children 
learn language as a means of talking about what they know so they can accomplish social 
goals important to them (Halliday, 1996; Thompson, 2005; Vygotsky, 1996) and it is agreed 
that language emerges from the child's explorations of the world in a rich social setting 
(Baldwin, 2005; Bloom, 1993; Rice, 1996). 
Current thinking behind the language intervention for babies and young children with a 
hearing loss is more closer to interactionist view suggests that children with a hearing loss 
have the same innate capacity to develop fluent spoken language as do children with normal 
hearing provided that they are given the same opportunities (Childress, 2004; Clark, 2007; Cole 
& Flexer, 2007; ). Clark (2007) states that “same opportunity”is sometimes difficult to create. 
Because knowledge of the presence of a hearing loss in a child often puts pressure on the 
significant adults in the child's environment. The pressure that parents experience  usually 
lead them to alter their natural interaction with their baby. The purpose of early intervention 
was therefore defined as to support and assist families in providing language learning 
opportunities for their infant within the activities, routines and events of everyday life in an 
interactional natural way rather than “teaching language”. The professionals who work in 
early intervention should be guiding and coaching parents to establish an appropriate 
quality interaction with their babies (Bailey et. al.,  1991; Baguley & Bamford, 2000; Clark, 
2007; DesJardin, et.al, 2006; Mahoney & Perales, 2003; Mahoney 2009; White, 2006).  
4. Parent-child interaction in language development and early intervention 
Studies concentrated on parent-child interaction in language development indicate that 
there are some speech adjustments which adults make when they interact with young 
language learners.  The speech addressed to children consists of short, well-formed 
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utterances and simple sentences. It is characteristically higher in pitch, more exaggerated in 
intonation and slower in tempo than speech among adults. It is highly redundant with lots 
of repetitions and closely tied to the immediate context (Bornstein & Tamis-LeMonda, 1997; 
Bornstein, et.al., 1999; Pine, 1994). This kind of speech is called “motherese” or child directed 
speech by several reserchers (Cole &Flexer, 2007, Eastabrooks, 2006; Otto, 2006; Pine, 1994). 
To answer the reasons for using speech adjustments several explanations were suggested 
and a general consensus is reached arguing that speech adjustment to young children are 
motivated by a desire to communicate rather than to teach the language (Bruner, 1990; Cole 
& Flexer, 2007; Lieven, 1994; Pine, 1994; Sokolov & Snow, 1994). It is suggested that these 
adjustments have two main functions: the facilitation of understanding and sustaining of 
attention (Cole & Flexer, 2007; Pine, 1994). It has a conversational nature but at the same 
time it helps to direct and control child's behaviour (Bornstein & Tamis-LeMonda, 1997; 
Bornstein, et.al., 1999). The speech adjustment can be properly understood by putting it back 
to the context in which it occurs but the context is itself multifaceted and extends far beyond 
the dyad itself, not only to the family in which child is growing up, but also to the culture or 
subculture of which it forms a part (Lieven, 1994).  
Young children's social and communicative skills were also found to be more precocious  
than their language skills during their interactions with adults  and  argued that it could 
serve as a facilitative source for language development (Bruner, 1983; 1990). Children were 
seen as active learners in interaction process rather than passive learners. The term 
“cognitive apprenticeship” is used to explain the child's learning and problem solving from 
“actively observing and participating in culturally defined problems with more skilled 
members in their society” (Sokolov & Snow, 1994, p. 44). Based on these observations, the 
connection between prelinguistic communicative intents in children and adults were 
studied widely in early language development and it was suggested that what children 
acquire and encounter is “language in use” during the language development process 
(Halliday, 1996). Language is a resource for making meaning and meaning is reflexive of the 
context. It is social, semantic and holistic (Thompson, 2005). Therefore communication and 
context of conversational interaction is central in the acquisition of language and the  data 
from controlled experiments must be completed by observational studies of children in their 
natural environments as well (Halliday, 1996). Bruner (1983) supported this view and 
argued that the study of communicative precursors to formal language was important and 
quite independent of the nature-nurture controversy suggesting to concentrate more on 
intention between the adult and the child. 
These summarized concepts are also relevant to intervention practices for children with a 
hearing loss (Brown & Nott, 2005; Clark, 2007; Estabrooks, 2006; Sokolov & Snow, 1994) 
especially for the ones before 3 years of age. Basic assumption is that if adequate auditory 
and linguistic experience is provided to most children who have hearing loss from an early 
age; cognitive and linguistic functioning can be expected to follow the normal course of 
development (Clark, 2007; Geers, 2004, as cited in Cole and Flexer, 2007; Houston, et.al., 
2003; Moller, 2000; Rice & Lenihan, 2005; Spencer, 2004; Wallace, et.al., 2000; Warren, 2000).  
The most reasonable course to follow in carrying out intervention is, establishing a normal 
language learning environment (Brown & Nott, 2005; Clark, 2007; Cole & Flexer, 2007; 
Hogan. et.al., 2008). The sequence of language learning is expected to include normal 
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agents that best understand child's intentions and thus can best provide the scaffolding that 
they needed during the early development (Brown & Nott, 2005; Bloom, 1993; Bruner,1983; 
Wilson, 1998; Mahoney & Wiggers, 2007; Mahoney, 2009).  
5. Effects of a hearing loss in interaction 
Studies in the past conducted with children older than 18 months of age showed that 
parents of children who have hearing loss undergo controlling, discouraging and negative 
interactions with their children which provide a less facilitative environment for language 
acquisition and for social and cognitive development (Schlesinger & Meadow, 1972). Some 
studies argued that linguistic competence of the child would determine the parent's 
interaction with the child. If the child's language level is behind their chronological age 
parental control, simplicity and directivenes in language are increased and becomes 
different than the language used while addressing normal hearing children at the same age. 
(Gregory, et. al., 1979). Even in the earliest stages, differences in interactive behaviour were 
reported. Meadow, et. al. (1981) indicated that deaf infants of three, five and eight months 
had more physical contact with their mothers than hearing infants, suggesting that mothers 
of deaf children exploit the tactile kinaesthetic channel for gaining and holding attention 
rather than well known child directed speech features such as shorter utterances. Hughes 
and Huntington (1986) reported distorted speech and phonologic/prosodic characteristics 
in some mothers' of deaf children. They were easily recognized by listening to audiotaped 
voices during their interaction with the child. It is argued that distorted speech and altered 
intonation make the speech even more difficult to understand since they effect the second 
formant information. These kind of interactive differences possibly had negative effects on 
language development of children with hearing loss in later ages. 
Early identification, amplification and intervention provide a chance to prevent deviances 
from normal interaction by providing auditory information to the child and supporting 
parents in their interactive skills immediately. Indeed it becomes possible to follow normal 
developmental patterns in language development without considerable delay and in most 
cases with no delay at all (Brown & Arehart, 2000; DesJardin, et.al., 2006; Moller, 2000; 
Hoberg-Arehart & Yoshinago-Itano, 1999; Houston, et.al., 2003; Robinshaw, 1995; Spencer, 
2004; Wallace, et.al., 2000; White, 2006, Yoshinago-Itano & Apuzzo, 1998). Starting with the 
diagnosis of the hearing loss, parents should be encouraged to follow normal interaction 
patterns during their daily life.  
Daily activities such as feeding, cleaning, dressing and simple play routines provide 
excellent opportunities of language learning for babies younger than one year old. The 
repetitive nature of the daily routines consolidates the experience and the language that 
accompanies them. By talking about the things they do during these activities parents are 
most likely to provide meaningful language input to the child. Following the baby's gaze 
and responding to his/her vocalizations help parents to regulate turn taking and to 
understand his/her intentions. (Brown & Nott, 2005; Clark, 2007). 
The professional should guide and coach the parents in such a way that they come to realize 
that listening and speaking are a way of life for development of language in babies with a 
hearing loss. The parents' awareness should be heightened on how much they are already 
doing naturally and to encourage them to do more of it. The idea is not to intrude into the 
child's self-absorbed exploratory play in order to engage him/her in talk every waking 
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minute, but to select or create opportunities for verbal interaction (Cole & Flexer, 2007). 
Auditory stimulation is the base of these kind of intervention and if language acquisition 
through audition is attempted, correct use of hearing aids or cochlear implants throughout 
the day has the utmost importance. 
6. Management and practical aspects in intervention  
6.1 Amplification and listening environment 
Hearing aids and cochlear implants properly adjusted are the core of auditory oral or verbal 
intervention programmes. It is possible to fit and adjust internal settings of the hearing aids 
or cochlear implants with objective techniques in today's technology. Digital hearing aids 
are so flexible that they can be easily set for very young ones and it is possible to programme 
cochlear implants using NRT (Hughes, et.al., 2000), eSRT (Kosaner, et. al., 2009) and cortical 
responses (Sharma, et. al., 2005) even for babies younger than one year old. Combined with 
careful behavioural observations at home and clinics it does not take long to achieve optimum 
adjustment of the hearing aids or cochlear implants. However, the main issue is the effective 
use of hearing devices after fitting (Brown & Nott, 2005; Clark, 2007; Cole & Flexer, 2007).   
Particular attention should be paid to train parents in effective use of hearing aids/cochlear 
implants during all waking hours of the baby. The parents must accept their responsibility 
in constant and efficient use of hearing aids or cochlear implants since babies spend all of 
their time with the family. When parents purchase the hearing aids it is the professional's 
role to help and supervise parents until they feel comfortable enough to check and fit the 
devices onto the baby properly (Clark, 2007). Guiding parents in hearing aid use and solving 
the problems related to hearing aids improves parents confidence in dealing with the 
devices and motivates them in efficient use.  They should be advised about the frequently 
checking the external controls of the devices and batteries during the day because babies 
and young children are not capable of signalling the problems of the incoming sound. 
Adults must detect and solve the problems in the hearing aids/cochlear implants to provide 
constant flow of the auditory information. It is possible to lock external control settings of 
the digital hearing aids/cochlear implants during programming of the device which 
provides confidence about the exact settings in daily use. Batteries should be checked if they 
keep supplying the power during the day. 
Feedback is the major problem while using hearing aids with the very young ones since the 
pinna is too small and soft to support the weight of the hearing aid and the neck support at 
this age is weak. It is possible to prevent feedback problem by using soft ear moulds and 
specially designed long spiral shaped tubing which allows attaching the hearing aids over 
shoulders until the baby start to hold his/her neck securely and sit up with no support.  
Parents also need to know that hearing aids/cochlear implants does not restore the hearing 
to the normal. It is necessary to inform parents on deteriorative effect of the background 
noise over speech sounds and the negative effect of the microphone distance on speech 
perception. It is easier to accomplish optimum microphone distance with babies during their 
first year in life since we talk to them literally in an “ear shot” while holding them in arms or 
in their cribs. It is also advised to use a FM system in noisy conditions.  
Parents should also be warned to be sensitive about voice clashes. It occurs while more than 
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minute, but to select or create opportunities for verbal interaction (Cole & Flexer, 2007). 
Auditory stimulation is the base of these kind of intervention and if language acquisition 
through audition is attempted, correct use of hearing aids or cochlear implants throughout 
the day has the utmost importance. 
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use of hearing devices after fitting (Brown & Nott, 2005; Clark, 2007; Cole & Flexer, 2007).   
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implants during all waking hours of the baby. The parents must accept their responsibility 
in constant and efficient use of hearing aids or cochlear implants since babies spend all of 
their time with the family. When parents purchase the hearing aids it is the professional's 
role to help and supervise parents until they feel comfortable enough to check and fit the 
devices onto the baby properly (Clark, 2007). Guiding parents in hearing aid use and solving 
the problems related to hearing aids improves parents confidence in dealing with the 
devices and motivates them in efficient use.  They should be advised about the frequently 
checking the external controls of the devices and batteries during the day because babies 
and young children are not capable of signalling the problems of the incoming sound. 
Adults must detect and solve the problems in the hearing aids/cochlear implants to provide 
constant flow of the auditory information. It is possible to lock external control settings of 
the digital hearing aids/cochlear implants during programming of the device which 
provides confidence about the exact settings in daily use. Batteries should be checked if they 
keep supplying the power during the day. 
Feedback is the major problem while using hearing aids with the very young ones since the 
pinna is too small and soft to support the weight of the hearing aid and the neck support at 
this age is weak. It is possible to prevent feedback problem by using soft ear moulds and 
specially designed long spiral shaped tubing which allows attaching the hearing aids over 
shoulders until the baby start to hold his/her neck securely and sit up with no support.  
Parents also need to know that hearing aids/cochlear implants does not restore the hearing 
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in their cribs. It is also advised to use a FM system in noisy conditions.  
Parents should also be warned to be sensitive about voice clashes. It occurs while more than 





inexperienced listener it is very difficult for a young child to know whom to attend to and it 
would deteriorate the intelligibility of the speech signals via hearing aids. 
It helps in constant and efficient use of the hearing aids if parents are convinced that their 
baby can hear with the amplification (Clark, 2007; Cole & Flexer, 2007, Estabrooks, 2006). 
Often, early indications or clues of the child progressing are the most effective and 
immediate encouragement for the parents. This can be achieved by demonstrating the 
child's responses to the sound during the intervention and leading parents to observe their 
child's responses to the sound at home. The professional can guide the parents about early 
indicators of the child’s hearing. These indicators include alertness to sound, turning to 
sound, quieting to sound, increased vocalizing, decreased vocalizing while listening and/or 
increased variety in vocalized sounds.  The questions about child's responses to the sound 
help parents to observe more closely their child. Seeing the responses to the sound 
motivates parents in efficient use of hearing aids, they become sensitive for monitoring 
progress in the child. 
6.2 Intervention sessions 
Frequency, duration and place of an intervention session varies depending on the state 
policies in a given country and theoretical base and facilities of the intervention centres. 
Intervention could be home-based or centre-based, it could be once or twice in a week or a 
month (Department of Public Health, 2009; NDCS, 2004; Hogan, 2008).  
Home based intervention has the advantage of  knowing families' real life and planning the 
intervention accordingly. It is also possible to create close to natural environments at centre 
based programs. Duration of a session is usually reported 45 minutes to 1.5 hours (Brown & 
Nott, 2005; Clark, 2007, Estabrooks, 2006; Hogan, 2008).  
In each session observing parents while interacting with the child is suggested (Brown & 
Nott, 2005; Clark, 2007; Estabrooks, 2007). Observing parents in interacting with the child 
serves several purposes. Firstly, the professional can evaluate the parents' strengths and 
weaknesses during their interaction with the child and guide the parents accordingly. 
Second, they have an opportunity to practice the new skills they acquired. Third it provides a 
chance to observe and monitor the progress in the child.  It must be remembered that the main 
aim is to lead the parents toward confidence, competence and independence in handling their 
child with hearing loss (Bailey, 1998; Childress, 2004; DesJardin, et.al., Estabrooks, 2007; Kaiser 
& Hancock, 2005). Therefore all the positive aspects of the interaction should be mentioned 
and explained to the parents. The parents become more receptive to the suggestions given by 
the professional when they realize their strengths. In every session only one feature of what 
has been observed should be discussed for improvement (Clark, 2007). 
The educational materials used in the sessions should be familiar and available at home. 
Using materials which are developmentally not appropriate to the child or are not available 
at home might be discouraging for the parents (Childress, 2004; Dunst, 2002; Mahoney, 2009; 
Odom& Wolery, 2003). Parents also may bring the toys, books or other materials to the 
session. For the babies younger than 6 months of age simple turn taking games, hiding and 
finding toys, popping up games and daily care routines of the infant can be used to interact 
in a language enabling way. When they grow a little older, simple household routines like 
sorting clothes to be washed, making fruit juice and tidying up can be performed. Parents 
Early Intervention with Children  
Who Have a Hearing Loss: Role of the Professional and Parent Participation 
 
125 
must understand to recognize opportunities to facilitate language learning during the  daily 
activities through following child's interest and being sensitive to communicative intentions 
of the child. Once parents understand to use language facilitating strategies in daily 
routines, they become active partners in creating these opportunities (Brown & Nott, 2005; 
Clark, 2007; Kaiser & Hester, 1995; Kaiser & Hancock, 2003; Wilson, 1998).  
Some time during the session must be spent in discussing the things parents have done with 
the child since the last time they have been to the session. Also parents must be asked  if 
they want to discuss any thing related to the child's development or progress. The parents 
should feel free to share their concerns or questions with the professional as well as positive 
signs of the progress. The professional should be able to refer parents to related 
professionals if their concerns are beyond the scope of the intervention process such as 
suspicion of a second handicap, neurological problems or necessity of psychiatric evaluation 
(Estabrooks, 2007; Clark, 2007; Lutherman, 2004).  
Each session should include a musical activity or a listening game to improve listening skills 
of the child.  Parents often need help to create suitable activities during the first few 
sessions. Therefore it is advised to dedicate time for age appropriate and enjoyable listening 
activities in each session. Parents must understand that these activities improve listening 
skills and are also enjoyable. Singing lullabies, rhymes and simple repetitive songs are 
highly recommended to widen the child’s listening experience and to develop a sense of 
rhythm (Clark, 2007; Cole & Flexer, 2007; Estabrooks, 2007). Naturally occurring sounds at 
home such as door bell, telephone ring, and sounds from outside can also be used to 
develop listening skills. Parents are advised to listen to the sounds at home themselves first, 
then draw the attention of the child to the sound and to show them the source.  
At the end of the session it is better to discuss language enabling activities and areas of 
language that might be focused at home. Caution should be taken that parents provide a 
language enhancing environment to the child. It must be remembered that language is a 
complex, specialized skill that develops in a child spontaneously and it is not something that 
parents teach their children (Pinker, 1994, as cited in Clark, 2007). 
Sometimes it is better for the parents to see the professional interacting and talking with 
their child in a natural way. Professional's attitude towards the child encourages parent to 
expect age appropriate development. It is highly motivating especially after the diagnosis 
for some parents to see someone treating their child in a normal way who is not solely 
focusing on the hearing loss.   
7. Role of the professional 
Advice given in the early years to the parents of children who have a hearing loss has long 
lasting effects on the children's development and future lives. The professionals who first 
come into contact with families seeking advice on how best to manage a young child who 
has a hearing loss bear tremendous responsibility for their futures (Clark, 2007). Their role is 
complex and challenging. It is different from other professional roles such as teachers or 
case managers, although it may include some aspects of these roles (Bailey, et.al., 1991; 
Hoberg-Arehart & Yoshinago-Itano, 1999; Kaiser & Hancock, 2003). Professionals who work 
with young children with disabilities must know how to partner with families, including 
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must understand to recognize opportunities to facilitate language learning during the  daily 
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Advice given in the early years to the parents of children who have a hearing loss has long 
lasting effects on the children's development and future lives. The professionals who first 
come into contact with families seeking advice on how best to manage a young child who 
has a hearing loss bear tremendous responsibility for their futures (Clark, 2007). Their role is 
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that intervention efforts are enhanced when families participate in early childhood 
programs (Bailey et al., 1998; Baguley, 2000; Bluebanning, 2004; Mahoney & Wiggers, 2007; 
Mahoney, 2009; White, 2006; Wilson, 1998). 
If a family centred and participation-based philosophy is adopted, roles of parents and 
professionals become different from traditional practice on the basis of four primary 
features: (a) activity leader, (b) use of natural materials,   (c) role of the parent, and (d) role of 
the provider. (Brown & Nott, 2005; Campbell & Sawyer, 2009; Dunst, 2002) In traditional 
practice, the professional is generally the activity leader, materials that are not likely to be 
natural to the home setting are used in intervention, the parent most frequently plays a 
passive role such as an observer, and the professional is the primary person interacting with 
the child. This type of intervention approach has been identified by a number of labels 
including one-on-one intervention or direct intervention (Dunst, 2002). In a participation-
based approach, the focus is on promoting a child’s participation within typical family 
activities and routines. The activity leader is the parent or child, materials natural to the 
activity or routine are used, the parent actively interacts with the child, and the professional 
plays a role of facilitator (Campbell & Sawyer, 2009; Childress, 2004; Dunst, 2002; Macy, et. 
al., 2009; Mahoney, 2009;) suggesting appropriate techniques and strategies to facilitate 
language development and sometimes interacting with the child to model the parents at 
certain techniques (Clark, 2007; Estabrooks, 2006).  
In order to work effectively in the field, the professional must be fluent in specific  
intervention they will teach parents (Kaiser & Hancock, 2003). Fluency requires mastery of 
specific intervention procedures, understanding of the conceptual basis of the intervention 
and its main assumptions.  The conceptual knowledge is required in order to explain the 
rational behind the each aspect of the procedure to parents, to place the intervention in the 
framework of the child's developmental characteristics, to relate the parents' behavior to the 
goals of the intervention and the family's goals for the child and themselves and to answer 
parents' questions (Brown & Nott, 2005; Estabrooks, 2006; Hogan, 2008).That is consistent 
with the findings indicating technical knowledge and skills of the service providers, parent 
education and diagnostic evaluations/ assessment of the child as the most beneficial aspects of 
early intervention experiences among the other properties as well (Foran & Sweeney, 2010). 
The ability to present the intervention in a way that is understood by the parents is another 
aspect which is crucially important (Kaiser & Hancock, 2003). The professional must be able 
to instruct parents on interacting in a language enabling way with their child and to 
troubleshoot with parents in their use of it in order to provide specific feedback, guidance 
and coaching toward effective implementation (Brown & Nott, 2005; Estabrooks, 2006; 
Kaiser & Hester, 1995; Kaiser & Hancock, 2003). This can be achieved by observing parents 
while they are interacting with their baby during play or daily activities. Depending on 
these observations, the needs of a specific parent child relationship at a specific language 
learning stage can be decided (Brown & Nott, 2005; Clark, 2007; Estabrooks, 2006). From the 
start parents must understand that the professional's task is to observe and to offer advice 
on the type of interaction that the professional sees them enjoy with the child. Initially some 
parents are resistant to this approach because they want to the child to receive therapy from 
the professional (Clark, 2007).  
Observing parent child-interaction either in daily activities or at play the professional 
gathers information on contingent responsiveness between the parent and the child, amount 
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of joint attention, and how it is created and maintained by both parties, parent's awareness 
on language facilitative opportunities. These are all critical for planning the intervention 
sessions. Parents are a valuable source of information about their child and their 
observations and judgements should be included while planning the intervention (Campbell 
& Sawyer, 2009; Eriks-Brophy, et.al., 2006; Knopf & Swick, 2008). 
It is seen as a professional's responsibility to encourage parents to involve actively in the 
intervention sessions in a way that is most suitable for the family. The professionals must 
realize uniqueness of each family to achieve this. It must also be kept in mind that 
relationships and interaction patterns within a family system are more complex than 
formerly believed. Family members assume familial roles and functions with proximal and 
distal features (Campbell & Sawyer 2009). Therefore, the needs, priorities, resources, desires, 
and wisdom of a child’s family should be taken into account. The presence of hearing loss in 
the child does not mean that the family has to alter what would have been its natural child 
rearing practice to fit the professional's concept of child rearing. The only time professional 
alters the way a child is managed is when there is behaviour that is inhibiting the 
development of listening and of spoken language (Clark, 2007).  
In recent years interpersonal relationship between parents and the professionals has gained 
considerable attention as another important aspect of successful intervention process. 
Research on the subject indicates its role in the development of family centred practices 
aiming to empower parents in special education (Knight & Woodsworth, 1999; Kratchowill, 
et. al., 2007; Lutherman, 2004; Macy, et. al., 2009).  
Park and Turnbull (2003) created a framework distinguishing interpersonal and structural 
components of effective partnership. They identified from the literature a series of 
interpersonal relationship attitudes, skills and beliefs that appear to contribute to effective 
partnership among families, professionals and agencies. Collaborative partnership 
characterized by factors such as trust, respect, communication, shared vision and cultural 
sensitivity were identified as critical for effective partnership. However these are subjective 
terms and their meaning can be different from one person to another.  
Bluebanning et al. (2004) emphasized the need for the operational definition of these terms. 
They argued that the clear operational definition of these terms may help professionals to 
develop a better understanding of the family perspectives leading to establish good quality 
early intervention services. Their study focused on parents' and professionals' descriptions 
of the terminology which are widely used in family centered, collaborative intervention 
programs. They described six collaborative themes and their behavioural indicators is 
stressed by parents and professionals.  Themes are defined as communication, commitment, 
equality, skills, trust and respect. Parents and professionals described behaviours related to 
each of these themes in substantial good agreement except commitment and equality. Parents 
talked of wanting professionals to “go the extra mile” and to be like one in the family in their 
involvement with them. Professionals expressed the same sentiments but they also expressed 
reservations about taking these concepts too far. These reservations centred on the perceived 
need to “empower” families to take charge of advocating for their child and themselves, and 
the concern that doing “too much” might foster co-dependency and actually harm the family. 
The questions of when being “like family” gets in the way of doing one's job and when 
“empowering” becomes disenfranchising are issues referring to the boundaries between 
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develop a better understanding of the family perspectives leading to establish good quality 
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programs. They described six collaborative themes and their behavioural indicators is 
stressed by parents and professionals.  Themes are defined as communication, commitment, 
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each of these themes in substantial good agreement except commitment and equality. Parents 
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guidelines on creating appropriate boundaries between families and professionals that 
preserve warm and committed relationships without disempowering families. 
8. Conclusion  
The children who are born with a hearing loss or acquired it early in life have never before 
had such a potential to hear, listen and talk. Advances in technology such as digital hearing 
aids and cochlear implants make language development through audition possible. This 
particular group of children can hear the sounds around them with greater ease than in the 
past. By early detection of the hearing loss and early intervention, these children have a 
chance to develop spoken language comparable to those of their hearing counterparts since 
they catch up the critical periods for language learning. 
Intervention programmes aim to establish normal interaction patterns which facilitate 
language development in infants and children with a hearing loss. These programs assume 
that children with a hearing loss have the same innate capacity with normal hearing 
children for language acquisition. By providing the same opportunities they can develop 
spoken language which is comparable to normal development. 
Parents are seen as partners in this approach and have the responsibility to ensure use of 
hearing aids/cochlear implants within all waking hours of the child. Professionals work 
with parents to elaborate their communicative strategies with the young child in their daily 
lives. They were encouraged to independently handle their child with a hearing loss. 
Professionals who work in the field are expected to give information that is timely, accurate 
and at the appropriate level of the individual parent. They need to possess active listening 
skills to define and address identified problems or needs. They should be foster confidence, 
competence and independence in parents. They must have strength in providing strategic 
guidance to parents by adopting the role of a mentor or coach. 
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guidelines on creating appropriate boundaries between families and professionals that 
preserve warm and committed relationships without disempowering families. 
8. Conclusion  
The children who are born with a hearing loss or acquired it early in life have never before 
had such a potential to hear, listen and talk. Advances in technology such as digital hearing 
aids and cochlear implants make language development through audition possible. This 
particular group of children can hear the sounds around them with greater ease than in the 
past. By early detection of the hearing loss and early intervention, these children have a 
chance to develop spoken language comparable to those of their hearing counterparts since 
they catch up the critical periods for language learning. 
Intervention programmes aim to establish normal interaction patterns which facilitate 
language development in infants and children with a hearing loss. These programs assume 
that children with a hearing loss have the same innate capacity with normal hearing 
children for language acquisition. By providing the same opportunities they can develop 
spoken language which is comparable to normal development. 
Parents are seen as partners in this approach and have the responsibility to ensure use of 
hearing aids/cochlear implants within all waking hours of the child. Professionals work 
with parents to elaborate their communicative strategies with the young child in their daily 
lives. They were encouraged to independently handle their child with a hearing loss. 
Professionals who work in the field are expected to give information that is timely, accurate 
and at the appropriate level of the individual parent. They need to possess active listening 
skills to define and address identified problems or needs. They should be foster confidence, 
competence and independence in parents. They must have strength in providing strategic 
guidance to parents by adopting the role of a mentor or coach. 
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Hearing Loss in Minor Head Injury 
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1. Introduction 
Hearing loss is a common problem encountered in ENT practice. Recognition of hearing loss 
as a problem by the patient usually occurs when speech frequencies are affected or when 
there is a sudden hearing loss. Hearing loss following head trauma or head injury is a major 
medical problem in adults (Bergemalm P-O&Borg.E. 2001) as well as children (Hough JVD 
&Stuart WD, 1968). The loss may go unnoticed when the speech frequencies are not affected. 
Sensorineural hearing loss at high frequencies is a frequent finding associated with head 
injuries (H.Alexander Arts). Hearing impairment can be due to central or peripheral causes, 
middle ear or cochlea being the most common site of peripheral injury. The most 
pronounced injury is fracture of temporal bone (Dahiya.R &Keller J.D, 1999). In both 
clinical and animal experimental studies it has been shown that there are various sites of 
pathology ranging from hair cell damage and degeneration of the organ of corti, ischemia 
of the 8th  nerve to damage of central auditory pathways (due to compromise of blood 
supply to the inner ear ) either partly or totally. In most cases hearing impairment 
dissipates during subsequent post traumatic period, but some times it may persist or 
progress.  
The causes of progression of hearing loss are not well known. Several explanations have 
been proposed such as development of perilymphatic fistula, secondary degenerative 
changes in cochlea following inner ear concussion possibly due to consequences of pre-
existing autoimmune disease (or trauma itself may initiate such a reaction towards specific 
inner ear proteins). Progression of hearing loss can be attributed to the synergistic effects 
between trauma, noise exposure, medication and meningitis.  
In developing countries roads are used not only by modern cars and buses, along with 
locally developed vehicles for public transport (three-wheeled scooter taxis, auto 
rickshaw’s), scooters and motorcycles, bicycles, but also by rickshaws, and animal or human 
drawn carts that has resulted in disproportionate increase in road traffic accidents compared  
to developed countries. Minor head injuries (WHO 2004) constitute a major portion of all 
accidents. Evaluation of these patients revealed presence of hearing loss in the high 
frequency range. Hence auditory assessment is needed in this group of patients. 
Evaluation of hearing loss in patients who sustain minor head injury has not been done in 
the Indian subcontinent. Therefore, this prospective study was done to evaluate the 
incidence of hearing loss and estimate its progression or regression by serial assessment 
over a period of six months  
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2. Classification of head injury 
 Hearing loss is a well known entity following head injury. The degree of hearing loss may 
vary depending on the severity of the head injury. The severity of Head injury is measured 
clinically using the Glasgow coma scale scoring system (G.C.S). The Glasgow Coma Scale 
was first published by Teasdale and Jennett in 1974. Several years later it was modified by 
Jennett and Teasdale and by Rimel et al (Rimel RW et al 1981, 1982) .This scoring system 
provides the best measure of severity of head injury. The score is the sum of the scale’s three 
measures of eye opening, best motor and verbal responses. This ranges from a score of 3 for 
a patient with no motor, verbal response or eye opening to painful stimuli, to 15 for a 
patient who is oriented, follows commands, and has spontaneous eye opening. Patients, 
who do not follow commands, speak or open their eyes, with a score of 8 or less, are by 
definition in coma. Head injury is defined as mild when the GCS score is either 13 or 14–15, 
moderate by a score of 9–12 or 13, and severe by a score of 3–8. The GCS score on admission, 
and its prognostic usefulness, are easily confounded by other factors particularly substance 
misuse, but sequential monitoring after admission plays a crucial role in detecting early 
deterioration and in its management. 
Culotta (Culotta VP et al, 1996) following a retrospective study found that patients with a 
GCS score of 13–15, represent a heterogeneous group with statistically significant different 
head tomography abnormalities. On the basis of findings they suggested separating patients 
with GCS score 13–14 into a different category from patients with a GCS score of 15, thus 
effectively redefining minor head injury. These findings were confirmed by a similar study 
by Gomez (Gomez PA,et al1996). Hsiang  , on the basis of a cohort study of 1360 patients 
with GCS score of 13–15 suggested that this group of patients could also be divided into two 
subgroups, mild head injury and high risk mild head injury(Hsiang JNK et al,1997). Mild 
head injury is defined as GCS 15 without radiographic abnormalities, high risk mild head 
injury being defined as GCS 13–14, or a GCS 15 with acute radiographic abnormalities. More 
recently Swann and Teasdale recognizing the limitation of the GCS with regard to minor 
head injury have suggested another sub classification. Mild head injury is defined as GCS 
13–14. Minor head injury is defined as GCS score of 15. The authors recognized in their 
monograph that this is a somewhat arbitrary definition. However in Clinical practice GCS is 
used in evaluation of Head injury (Swan IJ,Teasdale Gm 1999) 
Glasgow coma scale and score (Table-1). Glasgow coma score: (E+M+V) = 3–15. 
 
EYE OPENING BEST MOTOR RESPONSE VERBAL   RESPONSE 
Spontaneous - 4 Obeys commands   - 6      Oriented   - 5 
To speech     - 3       Localizes to pain      - 5    Confused, Disoriented-4 
To pain          - 2 Withdraws (Flexion) - 4    Inappropriate words - 3 
None              - 1        Abnormal flexion       -3 Incomprehensible sounds  -2    
  Abnormalextension - 2            No verbal response -1 
    No motor response - 1  
Table 1. Glasgow coma score     
In India, in the year 2000, official statistics revealed that 80,118 persons died and 3, 42,200 
were injured in road traffic accidents . However this is an underestimate, as not all accidents 
are reported to the police.   A study done in Haryana (India) recorded all traffic-related 
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injuries and deaths through bi-weekly home visits to all households in 9 villages for a year. 
This study showed that the ratio between critical, serious and minor injuries was 1:29:69. 
(Varghese .M .Mohan.D 2003). 
2.1 Definition of a mild head injury 
A mild head injury can be defined as an injury caused by blunt trauma and/or sudden 
acceleration /deceleration which produces a period of unconsciousness for 20 minutes or less, 
a Glasgow coma scale score of 13-15, no focal neurological deficit, no intracranial complications 
and computed tomographic findings limited to a skull fracture without evidence of contusion 
or hematoma.Despite the dissemination of information that is available on diagnostic criteria, 
controversies still exist in defining mild head injury and collecting patients. 
Estimating the duration of unconsciousness is difficult when witnesses are not available, 
second if the patient is intoxicated at the time of hospital admission it can obscure the 
assessment of severity of head injury.   
3. Hearing loss in head injury 
Deafness due to head injury is known since ancient times, the earliest account of which is 
the Edwin Smith papyrus, (Marc stiefel, 2006) the world's earliest known medical document, 
written around 1600 BC, but thought to be based on material from as early as 3000 BC. It is a 
textbook on trauma surgery, and describes anatomical observations physical examination, 
diagnosis, treatment, and prognosis of numerous injuries in exquisite detail. The symptoms 
and signs of head injury were given in considerable detail. It was noted that brain injuries 
were associated with changes in the function of other parts of the body. Feeble pulse and 
fever are associated with grievous injuries and deafness as well as aphasia are recognized in 
fractures of the temporal region. 
Sushrutha who is known as "Father of Surgery”  in India, even though he does not attach 
significance to the brain, however, considers head as the centre of all special senses and 
describes certain cranial nerves connected with specific sensory functions. He described two 
nerves lower down the back of the ear (vidhura), which, if cut, produce deafness; a pair of 
nerves (phana) situated inside the two nostrils, which if cut, cause anosmia. A pair of nerves 
below the outer end of the eye-brow, near the external corner of the eyeball (apanga) which 
if cut, cause total blindness. 
Alexander and Scholl (Alexander AF and Scholl) as early as 1938 reported a 31% incidence 
of hearing loss in patients with head injury. In 1939 Grove (Grove W.E) reported an 
incidence of 32.6% of sensorineural hearing loss and suggested that bleeding in the inner ear 
was the cause whereas Uffenorde (Uffenorde W, 1924) stated that stretching of the fibers of 
the cochlear nerve in the internal auditory canal bought on the hearing loss after head 
injury. Similar results were reported by Gurdijan,( Gurdijan ES 1933) Fradis and Podoshin 
(Podoshin .L&,Fradis.M,1975) and M R Abd al Hady ( M.R.Abd AL-HADY et al,1990). 
Griffiths ( M.V.Griffiths )in 1979 reported an incidence of 56% of sensorineural deafness in 
cases of mild head injury . He stated that there may be difference in outcome depending on 
the type of violence. A blow to the head with a soft object seems to cause less damage to the 
hearing system than a blow to the head with a hard object with the same power at impact. 
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The site of injury is important, frontal injuries resulting in a comparatively low incidence of 
hearing loss as compared to temporal blows. The type of audiogram recorded is an 
important indicator in assessing prognosis. Vertigo according to them has its own separate 
etiology and should be assessed and treated separately and not as a part of the post 
concussion syndrome.  
In the immediate post injury period the incidence of hearing loss is 56% and vertigo is 24% 
which is very high when compared to controls (8%).Hearing loss recovered within three 
months. Accordingly, the mechanism of low frequency hearing loss is seen in patients with 
hydrops and suggests a similar peripheral mechanism. He stated that the lesions lie in the 
peripheral labyrinth due to edema or hydrops both of which subside with excellent 
prognosis. High frequency hearing loss may be caused by concussion and intense acoustic 
stimulation, concussion being reversible. Griffiths study showed a residual hearing loss in 
14% of patients even after six months in cases of head injury with concussion without 
fracture.Vartiannenn (E.Vartianen et al, 1985) reported that in children who suffered blunt 
head trauma, 30% were found to have hearing loss of whom 16.3% had CHL and 13% had 
SNHL. One third of them recovered normal hearing with in six months. Similar results were 
reported by Zimmerman (William D.Zimmerman et al, 1993) Ludwig podoshin, (Podoshin 
.L. & Fradis.M, 1975) reported that conductive hearing loss due to head injury usually 
disappears in two months, if it persists ossicular discontinuity must be suspected.  
According to Andrew T Lyos (Andrew.T.Lyos et al, 1995) in case of temporal bone fracture, 
immediate profound hearing loss may be caused by avulsion of the nerve or severe damage 
to the membranous labyrinth. Concussion directly to the otic capsule or acoustic trauma via 
the ossicular chain is well described. If it is not severe, it produces transient cochlear 
hyperemia resulting in temporary threshold shift. Feldman (Feldman H, 1987) stated that, 
sudden hearing loss with delayed onset can also occur following head trauma, thus it may 
be due to the sequelae consisting of perilymph fistula in one of the windows or a fracture of 
the labyrinthine capsule, which may manifest for the first time after a period of years or 
even decades. 
Allison M Scott (Allison.M.Scot et al, 1999) found that in addition to low and high frequency 
hearing loss, audiograms with single and double sensorineural notches in mid frequency 
region may be related to head trauma.  
The site of hearing impairment can be peripheral or central although the peripheral 
structures i.e., the middle ear and cochlea represent the most common site of injury. 
Nassulphis (Nassulphis P et al, 1964) found damage in the Reissner membrane and 
degeneration of the organ of corti in the spiral ganglion and cochlear nerve in several 
patients suffering from hearing loss following head injury. According to Schuknecht and 
Davison (Harold F.Schuknecht & Roderick C.Davison, 1956) auditory symptoms following 
head injury can be grouped according to the classification of labyrinthine damages which 
are:(a). Longitudinal fracture of temporal bone (b). Transverse fracture of temporal bone (c). 
Labyrinthine concussion. Labyrinthine concussion may be described as perceptive deafness 
and vertigo resulting from a blow to the head without fracture of bony labyrinth capsule. 
The nystagmus is positional and may persist for several months. The underlying 
pathology was thought to be due to injury to the utricle and saccule. Histopathological 
evidence showed rupture of the membranous walls of the utricle and saccule and 
degenerative changes in the macula of the saccule. This injury is commonest in ear with 
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longitudinal fracture of the temporal bone, secondly in an ear opposite a temporal bone 
fracture and thirdly in a head injury with no evidence of skull fracture. According to them 
to produce labyrinthine concussion a head injury must be severe enough to cause loss of 
consciousness. 
Hearing loss is worst in the high frequency range and the peak loss is usually at 4000 Hz. 
The vertigo attacks are of postural type as described for patients having longitudinal 
fracture.  
Experiments on animals show that the deafness is due to injury of the organ of corti, 
identical with that which results from a shock pulse in the air as a bomb blast or a pistol 
shot. They found that it results in violent displacement of the basilar membrane and organ 
of corti, that both reversible and irreversible cellular injuries result. They estimated hearing 
loss in animals, cats subjected to head injury. The hearing loss was estimated by audiogram 
and compared with a cochlear chart and found that the primary effect of trauma is to the 
organ of corti and the nerve degeneration is secondary. It is in fact the presence of damage 
to the organ of corti which ruled out nerve injury as a primary effect. The slightest 
detectable histological changes consisted of anatomical derangement of outer hair cells and 
their supporting cells. In mild injuries the outer hair cells which are normally tall and 
rectangular appeared shorter and wider and the nuclei were smaller and the chromatin was 
condensed. In severe lesions there was a loss of external hair cells and the beginning of 
cytological changes in the Dieters cells and the supporting cells, further progressive stages 
of injury consisted of flattening of the organ of corti and finally its complete disappearance. 
In labyrinthine concussion histological examination of the auditory system revealed the 
significant pathological changes to lie in the cochlea, when there was damage to the organ of 
corti severest in the upper basal turn, the region serving 4000Hz frequency. Thus according 
to them partial permanent deafness occurs in about 50% of patients who sustain a blow to 
the head to produce unconsciousness. Even a mild head blow without loss of consciousness 
can occasionally result in deafness.  
According to Makashima and Snow (Kazumi Makashima & James .B. snow, 1975) 
experimental findings by means of assessment of preyer reflex and cochlear potentials in 
guinea pigs after stimulating head injury by shaking them in a padded cage till they became 
unconscious showed that in animals which did not have fracture of the skull showed 
hemorrhage in and laceration of the 8th nerve where it exits from the medulla oblongata. 
Animals killed after 6 days and 30 days showed slight to moderate degeneration of outer 
hair cells and Hensens cells in the apical and middle turns of the cochlea, changes in the 
Stria vascularis were minimal.  
The oto-neurological manifestations vary from patient to patient with head injury. 
Variability exists in type, severity and mode of onset of symptoms and signs. In some 
patients deterioration of hearing and vestibular functions occurs immediately after head 
injury and it may be transient or permanent. In other patients the symptoms may not 
manifest until later and deterioration of function may continue. According to them these 
facts suggest that there are various forms of trauma in the temporal bone and central 
pathways could be responsible for the deterioration of function.  
In a study done by E B Dorman (E.B Dorman et al 1982) the hearing loss was noted to be due 
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longitudinal fracture of the temporal bone, secondly in an ear opposite a temporal bone 
fracture and thirdly in a head injury with no evidence of skull fracture. According to them 
to produce labyrinthine concussion a head injury must be severe enough to cause loss of 
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Animals killed after 6 days and 30 days showed slight to moderate degeneration of outer 
hair cells and Hensens cells in the apical and middle turns of the cochlea, changes in the 
Stria vascularis were minimal.  
The oto-neurological manifestations vary from patient to patient with head injury. 
Variability exists in type, severity and mode of onset of symptoms and signs. In some 
patients deterioration of hearing and vestibular functions occurs immediately after head 
injury and it may be transient or permanent. In other patients the symptoms may not 
manifest until later and deterioration of function may continue. According to them these 
facts suggest that there are various forms of trauma in the temporal bone and central 
pathways could be responsible for the deterioration of function.  
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hypotheses have been put forward to explain the hearing loss that appears after brain 
concussion. 
According to Per-Olof Bergemalm (Per-olof Bergemalm, 2003) in cases of closed head injury 
74% of patients showed progression of > 15dB HL which was significantly greater than the 
spontaneous progression in the control group. Age and temporal bone fractures were risk 
factors for progression but not brain contusion or Swedish Reaction Level Scale (RLS) They 
found an association between early PTA (Pure tone Audiometry) and progression as well as 
regression i.e. poorer the initial PTA the greater the progression indicating the increased 
instability of the auditory system. The cause of progression is usually unknown. One of the 
possibilities is the development of perilymphatic fistula, other reasons may be secondary 
degenerative changes in the cochlea following inner ear concussion and hypoxia following 
disturbance of micro-circulation. It has also been speculated whether progression is due to 
pre-existing autoimmune disease or whether the trauma itself may initiate such a reaction 
towards specific inner ear proteins. There may also be synergistic interaction between 
trauma and the effects of noise exposure (Neuberger M Korpert K et al 1992) and the use of 
oto-toxic agents and medication (Jacobson CA&.Jacobson JT, 1989) 
According to Vernon and Press (Vernon JA, & Press LS, 1994)  only 8% of the patients who 
sustained head injury complained of tinnitus. 
Dizziness is a frequent complication of head injury. Numerous studies have attempted to 
quantify the incidence of neuro-otological abnormalities in patients with post traumatic 
dizziness. Toglia (Toglia J U et al, 1970) found out that 61% of patients had vestibular 
dysfunction. Gannon (Gannon RP et al, 1978) reported 32% and Wilson reported 57% neuro-
otological test abnormalities in patients who sustained minor or moderate head injury. In 
case of recurring case of dizziness an organic etiology must be suspected.  Hearing loss in 
the higher frequencies is sometimes seen as early as by age 20(Rakel R E, 2005) It increases 
systematically to age 60 (and beyond) and is largest at 4 kHz and 6 kHz and is much larger 
in males than in females.                                                  
A small Sensorineural hearing loss of 25dB at the age of 25 has little medical or social 
relevance, however by the age of 70 a hearing loss as a result of ageing is added to the pre-
existing hearing loss. This results in a moderate to severe sensorineural hearing loss. In 
other words a seemingly minor hearing loss at a very young age may become severe when 
combined with other factors which affect hearing. 
4. Anatomy of the ear and temporal bone  
From the point of view of injury to the ear the anatomy can be divided into preauricular 
pinna, post auricular region, tympanic membrane, external auditory canal, middle ear and 
inner ear. Preauricular region is the region of the ear in front of the auricle. Post auricular 
region is the region behind the auricle. The temporal bone is a composite structure and 
cconsists of tympanic bone, mastoid process, squamous and petrous parts. The tympanic 
bone forms the anterior, inferior and parts of the posterior wall of the external auditory 
canal. Laterally the tympanic bone borders the cartilaginous external auditory canal. The 
sqamous portion of the temporal bone serves as the lateral wall of middle cranial fossa and 
interfaces with the parietal bone superiorly and with the zygomatic process and the 
sphenoid anteriorly. 
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The mastoid portion of temporal bone is the inferiorly extending projection seen on the 
lateral surface of the temporal bone. It is composed of a squamous portion laterally and 
petrous portion medially separated by korner’s petro squamous septum. The petrous 
portion (Greek for ‘rock like’) guards the sensory organs of the inner ear. 
The tegmen tympani is the bony roof of the tympanic cavity, and separates it from the dura 
of middle cranial fossa. It is formed in part by petrous and part by the squamous bone, and 
the petrosquamous suture line, unossified in the young does not close until adult life.  
The floor consists of a thin plate of bone which separates the tympanic cavity from the dome 
of the jugular bulb, sometimes it is deficient. The anterior wall of tympanic cavity is narrow 
as the medial and lateral walls converge. The lower portion of the anterior wall is larger 
than the upper and consists of a thin plate of bone covering the carotid artery.  
4.1 The cochlea  
The bony cochlea lies in front of the vestibule and has an external appearance rather like the 
shell of a snail. The shell has approximately two and one half turns and its height is about 
5mm while the greatest distance across the base is about 9 mm.  
 
Fig. 1. Cross section of the cochlea 
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The basilar membrane which separates the scala media from the scala tympani consists of 
connective tissue fibers embedded in an acellular matrix. The organ of corti, tectorial 
membrane along with the basilar membrane makes up the cochlear partition. (Fig-1). 
 
Fig. 2. Organ of corti (Nolte (1993) The Human Brain 3rd Ed. Fig. 9-34B, p. 213. Cross-section 
through the Organ of Corti) 
The organ of corti (fig-2) is a ridge like structure containing the auditory sensory cells and a 
complex arrangement of supporting cells. The sensory cells are arranged in two distinct 
groups as inner and outer hair cells. There is a single row of inner hair cells, although 
occasionally extra hair cells may be apparent, and also three, four or five irregular rows of 
outer hair cells, with frequent gaps where individual hair cells are absent. Each hair cell 
consists of a body, which lies with in the organ of corti, and a thickened upper surface called 
the cuticular plate, from which projects a cluster of stereocilia or hairs. The stereocilia 
contains a core of actin molecules packed in a para crystalline array and covered with a cell 
membrane. The stereocilia are connected to each other along the sides by fine filaments 
called the side links. The tip of each stereocilium is connected to the sides of the next tallest 
stereocilium by a longer filament known as a tip link. The body of the inner hair cells is flask 
shaped, with a small apex and large cell body. The long axis of cell is inclined towards the 
tunnel of corti, and nerve fibers and nerve endings are located around the lower half of the 
body. The stereocilia projecting from the thickened cuticular plate are arranged in two or 
three rows parallel to the axis of the cochlear duct. The body of the outer hair cell is 
cylindrical with the nucleus lying close to the lower pole, where afferent and efferent nerve 
endings are attached. There are several rows of stereocilia but the configuration varies from 
a W shape at the base, through a V shape in the middle coil, to almost a linear array at the 
apex. The number of stereocilia also decreases in the passage from base to apex, where as 
the length increases, although not in a linear fashion. The hair cells are supported with in 
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the organ of corti by several types of specialized, highly differentiated cells. These are the 
pillar cells, Dieters cells and Hensen’s cells. In the fetus and the newborn there are about 
3500 inner hair cells and 13000 outer hair cells. 
5. Audiometric tests 
5.1 Pure tone audiometry 
It is the most commonly used method of measuring hearing acuity. It is a subjective test. The 
frequencies usually tested are at octave steps i.e., 125, 250, 500, 1000, 2000, 4000, 8000 Hz. A 
pure tone audiometer is an electronic instrument capable of producing pure tone sound of 
different frequencies at variable intensities. It helps in qualitative and quantitative diagnosis 
of hearing loss.  
5.2 Tympanometry 
It is the measurement of acoustic emissions in the external auditory meatus as a function of 
air pressure within the external auditory meatus. It provides a rapid atraumatic and 
objective technique for evaluating the integrity of (a) Middle ear transmission system, (b) 
Estimating middle ear pressure, (c) Estimating volume of ear canal or middle ear, (d) 
Evaluating Eustachian tube function. 
Type A Tympanogram indicate normal middle ear pressure as indicated by tympanogram 
peak at 0 daPa. Normally middle ear pressure typically falls between +50 and –100 daPa. 
Volume measurements more than 2 ml in children and 2.5ml in adults are usually indicative 
of tympanic membrane perforation or patent pressure equalization tube. 
Mild cochlear hearing loss has little effect on acoustic reflex thresholds for tonal stimuli. for 
patients with hearing losses that exceed 70 dB reflexes are typically absent. 
5.3 Oto-acoustic emissions 
As early as 1948, Gold  (Gold.T,1948) discovered that the outer hair cells of the cochlea could 
produce energy by an active mechanical process. However it was not until 1978 that Kemp 
(Kemp 1978) by a series of basic and clinical experiments demonstrated that the cochlea was 
capable of producing low intensity recordable sounds called oto-acoustic emissions (Fig-3). 
Oto-acoustic emissions (OAEs) can be defined as the audio frequency energy which 
originates in and is released from the cochlea, transmitted through the ossicular chain and 
tympanic membrane and measured in the external auditory meatus. They can occur either 
spontaneous or in response to acoustic stimulation. OAEs are believed to reflect the active 
biomechanical movement of the basilar membrane of the cochlea (Fig-4). This retrograde 
traveling wave is thought to be responsible for the sensitivity, frequency selectivity and 
wide dynamic range of the normal auditory system. Oto-acoustic emissions (OAEs) are 
believed to be the by product of   pre-neural mechanisms of the cochlear amplifier and in 
particular, to be linked to the normal functioning of the outer hair cells. Oto-acoustic 
emissions are vulnerable to a variety of agents such as acoustic trauma (Hamernik RP, 1996) 
hypoxia, (Rebillard.G Lavigne& Rebillard.M) and oto-toxic medications (Ress .B D et al, 
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Taking into account estimates of amplification provided by outer hair cells, complete 
destruction of OHC’S alone could result theoretically, in a hearing loss of 60 dB. Early 
investigations in to OAE’S proved that they are not present when the sensorineural hearing 
loss exceeds 40-50dB (Collet L, 1989), (Gorga, Michael P, 1997). 
DPOAEs measures have shown excellent intra-subject test reliability which allows 
monitoring of dynamic changes of cochlear function (V.Rupa, 2001) 
 
Fig. 3. Basilar membrane displacements produced in cadaveric human cochlea in response 
to 200Hz at 4 separate points of time. Envelope of travelling wave is also noted  
 
Fig. 4. Schematic representation of travelling wave along basement membrane 
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It has been established that DPOAEs are reduced or eliminated by compromise of middle ear 
conduction pathway. Normal middle ear functioning is pre-requisite for measuring DPOAE 
and it is therefore important to include immitance measurements while recording DPOAEs. 
This means is also used to confirm the presence of any middle ear pathology in MHI. 
6. Study 
In the study done in the ENT department of Christian Medical College India, 60 patients 
with history suggestive of mild head injury were evaluated over a period of six months.  
INCLUSION CRITERIA: All patients with (a) history suggestive of Mild Head injury (MHI) 
Glasgow coma scale scoring system [GCS] 13 – 15 and improving (b) age between 6 – 60 
years,(c) Patients discharged from casualty after observation period of 24 hours,(d) History 
of loss of consciousness of less than 20 minutes. 
EXCLUSION CRITERIA: Patients with past history of ear disease, previous head injury or 
noise trauma. and patients having family history suggestive of autoimmune disease and 
hearing loss. 
A detailed evaluation of the severity of injury using Glasgow coma scale scoring was done. 
Radiological investigations like X-Ray of skull (antero-posterior and lateral) and CT scan 
were used to detect skull fractures.  
The external auditory canal and tympanic membrane were assessed to rule out any signs of 
temporal bone fracture like bleeding from external auditory canal, palpable step deformity, 
tympanic membrane perforation or haemotympanum. If the external auditory canal was 
filled with clotted blood patient was called for assessment after a period of one week. Eyes 
were checked for nystagmus and conjugate deviation. Facial nerve function tests were done 
and when the patient was cooperative facial nerve function was graded according to House 
Brackmann scale (House JW, &Brackmann DE 1985) 
Pure tone audiometry was done and Hearing thresholds of 15-25 dB across the frequencies were 
considered to be as normal. Tympanometry was done using a probe tone frequency of 226Hz. 
An ipsilateral stapedial reflex at 1000 Hz was elicited. The ipsilateral acoustic reflex 
threshold was seen as normal if the level at which it is elicited falls between 70db and 100db.  
DPOAE testing was done at 1000Hz, 2000Hz, 3000Hz, 4000Hz, and 6000Hz. 
Repeat evaluation was done after a period of three and six months. A detailed oto-
neurological evaluation was done in all three visits and patients were specifically asked for 
symptoms of hearing loss tinnitus and vertigo 
6.1 Results and analysis 
Road traffic accidents (RTA) were the most common cause of Minor head injury as seen in 
all studies. The incidence of road traffic accidents in age groups 20-50 years, in our study, 
(Fig-5) was similar to the study done by Ludwig podoshin and M R Abd AL-Hady. A vast 
majority (75%) of the RTA’s (Road traffic accidents) (Fig-6) were two wheeler accidents and 
none wore helmets at the time of accident.  
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6.1 Results and analysis 
Road traffic accidents (RTA) were the most common cause of Minor head injury as seen in 
all studies. The incidence of road traffic accidents in age groups 20-50 years, in our study, 
(Fig-5) was similar to the study done by Ludwig podoshin and M R Abd AL-Hady. A vast 
majority (75%) of the RTA’s (Road traffic accidents) (Fig-6) were two wheeler accidents and 
none wore helmets at the time of accident.  
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Out of 60 patients 73% were asymptomatic, 15% complained of vertigo, 10% complained of 
hearing loss, and 2% complained of tinnitus (Fig-7). 
 
Fig. 8. Hearing loss in patients with MHI 
Out of 60 patients (120 ears tested), 38 % had normal hearing, 40% had sensorineural 
hearing loss, 7% had conductive hearing loss, and 15 % had mixed hearing loss (fig -8). 
 
Fig. 9. Pure tone audiometry 
Pure tone audiometry assessment of hearing immediately post trauma with respect to 
frequencies affected revealed that hearing loss was mainly in the high frequency region with 
greatest loss noticed at 4000 Hz and 8000 Hz (Fig-9). Significant hearing improvement on 
PTA was found at all the four frequencies with in three months after trauma  , 1000Hz (p-
38%(46) 
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value 0.014) , 2000Hz (p-value 0.006), 4000Hz (p-value<0.001), and 8000Hz (p-value 0.002)( 
Fig-10) ,( Fig-11),(Fig-12) . 
 
Fig. 10. Serial Pure Tone audiometry at 1000Hz,2000Hz,4000Hz,8000Hz over a period of six 
months 
DPOAEs are present across most frequencies at and above 1000Hz in 99 to 100% of ears with 
normal hearing and they are absent when sensorineural hearing loss exceeds 40-50dB which 
was similar in our study. No studies were found in literature where DPOAE was assessed in 
minor head injury. 
It was seen that DPOAE was absent in 38.6%  at 1000Hz, 36% at 2000Hz,  29.8% at 4000Hz in 
patients even with normal PTA  thresholds after mild head injury. 
In case of Mild hearing loss on PTA, there was absence of emissions in 70% at 1000 Hz, 69% 
at 2000Hz, 83% at 4000Hz. This would suggest that damage to outer hair cells becomes more 
pronounced when there is manifest hearing loss on PTA. In few cases with normal hearing, 
DPOAEs were absent through out the evaluation time period suggesting irreversible 
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Fig. 11. Pure tone audiometry showing progression of hearing loss affecting frequency of 
4000hz,8000hz in patient with left frontal bone fracture. Absence of DPOAEs  at 4000hz from 





value 0.014) , 2000Hz (p-value 0.006), 4000Hz (p-value<0.001), and 8000Hz (p-value 0.002)( 
Fig-10) ,( Fig-11),(Fig-12) . 
 
Fig. 10. Serial Pure Tone audiometry at 1000Hz,2000Hz,4000Hz,8000Hz over a period of six 
months 
DPOAEs are present across most frequencies at and above 1000Hz in 99 to 100% of ears with 
normal hearing and they are absent when sensorineural hearing loss exceeds 40-50dB which 
was similar in our study. No studies were found in literature where DPOAE was assessed in 
minor head injury. 
It was seen that DPOAE was absent in 38.6%  at 1000Hz, 36% at 2000Hz,  29.8% at 4000Hz in 
patients even with normal PTA  thresholds after mild head injury. 
In case of Mild hearing loss on PTA, there was absence of emissions in 70% at 1000 Hz, 69% 
at 2000Hz, 83% at 4000Hz. This would suggest that damage to outer hair cells becomes more 
pronounced when there is manifest hearing loss on PTA. In few cases with normal hearing, 
DPOAEs were absent through out the evaluation time period suggesting irreversible 















P T A _ 4 K
n o rm a l
m ild
m o d e ra te
m o d e ra te ly  se ve re














P T A _ 2 K
n o rm a l
m il d
m o d e ra t e
m o d e ra t e ly  s e v e r e
s e v e re
VISIT_NO 











































Fig. 11. Pure tone audiometry showing progression of hearing loss affecting frequency of 
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Fig. 12. Pure tone Audiometry and DPOAEs showing   conductive   hearing loss post trauma 
which returned to normal over a period of six months, but continues to have absent 
emissions at 4000 Hz, 6000 Hz 
 



















Fig. 14. DPOAE at 3000kz 
 
Fig. 15. DPOAE at 4000kz 
As the hearing improved oto-acoustic emissions were detectable, however in cases where 
the hearing loss progressed, emissions could not be recorded. Changes in DPOAEs were 
found to be statistically significant only at 3000 Hz (p value-0.002) and 4000Hz (p value-
0.003), in mild head injury. 
Dix-Hallpike positional test was positive in three patients for whom Epley’s repositioning 
maneuver was done and rests of the patients were treated with labyrinthine suppressants. 
One patient complained of tinnitus.  
On examination hemotympanum was noticed in 2 patients which resolved over a period of 
three months. 1 patient presented with laryngeal trauma, rest of the patients had bleeding 
either from the nose or the ear.  
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Bleeding from the ear was noticed to be due to laceration in the external auditory canal. 
Patients having ear bleeding were called after a week for auditory assessment, no active 
intervention was needed. 1 patient had ottis externa which was treated conservatively. 
 
Fig. 16. Distribution of fractures 
Out of 60 patients a total number of 15 patients were found to have skull fractures (fig-16). 
Of 5 patients with frontal bone fractures bilateral hearing loss was noticed in all the patients, 
of which mixed hearing loss improved but did not become normal.  
In patients who sustained temporal bone fractures, mixed fractures were seen in two 
patients, one patient had longitudinal fracture, and one had transverse fracture. 
Sensorineural hearing loss was found in four ears, mixed hearing loss was found in one 
ear, conductive hearing loss was noticed in one ear, and two ears were found to be 
normal. 
Sensorineural hearing loss was noticed in the patient who sustained a fracture of the 
occipital bone. 
Out of the three patients who sustained parietal bone fractures two patients were found to 
have normal hearing, the third patient had sensorineural hearing loss in one ear which  
became normal and mixed hearing loss in the other ear that improved. 
Bilateral sensorineural hearing loss was detected in patients who sustained facial bone 
fractures. 
Only one patient with parietal bone fracture with normal hearing complained of vertigo in 
which positional test was negative and was treated conservatively. 
Out of the four patients who fell from a height three patients had normal hearing and one 
had conductive hearing loss. Parietal bone fracture was detected in one patient who had 
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Delayed facial nerve paresis was seen in one patient who presented with history of bull gore 
injury which recovered within 3 months. 
7. Conclusion 
This prospective study was done in a tertiary care teaching hospital to look at the incidence 
of hearing loss in patients who sustained minor head injury. The behavior of hearing loss 
was evaluated by serial assessment of hearing. Road traffic accidents (RTA) were the most 
common cause of Minor head injury as seen in all studies. The incidence of road traffic 
accidents in age groups 20-50 years, in our study, was similar to the study done by Ludwig 
podoshin and M R Abd AL-Hady. Whereas in the study done by Griffith, the majority were 
seen in late teens. 
Two wheeler accidents were found to be the commonest cause of RTA causing minor head 
injury in our study,  whereas another study ( George .G.Browning at al 1982) reported that 
assault /fight was the major etiology causing minor head injury. 75% of the RTA’s were two 
wheeler accidents and none of them were wearing helmets at the time of accident. In about 
40% of our patient’s consumption of alcohol would have contributed to the road traffic 
accident. 
Symptoms of hearing loss were found in only 10% of patients which is in agreement with 
Harold F.Schuknecht (1956) and Kazumi Makashima et al (1975)   due to the involvement in 
high frequency region. The symptoms of vertigo were found to be   15% which is low as 
compared with Toglia JU et al (1970) who reported an incidence of  61%  and Rosalyn et al 
(1995)  who reported   95% of patients with symptoms of vertigo . Additionally a low 
Incidence of tinnitus was observed which is in agreement with Griffith. The incidence of 
Hearing loss in our study is 62% which is in agreement with a previous study Griffith (56%) 
with males being most affected. 
The commonest type of hearing loss was sensorineural loss confined to high frequencies. 
The degree of hearing loss determined the out come, and it was found in our study that 
patients who had moderate to severe hearing loss at the time of injury had a poorer 
prognosis as compared to those with normal hearing. Like the results of other  studies 
temporal bone fractures had a higher incidence of hearing loss as compared to  other facial 
bone fractures. 
In our study in India, Road traffic accidents (RTA) were the most common cause of Minor 
head injury. 75% of the RTA’s were two wheeler accidents and none of them were wearing 
helmets at the time of accident. In about 40% of our patient’s consumption of alcohol might 
have contributed to the road traffic accidents.  
Only 10% of patients complained of hearing loss ,however on evaluation  62% were found to 
have hearing loss. The commonest type of hearing loss was sensorineural loss confined to 
high frequencies. The prognosis was poor if the hearing loss was more severe. The degree of 
hearing loss determined the outcome, and it was found in our study that patients who had 
moderate to severe hearing loss at the time of injury had a poorer prognosis. Temporal bone 
fractures have a higher incidence of hearing loss, the symptoms of vertigo was found to be   
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and 4000 Hz is significant in assessing outer hair cell damage when compared to Pure Tone 
Audiometry in sub clinical hearing loss. 
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1. Introduction  
Hearing impairment is one of the most frequent sensory deficits in humans, affecting more 
than 250 million people in the world. Consequences of hearing loss include inability to 
interpret speech, often resulting in a reduced ability to communicate and delay in language 
acquisition. Untreated hearing loss may also cause economic and educational disadvantage, 
social isolation and cause stigmatization.  
There are three basic types of hearing loss based on the part of auditory system with the 
damage: conductive hearing loss, sensorineural hearing loss, and mixed hearing loss.  
Conductive hearing loss is the most common cause of hearing impairment both in children 
and in the adults and the incidence is significantly higher in children. In conductive hearing 
loss, the inner ear functions normally, but sound vibrations are blocked from passage through 
the ear canal, ear drum or across the tiny bones located in the middle ear. Patients with 
conductive hearing loss hear perceive bone-conducted sounds presented with a small vibrator 
to the skull with better thresholds than sounds presented through earphones. Conductive 
hearing loss is usually mild to moderate in degree and can be unilateral or bilateral and in 
most cases unilateral. Most type of conductive hearing loss is correctable by relatively minor 
medical or surgical treatments. More significant conductive hearing loss may be associated 
with skull and/or facial malformations which may require surgery for its correction. 
Trauma generally is a major cause of morbidity and mortality in any society [Paul & Peter 
2001]. Generally, trauma to the ear may result in fracture of the external auditory canal, 
tympanic membrane perforation, fracture to the ossicular chains, fracture of the temporal 
bone itself, damage to the cochlea or the facial nerve. Lesser bone trauma causes damage to 
the ossicular chains [Fradis & Podoshin 1975.] Hearing loss from trauma occurs in 22.5% of 
cases of temporal bone trauma and of these cases 16-30% have conductive hearing 
impairment [Fradis & Podoshin 1975, Ghoyareb B.Y et al 1987]. Hearing loss is defined as 
the averaged hearing loss at 1000, 2000 and 4000 Hz, measured by pure tone audiometry. 
This definition, although different from WHO/ISO definitions, is currently used in Nigeria 
because of its higher relevance to speech discrimination. It also corresponds to the standard 
proposed by the British Association of Otolaryngology and the British Society of Audiology 
(1983). Hearing is said to be impaired when the hearing level is above 25dB in the best ear. 
Hearing loss can have a profound impact on an individual’s emotional, physical, and social 
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dissatisfaction with life, reduced functional health and withdrawal from social activities. 
This chapter aims to profile hearing loss due to trauma and its aetiology.  
1.1 Anatomy and physiology of conductive hearing loss due to trauma 
The ear consists of three parts namely external, middle and inner ear. Conductive hearing 
loss occurs due to damage to the external or middle ear (Figure 1).  
The external ear consists of the pinna, and external auditory canal. The external auditory 
canal is about 2.5cm long. The external auditory canal extends from the concha to the 
tympanic membrane. The middle ear is made up of the Tympanic cavity, Aditus ad-antrum, 
mastoid air cells and Eustachian tube. It contains the ossicles, nerves and muscles and 
extends from the medial end of the tympanic membrane to the stapes footplate (figure 1.0).   
 
Fig. 1. Anatomical Diagram of the Ear   © 2009 WebMD, LLC. All rights reserved. 
1.2 Physiology of hearing 
Sound in the form of air waves arrives at the auricle and is transmitted through the external 
auditory canal. Sound then causes the tympanic membrane to vibrate. Vibration energy in 
the tympanic membrane is transmitted through the ossicles to the oval window into the 
cochlea. Pressure vibrations are transmitted into the scala vestibuli and into the cochlea. 
Vibrations of the scala vestibuli are greatest at the location where the resonance frequency of 
the cochlea corresponds to the frequency of the transmitted sound waves. In this way, a 
topographic representation of sound is possible. The basilar membrane vibrates which 
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causes deflection of the stereocilia, and stimulation of the cochlear nerve. Injury to middle 
ear causes hearing loss. The is due to the problem of impedance: the resistance of transfer of 
energy between two media. This can be understood by analogy with transmission of light 
through water. When sun shines on water some of the light is reflected, while the remaining 
is transmitted through the water. This is manifested as a glare on top of the water and also 
visibility below the surface. Without the middle ear, most of the sound would bounce off of 
the surface of the oval window and less sound would be transmitted into the cochlea. This is 
because sound must pass from one medium (air) into another (liquid) in order to stimulate 
the cochlea. 
The middle ear reduces the problem of impedance mismatch through several mechanisms. 
The effective ratio of these areas of the tympanic membrane to the oval window is about 
14:1 (Roger and Maurice 1992). A second mechanism by which the middle ear overcomes 
impedance mismatch is through the ossicles. The malleus is 1.3 times longer than the incus. 
The ossicles also constitute a lever mechanism with a mechanical advantage of 1.3:1 (Roger 
and Maurice 1992, Lee KJ 1995). The product of these areas and lever ratios represent the 
transfer ratio of the whole mechanism. 14 x 1.3 = 18:1 (Roger and Maurice 1992).  The 
vibration of cochlea fluids are processed and analyzed in such a way that data representing 
frequency, intensity and phase are transmitted as impulses along the auditory nerve via 
auditory pathway to brain for interpretation (Gibson 1978).   
Thus injury to either the tympanic membrane or the middle ear ossicles from trauma will 
result in loss of this physiological function causing impedance mismatch ultimately 
resulting in impaired hearing (Roger 1992, Lee KJ1995). 
The ear can be stimulated either with sound pressure waves or via vibrations applied 
directly to the skull. The latter is noted on audiograms as bone conduction and is used to 
distinguish the sensorineural component of hearing. There are three mechanisms in which 
vibratory energy placed directed onto the skull will cause stimulation of the cochlea:  
This can be through 
i. Distortional  
ii. Inertia-Ossicular 
iii. Osseo-tympanic mechanism 
1. The distortional mechanisms is due to vibration directly distorting the skull. As the 
cochlea is part of the skull, it would be distorted as well. Because the round window 
yields more than the oval window, the scala vestubuli and scala tympani have different 
compliances. This results in the deflection of the basilar membrane and deflection of 
steriocillia with stimulation of the auditory nerve. However in fractured temporal bone 
(longtitudinal or transverse fracture) affecting either the oval window, cochlea or 
semicircular canal, this smooth mechanism is interrupted (Stanley 2009)  
2. The inertial-ossicular mechanism of conductive hearing relates to the ability of vibration 
energy directed to the skull to cause motion of the ossicles. Vibration to the skull will 
cause the ossicles to move. Ossicular movement imparts its energy to the oval window 
which stimulates the cochlea. However, this is dependent on the direction of vibrations 
in the skull. If the direction of vibration is parallel to the axis of the movement of the 
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temporal bone injury resulting in fracture of the temporal bone or ossicular joint, 
fracture results in change or loss in the axis of ossicular movement and causes 
conductive hearing loss.  If the vector of skull vibration is perpendicular to the axis of 
the movement of the ossicles, the effect is negligible. As a vibrating object, the ossicles 
have a resonance frequency. Therefore the inertial-loss mechanism of conductive 
hearing is more prominent about the resonance frequency of the ossicles.  
3. The osseo-tympanic mechanism of bone conductive hearing is best illustrated by 
occlusion of the external auditory canal. Occlusion may be as a result of pathologic 
conditions such as fracture to the temporal bone with blood clots occluding the external 
auditory canal or cerumen impaction. Vibration energy is transmitted through the skull, 
causing a vibration of the soft tissues of the external auditory canal. This vibratory 
energy is transmitted into the air of the external auditory canal. Some energy escapes 
the external auditory canal while some reaches the tympanic membrane. The tympanic 
membrane is thus stimulated; energy is transferred to the ossicles and onwards to the 
cochlea. This explains why when the external ear canal is occluded, the bone-
conduction threshold improves. Vibration energy into the external auditory canal 
bounces back from the object occluding the external auditory canal. Less sound energy 
is lost and more is reflected onto the tympanic membrane.  
1.3 Aetiopathogenesis 
Hearing loss due to trauma is a common phenomenon worldwide. This could arise from 
assaults, road traffic injury, domestic, industrial and sports injuries. These are relatively on 
the increase in our society. Trauma to the head causing conductive hearing loss commonly 
involves the external ear, middle ear and temporal bone in road traffic injuries. The sources 
of injury or accidents most frequently encountered are those involving motor vehicles; 
however, industrial and athletic injuries may also present potential lesions to the temporal 
bone and middle ear. Appropriate use of safety devices, both in automobiles and in 
industrial and athletic activities, to protect the skull and head from trauma may eliminate or 
reduce many of these problems. However, compliance with advised safety precautions is 
often not adequate.  
1.4 External auditory canal injury 
Two types of injury are likely to involve the external auditory canal: blunt and penetrating 
trauma, thermal and caustic burns. Isolated blunt trauma to the ear canal is most often 
caused by the insertion of a foreign object into the ear to scratch the skin or to remove wax. 
The skin of the ear canal, particularly the anterior and inferior part of the canal, is quite thin, 
with a minimal sub-epithelial layer. The tender skin of this portion of the canal is easily 
abraded and will bleed readily, particularly if the patient is on anticoagulant or anti-platelet 
therapy. In most instances, the pain and the sight of blood from the ear canal cause the 
patient to seek medical attention. In some cases, however, a secondary infection develops, 
and pain, hearing loss, or infected drainage causes the patient to seek help. The canal should 
be gently cleaned using microscopic technique, and blood clots, debris, and wax should be 
removed. When the bleeding site has been identified, placing a small pledget  of Gelfoam 
coated with antibiotic ointment over it can readily control the bleeding. Alternatively, 
Gelfoam soaked with topical thrombin can be applied to the bleeding site. In rare cases, the 
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site must be cauterized and then packed with a Merocel wick. In contrast, the skin of the 
posterosuperior part of the canal is much thicker and is more resistant to abrasions and 
injuries. Posterior lacerations usually stop bleeding because the subepithelial layer is more 
developed; therefore, vessels in this area readily contract and clot off.( Mitchell KS   2003) 
After cleaning of the canal under good illumination, the tympanic membrane is inspected to 
determine the extent of injury. If an injury to the middle ear or temporal bone is discovered, 
a complete neurotologic examination is performed to evaluate the patient. Audiometric 
assessment can also be done to assess the degree of hearing loss. Blunt injuries to the 
temporal bone typically result from the head being forced against a stationary object in a 
deceleration injury or from an object being thrown directly at the head. Most injuries 
involving this region occur as a result of a glancing blow to the temporal region.  
Although soft tissue injuries to the auricle and canal occur, they are often accompanied by 
fractures of the external auditory canal, middle ear structures, otic capsule, or surrounding 
structures. Mandibular injuries, particularly those that drive the mandible posteriorly into 
the jaw joint, will occasionally fracture the anterior wall of the ear canal, resulting in 
laceration of the skin and exposure of bone. Following blunt trauma to the ear and temporal 
bone, the external auditory canal should be carefully cleaned and bleeding controlled as 
described earlier. If exposed bone is found, it should not be debrided  at this point but rather 
assessed later when the canal has healed. Radiographs, including facial bone computed 
tomographic (CT) scans and pantomographic mandibular views, should be obtained in 
these patients to define the injuries.  
Occasionally, a direct blow to the auricle results in an isolated fracture of the external 
auditory canal and mastoid process. This is a fracture not involving the deeper parts of the 
temporal bone that are in contact with the dura matter. Regardless of where the fracture has 
occurred, the clinician should be aware that squamous cell epithelium can be entrapped by 
the fracture fragments, leading to the development of a canal cholesteatoma. Canal fractures 
can also lead to chronic infection, bone sequestration, and stenosis of the canal. The 
development of any of these sequelae may necessitate surgical débridement, grafting, 
reconstruction, or meatoplasty to ensure a healthy open ear canal. Penetrating injuries of the 
external auditory canal are usually caused by gunshot or stab wounds. This may be 
anteriorly through the parotid gland which often involves the external auditory canal or 
posteriorly through the mastoid bone also involving the external auditory canal.  As a 
consequence, facial nerve injury, tympanic membrane perforation, and ossicular dislocation 
can result from gunshot wounds of the external auditory canal. 
The facial nerve is most likely to be injured at the stylomastoid foramen apparently because 
it is relatively fixed at that point. In the absence of any of these additional injuries (mastoid 
or parotid) gunshot wounds of the ear canal require cleaning, a light dressing, and 
prophylactic antibiotics. Occasionally, the canal must be stented using Silastic with 
sofratulle protection with steroid based antibiotic drop impregnated in it or sofratulle with 
steroid based antibiotic impregnated rolled and stuck into the canal. Lacerations of the 
external auditory canal can occur either anteriorly or posteriorly and are often accompanied 
by partial avulsion of the auricle. These patients should be carefully evaluated for injury to 
the facial nerve and the great vessels; radiographic studies including arteriography may be 
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occurred, the clinician should be aware that squamous cell epithelium can be entrapped by 
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can also lead to chronic infection, bone sequestration, and stenosis of the canal. The 
development of any of these sequelae may necessitate surgical débridement, grafting, 
reconstruction, or meatoplasty to ensure a healthy open ear canal. Penetrating injuries of the 
external auditory canal are usually caused by gunshot or stab wounds. This may be 
anteriorly through the parotid gland which often involves the external auditory canal or 
posteriorly through the mastoid bone also involving the external auditory canal.  As a 
consequence, facial nerve injury, tympanic membrane perforation, and ossicular dislocation 
can result from gunshot wounds of the external auditory canal. 
The facial nerve is most likely to be injured at the stylomastoid foramen apparently because 
it is relatively fixed at that point. In the absence of any of these additional injuries (mastoid 
or parotid) gunshot wounds of the ear canal require cleaning, a light dressing, and 
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débridement, and suturing to realign the various parts of the ear canal and auricle. 
Surprisingly, stenosis does not usually occur in these patients. 
Burns and caustic injuries to the ear canal often represent a potentially complicated situation 
in that severe burns can lead to circumferential scarring and stenosis of the canal. Most of 
these injuries are attributable to one of three mechanisms: a thermal burn, a caustic burn, or 
a welding injury. Thermal and caustic burns of the ear canal are usually associated with 
additional injury to the auricle, which may in itself lead to loss of cartilage, cicatrix 
formation, and stenosis of the canal. Most thermal burns of the ear canal are caused by flash 
injuries, fires, lightning strikes, or hot liquids such as oil. Similar to burns elsewhere on the 
body, the depth and extent of the burn should be determined and documented. Superficial 
thermal burns of the ear canal are usually treated with the application of antibiotic ointment. 
If more than half of the ear canal is involved or has third-degree burns, in addition to the 
application of antibiotic ointment, the canal is stented with soft Silastic tubing. Canal 
stenting is performed in an effort to prevent stenosis of the canal, which leads to the 
trapping of squamous debris and ultimately a destructive ear canal cholesteatoma. Stenosis 
of the canal is treated aggressively with corticosteroid injections, frequent dilations, and, in 
some cases, skin grafting or even meatoplasty. Caustic burns are usually caused by a 
chemical spill or a foreign object such as an alkaline battery. Thermal and acid burns cause 
coagulation necrosis, whereas alkaline burns cause liquefaction necrosis and leads to much 
more extensive injury over time (Mitchell KS 2003). 
Kavanagh and Litovitz reported a series of battery-related injuries to the ear canal that were 
much more frequent and severe than expected, including tympanic membrane perforation, 
exposed bone of the ear canal, sensorineural hearing loss, ossicular destruction, and facial 
paralysis (Kavanagh KT and Litovitz T 1986). They also noted that otic drops must be 
withheld in these patients as they provide an external electrolyte bath for the battery, 
enhancing leakage and generation of an external current with subsequent tissue electrolysis 
and hydroxide formation. The foreign body should be removed as soon as possible, under 
general anesthesia if needed (Capo JM, Lucente FE 1986). Once the injury has been assessed, 
caustic burns are treated much like thermal burns described earlier, with microscopic 
cleaning, antibiotic eardrops, and stenting if indicated. 
Welding injuries occur when hot slag or molten metal enters the meatus, usually resulting in 
either a small and localized burn of the ear canal or a tympanic membrane perforation. In 
most patients, microscopic cleaning, ciprofloxacin and hydrocortisone otic drops, and 
observation are the only measures indicated for welding injuries of the external auditory 
canal. 
1.5 Middle ear and Tympanic membrane injury 
The temporal bone and middle ear are composed of very dense bone. Relatively minor 
blows to the head would rarely cause a significant injury to the temporal bone and middle 
ear. The source of the injury that may involve the temporal bone must be of rather intense 
force.   
The injury seen with trauma to the head may be either from two major categories: blunt 
trauma to the skull and penetrating trauma to the skull. The nature of the injury will vary 
considerably based on the type of trauma delivered directly to the head. The degree of 
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hearing loss suffered by the patients also varies as discussed below. Trauma to the tympanic 
membrane and the middle ear can be caused by (1) overpressure, (2) thermal or caustic 
burns, (3) blunt or penetrating injuries, and (4) barotrauma. Of all these overpressure seems 
to be the most common. The major causes of overpressure include slap injuries and blast 
injuries. Slap injuries are extremely common and can be a result of either a hand or water 
slap. Slap injuries usually result in a triangular or linear tear of the tympanic membrane 
Most of these perforations cause mild hearing loss, aural fullness, and mild tinnitus. Blast 
injuries, although much less common in Nigeria, are potentially much more serious. Blast 
injuries may be caused by bomb explosions, gasoline explosions, rock blasting and air-bag 
deployment in automobile accidents. Blast injuries from bomb and gasoline explosions not 
only disrupt the tympanic membrane but also can cause temporal bone fracture, ossicular 
discontinuity, or high-frequency sensorineural hearing loss owing to cochlear injury. 
Following an overpressure injury, blood, purulent secretions, and debris should be carefully 
suctioned from the ear canal, and the perforation size and location should be recorded. 
Irrigation and pneumatic otoscopy should be specifically avoided in these patients. The 
ability to hear a whisper as well as tuning fork tests should be documented, and an 
audiogram should be obtained as soon as the patient’s condition allows. A complete 
neurotologic examination should also be performed in these patients to document the status 
of the cranial nerves including the facial nerve and the vestibular nerve as well as the central 
nervous system. If the tympanic membrane perforation is dry, it should be observed and 
patient advised to keep the ear dry also ototopical ear drops are not indicated. If there is 
CSF leakage or mucopurulent discharge from the middle ear through the tympanic 
membrane perforation, the clinician should determine and note if this is consistent with 
cerebrospinal fluid (CSF). If a CSF leak is suspected, immediate CT scan of the temporal 
bone should be obtained to rule out a fracture. If the drainage is not consistent with CSF, 
oral antibiotics and ciprofloxacin with hydrocortisone otic drop should be applied in the 
form of wick dressing is done. A history of vertigo or nausea and vomiting and an 
audiogram showing a conductive hearing loss of more than 30 dB suggest disruption of 
the ossicular chain. Profound sensorineural loss also may signify oval window or cochlear 
damage. 
Thermal injuries to the tympanic membrane include welding and lightning injuries. 
Welding injuries often result in non-healing perforations of the tympanic membrane, either 
as a result of infection or possibly because the slag acts to cauterize or devascularize the 
tympanic membrane as it passes through it. If infection occurs, the patient is treated with 
systemic antibiotics such as ciprofloxacin and steroid-based topical ear drops 
hydrocortisone otic drops. If the perforation is dry, it should be observed for a period of 12 
weeks for spontaneous healing. If the drumhead does not heal, surgical closure in the form 
of tympanoplasty should be performed. Lightning and electrocution injuries are also a form 
of thermal injurie which are not rare, and the most frequent injury to the ear is perforation of 
the tympanic membrane ((Panosian MS, Dutcher 1994) The most common vestibular 
disturbance is transient vertigo. Other clinical findings include sensorineural hearing 
impairment, conductive hearing loss, tinnitus, temporal bone fracture, avulsion of the 
mastoid process, burns of the ear canal, and facial nerve paralysis (ogren and Edmund 
1995). Management is similar to the welding injury as the tympanic membrane perforations 
caused by the lightning injury often do not heal, probably as a result of cauterization or 
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Caustic injuries to the tympanic membrane can cause its perforation. With alkaline agents, 
the tympanic membrane is damaged by liquefaction necrosis, that is, the alkaline caustic 
penetrates the tympanic membrane, causing occlusion of the vasculature that may extend 
farther than the visible perforation.  
As a result, the size of the perforation may not be fully appreciated until all of the 
inflammation is resolved. Furthermore, after caustic injuries, other middle ear pathologies 
observed include an extensive granulation reaction with scarification, ossicular fixation, 
chronic infection of the middle ear mucosa, canal blunting where the raw surfaces that 
surround the canal form a cicatrix, leading to narrowing of the ear canal and loss of the 
vibratory surface of the tympanic  membrane. Other complications are chronic myringitis on 
the surface of the tympanic membrane, creating a raw weeping surface with granulation on 
the surface of the drumhead. Treatment involved the use of systemic antibiotics, steroid-
based topical ear drops for aural dressing, audiologic assessment and a complete 
neurotologic evaluation to determine the extent of injury. When the ear has stabilized, and 
preferably when drainage has diminished, the middle ear and tympanic membrane can be 
reconstructed surgically.  
In Nigeria compared to the developed world it is difficult to know the economic impact of 
this injury both financially and otherwise. It is estimated that the annual cost of dealing with 
this tragedy is more than $100 billion in the USA. In a study done by the National Academy 
on Aging Society (NAAS) in 1999, it was found that the average value for time lost in a 
conductive injury due to trauma in the workplace costs more than US $8,000. [NAAS 1999]. 
However this data are not available for the developing countries. Trauma patients consume 
more health care resources than heart and cancer patients combined, and whereas mortality 
from heart disease and cancer is declining, the incidence from trauma is increasing 
[Boden&Galizzi 1999, Shires GT et al 1994].  
Blunt trauma to the skull most frequently occurs as the result of the head being thrown 
against a solid or semisolid object, or an object being thrown directly at the head. Soft tissue 
injuries of the external auditory canal may occur with blunt trauma, particularly trauma that 
is glancing in nature, that is, delivered in a sharp angle to the side of the head as opposed to 
a 90-degree injury. Fractures of the middle ear structures, otic capsule, and structures 
surrounding the otic capsule may occur from blunt trauma. The most common form of 
temporal bone fracture, occurring from blunt trauma, is the longitudinal fracture of the 
temporal bone. It is estimated that 70% to 90% of temporal bone fractures are longitudinal 
(Cannon and Jahrsdoerfer, 1983; Dolan, 1989; Nelson, 1979). These fractures most commonly 
result from direct lateral blunt trauma to the skull in the parietal region of the head. In 
considering the effect of a fracture of the skull and its relationship to the temporal bone, it is 
helpful to think of the fracture occurring initially in a weaker portion of the calvarium, such 
as the squamous portion of the temporal bone, and the fracture line extending toward the 
temporal bone. Recognizing that the otic capsule is extremely dense bone, the fracture will 
occur around the otic capsule, taking the course of least resistance (Dahiya et al 1999. The 
course of least resistance usually involves major foramina in the skull base, the most 
common being that of the carotid artery and the jugular bulb. Fractures are frequently near 
the roof of the external auditory canal and run parallel along the petrous apex extending 
anteriorly to the foramen lacerum and the carotid artery. The line may also extend into the 
temporomandibular joint regions.  
 




This is a retrospective review of 64 patients seen at the Ear, Nose and Throat clinic and the 
accident and emergency unit of the University of Ilorin Teaching hospital, Ilorin, Nigeria 
over a ten year period between January 1998 to Dec 2007. The patients had history of 
bleeding from the ear due to trauma from various causes. Patients with multiple traumas 
were also included and these had traumatic tympanic membrane perforation as part of the 
presentation. The data retrieved included the bio-data, the clinical presentation, source of 
injury, the clinical findings and the outcome of the patients. These were entered into an SPSS 
version 11.0 computer soft ware and analyzed descriptively.  
3. Results 
Seventy patients were found to have traumatic tympanic membrane perforation. However 6 
individuals were excluded because of incomplete data. Thus only 64 patients’ records were 
analyzed and formed the basis for this study. Age range of the patients was between 6 
months to 50 yrs with a mean age of 29.2yrs and modal age of 35 years. About 5 (7.9%) of 
them were ≤5years and majority of the patients were between 35 and 50years of age (Table 
1).  
There were 46 (71.9%) males and 18 (28.1%) females with a male to female ratio of 2.5:1. 
Males were affected in most of the aetiologies except in “fall” where no male patient was 
recorded (table 2). 
The commonest aetiology for trauma was from slaps, followed by road traffic injury (RTI) in 
35.9% and 23.5% patients, respectively (Table 3).  
Majority of the slap injury were from fights, security agents, senior students and cultist  
synonymous with Gangsterism (group of criminals especially those who are armed and use 
guns or group of students acting as terrorists within the school system.)at schools in 30.5%, 
17.4% and 17.4% respectively. (Table 4)  
Traumatic tympanic membrane perforation affected 36 left ears and 28 right ears. Majority 
of the patients (95%) had associated sudden hearing loss. Tinnitus was present in 52% while 
24 (37.5%) of the patients had progression to chronic suppurative otitis media (Table 5). It 
was observed that majority of the patients failed to follow up clinical visits once the 
symptoms of bleeding and pain had subsided. An average of three follow up visits per 
patient was recorded. Out of the few %that came for follow up check ups, only 7.8% had 
neo-membrane formation. 
 
Age in years Number & Frequency (%) 
6months- 5yrs 5 (7.9%) 
6years-10yrs 1 (1.6%) 
11-20yrs 15 (23.5%) 
21-34yrs 19 (29.7%) 
35-64yrs 24 (37.7%) 
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Slap 15 08 
Instrumentation 04 03 
Self during ear cleaning 05 02 
RTI 09 01 
Foreign body 10 03 
Explosion 03  
Fall  01 
Total 46 18 
Table 2. Predisposition and sex of patients. 
 
Aetiology Number &Frequency (%) 
Slaps 23 (35.9%) 
Instrumentations 7 (10.9%) 
Self Ear cleaning 7 (10.9%) 
Road Traffic Injury 15 (23.5%) 
Foreign body 08 (12.5%) 
Explosions 3 (4.7%) 
Falls 1 (1.6%) 
Table 3. Aetiological profile of TM perforations. 
 
Sources of slap Number & Frequency (%) 
Security Agent 4 (17.4) 
Assault from Fight 7 (30.5) 
Spouse 2 (8.7) 
Armed Robbery 3 (13.0) 
Senior student/cultists 4 (17.4) 
Sibling 3 (13.0) 
Table 4. Sources of Slaps. 
4. Discussion 
Trauma to the ear can be classified on the basis onf the anatomical location or the type of 
injury. This could be a simple blunt trauma to the pinna; laceration of the pinna, avulsion 
of part or the whole of the pinna; tympanic membrane perforation; dislocation of the 
ossicles; longitudinal and transverse fractures of the petrous temporal bone with 
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associated loss of inner ear and facial nerve function (Ologe FE 2002, Toner JG & Kerr AG 
1997, Okafor BC 1983, Ijaduola GTA 1986, Bhattia PL 1987, Ladapo AA 1979, Ijaduola 
GTA and Okeowo PA 1986). Previous studies have shown that trauma to the tympanic 
membrane and the middle ear can be caused by overpressure (slap, fight, assault from 
security agents and road traffic injury (RTI)), thermal or caustic burns, blunt or 
penetrating injuries such as instruments and barotraumas (Mitchell K. S 2003, da Lilly-
Tariah OB and Somefun OA 2007). Overpressure is by far the most common mechanism 
of trauma to the tympanic membrane (Mitchell K. S 2003) in our environment. Traumatic 
perforation of the tympanic membrane may be caused by direct impact of fluids and 
direct pressure from outside.  
The tympanic membrane (TM) is an important component of sound conduction as its 
vibratory characteristic is necessary for sound transmission in human beings (Richard R. G 
and Mark R.G 2003)  
Traumatic tympanic membrane perforation findings from our study are similar to findings 
elsewhere from the world (Ologe FE 2002, Mitchell K. S 2003, da Lilly-Tariah OB and 
Somefun OA 2007). Male to female ratio was found to be 2.5:1 with high predominance 
among males (72%). This is expected, as trauma is more common in this group of patients 
similar to other reported series (Ologe FE 2002, da Lilly-Tariah OB and Somefun OA 2007, 
Richard R. G and Mark R.G 2003). Our study of injury site indicated that the left ear is at a 
higher risk than the right ear in the ratio of 1.0:1.3 right to left which could be associated 
with the fact that most assailants were right handed, Thus it is likely that most of the acts of 
trauma such as slap occurred with the assailant and victims were facing each other making 
the left ear to be predominantly affected compared to the right side. Some of the causes of 
overpressure include slap injuries and blast injuries. Slap injuries are extremely common 
and can be result of either a hand or water slap and these injuries usually result in a 
triangular or linear tear of the TM (Mitchell K. S 2003). These slap injuries could be a 
product of fight or armed robbery attack. However, in our study it was found to be more 
common among the youth. In more than 50%of cases reviewed and those in the adult these 
cases were due to attack by the armed robbers or security agents. This was the highest cause 
of traumatic tympanic membrane perforation in our study as compared to a similar study in 
other regions of Nigeria where fight with spouse was the commonest aetiology recorded (da 
Lilly-Tariah OB and Somefun OA 2007). In contrast this type of injury made the least 
contribution in our study.  
Slaps were the commonest type of violence seen between individuals, mostly between 
security agents and the offender followed by those among students. However, another 
study found tympanic membrane perforation resulting from slap from marital conflict 
between wife and husband (Mitchell K. S 2003).  There is a need to educate the students and 
security agents on other punitive measure as there is predisposition to conductive hearing 
loss or an imminent chronic suppurative  otitis media if not properly managed. Slap was 
commoner among males than in females similar to another study (Mitchell K. S 2003). 
Trauma to the temporal bone with fracture and leakage of cerebrospinal fluid into the 
middle ear causing conductive hearing losses was second common in this study and this 
was found to be secondary to road traffic injury. The management protocol for skull base 









Slap 15 08 
Instrumentation 04 03 
Self during ear cleaning 05 02 
RTI 09 01 
Foreign body 10 03 
Explosion 03  
Fall  01 
Total 46 18 
Table 2. Predisposition and sex of patients. 
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Falls 1 (1.6%) 
Table 3. Aetiological profile of TM perforations. 
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Otolaryngologist perspective to avoid contamination with an ascending infection. This was 
also found to be higher among male subjects compared to the females, perhaps associated 
with the role of males in African society as the bread winners, working outside home and 
thus are at a higher risk of various type of traffic injuries compared to women who 
predominantly stay at home. Attempt at removing foreign body, ear cleaning with variety 
of objects including cotton bud and wax removal in an unskilled manner either by the 
parents or the primary care physician with TM perforation was an important cause of 
hearing loss found mostly among children as previously reported (Ologe FE 2002, Toner 
JG & Kerr AG 1997, Ladapo AA 1979, Ijaduola GTA and Okeowo PA 1986). There is a 
need for a primary care physician to provide patients with appropriate referral. Explosion 
is not a common phenomenon in our environment as the violence rate is still at a low 
level. Fall with perforation of tympanic membrane is an uncommon occurrence which has 
never been reported but was observed in a child, however the mechanism could not be 
explained.  
Traumatic perforations often occur in healthy members of the community with generally an 
excellent prognosis (Toner JG & Kerr AG 1997, Ijaduola GTA 1986).  Healing with formation 
of neomembrane was observed only in five patients (7.8%) and it is among the under five’s 
this is not surprising as they are still growing. 
5. Conclusion 
Traumatic perforation of the tympanic membrane is still common in our environment. It 
affects all age groups, with more males affected than females. Slaps and RTI are the 
commonest aetiologies seen. The left ear is affected more than the right and sudden 
hearing loss is the most common presentation. There is a need to educate the students and 
security agents on alternative punitive measures and to discourage the act of unskilled 
removal of foreign body from the ear. Early identification, evaluation and referral of 
patients by primary care physician who see these patients will reduce the attendant 
morbidity. 
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1. Introduction  
Exposure to chemicals in the workplace can lead to occupational chemical-induced hearing 
loss, as many chemicals have been internationally recognised as hazardous to hearing. A 
number of studies have demonstrated that, similar to noise, some chemicals not only affect 
the sensory organ of the auditory system (the cochlea) but also lead to adverse effects in 
central auditory structures. Morata and Lemasters (1995) suggested that the adverse 
auditory effects of chemicals such as solvents are due to a combination of oto-and neuro-
toxicity. Oto-toxicity induces outer hair cell (OHC) dysfunction in the cochlea (similar to the 
effects of noise), whereas neuro-toxicity induces central auditory dysfunction. The main 
audiological sign of oto-toxicity is poorer hearing thresholds than expected relative to age. 
Audiological signs of neuro-toxicity may or may not include poorer hearing thresholds, in 
addition to difficulties discriminating sounds, such as speech, particularly in adverse 
listening conditions.  
The aim of this review is to provide an in-depth discussion of occupational chemical-
induced hearing loss, taking into consideration ototoxic agents such as solvents, pesticides 
and metals, and their interaction with noise. Contemporary findings from research 
conducted in animals and humans are included here. Also, research findings from the 
authors with regard to the effect of exposure to mixtures of solvents on the peripheral and 
central auditory system will be addressed. Finally, in the section on international legislation 
of occupational chemical-induced hearing loss, a review of current legislation in a number 
of countries is presented.  
2. Solvent-induced hearing loss 
2.1 Overview of solvents 
A solvent is a liquid used to dissolve other substances. Most solvents are colourless liquids 
at room temperature that volatise easily and have strong odours. Solvents are most 
commonly inhaled in their volatised form and absorbed through the respiratory tract. 
Organic solvents are widely used around the world and many different industrial processes 
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Organic solvent Industrial uses 
Toluene Electroplating, adhesive manufacture, laboratory chemicals, metal 
degreasing, paint manufacture, paint stripping, paper coating, 
pharmaceuticals manufacture, printing, rubber manufacture, 
wood stains and varnishes, and footwear manufacture. 
Styrene Fabrication of fibreglass boats, pulp and paper manufacture and 
in plastics, resins, coatings, and paint manufacture. 
Xylene Laboratory chemicals, machinery manufacture and repair, paint 
manufacture, paint stripping, paper coating, pesticide 
manufacture, pharmaceuticals manufacture, printing, rubber 
manufacture, and in wood stains and varnishes. 
Ethyl benzene Machinery manufacture and repair, paint manufacture, paper 
coating, rubber manufacture, wood stains and varnishes. 
Trichloroethylene 
 
Electroplating, integrated iron and steel manufacture, machinery 
manufacture and repair, metal degreasing, pulp and paper 
manufacture. 
Table 1. Main industrial uses of some selected organic solvents. 
2.2 Evidence of the adverse auditory effects of solvents from animal studies 
Organic solvents such as toluene, styrene, xylene, and ethyl benzene have been identified as 
inducing damage to the outer hair cells (OHCs) in the cochlea of experimental animals 
(Campo et al., 1997; Cappaert et al., 1999; Cappaert et al., 2000; Crofton et al., 1994; Johnson 
& Canlon, 1994; Loquet et al., 1999; McWilliams et al., 2000; Pryor et al., 1987; Sullivan et al., 
1988; Yano et al., 1992). The damage caused by these solvents in its early stages occurs in the 
third row of external OHCs and it then progresses toward the second and first rows. The 
mid-range of audible frequencies for the rat is affected first and according to some authors 
the damage continues toward the apical zone of the cochlea (Campo et al., 1997; Johnson 
& Canlon, 1994). The damage impacts mainly at the mid-frequency region of  
experimental animal cochleae, and this distinguishes the auditory effects induced by 
solvents such as toluene from those observed with ototoxic drugs such as aminoglycoside 
antibiotics and cisplatin (Liu et al., 1997) which mainly affect the apical region of the 
cochlea.  
In the case of trichloroethylene, cochlear histopathology has revealed loss of spiral ganglion 
cells, mainly in the middle turn, and also an inconsistent loss of hair cells (Fechter et al., 
1998).  
Rebert et al. (1995) observed an increase in auditory brainstem response (ABR) latencies in 
rats after exposure by inhalation to pairs of solvents (trichloroethylene and toluene; xylene 
and trichloroethylene; xylene and chlorobenzene; chlorobenzene and toluene). Results of 
this study indicated an additive rather than a synergistic or antagonistic interaction. Other 
studies have also demonstrated additive ototoxic effects for styrene and trichloroethanol 
(Rebert et al., 1993), and styrene and ethanol (Loquet et al., 2000). This additive effect, as 
 
Occupational Chemical-Induced Hearing Loss 
 
173 
opposed to the synergistic effect found with combinations of solvents, implies that the 
mechanism of ototoxicity for these solvents may be similar. 
Research has also demonstrated that rats simultaneously exposed to both toluene and noise 
suffer a more severe hearing loss than the summated hearing loss obtained from an 
equivalent exposure level to each agent alone (Brandt-Lassen et al., 2000; Lataye & 
Campo, 1997). The synergistic interaction between noise and toluene occurs when both 
agents are presented simultaneously, or when toluene is immediately followed by noise. 
Lataye & Campo (1997) claimed that even if the coexistence of both mechanisms (the 
ototoxicity induced by toluene and that induced by noise) potentiates cochlear effects, it 
seems nevertheless that there are no other mechanisms induced by a simultaneous 
exposure to noise and toluene. Combined exposure to noise and styrene in rats has also 
shown the existence of synergism between these two agents (Lataye et al., 2000; Makitie et 
al., 2003).  
Evidence from Lataye et al. (2005) suggests that conditions such as level of activity of the 
rats may be an important factor in the mechanism of styrene-induced hearing loss. The 
researchers found that the same degree of styrene-induced hearing loss can be obtained by 
using concentrations approximately 200 ppm lower in active rats than in sedentary rats. This 
may explain why the studies conducted in experimental animals require higher solvent 
concentrations to induce hearing loss than in humans. Workers are not sedentary in the 
workplace. They usually are moving from one place to another, or manipulating machinery. 
Increased activity implies greater consumption of oxygen compared to sedentary 
conditions. The study of Lataye et al. (2005) has provided some explanation for the 
variations in concentrations that are needed to induce auditory dysfunction in experimental 
animals and humans. In animal models it is possible to control most of the variables; 
however, in humans many factors such as physical activity cannot be controlled 
experimentally. 
Lataye et al. (2007) found a striking increase (4.2 dB) in the cochlear microphonic potential 
amplitude which was followed after left-carotid administration of toluene in experimental 
animals. An increase in the cochlear microphonic potential relates to the inhibition of the 
efferent control of the OHCs, and thus a lack of inhibition in the mechanical response of the 
OHCs to electrical signals. Lataye et al. (2007) suggested that toluene inhibits the 
acetylcholine (Ach) receptors located in the efferent auditory system (medial olivocochlear 
bundle) that mediates the contraction of the OHCs in the cochlea. Similarly, Campo et al. 
(2007) found that toluene may inhibit the Ach receptors of the efferent motor neurons 
located near the facial nerve nuclei that mediate the middle ear muscle systems. These two 
studies represent the first evidence from animal models that solvents may induce central 
auditory dysfunction at the level of the efferent auditory system.  
In summary animal data demonstrates that solvents in isolation can induce OHC loss, and 
in the case of trichloroethylene, spiral ganglion cell loss—mainly in the middle turn of the 
cochlea—is observed. Also, it has been observed that solvents such as toluene adversely 
affect the efferent auditory system associated with the control of the contraction of the 
OHCs as well as with the mediation of the middle ear acoustic reflex. Synergism between 
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2.3 Evidence of the adverse effects of solvents on pure-tone thresholds: Studies on 
humans 
Exposure to a mixture of solvents may induce hearing loss in humans (Morata, Engel et al., 
1997) and, at some frequencies, solvents may damage the inner ear to a much greater extent 
than noise exposure (Sliwinska-Kowalska et al., 2000). Hearing loss induced by solvents has 
been found in workers exposed to a mixture of toluene, ethyl acetate and ethanol (Morata, 
Engel et al., 1997), and xylene and ethyl acetate (Sliwinska-Kowalska et al., 2000). Sliwinska-
Kowalska et al. (2000) found hearing loss in 30% of workers exposed to organic solvents, in 
20% of noise-exposed subjects, and in only 6% of non-exposed subjects. The relative risk 
value for hearing loss in workers exposed to solvents was greater (RR=9.6) in comparison to 
workers exposed only to noise (RR=4.2). Sulkowski et al. (2002) found high frequency 
sensorineural hearing loss in 42% of workers exposed to a mixture of solvents (not specified 
by the authors). In contrast, only 5% of the subjects in the control group (age-matched non-
exposed subjects) showed hearing loss. Studies in populations of workers mainly exposed to 
one type of solvent have been also conducted. High frequency (8-16 kHz) hearing loss has 
been suggested to be associated with styrene dose exposure in humans. In the study of 
Muijser et al. (1988), high frequency hearing thresholds were significantly increased in those 
workers with the greatest exposure to styrene. Also, Morata et al. (2002) found an additive 
damage effect of styrene for pure-tone thresholds at 2, 3, 4 and 6 kHz. The odds ratio for 
hearing loss estimated by Morata et al. (2002) was 2.44 times greater for each increment of 1 
mmol of mandelic acid (a biologic marker of styrene exposure) per gram of creatinine in 
urine. Morata et al. (2002) suggested that styrene can affect the mid-audiometric frequency 
of 2 kHz, which is in agreement to the findings of Sliwinska-Kowalska et al. (2001). Morata 
et al. (2002) also stated that styrene even below recommended values had a toxic effect on 
the auditory system. 
Sliwinska-Kowalska et al. (2003) found a 4-fold increase in the odds of developing hearing 
loss in subjects exposed to styrene. In this study the mean hearing thresholds (adjusted for 
age, gender, and exposure to noise) were significantly higher in a solvent-exposed group 
than in an unexposed reference group at all frequencies tested. A positive linear relationship 
was observed between average working life exposure to styrene concentrations and hearing 
thresholds at 6 and 8 kHz. Also, the effects of carbon disulphide on hearing have been 
explored (Morata, 1989). Results of pure-tone audiometry indicated a 66.7% prevalence of 
hearing loss among exposed workers and only 6.6% of this was attributed to non-
occupational causes (Morata, 1989).  
The possible synergism of combined exposure to solvents and noise on hearing has not been 
consistently identified in human studies. Some researchers have failed to find a synergistic 
effect between these agents on hearing. Jacobsen et al. (1993) in a cohort study showed a 
dominant effect of noise and no additional hearing risk as a result of solvent exposure. 
However, workers exposed only to solvents had a significantly increased risk ratio for 
hearing loss. Sliwinska-Kowalska et al. (2001), in a study conducted involving paint and 
lacquer factory workers, were not able to show any additional risk of hearing loss with a 
combined exposure to noise and a mixture of organic solvents, when compared with 
isolated exposure to solvents only. However, Polizzi et al. (2003) reported a case of a painter 
exposed to noise and a mixture of organic solvents. The authors described an unusual 
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pattern of hearing loss, which was characterised by a maximum loss in the low and mid-
frequencies. The researchers suggested that this pattern may be induced by a possible 
synergistic effect of noise exposure combined with solvents. However, this finding may 
have limited application as the data was collected from a single subject. Other evidence 
supporting the claim that solvents in combination with noise may have a synergistic effect 
on the auditory system in humans was reported by Sliwinska-Kowalska et al. (2003). They 
found an increase in the odds ratio for hearing loss of 21.5 in workers exposed to styrene, 
toluene, and noise. These authors suggested that a synergistic action of multiple ototoxic 
agents with noise was evident.  
A recent multicentre, cross-sectional study (Morata et al. 2011) of workers from Sweden, 
Finland, and Poland found an association between styrene exposure and poorer hearing 
thresholds than predicted by individuals’ age (when compared with ANSI S3.44 annexes A 
and B). The effect of noise exposure, with a mean which varied across centres between 80 
and 84 dBA, did not have a significant effect on hearing, except when in combination with 
styrene.  
Hearing loss induced by simultaneous exposure to noise and mixed solvents in the aviation 
industry was studied by Kim et al. (2005). This study found a prevalence of hearing loss of 
54.9% among workers exposed to both agents simultaneously; 17.1% among workers 
exposed only to noise; 27.8% among workers only exposed to a solvent mixture; and 6% 
among non-exposed workers. Relative risks adjusted for age were estimated to be 4.3 for 
the noise-only group, 8.1 for the noise and solvents group, and 2.6 for the solvents-
mixture group. Also, Kaufman et al. (2005) found that subjects exposed to noise and jet 
fuel for three years had an increase in adjusted odds for hearing loss (RR=1.7), and in 
those with a history of 12 years exposed to both agents the odds for hearing loss increased 
to 2.41. This study found that the effects of jet fuel exposure on hearing were statistically 
non-significant for more than 12 years of combined noise and jet fuel exposure. The 
authors suggested a plateau effect for jet fuel exposure and/or that the noise-induced 
hearing loss may become more important for those continuing to have exposure to both 
agents.  
All these studies provide evidence that solvents may induce peripheral hearing loss in 
human subjects. However, none of the previously mentioned studies provides evidence of 
central auditory dysfunction induced by solvent exposure or of the precise cochlear origin of 
such hearing losses. They only suggest poorer hearing thresholds among solvent-exposed 
subjects in comparison to non-exposed subjects. Next we discuss the scientific evidence for 
central auditory dysfunction associated with solvent exposure. 
2.4 Evidence of the adverse effects of solvents on the central auditory system: 
Studies on humans 
Many studies have found dysfunction of the central auditory nervous system (CANS) in 
workers exposed to a mixture of solvents (Fuente et al., 2006; Fuente & McPherson, 2007; 
Laukli and Hansen, 1995; Moen et al., 1999; Niklasson et al., 1998; Ödkvist et al., 1987; 
Ödkvist et al.,1992; Pollastrini et al., 1994; Varney et al., 1998). Fuente et al. (2006), Fuente & 
McPherson (2007), and Fuente (2008) have shown that workers exposed to a mixture of 
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as evidenced by abnormal results for a set of behavioural central auditory processing 
tests. Varney, Kubu et al. (1998) found abnormal results for a dichotic listening test among 
solvent exposed subjects in comparison to previously reported norms and to a control 
group of subjects. The authors claimed that dichotic listening appeared to be a useful tool in 
the assessment of solvent-exposed workers, particularly in those who have had intermediate 
levels of exposure and who do not show mental status deficits of disabling severity. 
Also, different studies have been conducted in workers exposed to solvents utilising 
electrophysiological techniques. Workers exposed to toluene obtained statistically 
significant higher absolute latencies and inter-peak latencies (IPL) between waves of the 
ABR (I-III IPL; I-V IPL; III-V IPL) than a non-exposed group of workers matched for gender 
and age (Abbate et al., 1993). Additional evidence of toluene-induced central auditory 
dysfunction in humans using ABR was shown by Vrca et al. (1996). Workers exposed to low 
concentrations of toluene obtained a significant decrease in all wave amplitudes of auditory 
evoked potentials. However, a study carried out by Schäper et al. (2003) did not find a 
toluene effect on ABR results in a group of workers exposed to toluene up to 50 parts per 
million (ppm). The authors suggested that toluene may induce central auditory dysfunction 
at levels above 50 ppm.  
ABR abnormalities due to carbon disulphide exposure have also been studied (Hirata et al., 
1992). A high percentage of workers exposed to carbon disulphide for more than 240 
months obtained prolonged IPL for the ABR components III-V (Hirata et al., 1992). Other 
electrophysiological measures such as P300 (a long latency auditory evoked potential) have 
also been utilised in solvent-exposed subjects. Vrca et al. (1997) found, in a group of workers 
exposed to low concentrations of toluene, prolonged latencies and lower amplitudes in the 
P300 response in comparison to a control group. Also, Moen et al. (1999) examined the P300 
component in a group of workers exposed to low levels of organic solvents in a paint factory 
and in a control group of non-exposed workers. The results indicated that the P300 latency 
was prolonged among the exposed workers compared to the control group before the summer 
vacation, and also, in the exposed group the P300 latency was significantly longer before the 
summer vacation than after. Similar results were found by Steinhauer et al. (1997).  
More recently, Draper and Bamiou (2008) presented a case study of a person exposed to 
xylene who presented with auditory neuropathy as evidenced by abnormal ABR results and 
presence of otoacoustic emissions (OAEs). The patient presented with a gradual 
deterioration in his ability to hear in difficult acoustic environments and also to hear 
complex sounds such as music, over a 40-year period. His symptoms began after exposure 
to xylene, and in the absence of any other risk factor.  
Fuente et al. (2011) conducted an investigation of central auditory functioning in normal-
hearing, solvent-exposed subjects compared to normal-hearing, non-exposed subjects with a 
comprehensive battery of behavioural central auditory function assessment procedures. 
Forty-six normal-hearing, solvent-exposed subjects and 46 normal-hearing, non-exposed 
subjects were investigated. The test battery comprised of pure-tone audiometry (PTA), 
Dichotic Digits (DD), Pitch Pattern Sequence (PPS), Filtered Speech (FS), Random Gap 
Detection (RGD), Masking Level Difference (MLD), and Hearing-in-Noise (HINT) tests. 
Analyses of covariance were performed to compare the mean values of the dependent 
variables (results for DD, PPS, FS, RGD, MLD, and HINT) between solvent-exposed and 
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non-exposed subjects. Age and average hearing thresholds (500-8000 Hz) were included in 
the analyses as covariates. Although all subjects had normal-hearing thresholds, significant 
differences for DD, PPS, FS, and RGD results were found between groups. Solvent-exposed 
participants presented with poorer results adjusted for age and hearing thresholds in 
comparison to non-exposed subjects.  
These results are in agreement with our previous studies in which significant differences 
between solvent-exposed and non-exposed subjects arose for the DD, RGD, HINT, PPS, and 
FS tests. Fuente et al. (2008) also showed that in a group of 100 workers exposed to a mixture 
of solvents and 100 non-exposed workers, solvents were significantly associated with poorer 
pure-tone thresholds, lower amplitudes of transient evoked otoacoustic emissions 
(TEOAEs), and poorer results for central auditory functioning tests. Recently, in a study 
investigating a group of 30 medical laboratory workers exposed to xylene and a control 
group of non-exposed workers, Fuente (2010) found significant differences between groups 
for ABR results. Xylene-exposed workers presented with longer ABR latencies than non-
exposed workers. Figure 1 summarises the results of our studies in different populations of 
workers exposed to solvents. 
 
Fig. 1. Summary of audiological findings in solvent-exposed subjects from Fuente 2008, 
2010) and Fuente et al. studies (2006, 2007, 2009, 2011). 
From Figure 1, it is possible to observe that different procedures can be utilised to evaluate 
possible adverse auditory effects of solvents on the auditory system. Taking into 
consideration that solvents may affect a wide range of aspects of audition, an approach 
using a comprehensive battery of tests is required to monitor hearing in solvent-exposed 
individuals. Table 2 summarises the audiological procedures that can be incorporated in the 
test battery to evaluate solvent-induced auditory dysfunction. The tests that have been 
included in Table 2 are those who have been shown to be sensitive to detect differences 
between solvent exposed and non-exposed subjects, based on our previous studies and on 
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investigating a group of 30 medical laboratory workers exposed to xylene and a control 
group of non-exposed workers, Fuente (2010) found significant differences between groups 
for ABR results. Xylene-exposed workers presented with longer ABR latencies than non-
exposed workers. Figure 1 summarises the results of our studies in different populations of 
workers exposed to solvents. 
 
Fig. 1. Summary of audiological findings in solvent-exposed subjects from Fuente 2008, 
2010) and Fuente et al. studies (2006, 2007, 2009, 2011). 
From Figure 1, it is possible to observe that different procedures can be utilised to evaluate 
possible adverse auditory effects of solvents on the auditory system. Taking into 
consideration that solvents may affect a wide range of aspects of audition, an approach 
using a comprehensive battery of tests is required to monitor hearing in solvent-exposed 
individuals. Table 2 summarises the audiological procedures that can be incorporated in the 
test battery to evaluate solvent-induced auditory dysfunction. The tests that have been 
included in Table 2 are those who have been shown to be sensitive to detect differences 
between solvent exposed and non-exposed subjects, based on our previous studies and on 
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Table 2. Recommended audiological tests for the evaluation of hearing in solvent-exposed 
subjects.  
3. Hearing loss associated with occupational exposure to pesticides 
3.1 Overview of pesticides 
The Food and Agriculture Organization (FAO, 2003, Page 6) has defined pesticides as “any 
substance or mixture of substances intended for preventing, destroying or controlling any 
pest, including vectors of human or animal disease, unwanted species of plants or animals 
causing harm during or otherwise interfering with the production, processing, storage, 
transport or marketing of food, agricultural commodities, wood and wood products or 
animal feedstuffs, or substances which may be administered to animals for the control of 
insects, arachnids or other pests in or on their bodies. The term includes substances intended 
for use as a plant growth regulator, defoliant, desiccant or agent for thinning fruit or 
preventing the premature fall of fruit, and substances applied to crops either before or after 
harvest to protect the commodity from deterioration during storage and transport”. 
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Most pesticides can be classified into chemical families. Table 3 summarises the four main 
chemical categories of pesticides according to the US Environmental Protection Agency. 
Pesticides are also often referred to according to the type of pest they control (e.g. 
fungicides, herbicides, insecticides, rodenticides).  
 
Pesticide Main characteristics
Organophosphates Developed in the 19th century and extensively used in World War 
II as nerve agents.  
Most commonly used pesticides today and mainly insecticides.  
Affect the nervous system of the target agent.  
Carbamates First introduced in the 1950s. 
Affect the nervous system of the target agent. 
Organochlorides Extensively used in the past 60 years. 
Organochloride pesticides such as dichloro-diphenyl-
trichloroethane (DDT) have been widely banned as they represent 
serious environmental and human health risks. 
Pyrethroids Developed for wide commercial use in the 1970s.  
They are used as insecticides in gardens, and with pets and 
livestock. 
Table 3. Main chemical families of pesticides and their characteristics.  
3.2 Scientific evidence of pesticide-induced auditory dysfunction 
Studies on the auditory effects of exposure to pesticides are rare. Harell et al. (1978) were 
one of the first research groups to describe pesticide-induced hearing loss. The authors 
reported a case of a 27-year-old male who was referred for a re-evaluation of his bilateral 
hearing loss. The onset of his hearing loss was more than six years before the follow-up 
hearing assessment,  and it developed after he sprayed several fruit trees for 15-20 minutes 
using a preparation containing 7.5% malathion and 15% methoxychlor. After intoxication 
with low levels of insecticides, the patient developed a permanent bilateral profound 
hearing loss with the presence of tinnitus, and also peripheral neuropathies in the 
extremities. Other initial signs such as renal failure and hepatic dysfunction gradually 
improved.  
A number of cross-sectional human studies have found hearing loss associated with the use 
of insecticides. A study comparing two groups of individuals exposed to organophosphates 
with different levels of pseudocholinesterase activity reported peripheral neuropathies in 
the group with low values of pseudocholinesterase. Pseudocholinesterase is an enzyme 
involved in the breakdown of acetylcholine and it is mainly found in the plasma and liver. 
Reduced plasma levels of pseudocholinesterase are an indicator of excessive 
organophosphate absorption. Both groups of individuals with low and high levels of 
pseudocholinesterase had sensorineural hearing loss, ranging in severity from low to 
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Mac Crawford et al. (2008) investigated self-reported hearing loss in licensed private 
pesticide applicators enrolled in the Agricultural Health Study in 1993-1997 in Iowa and 
North Carolina, USA. Results showed that exposure to herbicides, fungicides, or fumigants 
was not associated with hearing loss. However, organophosphates were associated with 
hearing loss, with a 17% increase in odds in the highest quartile of exposure. Carbamates, 
organochlorines and pyrethroids were not associated with hearing loss. The authors also 
found a positive association between self-reported hearing loss and several general 
measures of pesticide exposure such as high pesticide exposure events, pesticide poisoning 
and medical treatment for pesticide exposure. Additionally, the association of pesticide 
exposure with hearing loss was not modified or confounded by age. The authors concluded 
that the results of their study suggest that exposure to insecticides and, in particular, 
organophosphates, may contribute to hearing loss.  
Guida et al. (2010) studied 40 male individuals exposed to malathion and noise and 40 
individuals exposed only to noise. Individuals exposed to malathion and noise presented 
with significantly worse hearing thresholds for 4 kHz (both ears) and 3 kHz (left ear) than 
individuals exposed only to noise. Also, more than 60% of individuals exposed to 
malathion and noise had hearing loss in comparison to 42% of individuals exposed only 
to noise.  
Adverse central auditory effects associated with insecticide exposure have also been found. 
Teixeira et al. (2002) studied a group of 98 male workers with a minimum of 3 years 
insecticide exposure who used organophosphate and pyrethroid compounds, and a control 
non-exposed group of 54 administrative workers. The insecticide-exposed workers were 
divided into two subgroups, insecticide-exposed only, and insecticide-and-noise-exposed 
(with noise levels above 90 dBA). Two procedures to evaluate central auditory function 
were utilised, the pitch pattern sequence (PPS) and duration pattern sequence (DPS) tests. 
Results showed that 56% of insecticide-exposed workers had findings for PPS and/or DPS 
below normal ranges, and only 7% of the control non-exposed workers had results below 
normal ranges, for the DPS test only.  Statistically significant differences for PPS and DPS 
test results between insecticide only exposed workers and control non-exposed workers, 
and also between insecticide-and noise-exposed workers and control non-exposed 
workers were found. Insecticide-exposed workers performed significantly worse than 
non-exposed control workers in both PPS and DPS tests. Teixeira et al. (2002) concluded 
that chronic exposure to pyrethroid and organophosphate insecticides seems to affect 
central auditory function. They also suggested that central auditory functioning tests 
should be incorporated in the audiological evaluation of persons exposed to known 
neurotoxic substances.  
4. Hearing loss associated with occupational exposure to metals 
4.1 Overview of metals 
Currently there are 86 known metals. Before the 19th century only 24 of these metals had 
been discovered. Metals are used in their pure forms, in the form of compounds of two or 
more metals (alloys), and in the form of metal salts. Table 4 summarises the industrial uses 
of some common selected metals.  
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Metal Industrial uses 
Copper Power generation and transmission of electricity, electrical wires, roofing 
and plumbing, and industrial machinery. 
Lead Car batteries, ballast keel of sailboats and scuba diving weight belts, 
soldering and as electrodes in the process of electrolysis, polyvinyl 
chloride (PVC) plastic that covers electrical cords, glazing bars for stained 
glass or other multi-lit windows. 
Mercury Manufacture of industrial chemicals, electronic applications, cosmetics, 
manufacturing of thermometers and fluorescent lamps, medical 
applications such as dental amalgams, as part of preservatives in 
vaccines, and topical antiseptics. 
Zinc 
 
Galvanization, manufacturing of batteries, in copper-base alloys. 
Manufacture of zinc sheets to be used for sheathing or roofing. 
Lithium  Manufacture of batteries, ceramics, glass and pharmaceuticals. In rubber 
and thermoplastics industries, air treatment and in primary aluminium 
production.  
Table 4. Main industrial uses of some selected metals. 
4.2 Scientific evidence of metal-induced auditory dysfunction 
Evidence from animal studies suggests ototoxic effects may be induced by lead. Lasky et al. 
(1995) in a study conducted in monkeys found abnormal distortion product otoacoustic 
emissions and lower than normal ABR amplitudes in monkeys with the highest blood 
concentrations of lead.  
Hirata and Kosaka (1993) studied a group of lead exposed human subjects and a control 
non-exposed group through ABR, among other tests. Results showed that the mean IPL 
between components III and V of the ABR of lead-exposed workers was significantly 
prolonged compared with that of the control group.  
Counter and Buchanan (2002) studied ABR and pure-tone thresholds as biomarkers for 
neuro-ototoxicity in adult workers with chronic lead intoxication from long-term exposure 
in ceramic-glazing work. Blood samples collected from 30 subjects showed higher biological 
concentrations than the limits established by the World Health Organization (WHO). 
Sensorineural hearing loss for the frequencies 2, 3, 4, 6, and 8 kHz was found among lead-
exposed workers. ABR results showed delayed absolute latencies consistent with 
sensorineural hearing loss among individuals with elevated blood lead. Counter and 
Buchanan (2002) concluded that noise and lead intoxication were the cause of the hearing 
loss observed in the sample of subjects studied.  
Buchanan et al. (1999) investigated pure-tone thresholds and distortion product otoacoustic 
emissions (DPOAEs) in 14 children (28 ears) and 5 adults (10 ears) living in a highly lead-
contaminated environment in remote villages in the Andes Mountains of Ecuador. Blood 
lead levels for the children were higher than the U.S. Centers for Disease Control and 
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DPOAEs. No correlation of DPOAEs with blood lead level was found among the children. 
The group of adults had diminished DPOAEs which were consistent with noise-related 
hearing loss.  
Murata et al. (1993) examined ABR and event-related potential (P300) recordings, along with 
non-audiological assessments in lead workers. The sample consisted of 22 gun metal 
foundry workers occupationally exposed to lead, zinc, and copper. Among the workers with 
higher blood lead concentrations, the latencies of P300 were significantly prolonged when 
compared with a gender- and age-matched control group. Both ABR and P300 latencies 
were significantly correlated with the indicators of lead absorption among these workers.  
Discalzi et al. (1992) investigated the effects of industrial exposures to lead and mercury on 
the brainstem auditory pathway through ABR. The study included 22 workers exposed to 
lead, 8 workers exposed to mercury and 2 control groups of age- and gender-matched 
subjects never exposed to neurotoxic substances. The I-V IPL was examined. Results showed 
that both mercury and lead exposed workers had a significant delay for the I-V IPL. The 
researchers also found that those subjects with the highest level of lead in blood had a 
longer I-V IPL compared to workers with lower levels of lead in blood.  
5. International legislation  
It is well documented that workplace noise exposure is a significant health hazard that leads 
to permanent, occupational noise-induced hearing loss. For this reason, many countries 
have developed national exposure standards for occupational noise, based on levels of 
exposure which are considered safe for human hearing. Likewise, exposure to chemicals in 
the workplace can lead to occupational chemical-induced hearing loss, as many of these 
chemicals have been internationally recognised as being hazardous to hearing. However, 
unlike noise exposure, standards for permissible levels of exposure to chemicals such as 
solvents in the US and other countries do not consider the adverse effects of chemicals on 
human hearing. This is because human exposure-response relationships remain unclear and 
thus chemical exposure standards have not been modified to reduce the risk of hearing 
impairment. Currently, recommended or mandatory workplace exposure limits (OELs) 
have been developed in many countries for airborne exposure to gases, vapours and 
particulates. The most widely used limits, threshold limit values (TLVs), are those issued in 
the USA by the American Conference of Governmental Industrial Hygienists (ACGIH). 
Table 5 shows the current US permissible exposure limits for some organic solvents 
according to different US organisations.  
Taking into consideration the ototoxicity of many chemicals, some international bodies and 
governments have issued guidelines or recommendations regarding the ototoxicity of 
chemicals alone or when combined with noise. In the WHO  Special Report “Occupational 
exposure to noise: evaluation, prevention and control” (Goelzer, Hansen & Sehrndt, 2001), 
the combined exposure to noise and other factors such as solvents, vibrations and metal 
dust is noted and it is suggested that more stringent criteria than those specified as being 
standard in the document should be applied. Ototoxic properties are acknowledged on the 
International Chemical Safety Cards (a joint programme of the International Labour 
Organization, WHO, and United Nations; Obadia, 2003) only for toluene, xylene and 
potassium bromate. 
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Solvent OSHA NIOSH ACGIH 
Toluene 200 ppm 100 ppm 50 ppm 
Styrene 100 ppm 50 ppm 20 ppm 
Xylene 100 ppm 100 ppm 100 ppm 
Ethyl benzene  100 ppm 100 ppm 100 ppm 
Carbon disulfide 20 ppm 1 ppm 10 ppm 
N-hexane 500 ppm 50 ppm 50 ppm 
Table 5. Permissible exposure limits (PEL) to selected organic solvents according to different 
organisations in the U.S. PPM: parts per million; OSHA: Occupational Safety and Health 
Administration; NIOSH: National Institute for Occupational Safety and Health; ACGIH: 
American Conference of Industrial Hygienists. 
In the United States of America, the American Conference of Industrial Governmental 
Hygienists (ACGIH, 2009) recommends that when exposure to noise and to carbon 
monoxide, lead, manganese, styrene, toluene, or xylene occurs, then periodic audiometry 
should be carried out and the results should be carefully reviewed. Also, the U.S. Army Fact 
Sheet 51-002-0903 on Occupational Ototoxins and Hearing Loss states that since the 
exposure threshold for ototoxic effects is not known, audiometric monitoring is necessary to 
determine whether the substance affects the hearing of exposed workers. It includes 
recommendations for annual audiometric assessment for workers whose chemical exposure 
(disregarding the use of respiratory protection) equals 50% of the most stringent criteria for 
occupational exposure limits, regardless of the noise level.  
The Canadian Centre for Occupational Safety and Health (2009) has listed benzene, xylene, 
ethylbenze hydrogen cyanide, n-hexane, styrene, trichloroethylene, toluene, among others 
as chemicals associated with hearing loss.  
Organic solvents such as toluene, xylenes, styrene, and trichloroethylene are considered as 
industrial ototoxic agents under Australian and New Zealand legislation (AS/NZS 
1269.0:2005). Also, Australian government bodies such as Safe Work Australia and the 
Department of Commerce, have recognised solvents as ototoxic agents. Safe Work Australia 
(2010) indicated that some factors, such as ototoxic chemicals, may interact with noise to 
produce hearing loss that is greater than that associated with the effects of the individual 
causes. In addition, the presence of chemicals in the workplace has been suggested as being 
one of the possible factors leading to the maintained occurrence of noise-induced hearing 
loss (Safe Work Australia, 2010). In Australia (e.g., Queensland Government, 2004), it has 
been recommended, until revised standards are established, that the daily noise exposure of 
workers exposed to solvents be reduced to 80 dBA or below, and that regular audiometric 
testing should be carried out. Annual audiometry is highly recommended for Australian 
workers whose airborne exposures for some selected chemicals are at 50% or more of the 
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one of the possible factors leading to the maintained occurrence of noise-induced hearing 
loss (Safe Work Australia, 2010). In Australia (e.g., Queensland Government, 2004), it has 
been recommended, until revised standards are established, that the daily noise exposure of 
workers exposed to solvents be reduced to 80 dBA or below, and that regular audiometric 
testing should be carried out. Annual audiometry is highly recommended for Australian 
workers whose airborne exposures for some selected chemicals are at 50% or more of the 





Contaminants in the Occupational Environment (NOHSC 1003, 1995), regardless of the 
noise level.  
In Europe, the European Parliament published a noise directive (2003/10/EC), which has 
been adopted by all member countries since 2006. This directive calls on employers to 
consider the interaction of noise and work-related ototoxic substances on workers’ health 
and safety. The European Agency for Safety and Health at Work (2009) has listed solvents 
such as toluene, styrene, p-xylene, among others as agents with “good evidence” about their 
adverse effects on hearing. In Germany, a position paper on ototoxic industrial chemicals 
was issued by the “Noise” and “Hazardous Substances” working groups of the Deutsche 
Gesetzliche Unfallversicherung (DGUV)’s committee for occupational medicine (Deutsche 
Gesetzliche Unfallversicherung’s Occupational Medicine Committee, 2006). Among other 
recommendations, the position paper stated that public risk communication, including all 
points of contact, should be promoted, and that the ototoxicity of some chemicals should be 
taken into consideration when specifying occupational exposure limits.  
Finally, in Brazil workers can claim compensation for hearing loss induced by occupational 
exposure to ototoxic chemicals, as a regulation issued in 1999 (Ministério da Previdência e 
Assistência Social, 1999) recognises the adverse effect of certain chemicals on hearing.  
The scenario in most developing nations is very different. In many developing countries 
legislation is absent or under-enforced and local industrial workplace practices are 
performed without knowledge of the possible adverse health consequences of chemical 
agents. In these countries legislation requiring the safe usage of ototoxic chemicals used in 
industry and agriculture should be enacted, along with the establishment of adequately 
resourced monitoring agencies (Amedofu & Fuente, 2008).  
6. Conclusion  
The effects of chemical exposure on the auditory system have been studied by many 
authors. The findings suggest that chemicals such as solvents, pesticides and metals have 
both oto-and neuro-toxic properties. Studies conducted in animals have demonstrated that 
the outer hair cells are affected by solvents. The damage begins in the most external row of 
cochlear hair cells, and if the exposure continues the damage is spread to the middle and 
inner row of outer hair cells. A concomitant agent in many industries is noise exposure. 
Research conducted in animals and humans exposed to solvents and noise have found a 
synergism between these two agents. The ototoxicity induced by solvents appears to be 
different than the one induced by noise. Human studies in workers exposed to solvents 
have shown a higher prevalence of hearing loss among solvent-exposed workers when 
compared with non-exposed workers.  
Additionally studies conducted in human populations exposed to pesticides have shown 
that these agents are associated with poorer hearing thresholds as well as with poorer 
performance for some central auditory functioning tests. Research conducted in human 
subjects exposed to metals such as lead and mercury also indicates that these agents relate to 
auditory dysfunction.  
Current legislation in many countries establishes permissible exposure limits (PELs) for 
chemicals. These PELs are not based on the possible adverse auditory effects of chemicals. 
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Therefore, guidelines in some developed countries have emerged to reduce the risk of 
hearing loss/auditory dysfunction in workers exposed to chemicals alone or to chemicals in 
combination with noise. There is an urgent need for further studies to establish 
dose/response relationships. With this information legislation around the world could be 
modified regarding the PELs for ototoxic agents such as solvents, metals and pesticides.  
Health care professionals in the field of audition must be aware of the effects of chemicals 
on the auditory system and understand the complexity of such effects which relate to oto-
and neuro-toxic mechanisms. Chemical-exposed workers regardless of their noise exposure 
level should be routinely monitored with audiological procedures that investigate the 
peripheral and central auditory system. For these purposes, a test battery approach 
should be considered. There is still a lack of knowledge of the most sensitive audiological 
tests for the detection of chemical-induced auditory dysfunction. However, there is 
evidence that some tests can effectively detect some cases of central auditory dysfunction 
induced by solvent exposure. Such tests can be also used in populations of workers 
exposed to other chemicals that are known (or suspected) to have oto-and neurotoxic 
properties.  
Current industrial processes utilise massive quantities of chemicals that may jeopardise 
workers’ hearing health. It is the role of audiologists, other hearing health care, and 
occupational health and safety professionals to prevent chemical-induced hearing 
loss/auditory dysfunction. To assist prevention, the scientific evidence regarding chemical-
induced hearing loss should be disseminated among workers, employers, health care 
professionals and legislators. Inside factories action to reduce exposure to these agents is 
essential to decrease the burden of occupational chemical-induced hearing loss. Industry-
based initiatives should include the identification of populations at risk, the detection of 
early signs of chemical-induced hearing loss, and the delivery of hearing conservation 
programmes to chemical-exposed workers regardless of their noise exposure levels.  
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1. Introduction  
Studies on occupational hearing loss have focused on noise as the primary cause. While the 
effect of this physical agent on hearing has been demonstrated, an analysis closer to the site 
of exposure confirms that the presence of other contaminants, such as chemicals, can interact 
with noise. This association may influence a temporal variability in the manifestation of an 
occupational hearing pathology. 
In this respect, the term "working conditions" is too ambiguous (i.e., noise in the metal 
industry) as, in apparently similar conditions, several exposure environments can be 
identified: machining (noise+fluids, e.g. lathing), manufacture of structures (noise+fumes, 
e.g. welding) and surface protection (noise+solvents, e.g. painting), among others.  
The European Agency for Safety and Health at Work recognises that noise-induced hearing 
loss is the most common occupational disorder in Europe. It advises that, in order to achieve 
greater efficiency in its prevention, more attention must be paid to the combined risk factors 
(multiple exposures) in workers exposed to high noise levels and chemical compounds 
associated with their work. 
Similarly, recent studies conducted in the US (Agrawall et al., 2009) and New Zealand 
(Thorne et al., 2008) recognise noise-induced hearing loss as one of the most widespread 
occupational illnesses in these countries. Conclude that traditional noise monitoring and 
control methods have not achieved the expected results, identifying increasing prevalence in 
the general working population, and particularly in young people.  
This study aims to test the hypothesis of interaction between various physical and chemical 
pollutants and their influence on hearing. It obtains a complete temporal exposure model, 
based on survival analysis, which covers the entire working life of an individual between 
t=0 (start time) and t=50 years (maximum period). The study of multiple exposures using 
a qualitative variable allows the prevention cost associated with hygiene risk assessment 
(see 2.3.1. point 1) to be sufficiently reduced. This is also the methodology used in the 
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a qualitative variable allows the prevention cost associated with hygiene risk assessment 
(see 2.3.1. point 1) to be sufficiently reduced. This is also the methodology used in the 






The analysis was carried out using as sample data taken from a pre-existing database on 
occupational health. The aim was to assess the viability of using these historical databases 
and the quality of the information obtained from them with regard to the interaction 
between noise and chemicals and the effect of this interaction on hearing. 
The characteristics of the archive information determined the design of the study, the 
definition of the variables and the method of data analysis used. For instance, the 
instruments used to measure these variables in some cases may have changed over the 
prolonged time of this study and it is therefore difficult to maintain consistency. These 
instruments include: audiometers for identifying the decline in the auditory threshold; 
integrated sound level meters and dosimeters for the measurement of environmental noise; 
vacuum pumps for taking air samples, and instruments for chemical analysis used for 
collecting and quantifying environmental chemical contaminants. Consequently quantitative 
recording was avoided, defining measurements qualitatively (as binary variables) instead. 
This provided greater flexibility when evaluating variables, eliminating possible discrepancies 
associated with potential changes in technology and measurement criteria. 
Using a minimum amount of information, one discrete quantitative variable (length of time 
exposed to noise) and the remaining qualitative variables, it was possible to estimate the 
influence of a particular working environment on hearing in combination with certain 
personal habits. The results obtained are of descriptive and explanatory interest, providing 
information on the interactions between the stated variables and their effects on the 
individual. 
The analysis of the data was fast and economical, whereas obtaining pure samples of data 
would be less so. Furthermore, and as a corollary, average or high frequencies is required in 
order to give consistency to the analysis. In addition, if a classification is used to record a 
variable, it has to be entirely discrete. Failure to fulfil these two criteria (frequency and being 
discrete) can make analysis using the proposed methodology ineffective, as speculation 
about the data could lead to an unreliable interpretation of that data. 
The results obtained show that workers exposed to noise where metalworking fluids are 
present show a greater delay in hearing alteration than workers exposed only to noise. By 
contrast, workers exposed to noise where welding fumes are present exhibited an increase 
in hearing alteration compared to those exposed only to noise. This thereby demonstrates the 
antagonistic effect of metalworking fluids with noise and the synergic effect of welding fumes. 
As a preventative application, there exists a need for combined respiratory and auditory 
protection in processes that produce welding fumes, and the former should be effective 
against certain gases and metal components (use of integrated personal protection 
equipment). Fabric masks (a highly-used protection) do not meet this requirement, and nor 
do extraction systems. Environments with noise and metalworking fluids have the 
advantage in that the aforementioned masks can be used as respiratory protection combined 
with auditory protection. 
Based on recognised research for the study of this problem (Gobba, 2003), the study of 
pathogenic mechanisms, and evaluation of new multiple-exposure thresholds. This paper 
focuses on the second of these aspects, the purpose being to obtain patterns that allow for 
the comparison of various populations of workers in multiple-exposure conditions similar 
to those defined by such patterns. 
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In view of the above, the aim of this study is to analyse the influence of the combination of 
different chemical agents and noise on occupational hearing loss within the metal industry, 
to be aware of the interrelationships between such factors for preventive purposes. 
2. Material 
2.1 Study design 
A descriptive epidemiological study was conducted, using two types of sources: one based 
on the records of each individual, occupational medical examinations (OME), with a specific 
noise protocol (SNP), carried out on various dates during the inclusion period, providing 
their audiometric data, duration of exposure to noise, and personal habits.  
The second type involved on-site testing of a selection of job positions, in order to ensure the 
type and homogeneity of the environmental exposure conditions of the individuals in the 
companies included in the sample during the period of study, and environmental record of 
exposure (ERE).  
The study design presented is conceptually interpreted as longitudinal, as defined by 
Rothman (1986), the existence of a time interval between exposure and the onset of illness.  
With two observation points, at t=0 (estimated starting point for the specified sources, after 
having first carried out a strict process of selection of individuals to be included in the 
study) and at t=n (period in which the first audiometric test was performed).  
2.2 Sample collection 
The Aragonese population working in the metal industry during the study period 1991-
2000, was evaluated using the Industrial Companies Survey (Spanish acronym EIE) 
conducted by the Spanish National Statistics Institute (Spanish acronym INE), and an 
average population of 10,802 workers was obtained.  
The data was provided by the Spanish National Institute of Safety and Hygiene at Work 
(Spanish acronym INSHT) and the Aragon Institute of Occupational Safety and Health 
(Spanish acronym ISSLA), from a list of companies in their files.  
The initial sample size represented 10% of the workers, i.e. 1,080 individuals, using a 
systematic sampling of companies from said list.  
From the initial selection, the following were eliminated: individuals not exposed to 
occupational noise; those who presented alterations in audiometric tests due to causes other 
than noise; individuals who, prior to their exposure to occupational noise (t=0), had been 
subjected to noise outside work over a long period of time; individuals exposed to solvents 
and degreasing agents and products that did not qualify for inclusion. The final study 
sample included 558 workers.  
2.3 Description of variables 
A total of six variables were used, which can be divided into two groups. The first group, 
characterised by not having missing values consists of three variables, which define the 
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In view of the above, the aim of this study is to analyse the influence of the combination of 
different chemical agents and noise on occupational hearing loss within the metal industry, 
to be aware of the interrelationships between such factors for preventive purposes. 
2. Material 
2.1 Study design 
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on the records of each individual, occupational medical examinations (OME), with a specific 
noise protocol (SNP), carried out on various dates during the inclusion period, providing 
their audiometric data, duration of exposure to noise, and personal habits.  
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type and homogeneity of the environmental exposure conditions of the individuals in the 
companies included in the sample during the period of study, and environmental record of 
exposure (ERE).  
The study design presented is conceptually interpreted as longitudinal, as defined by 
Rothman (1986), the existence of a time interval between exposure and the onset of illness.  
With two observation points, at t=0 (estimated starting point for the specified sources, after 
having first carried out a strict process of selection of individuals to be included in the 
study) and at t=n (period in which the first audiometric test was performed).  
2.2 Sample collection 
The Aragonese population working in the metal industry during the study period 1991-
2000, was evaluated using the Industrial Companies Survey (Spanish acronym EIE) 
conducted by the Spanish National Statistics Institute (Spanish acronym INE), and an 
average population of 10,802 workers was obtained.  
The data was provided by the Spanish National Institute of Safety and Hygiene at Work 
(Spanish acronym INSHT) and the Aragon Institute of Occupational Safety and Health 
(Spanish acronym ISSLA), from a list of companies in their files.  
The initial sample size represented 10% of the workers, i.e. 1,080 individuals, using a 
systematic sampling of companies from said list.  
From the initial selection, the following were eliminated: individuals not exposed to 
occupational noise; those who presented alterations in audiometric tests due to causes other 
than noise; individuals who, prior to their exposure to occupational noise (t=0), had been 
subjected to noise outside work over a long period of time; individuals exposed to solvents 
and degreasing agents and products that did not qualify for inclusion. The final study 
sample included 558 workers.  
2.3 Description of variables 
A total of six variables were used, which can be divided into two groups. The first group, 
characterised by not having missing values consists of three variables, which define the 





exposed and the degree of hearing alteration. The second group of variables, characterised 
by having missing values, refers to certain personal habits (smoking, exposure to non-
occupational noise and use of hearing protection). These can modify the response of the 
individual to the environmental factors to which they are exposed at work. These variables 
therefore have to be controlled to achieve the most accurate interpretation of the results. 
2.3.1 Exposure or cause-effect variables (Table 1)  
1. "Exposure atmosphere" (AEXP). This was a nominal qualitative variable with three 
categories. Each category was treated as binary. The variable noise was determined using an 
integrated sound level meter to classify the individuals in terms of their degree of exposure 
and its duration. Chemicals were assessed by the presence or absence of the corresponding 
particles of fluids or smoke in the atmosphere at work. The classification of noise intensity, 
moderate or high, was adopted for this work. Each one of the three atmospheres at work 
considered were classified: (a) MF= mainly noise of moderate intensity [85-90) dB(A) in the 
presence of metalworking fluids; (b) N=only noise, of moderate or high intensity ≥ 85dB(A); 
(c) WF= mainly noise of high intensity ≥ 90dB(A) in the presence of welding fumes.  
 
Variables (Cause-Effect) n % 
EXPOSURE ATMOSPHERE (AEXP) 558
Noise Only, N 177 31.7
Noise+Metalworking Fluids, MF 146 26.2
Noise+Welding Fumes, WF 235 42.1

















Table 1. Exposure variables 
2. "Exposure time to noise" (TEXP). This was a discrete quantitative variable expressed in 
years. It was an estimation of the time that the worker had been exposed to noise 
throughout his or her working life. It was established by consulting the individual directly. 
The possibility of using both the age of the workers and the length of time they were 
exposed to noise as the time variable was assessed. The projection of each together on a 
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dispersion graph illustrates the variation between them. Age was rejected as a suitable 
variable, since in addition to not defining the real duration of exposure effectively it had to 
then be transformed to achieve its lineal distribution, whereas this was not a problem when 
the length of time exposed to noise was used as the variable.  
3. “Degree of hearing alteration” (DALT). This was an ordinal qualitative variable with five 
modalities. Each modality was treated as binary. The variable identified the degree of 
hearing alteration, defined as the decline in the auditory threshold according to acoustic 
frequency, measured using an audiometer. The audiometry studied at times gave rise to two 
types of problems in relation to the interpretation of the results. These concerned manual 
corrections to the audiometric profile and the impossibility of observing the audiometric 
profile. Therefore the degree of hearing alteration was recorded according to a diagnostic 
code assigned by the doctor responsible for the check-up based on the Klockhoff 
classification (1973): H=healthy (losses 25 dB); IAT=initial acoustic trauma (losses of 
between 25 and 40 dB); AAT=advanced acoustic trauma (losses of between 40 and 50 dB); 
MH=mild hypoacusis (losses of between 50 and 55 dB); AH=advanced hypoacusis (losses > 
55 dB). The losses indicated refer to the 4000 Hz frequency. There was also a loss of adjacent 
frequencies as the degree of hearing alteration increases.  
2.3.2 Habits or modifying variables (Table 2) 
4. "Smoking habit" (SH). A nominal binary variable. Recorded whether or not the subject 
smoked.  
5. “Noise outside work” (NOW). A nominal binary variable. Recorded whether or not noisy 
activities were undertaken outside of work.  
6. "Hearing protection" (HP). A nominal binary variable. Recorded whether or not hearing 
protection was used. 
 
Variables (Modifying) n % 
SMOKING HABIT (SH) 558  
No 147 26.3 
Yes 130 23.3 
Missing values 281 50.4 
NOISE OUTSIDE WORK (NOW)    558  
No 192 34.4 
Yes 35 6.3 
Missing values 331 59.3 
HEARING PROTECTION  (HP) 558  
No 103 18.5 
Yes 95 17 
Missing values 360 64.5 
Table 2. Habit variables 
The events were defined based on the "degree of hearing alteration" variable, treating this as 
a nominal variable of binary response. Since in reality it is an ordinal variable with five 
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represented the cases censored or in which the event did not occur, and the code (1) 
represented the event occurring. The system followed is represented in Table 3. This 
approach does not allow other reinterpretations of the type of censures to be used as they 
must necessarily be to the right because the exact decrease in the threshold is not available 
for each individual. Instead, only a diagnostic code is available, which did not allow us to 
define a specific decrease in dB and to relate this to the “duration of exposure” variable. 
 
Events Modalities ¿Event of Cox? 
Event 1: 
Healthy (code 0) 





Temporary effect (IAT) 
treated as permanent 
Event 2: 
Recovered (code 0) 







No falls in conversational freq. (code 0) 






Table 3. Definition of events 
3. Methods  
The way of initially tackling the analysis of the data was by defining the survival functions. 
The main focus of this study was to identify the patterns of hearing alteration over time, 
related to the environmental conditions to which the individuals were exposed and their 
“habits”. Once the survival functions were defined and examined, the data was analysed 
using various regression analysis techniques to identify the most suitable method. 
The starting point was one quantitative variable with the remaining variables being 
qualitative. We are in a limiting case when applying regression theory to the data, that as 
indicated by Martín & Paz (2007). 
Due to reason stated above the number of useful regression models was limited. Linear 
regression models require at least two quantitative variables. Models based on the 
discriminating function require the normal distribution of variables, an aspect which in this 
case was not satisfied as the only category contrasting with the rest (healthy) did not follow 
a normal distribution. The remaining categories of this variable are self-contained and as a 
consequence they cannot be analysed using this technique. Multivariate analysis of variance 
is not an alternative to discriminant analysis as it also requires at least two quantitative 
variables. 
Specific regression techniques for the analysis of quantitative variables also present 
problems. Thus, logistic regression with nominal binary or polytomous response (Silva & 
Barroso, 2004), does not allow the quantitative variable (taken as independent) to be 
correlated with the others variables. Ordinal regression (Greenland, 1994) is not operational 
either as it is an extension of the above.  
The most ideal model for the analysis of this situation is Cox's regression model, which 
makes it possible to work with only one quantitative variable (Cox & Snell, 1989). It also 
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makes it possible for both the response variable and the predictor variables to establish a 
strong dependence relationship with the single variable, thereby obtaining suitable variants 
of Cox's regression model for this particular case (Cox's regression with a time dependent 
variable). It is true that the character of this regression applied to the data is fundamentally 
explanatory as the prediction must be based on the most frequently recorded samples with 
the objective of ensuring the accuracy of the observations. 
The steps that were followed to apply Cox's model (Hosmer & Lemeshow, 1999) were: (1) 
Ensuring that the events defined were Cox type events: i.e. they occurred only once and 
after the event occurred it was set permanently; (2) Checking the proportionality and 
consistency of the risks. A graph was used based on the projection of the survival functions 
(demonstrated and not demonstrated); (3) Assessing the high multicollinearity or 
interdependence. Those variables defined prior to the study, with a correlation of above 0.8, 
were eliminated; (4) Assessing the linearity of the quantitative variable (duration of 
exposure). A graph was used based on the projection of the duration of exposure of each 
individual with respect to their partial residual plot (calculated with respect to their age); (5) 
Assessing the existence of influencing observations. Delta-beta values were used. (Cook's 
distance applied to Cox's regression). Values above 1 were rejected; (6) To identify any 
possible confusion and interaction between variables, the method involving changing model 
coefficients was used; (7) The correlation between beta coefficients was used to assess the 
stability of each model; (8) The fit of the models was assessed using probability reasoning; 
(9) The model was validated indirectly as it was not possible to obtain another, different 
sample with which to assess this aspect. Validation of the latent structure was used, 
obtained by the analysis of matches for each one of the two halves of the sample.  
3.1 Nonparametric reliability models 
The Kaplan-Meyer method (K-M) was used to obtain the survival function of a particular 
event associated with the various covariables, and for the contrast of functions and their 
meaning the Log-Rank test was used.  
Subsequently a Cox regression model was used, with the aim of explaining the relationships 
between the variables.  
3.2 Parametric reliability models  
To obtain the reliability functions the normal distribution model was used and for their 
contrast a U of Mann-Whitney and t-test was used. For this each one of the binary variables 
was transformed into another equivalent referring to duration of exposure.  
The parametric model was only used as a descriptor of the variables and for testing certain 
controls, hypotheses and predictions, starting with the probability distributions: (1) Tests to 
establish controls (regarding the population percentage, with reference to one or more 
alterations, which must not be exceeded). The tests concern establishing a common "cut off 
point" for the modalities of the variable “degree of hearing alteration”; (2) Hypothesis tests 
(regarding the development of hearing alteration). These involve the analysis of the 
differences in probabilities based on a real value and a theoretical value. An individual with 
a particular duration of exposure experiences a degree of hearing alteration (real value). In 
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hearing alteration (theoretical values); (3) Tests of predictions. This involves predicting the 
development of certain exposed populations, based on the previous controls and 
hypotheses, making it possible to improve preventative management systems. 
3.3 Comparison of survival models 
Survival functions obtained for the data from the sample, using a parametric and non-
parametric model, they were represented together in a graph to assess their equivalence. 
The interesting aspect of this equivalence is the complementarity of the results, allowing 
them to be used together i.e. where one model is not suitable, the other is. For example, for 
the initial data, regression is possible in a non-parametric approach but not in a parametric 
approach.  
Factorial methods were also used with the aim of exploring the relationships between 
variables. The most suitable factorial method was correspondence analysis carried out using 
a Burt table (Benzecri, 1992). The heterogeneity of frequency distributions between the 
variables implies a low degree of dependency between them, above all when considering 
the “habits” variables with respect to the “exposure” variables. This situation makes the 
final solution (analogous with the regression results) more contrived than deductive, an 
aspect which limits the formal application of the factorial model. The problem can be solved 
using differential topological models (Cova, Márquez & Tovar, 2001), based on Thom's 
morphogenetic theory (1971), which is a future direction for this research.  
4. Results 
The characteristics of the sample are shown in Tables 1 and 2, which summarise its structure 
with respect to the various variables considered.  
It is interesting to examine the categories within the “habits” variables, where the degree of 
personal protection, i.e. use of hearing protection, non-exposure to non-occupational noise 
and not smoking, is related to the atmosphere at work. It can be seen that as the noise level 
becomes more harmful the individuals tend to protect themselves more (Figure 1). This fact 
is very interesting when interpreting the effect on hearing of the noise and chemicals 
combination. 
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As can be seen in figure 2, the survival functions obtained through the Kaplan-Meyer 
method define how hearing alteration appears in individuals by event and for each work 
atmosphere. They show clear differences between event 1 and the others.  
Thus, in event 1 the "noise with metalworking fluids" atmosphere causes a delay in hearing 
alteration which is significant (p<0.05), whereas the "noise only" atmosphere and the "noise 
with welding fumes" atmosphere develop in unison, showing no differences between them 
(p>0.05).  
For events two and three, the curves that characterise each atmosphere are separated from 
one another significantly (p<0.05), indicating the time differences that exposure to each of 
them represents and for the same period (see variation of the medians and contrasts, Table 4 
and 5). It was demonstrated, furthermore, that the 0 to 15 years period of exposure to noise 
was low risk, in general presenting hearing alteration of less than 10% in the individuals 
exposed (Figure 2). 
The percentage of individuals affected, over this period gradually decreased as the event 
continued. Thus, event 1 principally characterises the variations in the hearing threshold of 
the recoverable type (initial trauma), event 2 non-recoverable but without alteration in 
conversational speech (advanced trauma) and in event 3 non recoverable variations with 
losses in conversational speech (hypoacusis). The situation described gives a dynamic to the 
process of hearing alteration which is characterised by the migration of the set of survival 
functions to the right. This explains the existence of a lower risk in the initial periods over 
time, demonstrating the suitability of the model (Figure 2).  
Obtaining univariate, bivariate and trivariate models (Table 6), based on the Cox regression, 
explains the effect of the various variables in the study, based on the hazard ratio. 
In considering the “smoking habit” variable it was found that its effect was antagonistic to 
atmospheres with metalworking fluids, although the hazard are more or less balanced, 
depending on the event. This indicates uniform action over time, which is different from 




N E C Q25 SE Q50 SE CI 95% Q75 SE 
MF 1 146 91 55 38 0.94 32 1.03 (30,34) 25 1.29 
N 1 177 124 53 33 0.70 28 0.75 (27,29) 21 1.65 
WF 1 235 185 50 32 0.73 27 0.61 (26,28) 22 0.77 
MF 2 146 35 111 44 2.43 40 1.69 (37,43) 35 1.10 
N 2 177 51 126 41 2.05 34 0.88 (32,36) 29 1.37 
WF 2 235 118 117 36 0.90 31 0.75 (30,32) 26 0.65 
MF 3 146 12 134 45 * 44 3.60 (37,51) 40 1.15 
N 3 177 25 152 45 * 41 1.72 (38,44) 32 1.62 
WF 3 235 62 173 40 0.44 36 1.49 (33,39) 30 0.76 
N=cases; E=events; C=censored; SE=standard error 
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N E C Q25 SE Q50 SE CI 95% Q75 SE 
MF 1 146 91 55 38 0.94 32 1.03 (30,34) 25 1.29 
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Fig. 2. No parametric survival functions, Kaplan-Meyer 
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Atmospheres Event Log Rank df Sig 
MF / N 1 15.64 1 0.0001 
WF / N 1 0.02 1 0.8904 
MF / N 2 9.22 1 0.0024 
WF / N 2 7.92 1 0.0049 
MF / N 3 9.79 1 0.0018 
WF / N 3 4.84 1 0.0279 
Table 5. Contrast of no parametric survival function 
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Fig. 3.1. Synergy (Competence) Fig. 3.2. Antagonism 
 
Fig. 3.3. Synergy Fig. 3.4. Antagonism 
 
Fig. 3.5. Antagonism Fig. 3.6. Synergy 
Fig. 3. Risk factor comparison with the personal habits through the hazard and according 
the event 
Smoking in the WF atmosphere produces a synergistic effect, the action of which is 
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have an antagonistic effect; tobacco loses its effect in relation to welding fumes in the 
medium term (event 2) and long term (event 3), both with p>0.05.  
The effect of non-occupational noise is antagonistic to that of metalworking fluids (Figure 
3.4.), accelerating hearing alteration uniformly depending on the event, although it is in 
event 2 where it is most apparent, decreasing in the following event (p>0.05). By contrast, 
the effect of MF atmospheres strengthens over time, or to put it another way, the delay in 





















H 13.13 11.39 85.63% 2.076 0.0004 2.05 1.16 0.852 0.708 
IAT 24.73 8.72 35.26% 1.001 0.2636 3.11 0.54 0.738 0.925 
AAT 27.38 8.07 29.47% 0.959 0.3163 3.24 0.42 0.702 0.938 
MH 29.31 7.92 27.02% 0.658 0.7788 3.34 0.31 0.679 0.930 
AH 32.62 7.30 22.38% 0.926 0.3571 3.45 0.32 0.631 0.942 
VC: Variation coefficient; K-S: Kolmogorov-Smirnov test; R2: Determination coefficient 
Table 7. Normality and linearity conditions 
 
Fig. 4.1. Normal 
 
Fig. 4.2. Cumulated Normal 
 
Fig. 4.3. Log Normal 












H IAT AAT MH AH
0
1














Fig. 3.1. Synergy (Competence) Fig. 3.2. Antagonism 
 
Fig. 3.3. Synergy Fig. 3.4. Antagonism 
 
Fig. 3.5. Antagonism Fig. 3.6. Synergy 
Fig. 3. Risk factor comparison with the personal habits through the hazard and according 
the event 
Smoking in the WF atmosphere produces a synergistic effect, the action of which is 
















































Exploration Databases on Occupational Hearing Loss 
 
203 
have an antagonistic effect; tobacco loses its effect in relation to welding fumes in the 
medium term (event 2) and long term (event 3), both with p>0.05.  
The effect of non-occupational noise is antagonistic to that of metalworking fluids (Figure 
3.4.), accelerating hearing alteration uniformly depending on the event, although it is in 
event 2 where it is most apparent, decreasing in the following event (p>0.05). By contrast, 
the effect of MF atmospheres strengthens over time, or to put it another way, the delay in 





















H 13.13 11.39 85.63% 2.076 0.0004 2.05 1.16 0.852 0.708 
IAT 24.73 8.72 35.26% 1.001 0.2636 3.11 0.54 0.738 0.925 
AAT 27.38 8.07 29.47% 0.959 0.3163 3.24 0.42 0.702 0.938 
MH 29.31 7.92 27.02% 0.658 0.7788 3.34 0.31 0.679 0.930 
AH 32.62 7.30 22.38% 0.926 0.3571 3.45 0.32 0.631 0.942 
VC: Variation coefficient; K-S: Kolmogorov-Smirnov test; R2: Determination coefficient 
Table 7. Normality and linearity conditions 
 
Fig. 4.1. Normal 
 
Fig. 4.2. Cumulated Normal 
 
Fig. 4.3. Log Normal 












H IAT AAT MH AH
0
1













Categories Normal Log Normal U Z Sig 1 t CV-t 2 Sig 
H-IAT 6811 -9.066 0.0000 3.7024 1.9839 0.0003 
IAT-AAT 8349 -2.698 0.0070 0.5595 1.9804 0.5768 
AAT-MH 3283 -1.193 0.2325 0.4361 1.9804 0.6635 
MH-AH 715 -2.309 0.0209 0.7795 1.9802 0.4372 
(1, 2) 2 tailed; CV-t: critical value for t 
Table 8. Contrast of parametric survival functions (U of Mann-Whitney and t-test)  
In WF atmospheres non-occupational noise produces a uniform effect depending on the event. 
It plays a more active role in event 1 in hearing alteration in relation to smoke (Figure 3.3.).  
The use of individual protection equipment produces an effect similar to that of 
metalworking fluids, although their effectiveness increases over time (Figure 3.6.). This is 
characteristic when the protection equipment is not used continuously. It also explains the 
major delay produced in MF atmospheres. 
In WF atmospheres the use of individual protection equipment is clearly antagonistic 
(Figure 3.5.), increasing in effectiveness over time, although the action of the WF atmosphere 
is much more powerful than the protection equipment. 
Subsequently the effect on hearing of exposure to all atmospheres in the metal industry was 
analysed. To do this the initial sample was subdivided into the 3 atmospheres studied and 
in turn each one of these was divided into the five phases of hearing alteration. In doing this 
the frequencies were considerably reduced and as a consequence the analysis was not very 
consistent. Using the combined analysis of atmospheres to study the various phases of 
hearing alteration was the most useful option. For this analysis a parametric model (log-
normal) was used to obtain the survival functions (Figure 4.3.). This has the advantage over 
those non-parametric models of the probability distribution of the event using continuous 
functions. This gives more precision to the distribution of each degree of hearing alteration 
and as a consequence to the identification of the time of the event (Figure 4, Table 8).  
In this case, the survival curves must be understood as the combination of individuals who 
present a specific hearing alteration, independently of the atmosphere to which they are 
exposed and their personal habits. Each function associated with a degree of hearing 
alteration characterises an average value i.e. a theoretical value consisting of the 
combination of the three atmospheres to which must be added the combination of "habits" 
of the individuals in the sample (Figure 4.1.).  
The conditions of normality and linearity of each degree of hearing alteration, obtained 
according to time, were assessed (Table 7).  
The similarity of the survival functions for the different degrees of hearing alteration was 
also assessed using parametric and non-parametric methods, with the objective of making 
both the results and their interpretation homogeneous (Figure 5). It should be noted that 
except for the group of healthy people who do not follow a normal distribution, the 
remaining degrees of hearing alteration do follow a normal distribution. It can also be seen 
that in accordance with the degree hearing alteration the mean value of the distributions are 
displaced to the right. This confirms the suitability of the sample, which is also corroborated 
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by the low frequency of individuals that are affected as the degree of hearing alteration 
increases. The spread of hearing alteration over time can be seen. Thus, once the level of 
advanced acoustic trauma is reached, the individual undergoes a more rapid process of 
hearing alteration. This can be substantiated, because the curves tend to unite more than in 
the IAT /AAT transition. 
 
 
Fig. 5.1. Healthy 
Fig. 5.2. IAT 
 
Fig. 5.3. AAT 
Fig. 5.4. MH Fig. 5.5. AH 
Fig. 5. Survival function equivalence obtained by parametric and no parametric models 
5. Discussion 
The qualitative methodology proposed for the study of the combined influence of noise and 
chemical pollutants on hearing loss (Conte et al., 2009) differs from that used in traditional 
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studies on the same topic. These perform a quantitative analysis of decreases in the hearing 
threshold, an aspect which was replaced by an audiogram classification based on a 
diagnostic reference. The duration of each individual's exposure to noise was also used, 
instead of their age, thereby improving the linear behaviour of the temporal variable. 
Finally, each chemical contaminant was characterised by a binary variable, thus avoiding 
the use of an environmental measurement value, which provides more general and less 
restrictive identification than quantitative environmental measurements.  
This study shows the influence of noise on hearing alteration, whether temporary (IAT) or 
permanent (AAT, MH, AH). This situation is consistent with studies conducted on the 
influence of this physical agent on hearing.  
Moreover, chemical agents taken as interacting with noise (MF and WF) have been 
considered by various researchers as pulmonary toxins (Godderis et al., 2008; Schaller et al., 
2007), due to the principal way they enter the body: by inhalation. It is nonetheless true that 
the influence of these agents on hearing loss, a toxic effect that can be considered indirect, 
has not been given due attention. 
 This study confirms the existence of an interaction between physical and chemical factors in 
the metal industry which influence the alteration of auditory function, and which can be 
characterised by three different exposure environments, WF with noise, MF with noise, and 
noise only. 
The interaction of the pollutants with the individual determines whether the auditory effects 
caused by the main risk factor (noise) develop more quickly or slowly in the worker. Thus, it 
can be identified that metalworking fluids delay the development and worsening of the 
various stages of auditory alteration, whereas welding fumes speed up the development of 
same. In this respect, the behaviour of one contaminant with another is antagonistic.  
The study also indicates that, in the case of welding fumes, the chemical agent is shown to 
be more detrimental to hearing. One of the main problems regarding welding fumes in the 
presence of noise is that, in general, the protection used is effective in muffling noise 
intensity but not in reducing the effect of the chemical agent. In this situation, cellulose 
masks or those of similar compounds have little effect, as their capacity to filter particles 
(such as charcoal) is not effective for gaseous molecules such as carbon monoxide, which is 
highly ototoxic (Gwin et al., 2005; Morley et al., 1999).  
As regards personal habits, there is a growing tendency to use hearing protection as the 
harmfulness of the environment increases. The interpretation of this fact is due to an 
increased personal willingness to use protective equipment when the individual feels some 
discomfort, which may be intuitively associated with the work environment. This study 
verifies that the increase in using protection is not sufficiently capable of improving 
auditory health conditions, supporting the negative effects of welding fumes on workers.  
With regard to the regression models, it has been demonstrated that the univariate models (MF 
and WF) are those which best, and more accurately, define each model according to the event.  
Despite a loss of accuracy, the bivariate models may be more interesting as regards 
application. For Event1, the variable SH is shown to be the most influential and best 
represented of the models. For this event, NOW is also considered an acceptable model, 
along with WF.  
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For Event2 the ideal models are MF with NOW and with HP, as well as WF with NOW. 
There is a decline in accuracy with respect to the previous event.  
For Event3 only the MF-HP model is considered suitable, with the other two habits losing 
significance. 
This indicates the influence obtained for each habit variable: SH influences IAT; NOW 
influences the development of AAT; HP is influential as protection at all stages, even if it is 
ineffective against fumes.  
The influence of smoking habits (SH) on the initial auditory alteration recognised in this 
study coincides with the results obtained by other authors (Pouryaghoub et al., 2007; Ferrite 
et al., 2005; Mizoue et al., 2003), but indicates the need for further research in order to 
properly assess this influence.  
6. Conclusions 
A methodological framework was presented which made it possible to use employment 
related health databases with limited information. The limitations of the data, resulting from 
possible changes in the way the data was obtained and recorded during the period under 
study, led to the use of qualitative, binary response variables and only one quantitative 
variable, namely the time of exposure to noise.  
With this situation as the starting point, it was established that that survival analysis is one 
of the best ways of analysing this type of data, both in relation to defining probability-time 
functions and their contrasts, and for modelling using Cox regression, in relation to both the 
application possibilities and the results reached (descriptive-explanatory in character).  
This research was aimed at the analysis of the interaction between noise and chemicals and 
its influence on occupational hearing loss. It was found that in the Aragonese metal sector, 
which was the focus of this study, there were three main atmospheres: noise with 
metalworking fluids, noise only and noise with welding fumes.  
The analysis made it possible to establish that hearing alteration in individuals was related 
to the exposure atmosphere. Thus, workers exposed to noise and metalworking fluids, who 
protected themselves less, experienced slower hearing alteration compared to those who were 
exposed to only noise, and workers exposed to welding fumes, who protected themselves 
more, suffered hearing alterations sooner than those who were only exposed to noise.  
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Hearing loss (HL) is the most common sensory defect in human beings, affecting 1.86 in 
1000 newborns around the world which half of it is due to genetic causes (Morton & 
Nance, 2006). HL can be syndromic or nonsyndromic. Individuals affected with 
syndromic form have additional clinical signs whereas nonsyndromic HL is not 
associated with other clinical signs and symptoms.  All Mendelian pattern of inheritance 
have been observed in nonsyndromic HL (NSHL) including autosomal dominant (AD), 
autosomal recessive (AR), X-linked inheritance (XL) and mitochondrial inheritance (MT); 
autosomal recessive is the main form of NSHL, i.e. 75-85 % of NSHL show AR pattern in 
affected pedigrees. 
As known, ear is the organ of hearing and balance. Hearing is dependent on a series of 
complex events. The ear has three anatomical parts including outer, middle and inner ear. 
The external ear which is composed of the auricle, ear canal and eardrum membrane 
collects sound waves and transmits them to the eardrum. Three tiny bones of middle ear 
(the ossicles) act as levers and conduct the sounds to the oval window, and finally 
through the cochlea (a snail-shaped organ) which has the auditory receptors (the organ of 
Corti) in the inner ear [Raphael & Altschuler 2003].  A collagen-based extracellular matrix, 
called tectorial membrane on top of the hair cells is vibrated by sound waves [Richardson 
et al., 2008]. Within the organ of Corti, physical vibrations produce a mechanoelectrical 
transduction which is detected by hair cells and these cells respond by producing 
electrical impulses. Nerves transmit these impulses to the brain where they are 
interpreted.  Different sound frequencies stimulate the hair cells in different parts of the 
organ of Corti and lead to perception of different sound frequencies. Sounds are 
processed in both sides of the brain but the interpretation of the sounds takes place at the 
left side of brain.  Sounds are heard at normal hearing thresholds between 0-20 dB across 
the 125-8000 Hz range while loss of more than 20 dB, is said to have hearing loss which is 
confirmed by measuring pure tone average (PTA) (average hearing sensitivity at 500, 1000 
and 2000 Hz).  
Nearly one hundred and twenty million people suffer from hearing impairment around the 
world.  History of some important events about human hereditary HL is shown in table 1 
[Nance & Sweeney, 1975; Wallis et al., 1988; Kimberling et al., 1990; Leon et al., 1992; 
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Guilford et al., 1994; Kelsell et al., 1997; Lynch et al., 1997; Eudy et al., 1998; Gorlin, 2004; 
Dror & Avraham 2009].  
 
Time Event 
Sixteenth century Reports indicating the prevention of the deaf from marrying 
Seventeenth century The mode of recessive and dominant HL 
Nineteenth century “The most frequent causes of congenital deafness are hereditary.. .”  
1968 One of the genetic forms of deafness was described 
1975 The forms of HL, the need for research and genetic counseling were 
described 
1988 An X-linked form of deafness was mapped in a large Mauritian 
family 
1990 The first locus for syndromic HL, USH2A, was mapped 
1992 The first locus for ADNSHL*, DFNA1, was mapped in a Costa Rican 
family 
1994 The first and second loci for ARNSHL■, DFNB1 and DFNB2, and 
DFNA2 loci were mapped 
1997 GJB2 and DIAPH1 genes were discovered for DFNB1 and DFNA1 
loci, respectively 
*Autosomal domiant non syndromic hearing loss, ■Autosomal recessive nonsyndromic hearing loss 
Table 1. Chronological events regarding hereditary HL. 
One of the main programs of the World Health Organization (WHO) is to encourage 
countries for the prevention of deafness [Emery, 2003].  Understanding the molecular and 
genetic mechanisms of HL may lead to development of new therapy and treatment 
approaches. Here, we review major causes leading to either syndromic or nonsyndromic 
HL. 
2. Classification of hearing loss 
Approximately two-thirds of the HL affected children show the problem at birth and 
unfortunately it may not be diagnosed before the age of 3 years.  HL has several 
classification criteria which are important for diagnosis, prognosis and treatment [Mahdieh 
et al., 2010a].  These criteria are summarized in table 2. 
2.1 Etiology 
Based on the cause of sensorineural deafness, HL is categorized into three major forms as 
acquired, genetic and unknown.  There are many causes for hearing loss:  
1. Acquired HL: infectious and pharmaceutical agents known as teratogens would affect 
the sense of hearing.  HL could occur by physiological, biochemical or infectious factors. 
 However, genetic background has an important effect on its occurrence. The risk 
factors that may affect the hearing process are as follows:  
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a. factors before birth including congenital infections (e.g. toxoplasmosis, measles, 
syphilis, smallpox, cytomegalovirus, herpes virus), congenital deformities of aurical 
and ear duct [Willems, 2004; Shin et al., 2011]. 
b. factors during birth including prematurity and low birth weight (less than 1500gr) 
and increased blood bilirubin [Willems, 2004]. 
c. factors affecting after birth including infections and bacterial meningitis, mumps, 
otitis media, blood infection and autotxic drugs such as aminoglycosides, head 
injury or skull fracture which lead to anesthesia [Willems, 2004]. 
2. Genetic HL: the genetic basis of HL is known for more than 100 years. In the early 
decade of 1800s, the Irish physician William Wild explained the inheritance of HL.  His 
theory differentiated between dominant and recessive inheritance.  He also observed 
that men showed more X-linked transmission [Willems, 2004]. 
2.2 Severity 
Intensity of the sound is calculated in units of decibel (dB), which is logarithm intensity of 
the sound wave to a reference sound intensity divided by ten [Willems, 2004]. The normal 
hearing threshold is 15 dB. A regular conversation occurs at level of 45 to 60 dB. 
2.3 Position of damage 
a. Conductive HL: Factors affecting sound transmission including aurical, ear canal, 
eardrum, outer and middle ear bones to the cochlea cause conductive HL.  The most 
common causes of conductive HL are the external and middle ear congenital 
abnormalities such as atrophy and dysplasia, duct obstruction, impacted cerumen, 
otitis, middle ear and Tympanic membrane problems. 
b. Sensorineural HL (SNHL): The disorder occurs in the auditory nerve or the cochlea. In 
other words, the abnormalities occur some place between the hair cells and auditory 
brain regions. The most common causes of SNHL are:  
b1. congenital causes such as rubella, syphilis, Usher syndrome, Alport Syndrome, 
Waardenburg syndrome and autosomal dominant and recessive sensorineural 
deafness [Friedman et al., 2003]. 
b2. acquired factors: Infections such as measles, cytomegalovirus, bacterial meningitis,  
autotoxicity of drug consumption, noise pollution including long-term exposure, 
presbycusis and sudden idiopathic HL [Willems, 2004]. 
c. Mixed HL: in this type of hearing loss, conductive and sensorineural problems are 
observed simultaneously. Infections such as tuberculosis, some syndromes and skull 
fractures may also cause mixed HL. 
2.4 Age of onset 
On the basis of the age of onset, HL is divided into the following types:  
a. Prelingual: Loss of hearing occurs before speech is acquired. If a child has a congenital 
hearing impairment, he would not be able to speak normally.  
b. Postlingual: Loss of hearing occurs after speech is developed. 
c. Presbycusis or age-related HL (ARHL): Epidemiologic studies show that nearly 25 % of 
60 year olds and more than 50 % of 80 year ages undergo ARHL [Dror & Avraham, 
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HL may be associated with other physical problems which are called syndromic HL.  
Genetic HLs without any other complications is called non-syndromic genetic hearing loss 
[Willems, 2004]. HL loci are named with the prefix DFN, followed by the mode of 
inheritance which is indicated by B, A, X and Y for autosomal recessive (DFNB), autosomal 
dominant (DFNA), X-linked (DFNX) and Y-linked (DFNY), respectively. The order in which 
loci have been described is denoted by a number after these letters, e.g. DFNB1 is the first 
identified locus causing autosomal recessive HL [Guilford et al., 1994]. 
 
Criterion Class Definition and example 
Age of onset Prelingual HL HL occurs before language acquisition 
Postlingual HL HL occurs after language acquisition 
Presbycusis Age-related HL 
Etiology 
 
Acquired Caused by environmental agents such as viral and 
bacterial infections (prenatal, e.g., CMV, toxoplasmosis, 
rubella; postnatal, e.g, meningitis), hyperbilirubinemia, 
head trauma, anoxia, noise exposure and ototoxic drugs 
Genetic Caused by gene mutation 
Idiopathic Unexplained cause 
Clinical 
phenotypes 
Syndromic associated with other symptoms 
Nonsyndromic Deafness is the only defect 
Position of 
damage 
Conductive HL Caused by a problem transferring sound waves through 
the external ear, tympanic membrane or middle ear 
Sensorineural HL Caused by damage to the inner ear (vestibulocochlear 
nerve) 
Mixed HL Caused by a combination of sensorineural and 
conductive HL 
Severity Mild  Difficulty in hearing of 26–40 dB sounds 
Moderate  41–55 dB 
Moderately severe 56–70 dB 
Severe  71–90 dB 





DFNA loci (DFNA1-64) 
Autosomal 
recessive 
DFNB loci (DFNB1-96) 
Sex-linked DFNX loci (DFN1-8) 
Y-linked DFNY loci (DFNY1) 
Mitochondrial 12SrRNA (MT-RNR1), tRNASer(UCN) (MT-TS1) 
Table 2. Various criteria for the classification of hearing loss. 
3. The frequency of genetic HL 
Genetic HL occurs 1 in 2000 to 1 in 650 live births [Morton & Nance, 2006].  About 70% of 
the cases are nonsyndromic [Tekin et al., 2001].  Studies show that 75% of nonsyndromic HL 
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are inherited as autosomal recessive [Tekin et al., 2001].  10-20% of cases are inherited as 
autosomal dominant and 1-5% are X-linked recessive.  Approximately, 1% of human genes, 
i.e 200 to 250 genes are responsible for hereditary HL [Finsterer & Fellinger, 2005]. So far, 
more than one hundred loci and 55 genes have identified which are involved in 
nonsyndromic HL (http://hereditaryhearingloss.org). 
4. Non-syndromic HL 
A high frequency of genetic HL occurs without any abnormality in other organs classified as 
non-syndromic HL.  Different patterns of inheritance have been observed in NSHL. 
4.1 Different types of NSHL 
Variety of protein coding genes such as gap junctions (connexin encoding genes), motor 
proteins (myosins) cytoskeletal (e.g. actin), ion channels, structural proteins (Tectorin alpha, 
Otoancorin, Stereocilin, etc), transcription factors (POU3F4, POU4F3 and Eyes absent 4 or 
EYA4), and additionally microRNA genes are involved in HL [Willems, 2004; Mencia et al., 
2009; Mahdieh et al., 2010a]. GJB2 mutations are seen in 50% of autosomal recessive HL in 
the Caucasians [Kelsell et al., 1997; Tekin et al., 2001]. Some genes e.g. GJB2 gene is 
expressed in a variety of organs of the body while others such as OTOAncorin is only 
expressed in the inner ear. 
4.1.1 Autosomal recessive non-syndromic HL  
Autosomal recessive non-syndromic HL (ARNSHL) was first described in 1846.  It is the 
severest form of congenital HL in which there is a defect in cochlea in nearly all cases.  
Loci of ARNSHL are designated as the DFNB; DF stands for Deafness and B indicates the 
autosomal recessive pattern of inheritance. Up to date, 46 genes and nearly 100 loci have 
been identified for HL (Table 3). Regarding different studies, connexin 26 gene mutations 
differ depending on geographical place and ethnicity [Zelante et al., 1997; Morell et al., 
1998; Mahdieh & Rabbani, 2009]. Here, we discuss the most common genes causing 
ARNSHL.   
4.1.1.1 GJB2 and GJB6 genes and connexins 
The first locus of ARNSHL designated as DFNB1 was identified by Guilford and colleagues 
in 1994. These researches confirmed linkage to chromosome 13q12-q13 in two 
consanguineous families [Guilford et al., 1994].  More consanguineous families of different 
ethnic groups were linked to the DFNB1 locus [Morle et al., 2000].  Phenotypic differences 
were observed within different families which indicated that allelic heterogeneity may be 
present in the locus DFNB1.  
GJB2 is a small gene encompassing 5.5 Kb.  It has two exons encoding a 4.2Kb mRNA and a 
protein of 226 amino acids.  A six repeat of G is located at position 30 to 35 of coding region 
of GJB2 gene from which deletion of one G is known as 35delG or 30delG (Figure 1) [Kelley 
et al., 1998].  35delG is the most common mutation in the Caucasians and may cause up to 
70% of all GJB2 gene mutations. Profound HL caused by GJB2 gene mutations is found in 
50% of the cases; 30% are severe, 20% moderate and 1-2% are mild cases [Smith & Hone, 
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expressed in the inner ear. 
4.1.1 Autosomal recessive non-syndromic HL  
Autosomal recessive non-syndromic HL (ARNSHL) was first described in 1846.  It is the 
severest form of congenital HL in which there is a defect in cochlea in nearly all cases.  
Loci of ARNSHL are designated as the DFNB; DF stands for Deafness and B indicates the 
autosomal recessive pattern of inheritance. Up to date, 46 genes and nearly 100 loci have 
been identified for HL (Table 3). Regarding different studies, connexin 26 gene mutations 
differ depending on geographical place and ethnicity [Zelante et al., 1997; Morell et al., 
1998; Mahdieh & Rabbani, 2009]. Here, we discuss the most common genes causing 
ARNSHL.   
4.1.1.1 GJB2 and GJB6 genes and connexins 
The first locus of ARNSHL designated as DFNB1 was identified by Guilford and colleagues 
in 1994. These researches confirmed linkage to chromosome 13q12-q13 in two 
consanguineous families [Guilford et al., 1994].  More consanguineous families of different 
ethnic groups were linked to the DFNB1 locus [Morle et al., 2000].  Phenotypic differences 
were observed within different families which indicated that allelic heterogeneity may be 
present in the locus DFNB1.  
GJB2 is a small gene encompassing 5.5 Kb.  It has two exons encoding a 4.2Kb mRNA and a 
protein of 226 amino acids.  A six repeat of G is located at position 30 to 35 of coding region 
of GJB2 gene from which deletion of one G is known as 35delG or 30delG (Figure 1) [Kelley 
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70% of all GJB2 gene mutations. Profound HL caused by GJB2 gene mutations is found in 
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groups [Morell et al., 1998; Mahdieh & Rabbani, 2009]. A large number of studies have been 
reported about GJB2 mutations including genotype-phenotype correlations, phenotypic 
variability, de novo mutations, dominant mutations, ethnic-specific distribution of 
mutations, digenic inheritance and allelic heterogeneity [del Castillo et al., 2002; Smith & 
Hone, 2003; Mahdieh et al., 2009; 2010b, 2010c].  Also, a modifier gene has been suggested 
because of intrafamilial phenotypic variability of the cases [Higert et al., 2009a; Mahdieh et 
al., 2010b].  
GJB2 and GJB6 genes are about 35 kb apart from each other.  GJB6 gene encodes a protein 
called Connexin 30 (MIM 604418) which has 261 amino acids.  Connexin 30 is produced in 
different tissues of the body such as the cochlea, brain and thyroid [Grifa et al., 1999]. The 
importance of this gene was evident when some families had a mutated allele of GJB2 and 
the second mutant allele was in the GJB6 (digenic inheritance) [del Castillo et al., 2002]. 
 
Locus Location Gene references 
X-Linked 
DFNX1 Xq22  PRPS1  Liu et al., 2010   
DFNX2  Xq21.1  POU3F4  De Kok et al., 1995   
DFNX4 Xp22  SMPX  del Castillo et al., 1996   
Autosomal Dominant 
DFNA1 5q31 DIAPH1 Lynch et al., 1997 
DFNA2A  1p34  KCNQ4 Kubisch et al., 1999  
DFNA2B  1p35.1 GJB3  Xia et al., 1998  
DFNA3A  13q11-q12  GJB2  Kelsell et al., 1997  
DFNA3B  13q12 GJB6 Grifa et al., 1999  
DFNA4  19q13  MYH14 Donaudy et al, 2004 
DFNA5  7p15  DFNA5 Van Laer et al., 1998  
DFNA6  4p16.3  WFS1 Bespalova et al., 2001  
DFNA9  14q12-q13  COCH Robertson et al., 1998  
DFNA10  6q22-q23  EYA4 Wayne et al., 2001  
DFNA11  11q12.3-q21  MYO7A Liu et al., 1997  
DFNA12  11q22-24  TECTA Verhoeven et al., 1998  
DFNA13  6p21  COL11A2 McGuirt et al., 1999  
DFNA15  5q31  POU4F3 Vahava et al., 1998  
DFNA17  22q  MYH9 Lalwani et al., 2000   
DFNA20  17q25  ACTG1 Zhu et al., 2003,  
DFNA22  6q13  MYO6 Melchionda et al.,  
DFNA28  8q22  GRHL2  Peters et al., 2002   
DFNA36  9q13-q21  TMC1 Kurima et al., 2002  
DFNA39  4q21.3  DSPP Xiao et al., 2001   
DFNA44  3q28-29  CCDC50  Modamio-Hoybjor et al., 2007   
DFNA48  12q13-q14  MYO1A Donaudy et al., 2003   
DFNA50  7q32.2  MIR96 Mencia et al., 2009 
DFNA51  9q21  TJP2 Walsh et al., 2010   
DFNA64 12q24.31-12q24.32 SMAC/DIABLO  Cheng et al., 2011   
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Locus Location Gene references 
Autosomal Recessive 
DFNB1  13q12  GJB2 Kelsell et al., 1997  
DFNB2  11q13.5  MYO7A Liu et al., 1997  
DFNB3  17p11.2  MYO15A  Wang et al., 1998  
DFNB4  7q31  SLC26A4  Li et al., 1998  
DFNB6  3p14-p21  TMIE Naz et al, 2002  
DFNB7/11  9q13-q21  TMC1 Kurima et al., 2002  
DFNB8/10  21q22  TMPRSS3  Scott et al., 2001  
DFNB9  2p22-p23  OTOF Yasunaga et al., 1999  
DFNB12  10q21-q22  CDH23 Bork et al., 2001  
DFNB15  19p13  GIPC3    Charizopoulou et al., 2011  
DFNB16  15q21-q22  STRC Verpy et al., 2001  
DFNB18  11p14-15.1  USH1C  Ouyang et al., 2002 
DFNB21  11q  TECTA Mustapha et al., 1999  
DFNB22  16p12.2  OTOA Zwaenepoel et al ., 2002  
DFNB23  10p11.2-q21  PCDH15 Ahmed et al, 2003  
DFNB24  11q23  RDX Khan et al., 2007  
DFNB25  4p13  GRXCR1    Schraders et al., 2010    
DFNB28  22q13  TRIOBP Riazuddin et al, 2006  
DFNB29  21q22  CLDN14 Wilcox et al., 2001  
DFNB30  10p11.1  MYO3A Walsh et al., 2002  
DFNB31  9q32-q34  WHRN Mburu et al., 2003  
DFNB32  1p13.3-22.1  GPSM2 Walsh et al., 2010  
DFNB35  14q24.1-24.3  ESRRB Collin et al., 2008  
DFNB36  1p36.3  ESPN Naz et al., 2004  
DFNB37  6q13  MYO6 Ahmed et al., 2003  
DFNB39  7q21.1  HGF Schultz et al., 2009  
DFNB42  3q13.31-q22.3  ILDR1   Borck et al., 2011   
DFNB49  5q12.3-q14.1.  MARVELD2 Riazuddin et al., 2006  
DFNB53  6p21.3  COL11A2 Chen et al., 2005  
DFNB59  2q31.1-q31.3  PJVK Delmaghani et al., 2006  
DFNB61  7q22.1  SLC26A5 Liu et al., 2003  
DFNB63  11q13.2-q13.4  LRTOMT/ COMT2 Ahmed et al., 2008   
DFNB66  6p21.2-22.3  LHFPL5 Shabbir et al., 2006 
DFNB72  19p13.3  GIPC3    Rehman et al., 2011  
DFNB73  1p32.3  BSND   Riazuddin et al., 2009   
DFNB74  12q14.2-q15  MSRB3   Ahmed et al., 2011 
DFNB77  18q12-q21  LOXHD1   Grillet et al., 2009  
DFNB79  9q34.3  TPRN Rehman et al., 2010   
DFNB84  12q21.2  PTPRQ Schraders er al., 2010  
DFNB91  6p25 SERPINB6 Sirmaci et al., 2010  
DFNB95  19p13  GIPC3    Charizopoulou et al., 2011   
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Fig. 1. Schematic structure and domains of Connexin 26 protein, Connexon and Gap 
Junction channel. A) The most common mutations in specific populations (35delG, 167delT, 
235delC, R143W and W24X mutations in the Caucasian, Ashkenazi Jewish, Japanese, 
Ghanian and Indian populations, respectively) are shown. 35delG, W24X, 167delT, 235delC 
and R143W located on NT, TM1, EC1, TM2 and TM3 domains, respectively. TM1-TM4 
denotes transmembrane domains, EC1-2 denotes extracellular domains, IC denotes 
cytoplasmic domain, NT denotes amino (NH2) terminus and CT denotes carboxyl (COOH) 
terminus. B) Six connexins can oligomerize to form hemichannels named connexons.  
Connexons then pass throughout the membrane to make the gap junction channels. 
Homomeric and heteromeric channels can be formed as connexins selectively interact with 
each other. 
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A few point mutations have also been reported in GJB6 as the cause of ARNSHL  GJB6 [del 
Castillo et al., 2005; Pallares-Ruiz et al., 2002].  Later studies determined that GJB6 mutations 
in cis state, not in trans, would destroy the GJB2 expression.  Therefore, the digenic 
hypothesis may not be correct.   Four large deletions have been recognized in GJB6 gene 
including del(GJB6-D13S1830), del(GJB6-D13S1854), del(chr13:19,837,344-19, 968,698) and 
920 Kb deletion [del Castillo et al., 2002, 2005; Wilch et al., 2010].  The deletions may include 
more than 10% of DFNB1alleles [Stevenson et al., 2003]. So far, del (GJB6-D13S1830) has not 
been seen in many populations [Mahdieh et al., 2004, 2011]. The del (GJB6-D13S1830) and 
del (GJB6-D13S1854) mutations not only truncate the synthesis of GJB6 gene but also destroy 
GJB2 gene expression.  
Connexins encoded by GJ genes are members of transmembrane family proteins that have 
20 members in humans [Holms & Steel, 1999].  These proteins were classified in three 
groups of alpha, beta and gamma proteins.  Common nomenclature system is based on 
molecular weight of proteins e.g. Cx26 and Cx32.  Despite the differences in the size and 
primary amino acid composition, connexins have similar topology.  These proteins have 
four transmembrane domains which are connected by two extracellular and one 
intracellular loop.  The carboxyl and amino terminals are located at the cytoplasmic side.  
Most cells express more than one type of connexin.  Gap junctions show different 
permeability and conductance which may create channels with specific characteristics.  
Also, in order to compensate for the decrease in the expression of some of the connexins, 
other connexins may be produced at an enhanced rate [Kumar & Kilula, 1996].  Hemi-
channels (connexons) are composed of six connexin subunits and two hemi-channels make 
the channel forming the gap junctions [Kelley et al., 1998].  The important role of these 
channels is transportation of potassium ions [Kelley et al., 1998] and glutamate released 
from hair cells to initiate action potential. Different connexins may be made up of hemi 
channels with homomer or heteromer subunits. 
4.1.1.2 MYO15A gene in DFNB3 locus 
In 1995, a report showed that 2% of rural individuals in the north coast of Bali, Indonesia 
were affected with a profound sensorineural non-syndromic HL.  Due to high percentage of 
deaf people in this village a local sign language had been created for communication [Wang 
et al., 1998].   
The locus was mapped on chromosome 17p11.2 by whole genome study.  MYO15A gene 
has 66 exons and 71097 bp, encoding a 11863 bp transcript [Liang et al., 1999].  Myosin gene 
was identified by positional and functional cloning approaches [Wang et al., 1998]. 
Mutations in the gene are responsible for 5% of severe to profound deafness cases in 
Pakistan [Friedman et al., 2003].  MYO15A gene mutations were reported in families from 
Turkey, Brazil and India [Kalay et al., 2007; Nal et al., 2007; Lezirovitz et al., 2008]. The role 
of myosin filaments can be traced in a variety of cellular functions including cell motility, 
muscle contraction, synaptic transmission, cytokenesis, endocytosis, exocytosis and 
probably in gene expression as a modulator [Craig & Woodhead, 2006; Loikkanen et al., 
2009]. As the organism gets more complex, there may be more myosin isoforms found in the 
organism [Oliver et al., 1999; Friedman et al., 1999].  The heavy chain of XV myosin has 3531 
amino acids.  There is a unique proline-rich region at the amino terminal of myosin which 
weighs 140KDa and has no similarity to any of the known proteins.  Next to this domain 
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The locus was mapped on chromosome 17p11.2 by whole genome study.  MYO15A gene 
has 66 exons and 71097 bp, encoding a 11863 bp transcript [Liang et al., 1999].  Myosin gene 
was identified by positional and functional cloning approaches [Wang et al., 1998]. 
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Turkey, Brazil and India [Kalay et al., 2007; Nal et al., 2007; Lezirovitz et al., 2008]. The role 
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sensory cells of cochlear, myosin is expressed in the pituitary gland, neuroendocrine cells, 
parathyroid and pancreas [Llyod et al., 2001].  It is also found in stereocilia of hair cells 
[Belyantseva et al., 2003]. 
4.1.1.3 SLC26A4 gene in DFNB4 locus 
DFNB4 locus, located at chromosome 7q31, was first reported to be linked to recessive non-
syndromic deafness in a large Middle-Eastern Druze family. In 1997, the SLC26A4 (Penderin 
coding protein) was identified by positional cloning at the pendred syndrome locus (Everett 
et al. 1997) and was later also shown to be the gene mutated in DFNB4 [Li et al., 
1998]. Pendred syndrome was identified in 1896 as neurosensory HL and goiter.  HL in 
Pendred syndrome is the most common cause of deafness due to defect of cochlea such as 
dilation sac and duct of endolyph and enlarged vestibular duct [Everett et al., 1997]. 
Mutations of SLC26A4 gene are the second leading cause of ARNSHL.  So far, more than 140 
mutations have been reported for Pendred syndrome.  Phenotypic spectrum of SLC26A4 
gene mutations varies from Pendred syndrome to nonsyndromic HL.  Four mutations are 
common in northern Europeans i.e L236P, T416P, E384G, IVS8 +1 G> A) [Hilgert et al., 
2008].   In a study conducted in Spanish population 27% had homozygous SLC26A4 
mutations [Pera et al., 2008].  Mutations of SLC26A4 gene have been observed in several 
ethnic populations [Albert et al., 2006; Hu et al., 2007; Yoon et al., 2008]. The prevalence of 
SLC26A4 gene mutation is about 40% in Caucasians of which 24% are bi-allelic [Albert et al., 
2006]. 
SLC26A4 gene has 21 exons within 57175 bp of DNA sequence.  Its transcript is about 5 Kb 
encoding into a 87KDa protein having 780 amino acids.  The gene is expressed in lining cells 
of endolymph duct as well as non-sensory cells of utricle, saccule, kidney and thyroid. 
 Various models have been reported for the structure of Pendrin protein.  New model 
suggests that pendrin protein is a transmembrane protein traversing fifteen times 
throughout the membrane [Dossena et al., 2009].  The protein in involved in anion exchange 
of HCO-, Cl-, I-and OH- ions [Mount & Romero, 2004].  
4.1.1.4 TMC1 gene in DFNB7/11 locus 
DFNB7 and DFNB11 were determined as the cause of HL on chromosome 9q13-q21 in two 
Indian and two inbred Israeli families, respectively [Jian et al., 1995].  In 2002, eight different 
mutations in TMC1 gene were linked to one DFNA36 family and eleven DFNB7/11 families 
[Kurima et al., 2002].  More than twenty different point mutations and two deletions have 
been identified in different families.  It seems that c.100C>T mutation includes 
appromximately 40% of all TMC1 mutations in Turkey [Hilgert et al., 2008, 2009b].  In a 
survey of 51 Turkish families, 5 patients had mutations of TMC1 gene [Hilgert et al., 2008].  
Mutations of TMC1 are responsible for at least 6% of all cases of ARNSHL in northeast and 
eastern part of Turkey [Kalay et al., 2005].  Three mutations c.100C> T (R34X), c.77611G> A 
and g.94615A> C have been reported in Iranian families [Hilgert et al., 2009b].  
Based on sequence homology studies, eight TMC genes exist in vertebrates. TMC1 gene has 
24 exons and encodes a 3201 nucleotide RNA.  It expresses a complete transmembrane 
protein with six membrane passing domain which has no similarity to proteins of known 
function.  Mouse ortholog transcript (TMC1) is expressed in cochlea and vestibular hair cells 
[Kurima et al., 2002].   
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4.1.1.5 TMPRSS3 gene in DFNB8/10 locus 
DFNB8/10 locus was separately mapped on chromosome 21q22.3 in two consanguineous 
Pakistani (DFNB8) and Palestinian families (DFNB10) [Bonné-Tamir et al., 1996; Veske et al., 
1996].  Haplotype analysis and sequencing analysis of the families resulted in detection of 
mutations in TMPRSS3 [Scott et al., 2001]. The gene belongs to a subfamily of trans-
membrane serine proteases type III protein [Szabo et al., 2003] expressed in supporting cells 
of the organ of Corti [Guipponi et al., 2002].  Although, the specific role of TMPRSS3 protein 
in growth, development and survival of auditory apparatus has not been found but it 
activates the epithelial sodium channel (ENaC) in vitro [Guipponi et al., 2002]. The mutated 
alleles of the gene may inactivate the serine protease catalytic activitiy.  Therefore, TMPRSS3 
proteolytic function may be important during the development of inner ear [Guipponi et al., 
2002, 2008].   
TMPRSS3 gene has 13 exons within 24 Kb, encoding a 2468 bp mRNA which 
encodes a protein with 454 amino acids [Guipponi et al., 2008]. In 2009, 16 mutations in 
TMPRSS3 have been reviwed and reported by a study [Hilgert et al., 2009b].  From 
25 studied Turkish families, three had mutations of TMPRSS3 gene [Wattenhofer et al., 2005; 
Sahin-Calapoglu et al., 2005].  Mutations of TMPRSS3 gene account for 1% of hearing loss in 
Caucasian children with non-syndromic HL [Wattenhofer et al., 2005].  Mutations of 
TMPRSS3 gene have been reported in 4 of 290 Pakistani families [Ahmed et al., 2004]. 
4.1.1.6 OTOF gene in DFNB9 locus 
OTOF gene contains 48 exons encoding a 1997 amino acid polypeptide called otoferlin   
which is member of Ferlin family of proteins [Mirghomizadeh et al., 2002].  Ferlin family of 
proteins have a domain called C2.  These proteins contain a transmembrane C-terminal 
domain [Yasunaga et al., 1999].  C2 domain is a structural domain in some proteins that are 
involved in directing proteins to the cell membrane [Davletov & Südhof, 1993].  
Otoferlin is expressed in the brain and cochlea.  This protein plays an important role in 
releasing neurotransmitters in the auditory nerve cells [Yasunaga et al., 1999].  Mutations of 
the gene can lead to auditory neuropathy in which the sound from inner ear is not 
transferred to the brain.  Q829X mutation is very common in the Hispanic which is the third 
cause of ARNSHL [Migliosi et al., 2002].  Mutations of the gene have been found in families 
of Lebanese origin [Yasunaga et al., 1999].  Varga et al. reported 8 mutations in 65 studied 
families with ARNSHL [Varga et al., 2006]. OTOF mutations have been found in Pakistani 
families; gene mutations may account for deafness in 2.3% of this population [Choi et al., 
2009]. 
4.1.1.7 CDH23 gene in DFNB12 locus 
The superfamily of cadherin has about 100 members with a variety of roles in cell adhesion, 
growth and developmental signaling, maintenance and function of the tissues [Jamora & 
Fuchs, 2002; Nelson & Nusse, 2004; Gumbiner, 2005; Halbleib & Nelson, 2006].  Cadherin 23 
protein has a role in connection of developing stereocilia [Siemens et al., 2004].  
In 1996, DFNB12 was mapped to chromosome 10q21-q22 in a consanguineous Syrian family 
[Chaib et al., 1996]. Usher syndrome type 1 D (USH1D) was also mapped to the same 
position.  Allelic mutations of the CDH23 gene encoding cadherin 23 cause DFNB12 HL and 





sensory cells of cochlear, myosin is expressed in the pituitary gland, neuroendocrine cells, 
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4.1.1.5 TMPRSS3 gene in DFNB8/10 locus 
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but nonsense and premature stop codon mutations cause Usher syndrome type 1D although 
this relationship is not definite.  No single gene mutation is common in this gene [Hilgert 
2009b].  In 64 Japanese families, five mutations were found in CDH23 [Wagatsuma et al., 
2007]. 
4.1.1.8 TMHS or LHFPL5 genes in DFNB67 locus 
Non syndromic HL in a Pakistani family linked to a new region on chromosome 6p21.1-
p22.3 defining a new locus, DFNB67 in 2006; TMHS or LHFPL5 gene was mapped in this 
region [Shabbir et al., 2006].  LHFPL5 has 4 exons and encodes a 2162 nucleotide mRNA and 
translates into a protein of 219 amino acids. The proposed structure of the protein is a four 
pass transmembrane domain.  Mutations of this gene have been reported 
in patients from Pakistan and Turkey (C161F, Y127C, P83fsX84).  TMHS is important for the 
transmission of sound. 
4.1.2 Autosomal dominant non- syndromic hearing loss 
Late onset, mild and progressive forms of HL are the usual phenotypes associated with 
autosomal dominant form of deafness. About 25 genes and more than 60 loci have been 
reported for autosomal dominant non- syndromic hearing loss (ADNSHL).  There is no 
frequent gene mutated in ADNSHL but mutations in some genes including WFS1, KCNQ4, 
COCH and GJB2 have been suggested to be common (Kelsell et al., 1997; Nie 2008; Higert et 
al., 2009).  
4.1.2.1 WFS1 gene and its protein 
The WFS1 (Wolfram) gene at DFNA6 locus, located on 4p16, consists of 8 exons and has a 
length of about 33.4 kb and a 3.6 kb transcript. It codes for a polypeptide of 890 amino acids 
[Hofmann et al., 2003]. The Wolframin protein is a resident component of the endoplasmic 
reticulum (ER) and may be involved in membrane trafficking, processing and/or regulation 
of ER calcium homeostasis [Fonseca et al., 2010]. In the inner ear, however, this protein may 
be helpful to maintain the appropriate levels of calcium ions and/or other charged particles 
required for hearing process [Cryns et al., 2003].  
Dominant mutations in WFS1 can cause a characteristic type of HL which affects the low 
frequencies and less loss in hearing in the high frequencies [Bespalova et al., 2001; Fukuoka 
et al., 2007]. It has been shown that dominant mutations are usually located in the C-
terminal domain. The recessive Wolfram syndrome is caused by numerous mutations 
distributed along the entire gene. Two mutations c.424_425ins16 and c.1362_1377del16 have 
a high frequency in some specific populations including Spanish patients and Italians, 
respectively [Gómez-Zaera et al., 2001; Colosimo et al., 2003]. It is hypothesized that, 
inactivating mutations may lead to Wolfram syndrome and missense mutations occurring in 
the C-terminal domain can cause the characteristic low-frequency ADNSHL [Cryns et al., 
2003]. 
4.1.2.2 KCNQ4 gene and its protein 
The KCNQ4 gene at DFNA2 locus, located on 1p34, consists of 14 exons and codes for a 
polypeptide of 695 amino acids, a voltage-gated potassium channel. It is a member of the 
KCNQ voltage-gated K+ channel family [Coucke et al., 1999]. It has an important role in K+ 
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secretion into the endolymph by strial marginal cells. Ten missense mutations, two small 
deletions and one splice mutation in KCNQ4 have been reported so far. It is believed that a 
dominant-negative effect of the missense mutations in this gene lead to interference of the 
mutant protein with the normal channel subunit, affecting the pore structure of the 
channels. Therefore, hearing loss with a lower age of onset is observed at all frequencies 
[Coucke et al., 1999; Akita et al., 2001]. Deletion mutations which have a haploinsufficiency 
effect lead to a milder HL with an older age of onset at high frequencies [Coucke et al., 1999; 
Akita et al., 2001]. 
4.1.2.3 COCH gene and its protein 
The DFNA9 causative gene, COCH located on 14q12-q13, consists of 11exons and encodes a 
550 amino acid extracellular matrix protein named cochlin. This protein has several domains 
including two von Willebrand factor A-like domains (vWFA1 and 2) and a LCCL domain (a 
region homologous to a domain in factor C of Limulus). To date, eleven missense mutations 
and one small deletion in COCH gene have been reported. Most of the missense mutations 
are located within exon 4 and 5 which encode the LCCL domain (Figure 2) [Robertson et al., 
1998; Collin et al., 2006]. 
 
Fig. 2. Schematic structure of cochlin and distribution of the mutations along its domains. 
The NT signal peptide is followed by a LCCL domain and two vWF domains. S indicates 
several cysteine residues, NT denotes amino (NH2) terminus and CT denotes carboxyl 
(COOH) terminus.  
4.1.3 X and Y linked HL 
There are fewer X-linked forms of HL (DFNX) than ARNSHL and ADNSHL.  X-linked form 
of deafness has been reported as prelingual or progressive in different families.  Five loci 
and three genes (POU3F4, SMPX and PRPS1) have been reported for X-linked HL 
(http://hereditaryhearingloss.org/).   
To date, only one locus has been linked to chromosome Y (DFNY1) that was found in a very 
large Chinese family (seven generations) [Wang et al., 2004]. They reported that the ages of 
onset for the patrilineal relatives were from 7 to 27 years. PCDH11Y, encoding a 
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4.1.4 Mitochondrial HL 
In healthy individuals, only one type of mitochondrial DNA genotype (homoplasmy) exists, 
but in many mitochondrial diseases, mitochondrial genome has mixed genotype 
(heteroplasmy).  Heteroplasmy differs from one tissue to another and can even differ within 
the cells of a tissue.  A few genes contribute to mitochondrial HL [Fischel-Ghodsian, 2003].   
Due to the important function of mitochondria in producing chemical energy through 
oxidative phosphorylation, mitochondrial DNA mutations can cause systemic 
neuromascular disorders such as HL.  mtDNA mutations may be inherited or acquired 
(Table 4); the inherited mitochondrial mutations can cause many clinical features including 
myopathy, neuropathy, diabetes mellitus and sensorineural HL [Finsterer & Fellinger, 2005; 
Guan 2011].   Acquired mitochondrial mutations may be associated with aging and age-
related HL or presbycusis [Fischel-Ghodsian, 1999, 2003].  Multiorganic mitochondrial 
syndromes are often lethal in homoplasmic state. Mitochondrial homoplasmy exists in 
LHON (Leber Hereditary Optic Neuropathy) and maternal inherited HL [Fischel-Ghodsian, 
2003]. Myoclonic epilepsy and ragged red fibers (MERRF), Kearns-Sayre syndrome (KSS) 
and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes are 
associated with progressive HL [Zeviani et al., 1998; Goto et al., 1990]. 
 
Reference  Phenotype  Mutation  Gene  
Estivill et al., 1998 NSHL/Aminoglycoside 
induced/worsened  




Zhao et al., 2004  NSHL/Aminoglycoside 
induced/worsened  
1494C->T  




Zhao et al., 2004 NSHL/Aminoglycoside induced/ 
parkinsonism, and neuropathy 
1095T>C 
Li et al., 2005 NSHL/Aminoglycoside induced 827A>G 
Pandya et al., 1999;  NSHL/Aminoglycoside induced 7444G>A MTTS1 
(tRNASer(UCN))  Fischel-Ghodsian, 2003 NSHL/Palmoplantar keratoderma  7445A->G  
Jaksch et al., 1998 NSHL/Neurological dysfunction, 
including ataxia, dysarthria and 
myoclonus  
7472insC  
Hutchin et al.2000 NSHL/no additional symptoms  7510T->C  
Friedman et al., 1999  NSHL/no additional symptoms  7511T->C  
Jaksch et al., 1998 HL/Progressive myoclonic epilepsy 
and ataxia 
7512T>C 




Kameoka et al., 1998 maternally inherited diabetes and 
deafness 
8296A>G tRNALys 
Gal et al., 2010 dystonia, stroke-like episodes and HL8332A>G 
Rigoli et al., 2001 maternally inherited diabetes and 
deafness 
14709T>C tRNAGlu 
Table 4. Identified mitochondrial DNA mutations in HL. 
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5. Age-related HL 
Biological changes accumulate in people during life as individuals age. About one hundred 
thousand individuals die each day of age-related causes around the world [de Grey, 2007]. 
Age-related HL (ARHL) or presbycusis is the most frequent sensory defect in the elderly 
people. It occurs due to accumulation of environmental and genetic changes i.e. gradual 
deleterious changes in the ear gives rise hearing impairment in older people. Approximately 
25 % of 60 year olds and more than 50 % of 80 year ages suffer from ARHL [Dror & 
Avraham, 2009; Huang & Tang, 2010]. Many heterogeneous factors including family history, 
exposure to loud noises, ototoxic medication, exposure to chemicals, free radical (reactive 
oxygen species) chronic medical conditions, malnutrition, mtDNA mutations, alcohol abuse 
and smoking etc. may cause this type of HL [Van Eyken et al., 2007b; Huang & Tang, 2010]. 
Some common deletions and acquired mtDNA point mutations due to reactive oxygen 
spicies (ROS) have also been suggested to cause prebyscusis. Although genetic studies on 
ARHL are increasing in the recent years, there is a little information about the role of genes 
to its etiology. Two basic approaches have been used to identify susceptibility genes for 
ARHL: the linkage study and the association study [Van Eyken et al., 2007b]. Several single 
nucleotide polymorphisms (SNPs) have been reported to correlate with presbycusis; 
variants in GRHL2, GRM7, KCNQ4 and N-acetyltransferase 2 are involved (Table 5) [Van 
Eyken et al., 2006, 2007a; Van Laer et al., 2008; Friedman et al., 2009]. Mutations in cadherin 
23 coded by CDH23 gene may also cause ARHL [Johnson et al., 2010]. More recently, a 
genome-wide association scan was conducted on ARHL in the genetically isolated Finnish 
Saami population. This study confirmed, and also provided further evidence for the role of 
the previous reported gene, GRM7 in ARHL. IQGAP2 gene was also proposed to be 
involved in presbycusis [van Laer et al., 2010]. Mechanism of ARHL is not well understood. 
However, new promising technology and strategies may help to discover the exact role of 
genetic mutations in presbycusis. Finding of the genetic variants causing ARHL will 
ultimately lead to discovery of new pharmaceutical interventions and the development of 
new approaches to identify at risk individuals.  
 
 Protein or Function Gene SNP (RS number) 
Van Eyken et 
al., 2006 
Potassium channel (voltage-gated) KCNQ4 SNP9 (rs727146) 
SNP12 (rs2149034) 
SNP18 (rs12143503) 
Unal et al., 
2005 
metabolism of cytotoxic, 





Van Laer et 
al., 2008 
transcription factor cellular 
promoter 2-like 3 





glutamate receptor, metabotropic,7GRM7 7155702T>A (rs11928865)
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Biological changes accumulate in people during life as individuals age. About one hundred 
thousand individuals die each day of age-related causes around the world [de Grey, 2007]. 
Age-related HL (ARHL) or presbycusis is the most frequent sensory defect in the elderly 
people. It occurs due to accumulation of environmental and genetic changes i.e. gradual 
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and smoking etc. may cause this type of HL [Van Eyken et al., 2007b; Huang & Tang, 2010]. 
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nucleotide polymorphisms (SNPs) have been reported to correlate with presbycusis; 
variants in GRHL2, GRM7, KCNQ4 and N-acetyltransferase 2 are involved (Table 5) [Van 
Eyken et al., 2006, 2007a; Van Laer et al., 2008; Friedman et al., 2009]. Mutations in cadherin 
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Saami population. This study confirmed, and also provided further evidence for the role of 
the previous reported gene, GRM7 in ARHL. IQGAP2 gene was also proposed to be 
involved in presbycusis [van Laer et al., 2010]. Mechanism of ARHL is not well understood. 
However, new promising technology and strategies may help to discover the exact role of 
genetic mutations in presbycusis. Finding of the genetic variants causing ARHL will 
ultimately lead to discovery of new pharmaceutical interventions and the development of 
new approaches to identify at risk individuals.  
 
 Protein or Function Gene SNP (RS number) 
Van Eyken et 
al., 2006 
Potassium channel (voltage-gated) KCNQ4 SNP9 (rs727146) 
SNP12 (rs2149034) 
SNP18 (rs12143503) 
Unal et al., 
2005 
metabolism of cytotoxic, 





Van Laer et 
al., 2008 
transcription factor cellular 
promoter 2-like 3 





glutamate receptor, metabotropic,7GRM7 7155702T>A (rs11928865)











6. Syndromic genetic deafness 
More than 400 syndromes have been described in OMIM. Here, genetic aspects of common 
syndromes which are associted with HL are briefly explained.  
Usher Syndrome: Usher syndrome, named after Charles Usher (1914) a British 
ophthalmologist, is the most prevalent cause of autosomal recessive HL, accounting for 
nearly 3-5 per 100,000 in the general population and 1-10% among profoundly deaf children 
[Boughman et al., 1983].  Several clinical subtypes have been distinguished based on its 
characterized features i. e. severity of the HL and the onset of retinitis pigmentosa [Yan & 
Liu, 2010].  Type 1 patients have profound HL, vestibular dysfunction and the onset of 
retinitis pigmentosa in childhood [Hope et al., 1997]. The type 2 patients have normal 
vestibular response, mild to moderate HL and RP begins in the second decade of life [Hope 
et al., 1997]. Progressive HL and variable vestibular response characterize type 3 patients 
and the onset of retinitis pigmentosa is variable as well [Smith et al., 1995]. Usher syndrome 
has a heterogeneous causality (Table 6); to date, 12 different loci and 10 genes have been 
reported (http://hereditaryhearingloss.org/). One of these identified genes, MYO7A, 
encoding myosin 7A, is a unique molecular motor for hair cells [Weil et al., 1995].  Cadherin 
23, an adhesion molecule, coded by CDH23 gene may have an important role in crosslinking 
of stereocilia [Bolz et al., 2001; Bork et al., 2001].   
 
Locus Gene Ref. 
USH1B (11q13.5) MYO7A Weil et al.,1995 
USH1C (11p15.1) USH1C Smith et al., 1992  
USH1D (10q22.1) CDH23 Bork et al., 2001  
USH1F (10q21-22) PCDH15 Ahmed et al., 2001  
USH1G (17q24-25) SANS Mustapha et al., 2002  
USH2A (1q41) USH2A Kimberling et al., 1990  
USH2C (5q14.3-q21.3) VLGR1 Weston et al., 2004  
USH2D (9q32) WHRN Ebermann et al., 2007 
USH3 (3q21-q25) USH3A Joensuu et al., 2001  
10q24.31 PDZD7 Ebermann et al., 2010 
Table 6. Reported genes for Usher syndrome. 
Pendred syndrome: Pendred syndrome, named after Vaughan Pendred (1896) a British 
physician, is the most common syndromic form of HL and associated with abnormal iodine 
metabolism (goiter).  It is an autosomal recessive disorder which accounts for 4-10% of deaf 
cases [Fraser 1965]. The defective organic binding of iodine in the thyroid gland may 
distinguished by a positive potassium perchlorate discharge test; however the test is not 
specific and its sensitivity is unclear.  HL is usually bilateral, severe to profound and may be 
present at birth, and sloping in the higher frequencies [Kopp et al., 2008]. The casual gene is 
SLC26A4 (PDS) on chromosome 7q31 encoding a protein named pendrin (Figure 3). It 
regulates transportation of iodine and chloride/ bicarbonate ions in the inner ear, thyroid, 
and kidney.  Mutations of this gene can cause NSHL DFNB4 and enlarged vestibular 
aqueduct syndrome as well [Everett et al., 1997]. 
 




Fig. 3. Hypothetic structure and domains of Pendrin protein. The most common mutations 
(L236P, IVS8+1G>A, T416P, and H723R) accounting for approximately 60% of the total PS 
genetic load are shown. TM1-TM12 denotes transmembrane domains, EC1-6 denotes 
extracellular domains, IC denotes cytoplasmic domain, NT denotes amino (NH2) terminus 
and CT denotes carboxyl (COOH) terminus. 
Alport syndrome: Alport syndrome, a hereditary disorder of basement membranes, is 
characterized by renal abnormalities including glomerulonephritis, hematuria (“red 
diaper”) and renal failure, and ocular problems as well as progressive sensorineural HL 
[Wester et al., 1995]. Mutations in various genes encoding type 4 collagen (COL4A3, 
COL4A4 and COL4A5) have been reported to cause Alport syndrome [Lemmink et al., 1994; 
Hudson et al., 2003]; nearly 85% of the cases are due to COL4A5 mutations [Hudson et al., 
2003].  These collagens are components of the basilar membranes, the spiral ligament and 
stria vascularis. X-linked pattern of inheritance is observed in the majority (80 %); the 
remaining shows autosomal recessive [Lemmink et al., 1994] and autosomal dominant [van 
der Loop et al., 2000], inheritance patterns. It is estimated that 10% to 15% of X-linked 
patients represent de novo mutations in COL4A5 [Gubler et al., 2007]. Since uremia leads 
to death in males prior to 30 years of age, it is essential to diagnose it early in men. 
Symptoms are usually more severe than women. The progressive sensorineural HL 
usually begins in the adolescent years [Wester et al., 1995]. The mechanism of HL has not 
been explained exactly yet, although the basement membrane damages are suggested to 
affect adhesion of the cells of the organ of Corti and basilar membrane leading to HL 
[Merchant et al., 2004]. 
Waardenburg syndrome: Waardenburg disease, named after Petrus Johannes Waardenburg 
(1886-1979), accounts for 1-3% of congenital HL [Read & Newton, 1997].  In addition, the 
disease shows other clinical features. Four types of syndrome can be distinguished on the 
basis of accompanying abnormalities [Read & Newton, 1997]: In type 1, patients show 
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graying of hair, white forelock, and vestibular dysfunction. Type 2 patients have similar 
phenotype but not dystopia canthorum. In type 3 (so called Klein-Waardenburg syndrome) 
[Klein, 1983], upper extremity abnormalities other Type 1 clinical features and dystopia 
canthorum and are observed.  In type 4 (so called Shah-Waardenburg syndrome) [Shah et 
al., 1981] patients demonstrate all findings shown in Type 2 with the addition of 
pigmentation abnormalities and Hirschsprung’s disease.  Sensorineural hearing loss is 
observed in 60 % and 90 % of type 1 and type 2 patients, respectively [Newton, 1990].  
Types 1 and 3 of Waardenburg syndrome occur due to mutations in the PAX3 gene 
encoding a DNA-binding protein essential for determining the fate of neural crest cells 
[Baldwin et al., 1994]. Type 2 is due to mutations in MITF gene [Tassabehji et al., 1994]. 
Mutations in three genes, EDN3, SOX10 and EDNRB genes, can lead to Type 4 [Edery et al., 
1996; Hofstra et al., 1996; Pingault et al., 1998].  SOX10 mutations, account for approximately 
half of type 4 patients and are likely responsible for about 15% of Type 2 as well [Bondurand 
et al., 2007]. In vitro studies have shown that EDN3 plays as a stimulation factor of 
proliferation and melanogenesis of neural crest cells.  EDNRB is suggested to have an 
important role in the development of epidermal melanocytes and enteric neurons.  SOX10 is 
a DNA-binding transcription factor and involved in promoting cell survival prior to lineage 
commitment [Kapur, 1999].  There is a wide range of variation in HL phenotype so that 
some patients may not exhibit HL.  
Branchio-oto-renal syndrome: Branchio-oto-renal syndrome (BOR) is an autosomal 
dominant disorder, accounting for 2% of profoundly deaf children and is characterized by 
branchial derived anomalies, otologic anomalies (Mondini’s dysplasia and stapes fixation) 
and renal malformation.  HL may affect 70-93% of the BOR patients but there is a high 
variability in age of onset and severity [Chen et al., 1995].  HL can be sensorineural, 
conductive or mixed, stable or progressive and mild or profound.  Mutations in EYA1 gene 
have been identified to cause BOR syndrome (BOR1) [Abdelhak et al., 1997].  It has been 
shown that this gene has a role in development of the inner ear and kidney [Abdelhak et al., 
1997].  Studies of transgenic mice have indicated that EYA1 homozygous knockouts have 
not developed ears and kidneys. In addition to EYA1, mutations in two genes named SIX1 
and SIX5 have been reported to cause BOR3 and BOR2, respectively [Ruf et al., 2004; 
Hoskins et al., 2007].  
Stickler Syndrome: Stickler Syndrome (STL), named after Stickler (1965), follows an 
autosomal dominant pattern of inheritance and is characterized by progressive 
sensorineural HL, cleft palate, abnormal development of the epiphysis, vertebral 
abnormalities and osteoarthritis. On the basis of clinical features, four types of STL exist.  
Type 1 patients have typical features of the disease including progressive myopia leading to 
retinal detachment, midface hypoplasia, cleft palate, variable sensorineural HL and 
vitreoretinal degeneration.  Mutations in COL2A1 gene encoding a fibrillar collage type 2 
subunitA1 can cause the classic phenotype [Ahmad et al., 1991]. There is no retinal 
detachment in Type 2 andthe phenotype is caused by COL11A1 gene mutations [Richards 
et al., 1996]. Facial abnormalities seen in Type 1 are not observed in Type 3. Mutations of 
COL11A2 lead to STL Type 3 [Vikkula et al., 1995]. Recently, mutations in COL9A1 have 
been identified to cause an autosomal recessive form of STL, Type 4 [Van Camp et al., 
2006]. 
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7. Genetic evaluation 
The main problem in the diagnosis of disorders such as deafness is its heterogenicity.  
Genetic study of HL has considerable benefits for patients which are as follows: 
a. Identifying the medical and non medical decisions e.g cochlear implant  
b. Carrier testing and prenatal diagnosis 
c. Prediction for the progressive state of the disease 
d. Eliminating unnecessary tests and investigations 
e. Providing appropriate genetic counseling before marriage, especially when they have 
heterogeneous conditions that carry different mutated genes. 
Genetic evaluation should be considered for children with newly diagnosed loss of hearing 
especially if no specific cause is determined.  For example, there is no need for genetic 
evaluation of the family of a child with HL due to meningitis; although, they may need 
assurance of not transmitting the disease to the next generation.  Genetic evaluation includes 
several steps: 
1. Reviewing the complete history of prenatal, neonatal and medical history of growth and 
development  
2. Complete physical examination of patients and other family members 
3. Evaluating the genetics, molecular and cellular diagnosis 
Based on previous studies, deaf people have positive assortive marriage; it is estimated that 
90% of deaf individuals marry deaf.  Depending on the pattern of inheritance they might 
have a deaf child.  For example if both parental recessive alleles are similar, there is 100% 
chance of having a deaf child; and if one of the parents carry a dominant form of HL and the 
other carry the recessive form of HL the chance would be 50% for the dominant gene. 
Early diagnosis of HL is important in gaining speech progression and social skills of the 
children which would lead to better life of these individuals and would later help them in 
cochlea implant.  Hereditary or genetic understanding of the causes of HL is important.  The 
benefits of this understanding and knowledge, not only allows physicians to help the 
families of at risk but also may help in treatment and control of HL.  Sometimes it is possible 
to prevent hearing loss from worsening.  HL may be one of the clinical signs of a syndrome 
and if the genetic cause of HL is determined it may help to predict and treat other clinical 
complications [Extivill et al., 1998]. 
8. Conclusion 
HL is the most common sensory defect affecting human beings. It is categorized on the basis 
of several criteria. Genetic factors can be traced in half of the cases. Nonsyndromic HL can 
follow any of the Mendelian inheritance patterns, but the majority are ARNSHL. 
Approximately fifty genes have been reported to be involved in HL, and based on an 
estimation nearly 200 to 250 genes may cause HL. Genetic understanding of the causes of 
HL and finding the molecular mechanism of hearing process are valuable for genetic 
counseling, prevention and development of new therapeutic approaches. Many studies have 
been published about finding  new genes causing prelingual nonsyndromic HL. Presbycusis 
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New technology and strategies such as next generation sequencing can help to discover new 
genes for deafness in future. 
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1. Introduction 
Nonsyndromic deafness in humans involves hearing loss as the only presenting feature in 
contrast to syndromes in which hearing loss is accompanied by other abnormalities. The 
majority of nonsyndromic deafness is recessively inherited which involves mutations of 
both alleles of a gene. 
Deafness is a sensory impairment which results in a partial or total loss in reception of 
sound. The intensity of sound can be measured in decibels (dB). It is usual to assess 
hearing thresholds at frequencies of 0.25, 0.5, 1, 2, 4 and 8 KHz. Sounds of each frequency 
are presented at different intensities to a subject and the response is recorded graphically 
as an audiogram. A loss in hearing is indicated if the threshold for perception of sound for 
any frequency is elevated by 10 dB or greater as compared to the defined standard value 
for each frequency. Like visual foveae, organisms also have acoustic foveae, in which a 
certain frequency occupies greater space and is resolved more than other frequencies. In 
humans, the frequencies of 2 to 4 KHz are finely resolved. The frequencies of 0.5-2 KHz 
are the most important for hearing conversations. Therefore, individuals can have usable 
hearing if deafness does not impair these frequencies to a profound degree. A hearing loss 
of >91 dB constitutes profound deafness while those between 41 to 90 dB are defined as 
moderate (41-55 dB), moderate to severe (56-70 dB) or severe hearing loss (71-90 dB), 
respectively. Progressive deafness involves a gradual loss in the ability to hear over  
time. 
The genetics and biology of moderate to severe and progressive hearing loss in humans has 
been understudied. More than 65 loci have been mapped for nonsyndromic recessively 
inherited deafness. Notably, mutations of only some of these genes are associated with 
stable moderate to severe hearing loss (Chishti et al., 2009; Naz et al., 2003; Villamar et al., 
1999; Zwaenepoel et al., 2002). The past few years have revealed mutations in more than 10 
genes and loci which can cause variable degrees of hearing loss or progressive deafness in 
humans. Additionally, the observation of intra- and inter- familial variability in the 
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inherited deafness. Notably, mutations of only some of these genes are associated with 
stable moderate to severe hearing loss (Chishti et al., 2009; Naz et al., 2003; Villamar et al., 
1999; Zwaenepoel et al., 2002). The past few years have revealed mutations in more than 10 
genes and loci which can cause variable degrees of hearing loss or progressive deafness in 
humans. Additionally, the observation of intra- and inter- familial variability in the 





a role for specific additional epistatic interactions which can modify the hearing loss in 
some instances. 
2. Molecular genetics  
Most individuals with inherited hearing loss suffer from profound deafness. It is 
hypothesized that the degree of hearing loss is profound when mutations affect genes which 
cause hair cell loss while it may be less severe or progressive in nature when mutations 
disrupt genes which affect hair cell function or that of the tectorial membrane (Grillet et al., 
2009). In other instances, presence of missense or nonsense mutations in the same gene have 
been associated with variability in degree of hearing loss (Pennings et al., 2004). 
Additionally, some mutations creating new cryptic splice sites within genes have also been 
associated with intra-familial variability of hearing loss (Lopez-Bigas et al., 1999). However, 
in some instances there are no genotype-phenotype correlations. For example individuals 
who are homozygous for the c.35delG mutation in GJB2  have phenotypes ranging from 
congenital and profound to early onset and mild hearing loss (Denoyelle et al., 1997; 
Snoeckx et al., 2005). There are a few other reports of identical mutations in the same gene in 
different subjects causing a significantly dissimilar hearing loss. This is illustrated by 
individuals with mutations in CDH23, CLDN14 or TRIC. Individuals who are homozygous 
for identical mutations in CDH23, CLDN14 or TRIC exhibit different degrees of hearing loss 
(Bashir, Fatima & Naz, 2010b; Riazuddin et al., 2006; Schultz et al., 2005). 
Less severe degree of hearing loss may also result when mutations create hypomorphic 
alleles or affect particular domains of proteins. For example, a hypomorphic allele is 
hypothesized to be responsible for the moderate to profound hearing loss in affected 
individuals at the DFNB73 locus (Riazuddin et al., 2009). It has also been shown that 
mutations that specifically disrupt the long isofrom of MYO15A cause less severe hearing 
loss in contrast to mutations which disrupt function of both isoforms (Bashir et al., in press, 
Cengiz et al., 2010; Nal et al., 2010).  
Intra- or inter- familal phenotypic variability is also observed due to progression of hearing 
loss (DFNB7, DFNB8, DFNB25, DFNB30, DFNB59, DFNB72/95, DFNB77, DFNB79, DFNB84 
and DFNB91) (Charizopoulou et al., 2011; de Heer et al., 2011; Ebermann et al., 2007b; Grillet 
et al., 2009; Li et al., 2010; Rehman et al., 2011; Schraders et al., 2010a; Schraders et al., 2010b; 
Sirmaci et al., 2010; Walsh et al., 2002; Weegerink et al., 2011). Younger individuals with 
mutations in BSND (DFNB73) also have a less severe degree of hearing loss which suggests 
a progressive nature of their hearing loss (Riazuddin et al., 2009). Other loci for which 
hearing loss is reported as less than profound are based on data from single families and the 
causative genes are unknown (DFNB32, DFNB33, DFNB71, DFNB89, DFNB93) (Basit et al., 
2011; Belguith et al., 2009; Chishti et al., 2009; Masmoudi et al., 2003; Medlej-Hashim et al., 
2002; Mustapha et al., 1998; Tabatabaiefar et al., 2011). For some deafness loci the degree of 
hearing loss was reported to be moderate to severe or severe in degree, but audiograms 
were not provided (DFNB13, DFNB22, DFNB32, DFNB33 and DFNB89) (Basit et al., 2011; 
Belguith et al., 2009; Masmoudi et al., 2004; Masmoudi et al., 2003; Zwaenepoel et al., 2002). 
The known instances in which the degree of hearing loss is less than profound or can 
progress to different degrees are summarized in Table 1.  
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LOCUS GENE PHENOTYPE REFERENCE 
DFNB1 GJB2 Mild to profound HL, No genotype-
phenotype correlation 
(Snoeckx et al., 2005) 
DFNB2* MYO7A A missense mutations may cause a 
less severe degree of HL 
(Hildebrand et al., 
2010) 
DFNB3 MYO15A Mutations affecting N-terminal 
extension domain cause less severe 
degree of HL  
(Cengiz et al., 2010; 
Nal et al., 2007) 
DFNB4 SLC26A4 Splice site and some missesnse 
mutations cause less severe degree of 
HL which may be progressive 
(Kitamura et al., 2000; 
Lopez-Bigas et al., 
1999; Luxon et al., 
2003) 
DFNB7 TMC1 Progressive HL in one family (de Heer et al., 2011) 
DFNB8 TMPRSS3 Hypomorphic alleles cause 
progressive HL  
(Hutchin et al., 2005; 
Scott et al., 2001; Veske 
et al., 1996; Weegerink 
et al., 2011) 
DFNB12 CDH23 Compound heterozygous mutations 
may cause progressive HL 
(Astuto et al., 2002) 
DFNB13 Unknown Progressive or Severe HL (No 
audiograms provided) 
(Masmoudi et al., 2004; 
Mustapha et al., 1998) 
DFNB16 STRC Moderate to severe HL (One 
audiogram provided) 
(Villamar et al., 1999) 
DFNB20 Unknown Moderate to profound HL, 
progressive inferred 
(Moynihan et al., 1999) 
DFNB21 TECTA Moderate to severe HL (Flat or U-
shaped audiograms) 
(Meyer et al., 2007; 
Naz et al., 2003) 
DFNB22 OTOA Moderate to severe HL (No 
audiogram provided) 
(Zwaenepoel et al., 
2002) 
DFNB25 GRXCR1 Progressive HL (Schraders et al., 
2010a) 
DFNB29 CLDN14 Moderate to profound HL, No 
genotype-phenotype correlation 
(Bashir et al., 2010b) 
DFNB30 MYO3A Progressive HL (Walsh et al., 2002) 
DFNB32 Unknown Severe HL (No audiograms provided) (Masmoudi et al., 
2003) 
DFNB33 Unknown Severe HL (No audiograms provided) (Belguith et al., 2009; 
Medlej-Hashim et al., 
2002) 
DFNB42 ILDR1 Moderate to profound HL  (Aslam et al., 2005; 
Borck et al., 2011b) 
DFNB49 TRIC Moderately severe to profound HL, 
No genotype-phenotype correlation 
(Riazuddin et al., 2006) 
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LOCUS GENE PHENOTYPE REFERENCE 
DFNB71 Unknown Severe HL (One audiogram provided) (Chishti et al., 2009) 
DFNB72/95 GIPC3 2 families with mild to severe HL, 
Individuals with a C terminal 
mutation have progressive HL 
(Charizopoulou et al., 
2011; Rehman et al., 
2011) 
DFNB73 BSND Younger individuals have less severe 
degree of HL 
(Riazuddin et al., 2009) 
DFNB77 LOXHD1 Progressive HL in one family (Grillet et al., 2009) 
DFNB79 TPRN Progressive HL in one family, 
Moderate to severe HL in another 
(Li et al., 2010)  
DFNB84 PTPRQ Progressive HL or Moderate to severe 
HL 
(Schraders et al., 2010a; 
Shahin et al., 2010a) 
DFNB89 Unknown Moderate to severe HL, no 
audiograms provided 
(Basit et al., 2011) 
DFNB91 SERPINB6 Progressive HL (Sirmaci et al., 2010) 
DFNB93 Unknown Moderate to Severe HL (Tabatabaiefar et al., 
2011) 
Table 1. List of nonsyndromic recessive deafness loci associated with less than profound 
deafness 
The table lists autosomal nonsyndromic recessive deafness loci for which at least two 
individuals are reported to have a less severe hearing loss (<80 dB). HL, Hearing loss. * Only 
one patient has a dramatically less severe degree of hearing loss. 
2.1a Genes involved in moderate to severe hearing loss  
Three genes have been identified in which mutations exclusively cause recessively inherited 
moderate to severe hearing loss in humans. Interestingly, they are either part of the tectorial 
membrane, or are in direct contact with it. The tectorial membrane acts as the cochlear 
amplifier and results in gain in sound intensity by 30 dB. No progression has been 
documented for hearing loss due to mutations in the three genes, STRC, TECTA and OTOA, 
although some variability in degree of auditory thresholds is observed in affected 
individuals with identical mutations in these genes. 
STRC (DFNB16) 
Mutations in STRC encoding stereocilin are reported to cause mild to severe deafness in 
humans with an onset in childhood at 3-5years with increased involvement of high 
frequencies (Verpy et al., 2001; Villamar et al., 1999). Additionally, mice with a targeted 
deletion of Strc become progressively deaf by P60 (Verpy et al., 2008).  The DPOAE cannot 
be recorded at P14 in Strc-/- mice though hearing thresholds are almost normal at that age.  
Strc-/- mice lack horizontal top connectors of outer hair cells’ stereocilia. It is interesting to 
note that stereocilin may establish contact with tectorial membrane as inferred by lack of 
characteristic ring like staining of STRC from tallest row of outer hair cell stereocilia in 
TectaΔENT/ΔENT mice which have disrupted tectorial membranes due to loss of TECTA (Verpy 
et al., 2008).  
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Inactivating mutations of TECTA lead to moderate to severe recessively inherited hearing 
loss in humans which can be more severe in the mid frequencies leading to a flat or U 
shaped audiogram (Meyer et al., 2007; Naz et al., 2003). TECTA is the major protein of the 
tectorial membrane which lies over the organ of Corti within the cochlea. The tectorial 
membrane is in contact with the tallest stereocilia of the outer hair cells and acts as a 
cochlear amplifier which was elegantly shown in mice with a targeted mutation in Tecta 
(Legan et al., 2000). TectaΔENT/ΔENT mice have detached tectorial membranes and the 
noncollagenous matrix is missing. TectaΔENT/ΔENT mutants are 35 dB less sensitive to sound. 
However DPOAE can be elicited at high threshold sounds of 65 dB SPL in TectaΔENT/ΔENT 
mice (Lukashkin et al., 2004) though these are absent in humans with homozygous 
inactivating TECTA mutations (Naz et al. 2003, unpublished data).  
OTOA (DFNB22) 
Two Palestinian families have been reported in which the affected individuals had hearing 
loss due to deleterious mutations in the gene encoding otoancorin, OTOA (Shahin et al., 
2010b; Zwaenepoel et al., 2002). The hearing loss was reported to be moderate to severe in 
one family while it was profound in the other. One of the families had a splice site mutation 
in OTOA (Zwaenepoel et al., 2002) while the second family with members affected with 
profound deafness had a complete deletion of the gene (Shahin et al., 2010b; Zwaenepoel et 
al., 2002). OTOA has sequence  similarity  to STRC (Jovine, Park & Wassarman, 2002) 
although its expression pattern is different. Both OTOA and STRC are predicted to be 
superhelical lectins which can bind the carbohydrate moieties of extracellular glycoproteins 
(Sathyanarayana et al., 2009). In mice, Otoa expression is restricted to specific regions 
between sites of attachment of tectorial membrane and underlying sensory epithelia. 
2.1b Loci involved in moderate to severe or severe hearing loss 
There are five chromosomal regions which have been implicated in genetics of moderate to 
severe hearing loss and the genes are currently unknown. Although DFNB32 and DFNB82 
were mapped to overlapping regions on chromosome 1, the identification of GPSM2 
mutations for the latter (Walsh et al., 2010) excluded this as the causative gene for the former 
since it lies outside the linkage interval of DFNB32 (Masmoudi et al., 2003). 
DFNB32, DFNB33, DFNB71, DFNB89, DFNB93 
Five loci for less severe hearing loss have been mapped to chromosomes 1p13.3-22.1, 
10p11.23-q21.1, 8p22-21.3, 16q21-q23.2 and 11q12.3-13.3 respectively (Belguith et al., 2009; 
Chishti et al., 2009; Masmoudi et al., 2003; Tabatabaiefar et al., 2011). All loci have been 
described in single families except for DFNB89 for which two families were reported. 
Deafness was described to be moderate to severe in degree in all affected individuals in 
these two families but no audiometric data was provided. Similarly, hearing loss is 
described as being severe in degree for families linked to both DFNB32 and DFNB33 
without provision of audiometric data. Patients in families described for DFNB71 and 
DFNB93 have severe and moderate to severe hearing loss respectively as documented by 1 
and 4 audiograms respectively. The identification of genes involved in pathogenesis due to 
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2.2 Genes involved in Intra- or inter- familial variability of hearing loss 
GJB2 (DFNB1) 
In the cochlea, gap junctions are proposed to maintain K+ homeostasis by transporting K+ 
away from the hair cells during auditory transduction (Kikuchi et al., 1995).  GJB2 encodes 
connexin 26 which oligomerizes to form a connexon (a hemichannel) which binds to a 
connexon from adjacent cell to form a functional gap junction in many tissues including the 
inner ear. GJB2 is expressed in the supporting cells and the stria vascularis in the cochlea. 
The important function of GJB2 in normal hearing is shown by the large number of 
mutations which have been reported in this gene from most diverse human populations 
which cause deafness. Although most individuals who are homozygous for c.35delG 
mutation in GJB2 have severe to profound deafness, many individuals with the identical 
mutation have a mild or a less severe hearing loss (Murgia et al., 1999). Additionally, 
patients who are compound heterozygous for one truncating mutation together with a 
missense mutation in GJB2 usually have a less severe hearing impairment (Liu et al., 2005; 
Snoeckx et al., 2005). 
MYO7A (DFNB2) 
MYO7A encodes a protein classified as an unconventional myosin which plays a role in 
intracellular trafficking. Unconventional myosins are actin-activated motor proteins with 
structurally conserved heads important for movement along actin filaments. The tails are 
highly divergent and are presumed to interact with different macromolecular components 
in the cell. All mutations in MYO7A except one cause severe to profound deafness. 
However, an individual with a missense mutation affecting the motor domain of MYO7A had 
a dramatically reduced hearing loss as compared to all other cases with MYO7A mutations, 
including those in his own family (Hildebrand et al., 2010). The onset of deafness was delayed 
to seven years of age and the degree of hearing loss was moderate to severe at the age of 31.  
MYO7A is present in cytoplasm of hair cells and in the stereocilia including the upper  tip-
link density (Grati & Kachar, 2011). Different mutations of Myo7a result in profound 
deafness in mice (Gibson et al., 1995).  However, one missense mutation affecting the kinesin 
and MyTH4 domains of myosin 7a leads to a severe deafness phenotype in contrast to other 
mice with mutations in Myo7a (Mburu et al., 1997).  
MYO15A (DFNB3) 
Mutations in MYO15A are a significant cause of deafness in many world populations. All 
pathogenic mutations in MYO15A except three which are located in exon 2 cause profound 
deafness. The four mutations were identified  in three Pakistani and one Turkish families 
and are associated with hearing loss which can range from moderate to severe or moderate 
to profound in degree (Bashir et al., in press, Cengiz et al., 2010; Nal et al., 2010). The 
mutations in alternatively spliced exon 2 affect the class 1 isoform of MYO15A which has a 
long N-terminal extension. The presence of residual hearing in affected individuals who 
have mutations in exon 2 of MYO15A is probably due to the availability of normally 
functioning short isoform of MYO15A which remains unaffected by the mutations in exon 2 
(Nal et al., 2007). 
MYO15A is a motor protein present in hair cells in a cap like structure at top of the 
stereocilia where it is known to interact with WHRN (Belyantseva et al., 2005). It is 
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interesting to note that mutations affecting the long isoform of WHRN (Ebermann et al., 
2007a)  also cause a less severe hearing loss in contrast to mutations which disrupt the short 
isoform (Mburu et al., 2003).  
Currently, no corresponding mouse carrying a mutation affecting the long N terminal 
extension domain has been reported. However, in shaker 2 mice, a missense mutation affects 
the motor domain of MYO15A and the mice are profoundly deaf (Probst et al., 1998) .  The 
stereocilia are extremely short and this defect can be fully rescued by transfecting shaker 2 
hair cells with MYO15A isoform 2 (Belyantseva et al., 2005). No specific role is known for 
MYO15A isoform 1 and its function remains to be elucidated. 
SLC26A4 (DFNB4/PDS) 
SLC26A4 mutations may cause Pendred syndrome or non-syndromic deafness with 
enlarged vestibular aqueducts. Considerable residual hearing is present in some affected 
individuals who are homozygous for mutations creating new splice sites in SLC26A4 
(Lopez-Bigas et al., 1999; Naz, 2001). These two described mutations create splice sites a few 
nucleotides away from the canonical donor sites, and support the hypothesis that variable 
degree of hearing loss in SLC26A4 linked families may indicate splice site mutations.  
Additionally, a few missense mutations of SLC26A4 also cause a significantly less severe 
hearing loss (Kitamura et al., 2000). Some mutations of SLC26A4  result in development of a 
progressive hearing loss (Luxon et al., 2003). 
SlC26A4 or pendrin is expressed in endolymphatic duct and sac as well as in the external 
sulcus in the cochlea (Everett et al., 1999). SLC26A4 plays a significant role in the 
maintenance of the ionic balance within the inner ear and is involved in bicarbonate 
secretion (Wangemann et al., 2007). There are three different mouse mutants of Slc26a4 
which lack pendrin but none of them model the less severe hearing loss observed in humans 
(Dror et al., 2010; Everett et al., 2001; Lu et al., 2011). However, recently, transgenic mice 
with Slc26a4 expression inducible by doxycycline on a background of mice lacking 
endogenous pendrin expression were generated. It was demonstrated that expression of 
pendrin at early embryonic stages of E0-E17.5 was necessary and sufficient to restore normal 
hearing in Tg[E];Tg[R];Slc26a4Δ/Δ mice (Choi et al., 2011). Ablating expression of Slc26A4 at 
this critical time results in complete or partial hearing loss in these mice, recapitatulating the 
phenotypes documented for many patients with mutations in SLC26A4 (Choi et al., 2011). 
CLDN14 (DFNB29) 
CLDN14 is an integral part of the tight junctions in the sensory epithelium within the inner 
ear. Only two mutations have been reported in this gene in four Pakistani families which 
cause hearing loss. The usual phenotype associated with the two mutations is severe to 
profound deafness (Wilcox et al., 2001). However members of one family with p.V85D 
mutation in CLDN14 have hearing loss which varies from moderately severe to severe in 
degree (Bashir et al., 2010b). It is interesting to note that mice with a targeted deletion of 
Cldn14 are profoundly deaf and no variability of hearing loss was observed in these mice 
(Ben-Yosef et al., 2003). 
ILDR1 (DFNB42) 
ILDR1 is a membrane protein with an Immunoglobulin-like extracellular domain, and has 





2.2 Genes involved in Intra- or inter- familial variability of hearing loss 
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mice with mutations in Myo7a (Mburu et al., 1997).  
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interesting to note that mutations affecting the long isoform of WHRN (Ebermann et al., 
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the motor domain of MYO15A and the mice are profoundly deaf (Probst et al., 1998) .  The 
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(Dror et al., 2010; Everett et al., 2001; Lu et al., 2011). However, recently, transgenic mice 
with Slc26a4 expression inducible by doxycycline on a background of mice lacking 
endogenous pendrin expression were generated. It was demonstrated that expression of 
pendrin at early embryonic stages of E0-E17.5 was necessary and sufficient to restore normal 
hearing in Tg[E];Tg[R];Slc26a4Δ/Δ mice (Choi et al., 2011). Ablating expression of Slc26A4 at 
this critical time results in complete or partial hearing loss in these mice, recapitatulating the 
phenotypes documented for many patients with mutations in SLC26A4 (Choi et al., 2011). 
CLDN14 (DFNB29) 
CLDN14 is an integral part of the tight junctions in the sensory epithelium within the inner 
ear. Only two mutations have been reported in this gene in four Pakistani families which 
cause hearing loss. The usual phenotype associated with the two mutations is severe to 
profound deafness (Wilcox et al., 2001). However members of one family with p.V85D 
mutation in CLDN14 have hearing loss which varies from moderately severe to severe in 
degree (Bashir et al., 2010b). It is interesting to note that mice with a targeted deletion of 
Cldn14 are profoundly deaf and no variability of hearing loss was observed in these mice 
(Ben-Yosef et al., 2003). 
ILDR1 (DFNB42) 
ILDR1 is a membrane protein with an Immunoglobulin-like extracellular domain, and has 





also exist which may be involved in lipoprotein transport (Borck et al., 2011b). Hearing loss 
due to mutations of this gene varies from moderate to profound in different individuals 
while it is severe in degree for one family with a mutation affecting the start codon of ILDR1 
(Borck et al., 2011b). Ildr1 is expressed in the developing mouse cochlea but the expression is 
low at birth. It increases gradually by P4 and P10. The pillar and Hensen cells have the 
highest expression of Ildr1 while it can also be detected in other cells in organ of Corti 
including the hair cells (Borck et al., 2011b). 
TRIC (DFNB49) 
TRIC or MARVELD2 encodes a tight junction protein with a ubiquitous expression in the 
epithelial junctions throughout the body tissues. In the inner ear, TRIC is specifically 
expressed in the tricellular junctions of sensory epithelia as well as those between 
supporting cells and the hair cells (Riazuddin et al., 2006). Affected individuals with 
identical mutations in TRIC show a wide range of variability in severity of deafness ranging 
from moderate to severe hearing loss to profound deafness (Chishti et al., 2008; Riazuddin et 
al., 2006). All mutations described in TRIC are predicted to produce truncated proteins and 
consequent inability to bind several scaffolding proteins.  
2.3 Genes involved in Progressive Hearing Loss 
There are a few genes mutations in which have been described to cause progressive loss in 
hearing (MYO3A, LOXHD1, PTPRQ and SERPINB6). Additionally, some mutations in genes 
which cause stable and profound deafness, for example TMC1 and TMPRSS3 also cause 
progressive hearing loss. Many different mutations have been described in TMC1, 
TMPRSS3, GRXRC1, PJVK, GIPC3, TPRN and PTPRQ in affected individuals from different 
countries. However, it is noteworthy that apart from DFNB8 (TMPRSS3), DFNB59 (PJVK)) 
and DFNB84 (PTPRQ) only one family is reported to have progression of deafness for each 
locus. All other mutations in these genes have been described to cause stable, moderate to 
profound deafness. This could be due to either of two reasons; the hearing loss associated 
with other mutations in these genes may also be progressive (slow or rapid progression) and 
has not been documented since many patients undergo audiometry at the time of 
enrollment in a genetic study. Alternatively, some mutations affecting a gene may cause a 
progressive hearing loss due to the type of mutation as for example those in TMPRSS3. 
Identical mutations may also cause stable or progressive hearing loss depending on the 
genetic background of the individuals. 
TMC1 (DFNB7) 
Homozygous inactivating mutations in TMC1 cause severe to profound prelingual hearing 
impairment at the DFNB7 locus. However, a Dutch family with autosomal recessive hearing 
loss was reported in which affected individuals had a postlingual onset, progressive hearing 
loss due to a mutation near the donor splice site of intron 19 (c.1763+3A→G) in TMC1 (de 
Heer et al., 2011). The hearing loss initially affected the high frequencies and by second 
decade of life the hearing loss progressed to profound degree. This was documented as a 
“corner audiogram”. Both normally spliced and aberrantly spliced TMC1 transcripts were 
detected in blood of the patients. The presence of some wild type protein may account for 
the late onset of deafness and residual hearing in the patients, or alternately, the truncated 
mutant protein may have residual function (de Heer et al., 2011).  
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TMC1 is a transmembrane protein present in hair cells and may be involved in intracellular 
protein trafficking. Additionally it is also proposed to play a role in differentiation of hair 
cells into functional auditory receptors. The deafness mice mutants carry a homozygous 
genomic deletion in Tmc1 and are profoundly deaf (Kurima et al., 2002). Currently there is 
no mouse model which mimics the recessively inherited progressive hearing loss due to 
mutations in Tmc1 though a model, Beethoven exists for dominant deafness DFNA36 and the 
mice have a missense mutation in Tmc1 (Vreugde et al., 2002). 
TMPRSS3 (DFNB8) 
The gene encoding serine protease, TMRSS3 is expressed in supporting cells, stria vasularis 
as well as in the spiral ganglion in the inner ear. Mutations in TMPRSS3 are responsible for 
deafness at the DFNB8 locus.  Most mutations in TMPRSS3 result in severe to profound 
deafness in many world populations. However there are many mutations in TMPRSS3 
causing less severe hearing loss which is progressive in nature. The first family with 
progression in hearing loss due to a TMPRSS3 mutation was reported from Pakistan. 
Affected members in this family suffered from progressive deafness with onset of hearing 
loss in childhood and had a mutation at a splice acceptor site in intron 4 (Scott et al., 2001; 
Veske et al., 1996). This is predicted to create an alternative splice acceptor site which on use 
introduces a frameshift in the open reading frame of TMPRSS3. It is hypothesized that this 
mutation may allow limited normal splicing since the actual splice site remains unchanged. 
Thus some normal TMPRSS3 could be produced accounting for progressive hearing loss 
observed in the affected individuals.  
There are other reports of mutations in TMPRSS3 causing post-lingual progressive deafness 
in British, Turkish, German and Dutch families (Elbracht et al., 2007; Hutchin et al., 2005; 
Wattenhofer et al., 2005; Weegerink et al., 2011). One of the first studies reported a British 
family with two affected individuals who were homozygous for a missense mutation in 
TMPRSS3 and suffered from moderate to severe hearing loss (Hutchin et al., 2005).  A recent  
study involved 8 small nuclear families from Holland and affected individuals were 
compound heterozygous for different mutations of TMPRSS3 including missense and 
frameshift mutations (Weegerink et al., 2011). The higher frequencies were affected first 
resulting in a distinctive “ski-slope” audiometric configuration followed by low frequency 
hearing loss resulting in a flat audiogram (Weegerink et al., 2011).   It was hypothesized that 
some mutations in TMPRSS3 result in creation of hypomorphic alleles accounting for  the 
less severe loss in hearing and progression of deafness observed in affected individuals 
(Weegerink et al., 2011). 
Tmprss3 was shown to be important for hearing in mice as well since mutants homozygous 
for a nonsense mutation in the gene suffer from deafness. The hair cells start to degenerate 
at P12 from basal to apical turn of the cochlea and the degeneration is complete by P14 
(Fasquelle et al., 2011). However, no mouse model has been reported which mimics the 
progressive hearing loss as observed in humans. 
CDH23 (DFNB12) 
Most mutations of CDH23 cause severe phenotypes of deafness or USH1D. However, a few 
missense mutations in CDH23 when present together in compound heterozygosity are 





also exist which may be involved in lipoprotein transport (Borck et al., 2011b). Hearing loss 
due to mutations of this gene varies from moderate to profound in different individuals 
while it is severe in degree for one family with a mutation affecting the start codon of ILDR1 
(Borck et al., 2011b). Ildr1 is expressed in the developing mouse cochlea but the expression is 
low at birth. It increases gradually by P4 and P10. The pillar and Hensen cells have the 
highest expression of Ildr1 while it can also be detected in other cells in organ of Corti 
including the hair cells (Borck et al., 2011b). 
TRIC (DFNB49) 
TRIC or MARVELD2 encodes a tight junction protein with a ubiquitous expression in the 
epithelial junctions throughout the body tissues. In the inner ear, TRIC is specifically 
expressed in the tricellular junctions of sensory epithelia as well as those between 
supporting cells and the hair cells (Riazuddin et al., 2006). Affected individuals with 
identical mutations in TRIC show a wide range of variability in severity of deafness ranging 
from moderate to severe hearing loss to profound deafness (Chishti et al., 2008; Riazuddin et 
al., 2006). All mutations described in TRIC are predicted to produce truncated proteins and 
consequent inability to bind several scaffolding proteins.  
2.3 Genes involved in Progressive Hearing Loss 
There are a few genes mutations in which have been described to cause progressive loss in 
hearing (MYO3A, LOXHD1, PTPRQ and SERPINB6). Additionally, some mutations in genes 
which cause stable and profound deafness, for example TMC1 and TMPRSS3 also cause 
progressive hearing loss. Many different mutations have been described in TMC1, 
TMPRSS3, GRXRC1, PJVK, GIPC3, TPRN and PTPRQ in affected individuals from different 
countries. However, it is noteworthy that apart from DFNB8 (TMPRSS3), DFNB59 (PJVK)) 
and DFNB84 (PTPRQ) only one family is reported to have progression of deafness for each 
locus. All other mutations in these genes have been described to cause stable, moderate to 
profound deafness. This could be due to either of two reasons; the hearing loss associated 
with other mutations in these genes may also be progressive (slow or rapid progression) and 
has not been documented since many patients undergo audiometry at the time of 
enrollment in a genetic study. Alternatively, some mutations affecting a gene may cause a 
progressive hearing loss due to the type of mutation as for example those in TMPRSS3. 
Identical mutations may also cause stable or progressive hearing loss depending on the 
genetic background of the individuals. 
TMC1 (DFNB7) 
Homozygous inactivating mutations in TMC1 cause severe to profound prelingual hearing 
impairment at the DFNB7 locus. However, a Dutch family with autosomal recessive hearing 
loss was reported in which affected individuals had a postlingual onset, progressive hearing 
loss due to a mutation near the donor splice site of intron 19 (c.1763+3A→G) in TMC1 (de 
Heer et al., 2011). The hearing loss initially affected the high frequencies and by second 
decade of life the hearing loss progressed to profound degree. This was documented as a 
“corner audiogram”. Both normally spliced and aberrantly spliced TMC1 transcripts were 
detected in blood of the patients. The presence of some wild type protein may account for 
the late onset of deafness and residual hearing in the patients, or alternately, the truncated 
mutant protein may have residual function (de Heer et al., 2011).  
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TMC1 is a transmembrane protein present in hair cells and may be involved in intracellular 
protein trafficking. Additionally it is also proposed to play a role in differentiation of hair 
cells into functional auditory receptors. The deafness mice mutants carry a homozygous 
genomic deletion in Tmc1 and are profoundly deaf (Kurima et al., 2002). Currently there is 
no mouse model which mimics the recessively inherited progressive hearing loss due to 
mutations in Tmc1 though a model, Beethoven exists for dominant deafness DFNA36 and the 
mice have a missense mutation in Tmc1 (Vreugde et al., 2002). 
TMPRSS3 (DFNB8) 
The gene encoding serine protease, TMRSS3 is expressed in supporting cells, stria vasularis 
as well as in the spiral ganglion in the inner ear. Mutations in TMPRSS3 are responsible for 
deafness at the DFNB8 locus.  Most mutations in TMPRSS3 result in severe to profound 
deafness in many world populations. However there are many mutations in TMPRSS3 
causing less severe hearing loss which is progressive in nature. The first family with 
progression in hearing loss due to a TMPRSS3 mutation was reported from Pakistan. 
Affected members in this family suffered from progressive deafness with onset of hearing 
loss in childhood and had a mutation at a splice acceptor site in intron 4 (Scott et al., 2001; 
Veske et al., 1996). This is predicted to create an alternative splice acceptor site which on use 
introduces a frameshift in the open reading frame of TMPRSS3. It is hypothesized that this 
mutation may allow limited normal splicing since the actual splice site remains unchanged. 
Thus some normal TMPRSS3 could be produced accounting for progressive hearing loss 
observed in the affected individuals.  
There are other reports of mutations in TMPRSS3 causing post-lingual progressive deafness 
in British, Turkish, German and Dutch families (Elbracht et al., 2007; Hutchin et al., 2005; 
Wattenhofer et al., 2005; Weegerink et al., 2011). One of the first studies reported a British 
family with two affected individuals who were homozygous for a missense mutation in 
TMPRSS3 and suffered from moderate to severe hearing loss (Hutchin et al., 2005).  A recent  
study involved 8 small nuclear families from Holland and affected individuals were 
compound heterozygous for different mutations of TMPRSS3 including missense and 
frameshift mutations (Weegerink et al., 2011). The higher frequencies were affected first 
resulting in a distinctive “ski-slope” audiometric configuration followed by low frequency 
hearing loss resulting in a flat audiogram (Weegerink et al., 2011).   It was hypothesized that 
some mutations in TMPRSS3 result in creation of hypomorphic alleles accounting for  the 
less severe loss in hearing and progression of deafness observed in affected individuals 
(Weegerink et al., 2011). 
Tmprss3 was shown to be important for hearing in mice as well since mutants homozygous 
for a nonsense mutation in the gene suffer from deafness. The hair cells start to degenerate 
at P12 from basal to apical turn of the cochlea and the degeneration is complete by P14 
(Fasquelle et al., 2011). However, no mouse model has been reported which mimics the 
progressive hearing loss as observed in humans. 
CDH23 (DFNB12) 
Most mutations of CDH23 cause severe phenotypes of deafness or USH1D. However, a few 
missense mutations in CDH23 when present together in compound heterozygosity are 





progressive in nature (Astuto et al., 2002). In two German siblings with deafness, the age of 
onset was also different, with onset of hearing loss at 4 and 6 years respectively. The degree 
of hearing loss was variable and there was asymmetric hearing loss in the older sibling.  
In the inner ear, CDH23 is expressed in the hair cells and Reissner’s membrane. Mice lacking 
CDH23 are profoundly deaf and suffer from developmental defects of the stereocilia (Di 
Palma et al., 2001). In contrast, ENU induced salsa mutants have a recessively inherited 
missense mutation in Cdh23 which affects the tip links of the stereocilia (Schwander et al., 
2009). These mice have a progressive hearing loss which increases from severe in degree to 
profound deafness by three months of age as a consequence of gradual loss of tip links and 
eventual hair cell death (Schwander et al., 2009).   
GRXCR1 (DFNB25) 
Splice site mutations were identified in GRXCR1 in two Dutch families while three missense 
and a nonsense mutation were identified in GRXRC1 in families from Pakistan and Iran 
which segregated with hearing loss (Odeh et al., 2010; Schraders et al., 2010a). Two 
mutations create alternative splice sites within GRXCR1 which on usage are predicted to 
create frameshifts in the open reading frame of the gene. The presence of alternatively 
spliced transcripts was demonstrated for one of the splice site mutations by an in vivo assay 
on lymphoblastoid cell lines derived from patients’ blood.  
The single affected individual in one of the Dutch families with a splice site mutation had a 
significantly milder phenotype of moderate to severe hearing loss which was not 
progressive in nature. Additionally, the hearing loss in affected members of another Dutch 
family and Pakistani families varied from moderate to profound in degree. The loss in 
hearing was progressive from moderate to profound in the Dutch family, while it was 
severe in the two families from Pakistan (Schraders et al., 2010a). The audiometric profile 
varied from flat to a slight U-shape and was down-sloping (Schraders et al., 2010a). Data 
was not provided about the audiometric profile of affected individuals in families from Iran, 
although hearing loss was reported to be severe to profound in degree (Odeh et al., 2010). 
GRXCR1 is predicted to contain a GRX-like domain. These domains take part in reversible S-
glutathionylation of proteins by which they are predicted to control activity or localization 
of the proteins. In the inner ear, Grxcr1 is expressed in the hair cells and is localized along 
the lengths of stereocilia exhibiting a differential pattern in levels of expression in young 
and adult mice (Odeh et al., 2010). There are five mutant alleles of Grxcr1 which cause 
profound deafness in the pirouette mice (Odeh et al., 2010). The absence of GRXCR1 results 
in formation of relatively short and thin stereocilia and cytocauds indicating actin 
abnormalities. This suggests that GRXCR1 plays an active role in development of actin 
architecture in the stereocilia (Beyer et al., 2000; Odeh et al., 2010). 
MYO3A (DFNB30) 
A class III myosin,  MYO3A is required for normal hearing as shown by a single family 
originating from Iraq in which affected individuals had a progressive hearing loss with 
onset in second decade of life (Walsh et al., 2002). Interestingly, three different mutations 
were identified in this family which were either present in homozygosity or individuals 
were compound heterozygous for any of the mutations. The hearing loss first affected high 
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frequencies. By the age of 50 there was moderate hearing loss at low frequencies while the 
high and middle frequencies were severely affected. All individuals were equally affected 
by the sixth decade of life. The three mutations identified in MYO3A included a nonsense 
and two splice site mutations. Hearing loss was significantly worse in affected individuals 
homozygous for the nonsense mutation than those who were compound heterozygous for a 
nonsense and a splice site mutation.  
MYO3A is present in the hair cells stereocilia at the tips in a characteristic pattern described 
as “thimble-like” (Schneider et al., 2006)  with presence at the stereocilia tip and also 
extending further down into the shaft of the stereocilia. Mice created as models for DFNB30 
mimic the hearing loss phenotype observed in humans.  Myo3aKI/KI mice have an engineered 
nonsense mutation in the gene and they exhibit a hearing loss which progresses from mild 
to moderate, and to moderate to severe between ages of 2.5 months to 13 months. More 
severe loss in hearing is observed for sounds of high frequencies. In Myo3aKI/KI mice, 
development of hair cells stereocilia is normal which is followed by a gradual loss of hair 
cells from basal to apical turn of the cochlea (Walsh et al., 2011). It is hypothesized that loss 
of MYO3A may result in failure of transport of essential components within stereocilia 
(Walsh et al., 2011). This affects signal transduction in the inner ear, leading to loss of 
function and ultimate degeneration of hair cells. 
PJVK (DFNB59) 
Mutations in PJVK cause hearing loss with or without auditory neuropathy. The hearing 
loss is severe to profound and stable in all individuals reported so far except in members of 
one Moroccan, one Iranian and three Arab families (Borck et al., 2011a; Ebermann et al., 
2007b; Schwander et al., 2007). Three affected individuals in the Moroccan family had 
deafness with onset by age of 4 in one individual and congenital hearing loss was observed 
in the other two individuals. The loss in hearing is severe in degree in the former and 
profound in the latter two individuals. Audiometry performed over a period of three years 
revealed a progressive nature of hearing loss for all three affected individuals.  Unlike other 
families with PJVK mutations which have missense mutations in the gene, this family had a 
frameshift mutation in exon 2 of the 7 exon gene and the mutation is predicted to severely 
truncate the protein. Hearing loss is also reported to be progressive in nature and moderate 
to profound in degree in a family from Iran with a frameshift mutation of PJVK but 
audiometric profiles were not provided (Schwander et al., 2007). Additionally, deafness due 
to a nonsense mutation in three Arab families is reported to cause stable moderate to severe 
hearing loss but no audiograms were provided (Borck et al., 2011a). 
PJVK exhibits 32% identity and 54% similarity over a stretch of 250 amino acids to DFNA5 
protein. It is expressed in the hair cells and spiral ganglion. Mice with a targeted knock-in 
missense mutation in Pjvk, Dfnb59tm1Ugds/tm1Ugd have a moderate to severe non-progressive 
hearing loss which is elevated at high frequencies (Delmaghani et al., 2006) unlike sirtaki 
mice which have a nonsense mutation in Pjvk  (Schwander et al., 2007). The sirtaki mice have 
outer hair cell functional defects as apparent by absent DPOAE and also suffer from 
progressive deafness. No morphological defects are apparent in the ears of the sirtaki or 
knock-in mutant mice. It is hypothesized that that functional null allele of Pjvk inactivates 
protein function in both hair cells and neurons, while the missense mutation affect its 





progressive in nature (Astuto et al., 2002). In two German siblings with deafness, the age of 
onset was also different, with onset of hearing loss at 4 and 6 years respectively. The degree 
of hearing loss was variable and there was asymmetric hearing loss in the older sibling.  
In the inner ear, CDH23 is expressed in the hair cells and Reissner’s membrane. Mice lacking 
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GRXCR1 (DFNB25) 
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frequencies. By the age of 50 there was moderate hearing loss at low frequencies while the 
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GIPC3 (DFNB72/15/95)  
GIPC3 encodes a PDZ domain containing protein which is important in peripheral auditory 
signal transmission. Mutations in this gene cause both profound deafness and progressive 
hearing loss. In a small Dutch hearing loss followed a different course in the two affected 
siblings. In the oldest affected individual, the loss in hearing was 70 dB HL at 11 months 
which progressed to 110 dB HL by 12 years of age. The hearing loss in second individual 
was 80 dB HL at 3 months which seemed to be stable as it only progressed to 90 dB HL by 
age of 14 years. (Charizopoulou et al., 2011). The mutation in GIPC3 identified in the Dutch 
family introduces a stop codon in exon 6 (p.W301X) truncating the C-terminal. It is 
hypothesized that since this mutation is in the last exon it will not cause nonsense mediated 
decay and will allow production of a mutant protein retaining some function.  
GIPC3 mutations have also been reported in seven other large families from Pakistan which 
include one framsehift and and six missense mutations (Rehman et al., 2011). The younger 
affected individuals in these families (7 and 9 years old) had better hearing as compared to 
the older affected individuals (20 and 25 years old). However, information is not available as 
yet whether hearing loss in any of the affected individuals is stable or progressive. 
A mutation affecting PDZ domain of GIPC3 has also been reported in mice which causes 
progressive hearing loss, ahl5 (Charizopoulou et al., 2011). The mice have a moderate 
hearing loss at one month of age which progresses to profound in degree by 1 year of age. 
The higher frequencies are affected first with eventual involvement of all frequencies. 
DPOAE and the endocochlear potential are gradually affected as well. The stereocilia are 
defective and degenerate together with the spiral ganglion cells. 
BSND (DFNB73) 
BSND encodes barttin which is an essential subunit for two chloride channels. Heteromeric 
channels formed by barttin and the chloride channels play an important role in potassium 
recycling in the inner ear (Estevez et al., 2001). A missense mutation, p.I12Tof BSND 
segregates with hearing loss in three families from Pakistan while in a fourth family it is 
present with a nonsense mutation in compound heterozygosity (Riazuddin et al., 2009). The 
younger individuals have a less severe hearing loss as compared to the older affected 
individuals suggesting that BSND may be involved in aetiology of progressive deafness. 
Functional analysis of the p.I12T mutation of BSND in HEK293T cells have demonstrated 
that function of the channels is unaffected. However, the number of channels on the surface 
membrane is reduced which results in a decreased current amplitude (Riazuddin et al., 2009). 
LOXHD1 (DFNB77) 
The 15 PLAT (polycystin/lipoxygenase/a-toxin) domains encoding gene LOXHD1 was 
found to be mutated in an Iranian family with postlingual onset of hearing loss at ages 
ranging from 7 to 8 years. Affected individuals in the family had preserved hearing at low 
frequencies in the beginning. The loss was mild to moderate at frequencies of 0.5 to 2 KHz. 
Hearing loss worsened during childhood and adolescence to moderate to severe at mid and 
high frequencies. All frequencies were affected eventually (Grillet et al., 2009). A nonsense 
mutation, p.R670X was identified which introduces a premature stop codon at the C-
terminal end of f the fifth PLAT domain. This could either lead to a protein lacking 10 PLAT 
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domains or nonsense mediated decay of the transcript could lead to absence of LOXHD1. In 
contrast, the only other mutation reported in LOXHD1 is a founder mutation, p.R1572X, in the 
Ashkenazi Jews and causes prelingual profound degree of deafness (Edvardson et al., 2011). 
Normally LOXHD1 is present along the lengths of hair cell stereocilia plasma membrane 
while it cannot be detected at the tips of the stereocilia (Grillet et al., 2009). Interestingly, the 
hair cells bodies have no expression of LOXHD1. ENU induced samba mutants homozygous 
for a missense mutation in Loxhd1 acquire hearing loss by 3 weeks of age and are completely 
deaf by eight weeks. The stereocilia develop normally. However, the hair cells have 
functional defects and DPOAE cannot be elicited from ears of samba mutants. Morphological 
defects are also observed in the inner ears of samba mutants with fused stereocilia and 
ruffled membranes at the apical cell surfaces. Additional degenerative changes are visible by 
post natal day 90 which include hair cell loss (Grillet et al., 2009). 
TPRN (DFNB79) 
Mutations of TPRN cause different degrees of hearing loss in humans. In a Dutch family, 
hearing loss is documented as moderate to severe in degree till 11 years of age and by 15 
years it progresses to profound deafness (Li et al., 2010). In contrast, hearing loss in a 
Moroccan family is severe in degree even in the third decade of life (Li et al., 2010). Affected 
members of the Dutch family had a nonsense mutation in exon 1 of TPRN while the affected 
individuals in the Moroccan family were homozygous for a frameshift mutation in exon 1. It 
is interesting to note that the same frameshift mutation as observed in the Moroccan family 
was also identified in a Pakistani family. However, individuals in this family had profound 
degree of deafness (Khan et al., 2009; Rehman et al., 2010). 
TPRN is present in the supporting cells as well as at the base of hair cells’ stereocilia in the 
organ of Corti at the taper region of each stereocilium just above the cuticular plate (Rehman 
et al., 2010).  
PTPRQ (DFNB84)  
Congenital hearing loss which has been shown to be progressive in nature is associated with 
mutations in PTPRQ, a gene which encodes a phosphatase specific for phoshatidyl inositol, 
PI(4,5)P2 (Schraders et al., 2010b; Seifert et al., 2003). PI(4,5)P2 plays an important part in actin 
remodeling. Hearing loss due to mutations PTPRQ is severest in a Dutch family with a 
p.Y497X mutation and hearing loss was self reported to have progressed to profound by the 
third to fourth decade of life. However in affected individuals of a Moroccan family, a 
p.R457G mutation in PTPRQ caused a less severe loss in hearing. The loss  in hearing was 
moderate which had deteriorated with age (Schraders et al., 2010b). Otoacoustic emissions 
were normal at the age of 13 months. The 1 to 2 KHz frequencies seemed to be more affected 
comparable to that observed in members of a Palestinian family with moderate to severe 
hearing loss also with a mutation of PTPRQ (Shahin et al., 2010a). In the Palestinian family, 
there were four affected individuals with considerable variation of hearing loss. A nonsense 
mutation, p.Q429X, was observed in PTPRQ for this family (Shahin et al., 2010a). Data is not 
available about progression of deafness in the Palestinian family.  
Ptprq is transiently expressed over a period of first three weeks in mouse hair cells at the 
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in plasma membranes (Sakaguchi et al., 2008). PTPRQ has been shown to be required for 
formation of shaft connectors and the taper of the stereocilia (Goodyear et al., 2003; 
Sakaguchi et al., 2008). Two transgenic mouse mutants, Ptprq-TM-KO and  Ptprq-CAT-KO 
were generated in which the alleles encode proteins lacking transmembrane and catalytic 
domains of PTPRQ respectively (Goodyear et al., 2003). Cochlear development was normal 
in both mice and there was progressive deterioration of the sensory epithelium. Inner hair 
cells abnormalities were apparent by P1. Some stereocilia were misaligned or missing in the 
basal turn of cochlea. Stereocilia eventually fused and ultimately the organ of Corti 
disappeared in some mice by the age of three months (Goodyear et al., 2003).  
SERPINB6 (DFNB91) 
A single Turkish family has been described in which affected individuals have a mutation in 
SERPINB6 segregating with hearing loss. The nonsense mutation, p.E245X was shown to 
substantially decrease the amount of the mutant transcript in blood of affected individuals 
(Sirmaci et al., 2010). The degree of hearing loss is moderate to severe with some residual 
hearing in all affected individuals. The 54 year old individual was the oldest and had the 
severest degree of hearing loss with greater degree of loss at high frequencies. The two 
younger individuals 24 and 23 years respectively, presented with moderate to severe 
hearing loss which was more severe in the 23 year old patient. Progressive nature of 
hearing loss was self reported by affected individuals but had not been documented by 
audiometry.  
SERPINB6 is present in the hair cells in the organ of Corti as well as the greater epithelial 
ridge and may function as an inhibitor of proteases. It is hypothesized that SERPINB6 
prevents non-specific tissue damage to inner ear tissue by inhibiting proteases. A transgenic 
mouse line lacking Serpinb6 was created (Scarff et al., 2004) but the hearing status of the mice 
and inner ear structure was not evaluated. It will be interesting to identify if Serpinb6-/- mice 
have deafness at onset of hearing or whether they exhibit progressive deafness. 
So far the results of genetic studies have revealed that although moderate to severe hearing 
loss is the usual finding for individuals with mutations in STRC, TECTA and OTO and in 
some individuals with mutations which cause progressive deafness, some individuals with 
mutations in other genes, for example GJB2, CLDN14 or TRIC also have similarly milder 
phenotypes. Additionally, identical mutations in a gene may cause either progressive or 
stable hearing loss (Bashir et al. manuscript in preparation). Research has also shown that 
genes involved in progressive hearing loss may also have implications for age related 
hearing loss. For example, a polymorphism in Cdh23 has been associated with age related 
hearing loss in different mice strains (Noben-Trauth, Zheng & Johnson, 2003).  
2.4a Moderate to severe or progressive deafness in Usher Syndrome 
Usher syndrome (USH) is a common syndrome of deafness-blindness and can be easily 
misdiagnosed as nonsyndromic hearing loss since onset of retinitis pigmentosa is gradual 
and the early manifestation can be very mild in some cases. So far mutations in 4 genes have 
been identified which cause the less severe phenotypes of hearing loss in Usher syndrome 
(USH2A, GPR98, WHRN and CLRN1). Additionally, some mutations of genes which cause 
Usher type 1 can also cause phenotypes termed as atypical usher syndromes. 
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Hearing loss for USH2 can vary from mild to severe in degree and may also show 
interfamilial variation (Abadie et al., 2011). The four Usher genes are expressed in hair cells 
where except for CLRN1, all proteins interact at the ankle link in the stereocilia and form a 
complex. 
USH2A (USH2A) 
Usher type 2A is the most frequent cause of Usher syndrome. A large number of missense, 
nonsense, insertion and deletion mutations have been identified in USH2A. The mutations 
were first described in North European, Spanish and African American patients (Eudy et al., 
1998). USH2A encodes a large transmembrane protein, usherin, with an intracellular PDZ 
binding domain. Usherin is present in both outer and inner hair cells stereocilia and cannot 
be detected by 2 months of age in mice (Liu et al., 2007).  Ush2a-/- transgenic mice have a 
moderate, non-progressive hearing loss which is more noticeable at high frequencies, 
mimicking the phenotype observed in humans (Liu et al., 2007). In the ears of the Ush2a-/- 
mice the inner hair cells and stereocilia are intact in all but at the basal turn of the cochlea 
where widespread loss of outer hair cells is observed. 
GPR98 (USH2C) 
Mutations of GPR98 or VLGR1 were first described in USH2 patients from United States and 
Sweden (Weston et al., 2004). Gpr98 is expressed transiently during the first week in mice 
and is no longer detectable by P11. GPR98 forms the ankle links that connect the stereocilia 
of hair cells at their base in the developing hair cell bundles. Transgenic Vlgr1/del7TM mice 
which lack transmembrane and cytoplasmic domains of the protein are severely deaf by 
third week of life and lack ankle links (McGee et al., 2006). The stereocilia are arranged in a 
more rounded shape as compared to the “V” like pattern present in the wild type mice. A 
gradual loss of both type of hair cells and pillar cells is observed at the base of the cochlea 
(McGee et al., 2006). 
WHRN (USH2D) 
The description of USH2D (WHRN) is based on only two families from Germany and 
Portugal. The patients in the German family had mild to moderate hearing loss (Ebermann 
et al., 2007a) while the Portuguese family had variable degree of hearing loss with post 
lingual onset which was progressive in nature (Audo et al., 2011). In the German family two 
mutations in WHRN were detected in compound heterozygosity, involving a nonsense 
mutation in exon 1 and a splice site mutation in intron 2. The splice site mutation causes an 
in-frame skipping of the second exon and is predicted to result in production of an aberrant 
protein (Ebermann et al., 2007a). In the Portuguese family a deletion mutation was detected 
in exon 2 which is predicted to truncate the protein or mark the message for nonsense 
mediated decay (Audo et al., 2011). These mutations disrupt only the long isoform of WHRN. 
Mice with a targeted deletion of the long isoform of whirlin have some partial hearing (75 
dB SPL) which is non-progressive in nature (Yang et al., 2010) . The inner hair cells 
stereocilia are unaffected while the outer hair cells stereocilia loose their characteristic “V” 
shaped formation and assume a “U” shape. Some of the stereocilia are missing from the 
innermost row in outer hair cells. However, unlike whirler mutant mice who are deaf due to 
a deletion in Whrn disrupting both isoforms of the protein, mice with targeted ablation of 
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mimicking the phenotype observed in humans (Liu et al., 2007). In the ears of the Ush2a-/- 
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GPR98 (USH2C) 
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and is no longer detectable by P11. GPR98 forms the ankle links that connect the stereocilia 
of hair cells at their base in the developing hair cell bundles. Transgenic Vlgr1/del7TM mice 
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third week of life and lack ankle links (McGee et al., 2006). The stereocilia are arranged in a 
more rounded shape as compared to the “V” like pattern present in the wild type mice. A 
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et al., 2007a) while the Portuguese family had variable degree of hearing loss with post 
lingual onset which was progressive in nature (Audo et al., 2011). In the German family two 
mutations in WHRN were detected in compound heterozygosity, involving a nonsense 
mutation in exon 1 and a splice site mutation in intron 2. The splice site mutation causes an 
in-frame skipping of the second exon and is predicted to result in production of an aberrant 
protein (Ebermann et al., 2007a). In the Portuguese family a deletion mutation was detected 
in exon 2 which is predicted to truncate the protein or mark the message for nonsense 
mediated decay (Audo et al., 2011). These mutations disrupt only the long isoform of WHRN. 
Mice with a targeted deletion of the long isoform of whirlin have some partial hearing (75 
dB SPL) which is non-progressive in nature (Yang et al., 2010) . The inner hair cells 
stereocilia are unaffected while the outer hair cells stereocilia loose their characteristic “V” 
shaped formation and assume a “U” shape. Some of the stereocilia are missing from the 
innermost row in outer hair cells. However, unlike whirler mutant mice who are deaf due to 
a deletion in Whrn disrupting both isoforms of the protein, mice with targeted ablation of 





CLRN1 (USH3A)  
The deafness phenotype associated with USH3 involves postlingual, progressive hearing 
loss. The time of onset and severity of hearing loss can be highly variable (Ness et al., 
2003). So far only one gene, CLRN1 has been identified which causes an USH3 phenotype 
(Joensuu et al., 2001). In contrast to other world populations, mutations in CLRN1 are a 
frequent cause of Usher syndrome in the Finnish population. Clrn1-/- mice have early 
onset hearing loss and are profoundly deaf by P30 (Geng et al., 2009). Clrn1-/- mice have 
demonstrated that CLRN1 is important for normal maturation of hair cells as well as the 
afferent nerve synapses. Absence of CLRN1 in mice leads to gradual loss of outer hair 
cells and supporting cells which is most severe at the basal turn of the cochlea (Geng et 
al., 2009).  
CLRN1 is a small 232 amino acid transmembrane protein which is present at both the basal 
and apical poles of the hair cells with expression being higher in outer hair cells as 
compared to the inner hair cells (Geng et al., 2009; Zallocchi et al., 2009). Clrn1 is also 
expressed in the spiral ganglion (Geng et al., 2009; Zallocchi et al., 2009). In mice, CLRN1 
cannot be detected at the apex of hair cells at P1 and continues to be expressed in both the 
pre- and post-synaptic regions of outer hair cell type I afferent ribbon synapses (Zallocchi et 
al., 2009). Additionally, CLRN1 may also have a role in actin assembly (Tian et al., 2009) and 
intracellular vesicle transport (Zallocchi et al., 2009). 
2.4b Atypical manifestations of hearing loss in Usher syndrome 
Atypical USH is genetically heterogeneous. Two different mutations of SANS (USH1G) 
have been reported to cause a USH2 like phenotype in two consanguineous families from 
Turkey and Pakistan (Bashir, Fatima & Naz, 2010a; Kalay et al., 2005). Similarly, some 
mutations in MYO7A (USH1B) cause an USH3 phenotype (Liu et al., 1998). Additionally, 
two mutations in CDH23 (USH1D), result in an atypical phenotype of milder USH3. These 
involve a missense and an intronic mutation which are compound heterozygous in a 
German family with two affected siblings (Astuto et al., 2002). Some USH2A mutations 
also cause atypical manifestations and the phenotype resembles that of USH3 (Liu et al., 
1999). On the converse, it is interesting to note that though majority of the mutations in 
CLRN1 cause a USH3 phenotype, some mutations in the same gene cause a more severe 
USH1 phenotype (Aller et al., 2004; Pennings et al., 2003) or in some cases an USH2 
phenotype (Sadeghi et al., 2005). The finding of identical mutations in some cases which 
cause both the less severe or the more profound USH phenotype suggest the importance 
of genetic background in manifestation of the disorder and a role of modifiers in its 
aetiology. 
2.5 Modifiers in less severe hearing loss 
To date a single modifier, DFNM1, has been mapped to chromosome 1 which completely 
ameliorates hearing loss (Riazuddin et al., 2000) but the gene is currently unknown. 
Targeted sequencing of the linked region from DNA of both affected and unaffected 
individuals using massively parallel sequencing technology may identify the causative 
change in future.  
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A role of modifier genes in reducing severity of hearing loss is suspected for many other 
deafness loci as well, especially those showing a wide phenotypic variation in presence of 
identical genetic mutations. However, currently no locus has been mapped or any gene 
identified as a potential modifier. Usually each family has few individuals with sufficiently 
different phenotypes to make gene mapping studies feasible. Using whole genome 
sequencing approaches in either a small subset of such individuals or in larger families may 
identify genetic modifiers in future.  
GJB2 is the most widely sequenced deafness genes and mutations in this gene are associated 
with deafness which is mild in degree to more profound losses. However, it has not been 
possible to map a genetic modifier which reduces severity of hearing loss using either 
traditional linkage analysis or association studies. A whole genome association study on 
DNA of more than a thousand GJB2 c.35delG homozygous individuals living across Europe 
and North America regions failed to identify a single locus as a modifier in individuals with 
mild phenotypes of hearing loss. However, some SNPs with smaller modifying effects on 
the phenotype were identified (Hilgert et al., 2009).  It is possible that a more stringent 
ethnic definition and data re-analysis in a smaller group may succeed in mapping a single 
locus for at least a subset of the participants.  
The unavailability of different cell types derived from inner ear tissues in humans have 
inhibited direct evaluation of modifier genes in hearing loss by transcriptional analysis as 
for other disorders such as spinal muscular atrophy (Oprea et al., 2008). However, induced 
pluripotent stem cell lines can be derived from more and less severely affected deaf 
individuals respectively. These could be then differentiated in vitro into the relevant 
cochlear cell types followed by comparison of their mRNA expression profiles. This may 
help in identification of genetic modifiers in future. 
Modifiers of hearing loss identified in mice may also be eventually found to be implicated in 
humans. Currently, only two genes have been identified which result in complete rescue of 
hearing defects in mice. For example alleles of Cdh23 and Mtap1a can rescue hearing loss in 
mice with mutations in Atp2b2 and Tub respectively (reviewed by Yan & Liu, 2010). 
Targeted sequencing of these genes in humans may also identify comparable variants 
important for modification of hearing loss. 
3. Conclusions 
Genes and loci continue to be identified in aetiology of moderate to severe and progressive 
deafness. Current research has revealed that different alleles of a deafness gene can cause 
less severe hearing loss or more profound deafness. Further work needs to be carried out to 
identify additional loci and genes for progressive deafness and those for less severe hearing 
loss phenotypes as well as modifiers in the genetic background that suppress or enhance 
hearing loss. The contribution of different genes to moderate to severe and progressive 
hearing loss also needs to be studied in different world populations. Additionally, it remains 
important to document hearing loss in families which have already been described to suffer 
from moderate to severe hearing loss in order to check for progression of hearing loss in 
future. Strategies need to be evolved for identification of modifiers which will elucidate 
molecular pathways involved in normal hearing. This may be of help in designing strategies 
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2. Clinical syndromes 
2.1 Goldenhar syndrome     
Hemifacial microsomia (or Goldenahr syndrome or oculo-auricolar-vertebral syndrome) is 
usually a sporadic disorder even if there is evidence of familial transmission. In some cases 
autosomal recessive and autosomal dominant inheritance have also been described. The 
incidence of Goldenhar syndrome is reported to be approximately 1 in 5,000-25,000 live 
births (Editorial Team Orphanet, 2005). Genetic heterogenity is frequently observed . 
Kelberman et al performed a genome search for linkage in two families with features of 
hemifacial microsomia and identified data highly suggestive of linkage to a region of 
approximately 10.7 cM on chromosome 14q32 for one family (Kelberman et al., 2001). 
During embryogenesis the correct development of the 1st or the 2nd branchial arches are 
hypothesized to be interrupted resulting in Goldenhar Syndrome.  Clinical features mainly 
consist of a hemifacial microsomia. Maxillary, temporal, malar and skull bones can also be 
involved. Auricular malformations range from mild abnormalities in the external ears (such 
as preauricular tags or pinnae hypoplasia of various degrees) to anotia. Vertebrae 
abnormalities (e.g. hemivertebrae and fused vertebrae) as well as facial cleft or ocular 
abnormalities (epibulbar dermoid, eyelid coloboma, microphtalmia, retinal anomalies) are 
described. Mouth opening can be modified by mandibular hypoplasia. Congenital heart 
diseases of various degrees (e.g. ventricular septal defect of Tetralogy of Fallot) or a wide 
range of CNS malformations can be associated too.  Bony involvement can cause weakness 
of cranial nerves. Mental retardation is described in 5-15% patients. Kidney, pulmonary or 
gastrointestinal abnormalities can also be associated less frequently. (OMIM 164210; Toriello 
et al., 2004) 
Hearing loss in Goldenhar syndrome usually ranges from mild to moderate conductive 
impairment and severe to profound sensorineural hearing loss (Skarzynski et al., 2009). 
Deformity of the auricle, external auditory canal atresia and malformation of the tympanic 
cavity or ossicles may be the main cause of conductive hearing impairment. Abnormalities 
of the stria vascularis and the semicircular canals have also been reported (Scholtz et al., 
2001). Sensorineural hearing loss and facial nerve disfunction is often underestimated. In the 
study by Carvalho et al (Carvalho et a.l, 1999) 11% of the patients with Hemifacial 
microsomia had sensorineural hearing loss.  
2.2 Charge syndrome 
In 1981 Pagon et al. first introduced the acronym “CHARGE” to define a nonrandom 
association of the following features: Coloboma, Heart defect, Atresia choanae, Retarded 
growth and development, Genital hypoplasia and Ear anomalies/deafness.                           
Charge syndrome (OMIM 214800) is a rare disorder with an incidence of about 1 in every 
8500–10000 births (Issekutz et al., 2005). CHARGE syndrome is an autosomal dominant 
disorder. Mutations in CHD7 have been detected in more than 75% of CHARGE patients. 
CHD7 belongs to the gene family coding for ChromodomainHelicase DNA binding 
proteins. During early human development, CHD7 is expressed in the undifferentiated 
neuroepithelium and in mesenchyme of neural crest origin. It is thought to play a role in 
regulating the expression of important developmental genes in mesenchymal cells derived 
from the cephalic neural crest, by chromatin remodeling. The phenotype of CHARGE 
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syndrome can also be caused by mutation in the semaphorin-3E gene. (Michelucci et al., 
2010).Patients with Charge syndrome have a typical square-flattened face, usually 
asymmetric, with a bulbous nasal tip, long philtrum, low-set and dysplastic ears, 
antimongoloid slant of palpebral fissures, anteverted nares and malar hypoplasia. Ptosis 
and cleft lip or palate can also be associated findings.  (OMIM 214800).  Based on Blake et al 
definition, individuals with all four major characteristics (the classical 4C's: Choanal atresia, 
Coloboma, Characteristic ears and Cranial nerve anomalies) or three major and three minor 
characteristics (Cardiovascular malformations, Genital hypoplasia, Cleft lip/palate, 
Tracheoesophageal fistula, Distinctive CHARGE facies, Growth deficiency, Developmental 
delay) are highly likely to have CHARGE syndrome. Nevertheless any infant with one or 
two major criteria and several minor characteristics is highly suspected to have CHARGE. 
(Blake et al). Based on Verloes criteria the presence of three major findings (Coloboma of the 
iris or choroid, with or without microphthalmia, Atresia of Choanae, Hypoplastic semi-
circular Canals) are necessary and sufcient to make a diagnosis of CHARGE, even if no 
other features are present. Patients with ‘‘borderline phenotypes’’ are classied in two 
groups: partial (or incomplete) CHARGE and atypical CHARGE. Partial CHARGE are those 
individuals who have two major signs but only one minor sign (minor signs for Verloes are 
Rhombencephalic dysfunction, Hypothalamo-hypophyseal dysfunction, Abnormal middle 
or external ear, Malformation of mediastinal organs, Mental retardation), whereas 
individuals with atypical CHARGE are those who have two major signs and no minor sign, 
or one major sign and at least three minor signs of CHARGE. (Verloes et al., 2005)                          
Coloboma is uni-lateral or bilateral, involving iris, retina and/or disc.  
Heart defects in CHARGE syndrome are mainly conotruncal defects or aortic arch 
anomalies. Urinary defects range from abnormalities of kidney (or genitourinary tract) size 
or position to renal agenesis, genital hypoplasia, which is typically recognized only in males 
(micropenis/cryptorchidism). Almost every part of the audiologic system can be involved in 
Charge association.  External ears are typically low-set and malformed. Unusually shaped 
and floppy external Pinnae can cause difficulties in placing behind-ear- hearing aids. Ear 
canals may be stenotic. The most common audiological features are severe-to-profound 
asymmetric mixed losses. (Edwards et al., 2002). Ossicular anomalies (eg stapes or incus 
abnormalities), absence of oval window or absence of the stapedium muscle and middle ear 
effusion (eustachian tube dysfunction from craniofacial malformation is a common finding) 
cause conductive hearing loss which is often asymmetrical and fluctuating in nature, usually 
greater on low frequencies. (Dhooge et al., 1998) . Cochlear malformations such as 
Mondini’s Displasia can contribute to hearing loss. Cochlear involvement is greatest for high 
frequencies (Thelin et al., 1986). Abnormalities of the semicircular canals can be found in 
most patients (Morimoto et al., 2006). Auditory neural pathway abnormalities (such as 
hypoplasia or absence of the auditory nerve) may be involved as well.  
2.3 Pierre Robin sequence 
This condition is commonly defined Pierre Robin “sequence” instead of “syndrome” 
because the major clinical features have a common origin. The mandibular hypoplasia starts 
being evident in the first period of gestation and causes an anomalous position of the 
tongue. This prevents the correct development of the palate. At birth micrognathia, 
glossoptosis and cleft palate are the main signs. Consequently, respiratory, feeding and 
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Pierre Robin sequence is usually a sporadic event with an estimated prevalence of about 
1/10.000. In about 10% of patients a familial transmission has been described although the 
involved genes have not been identified.  
Hearing loss is typically conductive and bilateral patients with Pierre Robin sequence. In 
Middle ear effusion is a finding in most patients. Therefore the use of tympanostomy 
(ventilation) tubes is the therapy of choice in patients with Pierre Robin Sequence. In a study 
by Handzic et al the mean hearing loss at speech frequencies was 24.5 dB (Handzić J et al., 
1995, 1996). Pierre Robin Sequence is also a risk factor for sensorineural Hearing Loss: the 
30% of the Pierre Robin patients in a study (Medard et al., 1999) had congenital permanent 
sensorineural evolutive hearing loss.  
Another study revealed multiple architectural anomalies involving the entire ear such as 
abnormal auricles or ossicles, aplasia of the lateral semicircular canals or a large vestibual 
aqueduct (Gruen et al., 2005).  
2.4 Stickler syndrome 
Stickler syndrome affects about 1 in every 7.500/9.000 newborns. Mutations in the COL2A1, 
COL9A1, COL11A1, and COL11A2 genes impairing collagen production have been identified 
as the cause of this disorder. Except for COL9A1 mutations which are transmitted in an 
autosomal recessive fashion, the syndrome is autosomal dominantly inherited. The affected 
patients show a typical long and flat face with malar and mandibular hypoplasia (midface 
hypoplasia).  The nose is small with a depressed nasal bridge and anteverted nares. The 
flatness of the face gives the appearance of large eyes. Vision is altered: myopia, cataracts, 
glaucoma and retinal detachment can be some of the associated findings. Cleft palate, bifid 
uvula  and macroglossia may also occur.  
Joint  problems are presented by the patients from an early age. This involves arthritis which 
causes joint pain and stiffness. Flattened vertebrae and spine deformity such as scoliosis or 
kyphosis vertebral may also be present. Additionally, the prevalence of mitral valve 
prolapse in this syndrome has been reported to be higher than that in the general 
population.                              
Hearing loss can be both sensorineural and conductive. The conductive hearing loss in 
Stickler syndrome type I (COL2A1) can be due to the stapedial fixation. It can therefore be  
improved by stapes surgery. (Baijens et al., 2004)                              
Mutations in the fibrillar collagen genes COL11A1 and COL11A2 can cause sensorineural 
hearing loss probably due to the essential role these two genes have in the function of the 
basilar or tectorial membranes. There seems to be a correlation of hearing loss severity, 
onset, progression and affected frequencies with the underlying mutated collagen gene 
(Shpargel et al, 2004). In the study by Admiraal et al the mean sensorineural hearing 
threshold in Stickler patients with COL11A2 mutation was about 40 dB HL and was liable to 
increase at the highest frequencies. (Admiraal et al., 2000) 
In the study conducted by Szymko-Bennett (Szymko-Bennett et al., 2001) most of the 46 
adults with Stickler syndrome had a sensorineural hearing loss, affecting high frequencies. 
Additionally, hearing loss was not more progressive as compared to age-related hearing 
loss. 
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2.5 Brachio-Oto-renal (BOR) syndrome 
Branchio-oto-renal syndrome (OMIM 113650) is a genetic condition with a prevalence of 
1/40.000 births and has an autosomal dominant mode of inheritance.    EYA1, SIX1, and 
SIX5 are three genes which are known to be mutated in this syndrome. The syndrome is 
called “Branchio-oto-renal” because malformations of the second branchial arch are 
associated with ears and renal abnormalities. The face is typically long and narrow with a 
constricted palate. (Alkis et al., 2002)Kidney and urinary tract show various degree of 
involvement. Shape or position abnormalities can be isolated or associated with an impaired 
renal function. Abnormalities in the development of the second branchial arch lead to neck 
malformations such as branchial cleft, cysts or fistulae.   
Auditory system involvement ranges from pinnae abnormalities such as microtia, 
abnormally shaped ears, pre-auricular tags or pits to inner ear or middle ear malformations 
leading to sensorineural, conductive or mixed hearing loss. Hearing impairment occurs in 
75%-93% of patients with BOR syndrome and ranges from mild to profound. Age of onset 
varies from early childhood to adult age. Younger patients manifest greater threshold 
fluctuation. Inner and middle ear anomalies ranges from cochlear hypoplasia, semicircular 
canals hypoplasia, ossicular anomalies, external auditory canal stenosis or atresia,  
vestibular displasia, enlarged aqueductus or endolymphatic sac (the last seems to 
predispose to more severe hearing impairment), absence of stapedium muscle or Eustachian 
tube dilation and cochlear nerve deficiency.  (Huang et al., 2011; Kemperman et al., 2004) 
2.6 Treacher-Collins syndrome 
Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial 
development with an incidence of 1 in 50.000 live births. It shows genetic heterogeneity: 
Treacher Collins syndrome-1 (TCS-1) (OMIM 154500) is caused by a heterozygous mutation 
in TCOF-1 located on chromosome 5q32 (Wise et al., 1997). Treacher Collins syndrome-2 
(OMIM 613717) is caused by an heterozygous mutation in  POLR1D on chromosome 
5q3213q12.2, while TCS-3 (OMIM 248390) is caused by an heterozygous mutation in the 
POLR1C gene on chromosome 6. However, about 60% of TCS patients have de novo gene 
mutations. Some authors hypothesize that these genetic mutations lead to an aberrant 
expression of a nuclear protein critically required during human craniofacial development. 
Facial abnormalities are usually bilateral in TCS. They involve facial bones showing 
zygomatic arches hypoplasia, hypoplasia of supraorbital rims and micrognathia. The face is 
narrow with an antimongoloid slant of the eyes and hypertelorism. Coloboma of the lower 
lid can be present with deficiency of cilia medial to the coloboma. Ophthalmologic defects 
such as vision loss or refractive errors require specialistic evaluation: Preauricular hair 
displacement is a typical finding. 
External ear show abnormalities ranging from various degree of pinnae malformations to 
microtia. About 40-50% of the patients with Treacher Collins have conductive hearing loss 
(often compounded by a high-frequency sensory component) mainly caused by hypoplasia 
of the middle ear or malformations of the ossicles. Inner ear is usually normal.                          
Pron et al. reported on the hearing loss and computerized tomography (CT) assessments of 
ear malformations in a large pediatric series of patients with Treacher Collins. Of the 23 
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2.5 Brachio-Oto-renal (BOR) syndrome 
Branchio-oto-renal syndrome (OMIM 113650) is a genetic condition with a prevalence of 
1/40.000 births and has an autosomal dominant mode of inheritance.    EYA1, SIX1, and 
SIX5 are three genes which are known to be mutated in this syndrome. The syndrome is 
called “Branchio-oto-renal” because malformations of the second branchial arch are 
associated with ears and renal abnormalities. The face is typically long and narrow with a 
constricted palate. (Alkis et al., 2002)Kidney and urinary tract show various degree of 
involvement. Shape or position abnormalities can be isolated or associated with an impaired 
renal function. Abnormalities in the development of the second branchial arch lead to neck 
malformations such as branchial cleft, cysts or fistulae.   
Auditory system involvement ranges from pinnae abnormalities such as microtia, 
abnormally shaped ears, pre-auricular tags or pits to inner ear or middle ear malformations 
leading to sensorineural, conductive or mixed hearing loss. Hearing impairment occurs in 
75%-93% of patients with BOR syndrome and ranges from mild to profound. Age of onset 
varies from early childhood to adult age. Younger patients manifest greater threshold 
fluctuation. Inner and middle ear anomalies ranges from cochlear hypoplasia, semicircular 
canals hypoplasia, ossicular anomalies, external auditory canal stenosis or atresia,  
vestibular displasia, enlarged aqueductus or endolymphatic sac (the last seems to 
predispose to more severe hearing impairment), absence of stapedium muscle or Eustachian 
tube dilation and cochlear nerve deficiency.  (Huang et al., 2011; Kemperman et al., 2004) 
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in TCOF-1 located on chromosome 5q32 (Wise et al., 1997). Treacher Collins syndrome-2 
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5q3213q12.2, while TCS-3 (OMIM 248390) is caused by an heterozygous mutation in the 
POLR1C gene on chromosome 6. However, about 60% of TCS patients have de novo gene 
mutations. Some authors hypothesize that these genetic mutations lead to an aberrant 
expression of a nuclear protein critically required during human craniofacial development. 
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zygomatic arches hypoplasia, hypoplasia of supraorbital rims and micrognathia. The face is 
narrow with an antimongoloid slant of the eyes and hypertelorism. Coloboma of the lower 
lid can be present with deficiency of cilia medial to the coloboma. Ophthalmologic defects 
such as vision loss or refractive errors require specialistic evaluation: Preauricular hair 
displacement is a typical finding. 
External ear show abnormalities ranging from various degree of pinnae malformations to 
microtia. About 40-50% of the patients with Treacher Collins have conductive hearing loss 
(often compounded by a high-frequency sensory component) mainly caused by hypoplasia 
of the middle ear or malformations of the ossicles. Inner ear is usually normal.                          
Pron et al. reported on the hearing loss and computerized tomography (CT) assessments of 
ear malformations in a large pediatric series of patients with Treacher Collins. Of the 23 





atresic canal. In most cases, the middle ear cavity was hypoplastic and dysmorphic with 
aberrants ossicles while inner ear structures were normal. The majority of patients had 
asymmetric conductive hearing loss of various degrees. Hearing loss was bilateral and 
mixed in three patients. (Pron et al., 1993; Jahrsdoerfer et al., 1995). 
2.7 Apert syndrome 
Apert syndrome (or Acrocephalosyndactyly) (OMIM 101200) occurs in about 1 every 65.000-
88.000 newborns. It is usually sporadic but some familial cases with an autosomal dominant 
way of inheritance have been observed. Mutations in FGFR2 (fibroblast growth factor 
receptor-2) increase the number of precursor cells involved in the osteogenic process leading 
to increased subperiosteal bone matrix and premature ossification. Consequent premature 
skull bone ossification leads to craniosynostosis (especially affecting the coronal sutures) 
which is the main clinical pattern in Apert syndrome (Rice et al., 2008). Patients with this 
condition have a typical back to front flat skull with frontal bossing which is longer than 
usual. Eyes are wide set and the midface is typically hypoplastic with a retrusion of 
supraorbital wings which make proptosis evident, eyebrows interruption, a beaked nose 
and a small upper jaw causing crowded upper teeth projecting back to the lower teeth.   
Cranial abnormalities are quite directly related to brain development: mental status ranges 
from normal intelligence to various degree of mental retardation. Hydrocephalus and 
malformations of corpum callosum or septum pellucidum are common findings.        
Craniofacial abnormalities are associated to finger or toes webbing: syndactyly of at least 
three finger or three toes typically involves bones structure. When vertebral abnormalities 
occur, C5-C6 fusion is typically observed.  Hyperhidrosis is frequently reported as is also 
skin with acne.   
Vision and auditory problems are usual findings in Apert syndrome.  
Hearing loss is a common diagnosis in these patients. The conductive hearing loss, usually 
bilateral, may be due to ossicular chain fixation or otitis media with effusion. Hearing loss is 
rarely present at birth. In about 50% of the cases hearing loss is acquired by the age of 20. It 
ranges from mild to moderate, predominantly affecting the lower frequencies. The incidence 
of congenital hearing loss is low (3–6%) (Rajenderkumar et al., 2005). 
In a study by Zhou et al. hearing loss was found in 90% of the 20 pediatric patients with 
Apert syndrome and 80% of them had conductive hearing loss. Air-bone gaps were found at 
all frequencies, maximum at the low ones. Inner ear anomalies were found in all patients at 
CT scans of the temporal bones. The most frequent anomalies were dilated vestibule, 
malformed lateral semicircular canal and cochlear dysplasia (Zhou et al., 2009) 
2.8 Crouzon syndrome 
Crouzon syndrome (OMIM 123500) was first described in 1912 by Crouzon. It is a condition 
which is inherited in an autosomal dominant way. In Europe it occurs in 1 child every 
50.000 live births. The syndrome is caused by mutation in the fibroblast growth factor 
receptor 2. Mutations in this gene lead to the production of an abnormal protein which 
overstimulates immature cells to form mature bone cells. The premature fusion of skull 
sutures causes the typical synostosis which begins in the first year of life and is completed 
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by 2-3 years from birth. Different patterns of skull growth depend on which suture is mainly 
involved (Harroop et al., 2006; Kirman et al., 2005).Increased intracranial pressure can occur, 
mainly when treatment is delayed.                   
The face is typically huge with a high forehead, proptosis which causes external strabismus, 
hypertelorism, prognathism and hypoplastic upper jaw which leads to dental problems. The 
nose is usually beak shaped. Cleft lips or palate have sometimes been observed.   
Hearing loss is mainly conductive and is due to auditory canal abnormalities such as 
middle ear effusions, intratympanic bony masses, ossicular or oval window malformations. 
Sensorineural hearing loss may rarely occur.        
In the study by De Jong et al. mild or moderate hearing loss (mostly conductive) was found 
in 28.5% of patients with Crouzon syndrome (De Jong et al., 2011). 
In the study by Orvidas et al 8 of the 19 patients with Crouzon syndrome  had ear anomalies 
ranging  from pinna malformations to auditory canal atresia while 10 had proper hearing 
impairment: in 4 of them conductive hearing loss was found (mainly due to ossicular 
fixation and otitis media) in 4 of them hearing loss was sensorineural while in 2 was mixed 
(Orvidas et al., 1999) 
A particular variant of Crouzon syndrome caused by a mutation in FGFR3 has been 
described in association to Acanthosis Nigrigans. In these patients hydrocephalus, coanal 
stenosis or atresia and Chiari malformation have been described. (Arnaud-López et al., 
2007) 
2.9 Pfeiffer syndrome 
Crouzon syndrome and Pfeiffer syndrome (OMIM 101600) are allelic disorders with 
overlapping features. Pfeiffer syndrome is an autosomal dominant condition which occurs 
in 1 every 100.000 live births. It is caused by mutations in FGFR1 or FGFR2 which cause 
prolonged signaling which over stimulates premature cells in the developing embryo. This 
causes the premature fusion of skull bones. Early fusion of the coronal and lambdoid 
sutures and occasionally of the sagittal sutures leads to an abnormal skull shape.  
The face is usually broad with midface hypoplasia, prognatism, high forehead, flat occiput, 
hypertelorism and swallowing orbits which cause proptosis. Upperways obstruction can 
follow midface hypoplasia and nasal obstruction (Vogels et al., 2006). 
Skull malformation is associated to limb abnormalities such as short and broad deviating 
thumbs, big toes and syndactyly of the second and third fingers.  
Three different subtypes of this condition have been described. In type 1 patients, mild skull 
and facial abnormalities such as brachycephaly and midface hypoplasia are associated with 
fingers and toes malformations while neurological development is usually normal. In type 2 
patients trilobated skull deformity is associated with neurological problems such as 
underdeveloped brain or increased intracranial pressure. Proptosis is evident and causes 
visual problems. Other limb defects such as elbow ankylosis are associated to fingers and 
toes abnormalities. Kidney malformations can also occur. Type 3 patients are similar to type 
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by 2-3 years from birth. Different patterns of skull growth depend on which suture is mainly 
involved (Harroop et al., 2006; Kirman et al., 2005).Increased intracranial pressure can occur, 
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hypertelorism and swallowing orbits which cause proptosis. Upperways obstruction can 
follow midface hypoplasia and nasal obstruction (Vogels et al., 2006). 
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thumbs, big toes and syndactyly of the second and third fingers.  
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fingers and toes malformations while neurological development is usually normal. In type 2 
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underdeveloped brain or increased intracranial pressure. Proptosis is evident and causes 
visual problems. Other limb defects such as elbow ankylosis are associated to fingers and 
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Otologic malformations and hearing loss are common features in Pfeiffer syndrome. They 
are mainly due to external auditory canal or middle ear malformation. For example atresic 
or stenotic auditory canal, hypoplasic ossicules or fixed ossicular chain, hypoplasic or 
enlarged middle ear cavity can be common findings. The inner ear is usually normal though 
an enlarged internal acoustic meatus may be present. (Cremers et al., 1981)  
In a study by Vallino et al. hearing loss, mostly moderate to severe, was present in eight of 
the nine patients with Pfeiffer syndrome. Seven patients had conductive hearing loss and 
one had mixed loss (Vallino-Napoli et al., 1996).   
Sensorineural hearing loss is less common and may be related to the effect of FGFR 
mutations on cranial nerve or inner-ear development. (Desai et al., 2010)  
2.10 Saethre-Chotzen syndrome 
This is a genetic condition with an incidence which ranges from 1:25.000 to 1:50.000 births 
(OMIM 101400). It is inherited in an autosomal dominant way and it is caused by mutation 
of TWIST1. Patients with Saethre-Chotzen syndrome typically show an abnormal fusion in 
the skull’s bones causing the typical appearance: brachycephaly, low frontal hair line, 
flattened nasofrontal angle with a beaked nose, widely spaced eyes, ptosis, facial 
asymmetry.  Fingers and Toes defects such as mild syndactyly and a broad or duplicated 
thumb or hallux are typical; vertebral anomalies and short stature can also be associated.   
Mild external ear anomalies can be additional findings. The hearing defect is usually 
conductive (Clauser et al., 2004) and can be due to stapes ankylosis,  fixed ossicular chain, 
microtia or enlarged vestibules (sometimes associated to a  small epitympanum and small or 
even absent mastoids) (Ensink et al., 1996). Mixed hearing loss due to brain stem anomalies 
has also been described (Lamonica et al., 2010). 
2.11 Townes-Brocks syndrome 
Townes-Brocks syndrome (OMIM 107480) is a genetic condition showing an incidence of 
about 1 in 250.000 live births. It is caused by mutations in SALL1 causing abnormal 
production of transcription factors. It is inherited in an autosomal dominant pattern.  
Patients with this syndrome typically show the triad: anus imperforatus (in about the 82% of 
the patients) with rectovaginal or rectoperineal fistula, external ear anomalies (85%) usually 
associated with thumbs malformation (89%) such as thumb duplication or hypoplasia.  
In 65%of cases sensorineural or conductive hearing loss are part of the clinical presentation. 
External ear anomalies range from overfolded superior helices which cause the typical satyr 
form, to microtia, preauricolar tags or pits and can be associated to middle ear anomalies 
(e.g. ossicular abnormalities, hypoplastic malleus head and abnormally shaped oval window 
andincus. (Toriello et al., 2004; Powell et al., 1999). The hearing loss is predominantly 
sensorineural and slowly progressive (from mild during early childhood to moderate in 
early adulthood), it affects high-frequency thresholds more than the low-frequency ones and 
has a variable, but usually small, conductive component. (Rossmiller et al., 1994) 
Renal and genitourinary abnormalities, congenital heart disease, foot malformation and 
mental retardation have also been described in Townes-Brocks syndrome. 
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2.12 Miller syndrome  
Miller syndrome or postaxial acrofacial dysostosis (OMIM 263750) is a rare condition which 
affects fewer than 1 in 1 million of newborns. It has an autosomal recessive mode of 
inheritance. Mutations in DHODH cause this syndrome disrupting the development of the 
first and second pharyngeal arch.  Patients with this syndrome typically show craniofacial 
abnormalities such as malar hypoplasia, micrognathia, down-slanting eyes with drooping of 
the lower eyelids (which becomes more evident with age) and coloboma, cleft palate, long 
philtrum and small, protruding "cup-shaped" ears.  
Craniofacial abnormalities are associated with limb defects such as syndactyly, hypoplasia 
or absence of fingers or toes (eg the fifth digits), hypoplasia of forearms or lower legs.  
Extra nipples, vertebrae or ribs deformities have been described while abnormalities of the 
heart, kidneys, genitalia, or gastrointestinal tract are less common.  
Hearing loss is usually caused by defects in the middle ear (various degree conductive 
hearing loss). (Toriello et al., 2004) 
2.13 Nager acrofacial dysostosis  
Nager syndrome (OMIM 154400) is a rare condition (about 70 cases have been described) 
and the involved genes are unknown. Both autosomal and recessive cases have been 
described. Facial malformation is associated with limbs abnormalities. The face shows 
maxillar hypoplasia and micrognatia. The eyes have typical downslanting fissures with 
ptosis of the upper lids, lack or absence of the lower eyelashes and occasionally coloboma of 
the lower lids.  
Ears can show various degree of malformations which range from abnormal positioning to 
microtia. Auditory canal or middle ear can be involved leading to conductive hearing loss. 
Otitis media is a common problem. In a study by Herrmann et al. 8 over 10 patients with 
Nager syndrome had pure conductive hearing loss (> 30 db HL in 90% of cases, between 55 
and 70 dB HL in 40% of patients) while in 2 cases hearing impairment was mixed. In the last 
two cases the sensorineural deficit was progressive and developed later in childhood. A 
Choleasteatoma has been described in some cases.  
Limb malformations consist of hypoplasia or absence of radius, radioulnar synostosis, and 
hypoplasia or absence of the thumbs. Phocomelia is rare. Renal and genital abnormalities 
occasionally occur. (Opitz et al., 2003) 
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Charge 
syndrome 
• Choanal atresia 
• Coloboma 
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nasal bridge and anteverted 
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fistulae 
• Ear abnormalities 
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• Hypoplasia of supraorbital 
rims  
• Micrognathia  
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• Antimongoloid slant of the 
eyes and hypertelorism 
• Coloboma of the lower lid 
with deficiency of cilia medial 
to the coloboma 
• Large nose is with hypoplastic 
alae  
• Down-turning mouth  
• Cleft palate 
• External ear abnormalities 
Genetic 
heterogeneity: 
TCS-1, TCS-2 and 










hearing loss. Few 
cases of mixed 




• Craniosynostosis  
• Frontal bossing  
• Wide set eyes  
• Hypoplastic midface 
FGFR2 mutations Mild to moderate 
conductive 
hearing loss  
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• Micrognatia 
Not known Conductive or 
mixed hearing 
loss 
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Imaging studies of middle and inner ear are required for better management of the 
craniofacial syndromes. They are necessary for a correct diagnosis of anatomical aberrations 
and for the planning of the surgical intervention. 
MRI is the first-choice of imaging technique for craniofacial syndromes, midface masses and 
brain abnormalities; it is important in showing the anatomy of the brain and the soft tissue 
structures and in detecting any associated cerebral malformations.   
 
 Case 1 Case 2 Case 3 Case 4 
Gender M M F F 
Family 
History 




The mother was 
17-yrs old and 


























until 34 weeks of 
























Term delivery at 




delivery at 41 weeks of GA. 
At birth ventilation support 
was required because of 








The weight at 
birth was 2035 g 
(10th-25th  
percentile), 
length was 46,5 
cm (50th -75th ), 
Birth Weight 
3400 g (10th-50th  
percentile); Birth 
length 50 cm 
(10th-50th  ). He 
had bilateral 
At birth she weighed 2680 g 
(3th-10th  centile), length 
was 47 cm (3th-10th), and 
her  head circumference was 
33.5 cm (10th-50th). She was 
pale and had petecchiae at 
At birth she 
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 Case 1 Case 2 Case 3 Case 4 
Gender M M F F 
and head 
circumference 




























of the right 
choana, 
characteristic 
external ears and 









small mouth and 
inverted V-
shaped upper 






upper limbs, neck, head, 
axillae and inguinal region. 
She showed mild hypotonia 
and characteristic facial 
features: plagiocephaly, with 
flat occiput, frontal bossing, 
head bent to the left, left 
eyelid ptosis; thin upper lip 
with long filtrum and short 
tongue frenulum. 
Clinodactily of the fifth 
fingers. Bilteral shortness of 
ulna and radius with carpal 
bones relatively longer than 
fore-arm. Mild enlargement 
of cardiac profile. 
edematous 
eyelids and 












ears, right eye 
ptosis, rounded 


































the great arteries 
surgically 
corrected during 
the first week of 












He was fed via 
percutaneous 
endoscopic 
Low platelets count  
(16.000/mmc). Cranial USS 
showed mild dilation of 
lateral ventricles, 
hyperechogenic areas in the 
basal ganglia and 
candelabrum-like 
appearance of the thalamus. 
Echocardiography showed 
mild increasing pulmonary 
transvalvular gradient and 
atrial septum defect (ostium 
secundum). 
Growth deficiency with 
delayed motor milestones 
and delayed development of 
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 Case 1 Case 2 Case 3 Case 4 
Gender M M F F 
treated at 7 














(PEG) from the 




reflux. He also 
required a 
tracheostomy 
between ages of 
2 and 5 months. 




threshold of 50 
dB HL on the 
right side and 70 








threshold of 55 
dB on the left 
and 45 dB HL on 





(bilateral average threshold 







90 dB on the left 
and 75 dB HL 
on the right at 
2000-4000 Hz). 
Partially 










pointed out a 
male karyotype 












The patient met 
all the four major 
and six minor 




exon 2 of CHD7 
gene revealed 
the presence of a 
nonsense 
mutation: a C→T 







revealed a female karyotype 
with a chromosome deriving 




CGH array revealed a 
microduplication at region  
6pter → 6p22.3 in the short 
arm of chromosome 6 and a 
microdeletion at the region 
11q24.2 →11qter in the long 






deletion at the 




pointed out a 10 
Mb de novo 
interstitial 
deletion in the 
regionq31.1-
9q31.3. 
Table 2. Some clinical cases observed at Neonatology Unity of Santa Chiara University 
Hospital of Pisa                    
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CT (best of all three dimensional CT)  is the referral technique for studying syndromes of the 
first and second branchial arch: the resolution provided by this technique  for the fine bony 
craniofacial structures is unmatched by other modalities. It is useful for example in 
diagnosing early suture fusion and in detecting any underlying abnormality of the brain. It 
is also useful when choanal stenosis or pyriform cavity or nasolacrimal ductus abnormalities 
are present as well as when anomalies of the temporal bone, osseous labyrinth, or internal 
and external acoustic canal are involved. The choice between techniques depends on the 
anatomical or functional damage which causes the hearing loss but often only the combined 
use of MRI and CT is able to give a complete imaging of craniofacial malformations. (Lowe 
et al., 2000; Johnson et al., 2001; Tokumaru et al., 2006) 
4. Conclusion 
The knowledge of clinical characteristics of syndromes is still the first and most important 
step for reaching a correct diagnosis. The clinical appearance leads the clinician to suggest 
various genetic tests to make a definitive diagnosis.  Although many syndromes with 
craniofacial malformations and hearing loss are known, there are many patients with 
craniofacial abnormalities and deafness whose disorder cannot be currently classified into 
any syndrome (Table 2). These patients may have detectable genetic aberrations (e.g. 
chromosomal abnormalities such as deletions or duplications). The imaging aid to the 
diagnosis and for intervention in hearing loss associated with these syndromes is certain. 
The choice between CT o MRI depends on the anatomical/functional damage which causes 
the hearing. 
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1. Introduction 
Usher syndrome (USH) is an autosomal recessive genetic disease, characterized by both 
deafness and blindness. It was first described by Albrecht von Grafe, a German 
ophthalmologist, in 1858 (von Graefe, 1858) and then named after Charles Usher, a British 
ophthalmologist, who reported the inheritance of this disease on the basis of 69 cases in 1914 
(Usher, 1914). USH is clinically heterogeneous and is categorized into three types, according 
to the severity of its hearing and vestibular symptoms (Smith et al., 1994; Petit, 2001). Type I 
(USH1) patients have congenital severe to profound deafness as well as vestibular 
dysfunction; Patients with USH2 exhibit congenital moderate degree of hearing loss and 
normal vestibular function; and those with USH3 display progressive hearing impairment 
and occasional vestibular dysfunction. The vision problem of all three types is manifested as 
retinitis pigmentosa (Hartong et al., 2006; Sadeghi et al., 2006; Fishman et al., 2007; Sandberg 
et al., 2008; Malm et al., 2011), showing early night and peripheral vision loss and eventual 
central vision loss.  
USH is the most common genetic cause of combined blindness and deafness, occurring in 
about 1 in 23,000 people worldwide (Boughman et al., 1983; Keats and Corey, 1999; Hartong 
et al., 2006). It represents 50% of the blindness-deafness cases, 5% of all congenital deafness 
and 18% of retinitis pigmentosa (Millan et al., 2011). In Europe, USH1, USH2 and USH3 
generally account for 25-44%, 56-75%, and 2% of all USH cases, respectively (Grondahl, 
1987; Hope et al., 1997; Rosenberg et al., 1997; Spandau and Rohrschneider, 2002). Due to the 
regional founder effect, USH3 is much more common in Birmingham and Finland 
(Pakarinen et al., 1995; Hope et al., 1997). To date, there is no cure for this disease. USH 
patients mainly rely on early diagnosis and early education to adapt themselves to their 
dual sensory loss.  
2. USH genes 
USH is genetically diverse besides its clinical heterogeneity. Currently, eleven loci have been 
identified (Hereditary hearing loss homepage and Hmani-Aifa et al., 2009), and nine genes 
on these loci are known. Among these genes, five are involved in USH1, three in USH2 and 
one in USH3 (Reiners et al., 2006; Williams, 2008; Millan et al., 2011). Although the functions 
of some USH genes are relatively clear now in the inner ear (see section 6), extensive work is 





Scholtz AW, Fish JH 3rd, Kammen-Jolly K, Ichiki H, Hussl B, Kreczy A, Schrott-Fischer A. 
Goldenhar's syndrome: congenital hearing deficit of conductive or sensorineural 
origin? Temporal bone histopathologic study. Otol Neurotol. 2001 Jul;22(4):501-5 
Shpargel KB, Makishima T, Griffith AJ.Col11a1 and Col11a2 mRNA expression in the 
developing mouse cochlea: implications for the correlation of hearing loss 
phenotype with mutant type XI collagen genotype. Acta Otolaryngol. 2004 
Apr;124(3):242-8 
Skarzyński H, Porowski M, Podskarbi-Fayette R. Treatment of otological features of the 
oculoauriculovertebral dysplasia (Goldenhar syndrome). Int J Pediatr 
Otorhinolaryngol. 2009 Jul;73(7):915-21 
Szymko-Bennett YM, Mastroianni MA, Shotland LI, Davis J, Ondrey FG, Balog JZ, Rudy SF, 
McCullagh L, Levy HP, Liberfarb RM, Francomano CA, Griffith AJ. Auditory 
dysfunction in Stickler syndrome. Arch Otolaryngol Head Neck Surg. 2001 
Sep;127(9):1061-8 
Thelin JW, Mitchell JA, Hefner MA, Davenport SL. CHARGE syndrome. Part II. Hearing 
loss. Int J Pediatr Otorhinolaryngol. 1986 Dec;12(2):145-63 
Tokumaru Aya M., Barkovich A. James, Ciricillo Samuel F., and Edwards Michael S. B.. 
Skull Base and Calvarial Deformities: Association with Intracranial Changes in 
Craniofacial Syndromes. Am J Neuroradiol  1996; 17:619–630 
Toriello HV, Reardon W, Gorlin R J. Hereditary Hearing Loss and Its Syndromes. Oxford 
University Press,2004 
Vallino-Napoli LD. Audiologic and otologic characteristics of Pfeiffer syndrome.Cleft Palate 
Craniofac J. 1996 Nov;33(6):524-9 
Verloes A. Updated Diagnostic Criteria for CHARGE Syndrome:A Proposal. American 
Journal of Medical Genetics 133A:306–308 (2005) 
Vogels Annick and Fryns Jean-Pierre.Pfeiffer syndrome. Orphanet Journal of Rare Diseases 
2006, 1:19 
Wise CA, Chiang LC,  Paznekas WA et al.TCOF1 gene encodes a putative nuclear 
phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout 
its coding region. Proc Nat Acad Sci 94:3110-3115,1997 
Zhou G, Schwartz LT, Gopen Q. Inner ear anomalies and conductive hearing loss in children 
with Apert syndrome: an overlooked otologic aspect. Otol Neurotol. 2009 
Feb;30(2):184-9. 
14 
Usher Syndrome: Genes, Proteins, Models, 
Molecular Mechanisms, and Therapies  
Jun Yang 
Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah 
USA 
1. Introduction 
Usher syndrome (USH) is an autosomal recessive genetic disease, characterized by both 
deafness and blindness. It was first described by Albrecht von Grafe, a German 
ophthalmologist, in 1858 (von Graefe, 1858) and then named after Charles Usher, a British 
ophthalmologist, who reported the inheritance of this disease on the basis of 69 cases in 1914 
(Usher, 1914). USH is clinically heterogeneous and is categorized into three types, according 
to the severity of its hearing and vestibular symptoms (Smith et al., 1994; Petit, 2001). Type I 
(USH1) patients have congenital severe to profound deafness as well as vestibular 
dysfunction; Patients with USH2 exhibit congenital moderate degree of hearing loss and 
normal vestibular function; and those with USH3 display progressive hearing impairment 
and occasional vestibular dysfunction. The vision problem of all three types is manifested as 
retinitis pigmentosa (Hartong et al., 2006; Sadeghi et al., 2006; Fishman et al., 2007; Sandberg 
et al., 2008; Malm et al., 2011), showing early night and peripheral vision loss and eventual 
central vision loss.  
USH is the most common genetic cause of combined blindness and deafness, occurring in 
about 1 in 23,000 people worldwide (Boughman et al., 1983; Keats and Corey, 1999; Hartong 
et al., 2006). It represents 50% of the blindness-deafness cases, 5% of all congenital deafness 
and 18% of retinitis pigmentosa (Millan et al., 2011). In Europe, USH1, USH2 and USH3 
generally account for 25-44%, 56-75%, and 2% of all USH cases, respectively (Grondahl, 
1987; Hope et al., 1997; Rosenberg et al., 1997; Spandau and Rohrschneider, 2002). Due to the 
regional founder effect, USH3 is much more common in Birmingham and Finland 
(Pakarinen et al., 1995; Hope et al., 1997). To date, there is no cure for this disease. USH 
patients mainly rely on early diagnosis and early education to adapt themselves to their 
dual sensory loss.  
2. USH genes 
USH is genetically diverse besides its clinical heterogeneity. Currently, eleven loci have been 
identified (Hereditary hearing loss homepage and Hmani-Aifa et al., 2009), and nine genes 
on these loci are known. Among these genes, five are involved in USH1, three in USH2 and 
one in USH3 (Reiners et al., 2006; Williams, 2008; Millan et al., 2011). Although the functions 
of some USH genes are relatively clear now in the inner ear (see section 6), extensive work is 





2.1 USH1 genes 
In the past 20 years, seven loci have been assigned to USH1. They are USH1B-H. USH1A was 
first localized on 14a32.1 from a study in nine USH1 families in the Poitou-Charentes region of 
France, and was recently withdrawn due to the discovery that most of these families in fact 
carry mutations on the USH1B locus (Gerber et al., 2006). The genes underlying USH1B, 
USH1C, USH1D, USH1F, and USH1G have been identified as MYO7A (myosin VIIa) (Weil et 
al., 1995), USH1C (harmonin) (Bitner-Glindzicz et al., 2000; Verpy et al., 2000), CDH23 
(cadherin 23) (Bolz et al., 2001; Bork et al., 2001), PCDH15 (protocadherin 15) (Ahmed et al., 
2001; Alagramam et al., 2001b), and USH1G (SANS) (Weil et al., 2003), respectively. Among 
them, MYO7A, USH1C, CDH23 and PCDH15 are also the causative genes for nonsyndromic 
deafness, DFNB2/DFNA11 (Liu et al., 1997; Weil et al., 1997), DFNB18 (Ahmed et al., 2002), 
DFNB12 (Bork et al., 2001), and DFNB23 (Ahmed et al., 2003), respectively. The USH1E and 
USH1H loci were mapped to chromosome 21q21 and 15q22-23 (Chaib et al., 1997; Ahmed et 
al., 2009 ). However, the genes at these loci have not yet been pinpointed.  
MYO7A is the most prevalent gene causing USH1 (Astuto et al., 2000). It encodes an 
unconventional actin-based motor protein with the conserved motor domain and five IQ 
motifs (Figure 1A). These domains are responsible for binding to actin, ATP, and myosin 
light chain. Therefore, MYO7A may move its cargos along the actin filaments using the 
energy generated from the hydrolysis of ATP. However, the motor domain of MYO7A 
shows a strong affinity to ADP and, thus, stays bound to actin filament for a long time 
(Heissler and Manstein, 2011). In this case, MYO7A may be involved in generating tensions 
between two proteins or cellular structures. The tail of MYO7A has a series of protein-
protein interaction domains, including a single α-helix (SAH), a coiled-coil domain (CC), 
two myosin tail homology 4 domains (MyTH4), two band 4.1, ezrin, radixin, moesin 
domains (FERM), and a src homology 3 domain (SH3) (Figure 1A). These domains are 
thought to be engaged in binding to cargos and/or anchoring to proteins. 
Harmonin (also known as AIE-75 or PDZ-73) is expressed in many different tissues 
(Kobayashi et al., 1999; Scanlan et al., 1999). Nine transcripts have so far been discovered 
(Verpy et al., 2000; Reiners et al., 2003). They are categorized into three groups, isoforms a, b 
and c (Figure 1B). All these isoforms have multiple PDZ (postsynaptic density 95; discs 
large; zonula occludens-1) domains and at least one CC domain. The CC domain is reported 
to participate in harmonin dimerization (Adato et al., 2005b), and the PDZ domain is well 
known to interact with PDZ-binding motifs (PBMs) in other proteins (Sheng and Sala, 2001). 
Isoform b specifically has a proline, serine and threonine-rich (PST) domain. This domain 
has been demonstrated to bind and bundle actin filaments (Boeda et al., 2002). In summary, 
harmonin may organize a multi-protein complex and attach this complex to actin filaments. 
CDH23 and PCDH15 both have multiple transcripts and are grouped into isoforms a, b and 
c for CDH23 (Lagziel et al., 2005; Lagziel et al., 2009) and isoforms CD1, CD2, CD3 and SI for 
PCDH 15 (Ahmed et al., 2006) (Figures 1C and 1D). As the distant members of the classical 
cadherin superfamily, the proteins of these two genes have various repeats of extracellular 
cadherin (EC) domains in their extracellular regions. Accordingly, it has been proposed and 
supported by many studies in hair cells (see below) that the two proteins function in cell 
adhesion through their homophilic and heterophilic interactions. The two proteins probably 
anchor to the intracellular structures through the PBMs in their cytoplasmic regions (Figures 
1C and 1D).  
 




Fig. 1. Domain structures of USH1 proteins 
Mutations in SANS are rare in USH1 patients. Some mutations, such as c.1373 A>T and 
c.163_164 + 13del15, cause the clinical symptoms close to USH2 (Kalay et al., 2005; Bashir et 
al., 2011). The protein of this gene consists of several putative protein-protein interaction 
domains, including three ankyrin –like (ANK) repeats, a central (CEN) domain, a sterile 
alpha motif (SAM) and a PBM (Figure 1E). Therefore, like harmonin, SANS is believed to be 
a putative scaffold protein. 
2.2 USH2 genes 
Four USH2 loci were originally defined, USH2A-D. The genes responsible for USH2A, 
USH2C, and USH2D are USH2A (usherin) (Eudy et al., 1998), GPR98 (G Protein-coupled 
Receptor 98) (Weston et al., 2004), and WHRN (whirlin) (Ebermann et al., 2006), respectively. 
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(Bok et al., 2003). However, further study of the consanguineous Tunisian family carrying 
the USH2B locus demonstrates that mixed mutations in the GPR98 and PDE6B genes are 
responsible for the disease manifestation in the family and, thus, the USH2B locus was 
withdrawn (Hmani-Aifa et al., 2009). Moreover, a novel USH2 locus has recently been 
localized on the chromosome 15q, though the underlying gene has not been identified so far 
(Ben Rebeh et al., 2008). ‘ 
 
Fig. 2. Domain structures of USH2 proteins 
USH2A is the most predominant causative gene in all USHs among different human ethnic 
populations (Eudy et al., 1998; Dreyer et al., 2000; Weston et al., 2000; Aller et al., 2004; van 
Wijk et al., 2004; Adato et al., 2005a; Hartong et al., 2006; Baux et al., 2007; Kaiserman et al., 
2007; Dreyer et al., 2008; Nakanishi et al., 2009; Yan et al., 2009; McGee et al., 2010). Its 
mutations lead to a wide spectrum of vision and hearing defects in patients. Some USH2A 
mutations, such as p.C759F and p.G4674R, are known to cause only nonsyndromic retinitis 
pigmentosa (Rivolta et al., 2002; Seyedahmadi et al., 2004; Kaiserman et al., 2007). USH2A 
has 72 exons and is expressed as isoforms A and B (Figure 2A). Isoform B, the major isoform 
in the retina (Liu et al., 2007), is an extremely large transmembrane protein with 5202 amino 
acids (aa) in humans (van Wijk et al., 2004). Its long extracellular region has repeated various 
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laminin (Lam) and fibronectin III (FN3) functional domains common in cell adhesion proteins 
and extracellular matrix proteins. Its cytoplasmic region has a PBM. Isoform A is an N-
terminal 1546-aa fragment of isoform B. USH2A is thought to be involved in cell adhesion. 
The GPR98 gene, also known as VLGR1 (Very Large G protein-coupled Receptor 1) and 
MASS1 (Monogenic Audiogenic Seizure Susceptibility 1), exists only in the vertebrate 
(Gibert et al., 2005) and is one of the largest genes, with 90 exons (McMillan et al., 2002). Its 
mRNA is present mostly in the brain and spinal cord during development (McMillan et al., 
2002; Weston et al., 2004), but it can also be found in many other tissues (Nikkila et al., 2000; 
Skradski et al., 2001; McMillan et al., 2002; Weston et al., 2004). GPR98 expresses multiple 
mRNA transcripts, including isoforms a, b and c in humans and isoforms b, d, e and Mass1 
in rodents (Figure 2B) (Nikkila et al., 2000; Skradski et al., 2001; McMillan et al., 2002; Yagi et 
al., 2005). Mutations in the longest isoform, isoform b, have been identified in patients with 
USH2C (Weston et al., 2004; Ebermann et al., 2009; Hilgert et al., 2009). Additionally, 
different mutations along the murine Gpr98 gene share common phenotypes in vision and 
hearing (Skradski et al., 2001; McMillan and White, 2004; Johnson et al., 2005; Yagi et al., 
2005; McGee et al., 2006; Michalski et al., 2007; Yagi et al., 2007). These findings suggest that 
isoform b is the major isoform in both the retina and the inner ear and is essential for vision 
and hearing. This isoform is 6306 aa long in humans. It has signature domains of family B of 
G protein-coupled receptors (GPCRs), i.e., a GPCR proteolytic site (GPS) and a 7-
transmembrane domain (7TM). Therefore, GPR98 may function in signal transduction. 
GPR98 also has a PBM at its C-terminus.  Along its long extracellular region, it has a laminin 
globular-like domain (LamG_L), an epilepsy associated repeat (EAR)/epitempin (EPTP) 
domain, and multiple tandem-arranged Calxβ domains. While the function of EAR/EPTP is 
unknown, LamG_L is a cell adhesion domain, and the Calxβ domain is able to bind to Ca2+ 
with low affinity in vitro (Nikkila et al., 2000; McMillan and White, 2011).  
Mutations of whirlin cause either USH2D or nonsyndromic deafness, DFNB31. Interestingly, 
mutations at the N-terminal half of the gene, such as p.P246HfxX13 and compound 
heterozygosity of p.Q103X and c.837+1G>A, are manifested as USH2D (Ebermann et al., 
2006; Audo et al., 2011), while mutations at the C-terminal half, such as p.R778X and 
c.2423delG, were found in patients with DFNB31 (Mburu et al., 2003; Tlili et al., 2005).  
Whirlin has multiple mRNA transcripts in the inner ear and the retina (Mburu et al., 2003; 
Belyantseva et al., 2005; van Wijk et al., 2006; Yang et al., 2010), which can be conceptually 
translated into three groups of proteins, the long, N-terminal, and C-terminal isoforms 
(Figure 2C). The long isoform contains three PDZ domains and a proline-rich region (PR). 
Thus, whirlin is a homolog of harmonin. At the protein level, whirlin mainly expresses the 
long isoform in the retina and the long and C-terminal isoforms in the inner ear (Yang et al., 
2010). Because both the PDZ domain and PR region are protein interaction modules, whirlin 
is believed to be implicated in the assembly of multi-protein complexes at specific 
subcellular locations, similar to harmonin.  
2.3 USH3 and USH related genes 
The only gene currently identified in USH3 is clarin-1 for the USH3A locus (Joensuu et al., 
2001; Adato et al., 2002; Fields et al., 2002). Like other USH genes, clarin-1 has multiple 
transcript variants due to different splicings and usages of transcription start sites 





(Bok et al., 2003). However, further study of the consanguineous Tunisian family carrying 
the USH2B locus demonstrates that mixed mutations in the GPR98 and PDE6B genes are 
responsible for the disease manifestation in the family and, thus, the USH2B locus was 
withdrawn (Hmani-Aifa et al., 2009). Moreover, a novel USH2 locus has recently been 
localized on the chromosome 15q, though the underlying gene has not been identified so far 
(Ben Rebeh et al., 2008). ‘ 
 
Fig. 2. Domain structures of USH2 proteins 
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laminin (Lam) and fibronectin III (FN3) functional domains common in cell adhesion proteins 
and extracellular matrix proteins. Its cytoplasmic region has a PBM. Isoform A is an N-
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al., 2005). Mutations in the longest isoform, isoform b, have been identified in patients with 
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and hearing. This isoform is 6306 aa long in humans. It has signature domains of family B of 
G protein-coupled receptors (GPCRs), i.e., a GPCR proteolytic site (GPS) and a 7-
transmembrane domain (7TM). Therefore, GPR98 may function in signal transduction. 
GPR98 also has a PBM at its C-terminus.  Along its long extracellular region, it has a laminin 
globular-like domain (LamG_L), an epilepsy associated repeat (EAR)/epitempin (EPTP) 
domain, and multiple tandem-arranged Calxβ domains. While the function of EAR/EPTP is 
unknown, LamG_L is a cell adhesion domain, and the Calxβ domain is able to bind to Ca2+ 
with low affinity in vitro (Nikkila et al., 2000; McMillan and White, 2011).  
Mutations of whirlin cause either USH2D or nonsyndromic deafness, DFNB31. Interestingly, 
mutations at the N-terminal half of the gene, such as p.P246HfxX13 and compound 
heterozygosity of p.Q103X and c.837+1G>A, are manifested as USH2D (Ebermann et al., 
2006; Audo et al., 2011), while mutations at the C-terminal half, such as p.R778X and 
c.2423delG, were found in patients with DFNB31 (Mburu et al., 2003; Tlili et al., 2005).  
Whirlin has multiple mRNA transcripts in the inner ear and the retina (Mburu et al., 2003; 
Belyantseva et al., 2005; van Wijk et al., 2006; Yang et al., 2010), which can be conceptually 
translated into three groups of proteins, the long, N-terminal, and C-terminal isoforms 
(Figure 2C). The long isoform contains three PDZ domains and a proline-rich region (PR). 
Thus, whirlin is a homolog of harmonin. At the protein level, whirlin mainly expresses the 
long isoform in the retina and the long and C-terminal isoforms in the inner ear (Yang et al., 
2010). Because both the PDZ domain and PR region are protein interaction modules, whirlin 
is believed to be implicated in the assembly of multi-protein complexes at specific 
subcellular locations, similar to harmonin.  
2.3 USH3 and USH related genes 
The only gene currently identified in USH3 is clarin-1 for the USH3A locus (Joensuu et al., 
2001; Adato et al., 2002; Fields et al., 2002). Like other USH genes, clarin-1 has multiple 
transcript variants due to different splicings and usages of transcription start sites 





transmembrane domains and a C-terminal potential PBM (Figure 3). Clarin-1 shows a 
sequence homologous to stargazin, an auxiliary subunit of ion channels in the synapse 
(Osten and Stern-Bach, 2006; Tomita et al., 2007). Presently, several research groups are 
intensively focusing on understanding this gene (Aarnisalo et al., 2007; Geller et al., 2009; 
Geng et al., 2009; Tian et al., 2009; Zallocchi et al., 2009). However, the biological function 
and cellular expression of clarin-1 still remain elusive.  
 
Fig. 3. Domain structure of USH3A 
Recently, PDZD7 was shown to be a modifier gene for the retinal symptom in USH2A 
patients and, together with USH2A or GPR98, to contribute to a digenic USH form 
(Ebermann et al., 2010). Interestingly, this newly identified USH modifier and contributor 
gene is also a homolog of harmonin. It has several isoforms (Schneider et al., 2009; 
Ebermann et al., 2010). The long isoform has three PDZ domains and one PR region. The 
two short isoforms are the N-terminal fragments of the long isoform with only two PDZ 
domains. However, the short isoforms have not been confirmed at the protein level. Similar 
to both harmonin and whirlin, different mutations in PDZD7 are involved in either USH or 
nonsyndromic deafness. A homozygous reciprocal translocation, 46,XY,t(10;11)(q24;q23), 
was found to disrupt the PDZD7 gene at intron 10, which causes nonsyndromic congenital 
hearing impairment (Schneider et al., 2009). A heterozygous p.R56PfsX mutation of PDZD7 
was found to exacerbate retinal degeneration in an USH2A patient, compared to her sibling 
carrying the same USH2A mutation. Additionally, the heterozygous mutations of PDZD7, 
c.1750-2A>G and p.C732LfsX, are present in USH patients with a heterozygous USH2A 
mutation, p.R1505SfsX, and with a heterozygous GPR98 mutation, p.C732LfsX, respectively 
(Ebermann et al., 2010). 
3. Animal models  
Numerous spontaneous and transgenic USH animal models are now available. Table 1 lists 
the detailed information about the mouse models. The majority of these models show 
congenital hearing loss as expected. However, only a few of them, Ush1c knockin, Ush2a 
knockout, and whirlin knockout mice, manifest obvious widespread retinal degeneration. 
Ush1cdfcr mice on some specific genomic background and Myo7a4626SB and Cdh23V double 
mutant mice show only slight retinal degeneration (Johnson et al., 2003; Lillo et al., 2003; 
Williams et al., 2009). Among the rest of the USH mouse models, some Myo7a, Cdh23, 
Pcdh15, and Grp98 mutant strains show abnormal electroretinogram (ERG) responses but no 
retinal degeneration (Libby and Steel, 2001; Libby et al., 2003; Haywood-Watson et al., 2006; 
McGee et al., 2006), indicating that the function of photoreceptors is compromised. The 
reasons for the discrepancy between USH patient symptoms and USH mutant mouse 
phenotypes are largely unclear. Many factors could contribute to this, such as the gene 
isoform composition, mutation type and position in the genes, genomic background, 
redundant protein compensation, photoreceptor structure and physiology, influence of non-
genetic factors, sensitivity of diagnostic measures, etc. (El-Amraoui and Petit, 2005). 
Additionally, although retinitis pigmentosa in USH is characterized to have an onset before 
 
Usher Syndrome: Genes, Proteins, Models, Molecular Mechanisms, and Therapies 
 
299 
or during puberty (Smith et al., 1994; Petit, 2001), more and more atypical USH patients 
have been found (Edwards et al., 1998; Sadeghi et al., 2006; Cohen et al., 2007; Fishman et al., 
2007; Sandberg et al., 2008; Malm et al, 2010.; Bashir et al., 2011). These patients have 
relatively late onset vision loss, which may explain the lack of retinal phenotype in most 
USH mutant mice, whose lifespan is only about two years. 
Zebrafish models for several USH genes have also been reported, including mariner (myo7a), 
ush1c, sputnik (cdh23), and orbiter (pcdh15) (Phillips et al., 2011; Nicolson et al., 1998; Ernest 
et al., 2000; Sollner et al., 2004; Seiler et al., 2005). Defects in hearing, balance, and vision are 
manifested during the early life in two ush1c mutants. Interestingly, zebrafish has two 
orthologs of PCDH15. Disruption of one leads to the auditory and vestibular dysfunction, 
while disturbance of the other results in defects in the photoreceptor structure and retinal 
function. Mariner exhibits similar phenotypes to Myo7a mice in hearing, balance and vision. 
Sputnik has problems with the auditory and vestibular system, but its vision phenotype has 
not been reported. Currently, studies on other USH genes in zebrafish using the morpholino 
knockdown technique are being actively pursued (Ebermann et al., 2010).  Moreover, a rat 
model with a point mutation leading to premature truncation of Myo7a was generated by N-
ethyl-N-nitrosourea mutagenesis and named Tornado (Smits et al., 2005). In this model, 
hearing but not vision defects have been characterized. Therefore, exploration of USH genes 
in more vertebrate organisms will provide additional ways to understand the biological 
functions of these genes, in particular, in the retina. 
Model name Mutations Phenotypes References 
USH1    
Myo7a    
Myo7ash1 p.R502P Circling, head tossing, hearing 
impairment 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a6J p.R241P Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a26SB p.F1762I Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a816SB p.L646_Q655del Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a3336SB p.C2144X Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a4494SB p.A246fs?X5 Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Liu et al., 1999; Libby 
and Steel, 2001) 
Myo7a4626SB p.Q720X Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
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was found to disrupt the PDZD7 gene at intron 10, which causes nonsyndromic congenital 
hearing impairment (Schneider et al., 2009). A heterozygous p.R56PfsX mutation of PDZD7 
was found to exacerbate retinal degeneration in an USH2A patient, compared to her sibling 
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c.1750-2A>G and p.C732LfsX, are present in USH patients with a heterozygous USH2A 
mutation, p.R1505SfsX, and with a heterozygous GPR98 mutation, p.C732LfsX, respectively 
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Numerous spontaneous and transgenic USH animal models are now available. Table 1 lists 
the detailed information about the mouse models. The majority of these models show 
congenital hearing loss as expected. However, only a few of them, Ush1c knockin, Ush2a 
knockout, and whirlin knockout mice, manifest obvious widespread retinal degeneration. 
Ush1cdfcr mice on some specific genomic background and Myo7a4626SB and Cdh23V double 
mutant mice show only slight retinal degeneration (Johnson et al., 2003; Lillo et al., 2003; 
Williams et al., 2009). Among the rest of the USH mouse models, some Myo7a, Cdh23, 
Pcdh15, and Grp98 mutant strains show abnormal electroretinogram (ERG) responses but no 
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isoform composition, mutation type and position in the genes, genomic background, 
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or during puberty (Smith et al., 1994; Petit, 2001), more and more atypical USH patients 
have been found (Edwards et al., 1998; Sadeghi et al., 2006; Cohen et al., 2007; Fishman et al., 
2007; Sandberg et al., 2008; Malm et al, 2010.; Bashir et al., 2011). These patients have 
relatively late onset vision loss, which may explain the lack of retinal phenotype in most 
USH mutant mice, whose lifespan is only about two years. 
Zebrafish models for several USH genes have also been reported, including mariner (myo7a), 
ush1c, sputnik (cdh23), and orbiter (pcdh15) (Phillips et al., 2011; Nicolson et al., 1998; Ernest 
et al., 2000; Sollner et al., 2004; Seiler et al., 2005). Defects in hearing, balance, and vision are 
manifested during the early life in two ush1c mutants. Interestingly, zebrafish has two 
orthologs of PCDH15. Disruption of one leads to the auditory and vestibular dysfunction, 
while disturbance of the other results in defects in the photoreceptor structure and retinal 
function. Mariner exhibits similar phenotypes to Myo7a mice in hearing, balance and vision. 
Sputnik has problems with the auditory and vestibular system, but its vision phenotype has 
not been reported. Currently, studies on other USH genes in zebrafish using the morpholino 
knockdown technique are being actively pursued (Ebermann et al., 2010).  Moreover, a rat 
model with a point mutation leading to premature truncation of Myo7a was generated by N-
ethyl-N-nitrosourea mutagenesis and named Tornado (Smits et al., 2005). In this model, 
hearing but not vision defects have been characterized. Therefore, exploration of USH genes 
in more vertebrate organisms will provide additional ways to understand the biological 
functions of these genes, in particular, in the retina. 
Model name Mutations Phenotypes References 
USH1    
Myo7a    
Myo7ash1 p.R502P Circling, head tossing, hearing 
impairment 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a6J p.R241P Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a26SB p.F1762I Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a816SB p.L646_Q655del Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a3336SB p.C2144X Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a4494SB p.A246fs?X5 Circling, head tossing, 
deafness 
(Mburu et al., 1997; 
Liu et al., 1999; Libby 
and Steel, 2001) 
Myo7a4626SB p.Q720X Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 






Model name Mutations Phenotypes References 
Myo7a7J p.A1363AfsX27 Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001; Yang et al., 
2011) 
Myo7aHdb p.I178F Circling, head tossing, low-
frequency hearing impairment
(Rhodes et al., 2004) 
Myo7a8J Not known Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a9J Not known Circling?, head tossing?, 
deafness?, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Harmonin    
Ush1c knockout Replacement of 
exons 1-4 with β-
gal/neo cassette 
Circling, head tossing, 
deafness 
(Tian et al., 2010) 
Ush1cdfcr A deletion 
involving exons 12-
15, A-D 
Circling, head tossing, 
deafness, slight retinal 
degeneration at 9 months of 
age 
(Johnson et al., 2003) 
Ush1cdfcr-2J One bp deletion in 
exon C 
Circling, head tossing, 
deafness 
(Johnson et al., 2003) 
Ush1ctm1.1Ugds Exon 1 deletion Circling, head tossing, 
deafness 
(Lefevre et al., 2008) 
Ush1c knockin c.216G>A Circling, head tossing, 
deafness, retinal degeneration 
(Lentz et al., 2007; 
Lentz et al., 2010) 
Ush1c-PDZ2AAA Replacement of 
GLG (221-223aa) in 
PDZ2 with AAA 
Hair bundle defect (Grillet et al., 2009) 
Cdh23    
jera p.V2360E deafness (Manji et al., 2011) 
erlong p.S70P Circling, head tossing, 
deafness 
(Han et al., 2010) 
salsa p.E737V Circling, head tossing, 
deafness 
(Schwander et al., 
2009) 
Cdh23V p.N279EfsX39 Circling, head tossing, 
deafness, reduced ERG 
responses 
(Wilson et al., 2001; 
Libby et al., 2003) 
Cdh23V-J p.E1169NfsX7 Circling, head tossing, 
deafness 
(Wilson et al., 2001) 
Cdh23V-2J c.4104 + 1G>A Circling, head tossing, 
deafness, faster ERG responses
(Di Palma et al., 
2001b; Libby et al., 
2003) 
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Model name Mutations Phenotypes References 
Cdh23V-3J p.W1764X Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V4J p.N2718del3 Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V5J p.R2935X Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V-6J p.E302X Circling, head tossing, 
deafness 
(Di Palma et al., 
2001b) 
Cdh23V-7J p.Y1197MfsX47 Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V-ngt p.G49VfsX3 Circling, head tossing, 
deafness 
(Wada et al., 2001) 
Cdh23V-Alb c.1635C>Tdel119 Circling, head tossing, 
deafness, normal ERG 
responses 
(Di Palma et al., 
2001b; Libby et al., 
2003) 
Cdh23Vbus c.9633 + 1G>A Circling, head tossing, 
deafness 
(Yonezawa et al., 
2006) 
Cdh23Ahl c.753G>A Susceptibility to age-related 
hearing loss 
(Noben-Trauth et al., 
2003) 
Pcdh15    
Pcdh15av-J p.A645_K922del Circling, head tossing, 
deafness, normal retinal 
function 
(Alagramam et al., 
2001a; Ball et al., 
2003) 
Pcdh15av-2J p.D31_N57del  Circling, head tossing, 
deafness, normal retinal 
function 
(Alagramam et al., 
2001a; Ball et al., 
2003) 
Pcdh15av-3J p.E1373RfsX36 Circling, head tossing, 
deafness, normal retinal 
function 
(Alagramam et al., 
2001a; Ball et al., 
2003) 
Pcdh15av-5J IVS14-2A>G Circling, head tossing, 
deafness, reduced ERG 
responses 
(Washington et al., 
2005; Haywood-
Watson et al., 2006) 
Pcdh15av-6J p.G962_K1008del Circling, head tossing, 
deafness 
(Alagramam et al., 
2011) 
Pcdh15av-Jfb p.D701GfsX17 Circling, head tossing, 
deafness, reduced ERG 
responses 
(Hampton et al., 
2003; Haywood-
Watson et al., 2006) 
Pcdh15av-
TgN2742Rpw 
A large insertion Circling, head tossing, 
deafness, normal retinal 
function 
(Alagramam et al., 
2001a; Ball et al., 
2003) 
Sans    
Ush1gjs p.E228RfsX8 Circling, head tossing, 
deafness 





Model name Mutations Phenotypes References 
Myo7a7J p.A1363AfsX27 Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001; Yang et al., 
2011) 
Myo7aHdb p.I178F Circling, head tossing, low-
frequency hearing impairment
(Rhodes et al., 2004) 
Myo7a8J Not known Circling, head tossing, 
deafness, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Myo7a9J Not known Circling?, head tossing?, 
deafness?, reduced ERG 
(Mburu et al., 1997; 
Libby and Steel, 
2001) 
Harmonin    
Ush1c knockout Replacement of 
exons 1-4 with β-
gal/neo cassette 
Circling, head tossing, 
deafness 
(Tian et al., 2010) 
Ush1cdfcr A deletion 
involving exons 12-
15, A-D 
Circling, head tossing, 
deafness, slight retinal 
degeneration at 9 months of 
age 
(Johnson et al., 2003) 
Ush1cdfcr-2J One bp deletion in 
exon C 
Circling, head tossing, 
deafness 
(Johnson et al., 2003) 
Ush1ctm1.1Ugds Exon 1 deletion Circling, head tossing, 
deafness 
(Lefevre et al., 2008) 
Ush1c knockin c.216G>A Circling, head tossing, 
deafness, retinal degeneration 
(Lentz et al., 2007; 
Lentz et al., 2010) 
Ush1c-PDZ2AAA Replacement of 
GLG (221-223aa) in 
PDZ2 with AAA 
Hair bundle defect (Grillet et al., 2009) 
Cdh23    
jera p.V2360E deafness (Manji et al., 2011) 
erlong p.S70P Circling, head tossing, 
deafness 
(Han et al., 2010) 
salsa p.E737V Circling, head tossing, 
deafness 
(Schwander et al., 
2009) 
Cdh23V p.N279EfsX39 Circling, head tossing, 
deafness, reduced ERG 
responses 
(Wilson et al., 2001; 
Libby et al., 2003) 
Cdh23V-J p.E1169NfsX7 Circling, head tossing, 
deafness 
(Wilson et al., 2001) 
Cdh23V-2J c.4104 + 1G>A Circling, head tossing, 
deafness, faster ERG responses
(Di Palma et al., 
2001b; Libby et al., 
2003) 
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Model name Mutations Phenotypes References 
Cdh23V-3J p.W1764X Circling, head tossing, 
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(Di Palma et al., 
2001a) 
Cdh23V4J p.N2718del3 Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V5J p.R2935X Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V-6J p.E302X Circling, head tossing, 
deafness 
(Di Palma et al., 
2001b) 
Cdh23V-7J p.Y1197MfsX47 Circling, head tossing, 
deafness 
(Di Palma et al., 
2001a) 
Cdh23V-ngt p.G49VfsX3 Circling, head tossing, 
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(Wada et al., 2001) 
Cdh23V-Alb c.1635C>Tdel119 Circling, head tossing, 
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responses 
(Di Palma et al., 
2001b; Libby et al., 
2003) 
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(Yonezawa et al., 
2006) 
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2003) 
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responses 
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2005; Haywood-
Watson et al., 2006) 
Pcdh15av-6J p.G962_K1008del Circling, head tossing, 
deafness 
(Alagramam et al., 
2011) 
Pcdh15av-Jfb p.D701GfsX17 Circling, head tossing, 
deafness, reduced ERG 
responses 
(Hampton et al., 
2003; Haywood-
Watson et al., 2006) 
Pcdh15av-
TgN2742Rpw 
A large insertion Circling, head tossing, 
deafness, normal retinal 
function 
(Alagramam et al., 
2001a; Ball et al., 
2003) 
Sans    
Ush1gjs p.E228RfsX8 Circling, head tossing, 
deafness 





Model name Mutations Phenotypes References 
Ush1gjs-2J p.L81GfsX103 Circling, head tossing, 
deafness 
* 
Ush1gF1 Exon 2 flanked 
with FRT sites 
Hearing defects after deletion 
of exon 2 
(Caberlotto et al., 
2011) 
USH2    
Ush2a    
Ush2a knockout replacement of 
exon 5 with a 
neomycinr cassette 
hearing impairment, retinal 
degeneration  
(Liu et al., 2007) 
Gpr98    
Gpr98 knockout replacement of 





(Yagi et al., 2005; 




exons 2-4 with a 
EYFP-neomycinr 
cassette 
defects in hair cell stereocilia  (Yagi et al., 2007) 
Frings & 
BUB/BnJ 
a G deletion at 6864 
bp (NM_054053) 





(Skradski et al., 2001; 
Johnson et al., 2005) 
Gpr98/del7TM replacement of 




impairment, mildly abnormal 
ERG responses 
(McMillan and 
White, 2004; McGee 
et al., 2006) 
Whrn    
Whrn knockout partial replacement 
of exon 1 with a 
neomycinr cassette 
hearing impairment, retinal 
degeneration  
(Yang et al., 2010) 




hearing impairment, no retinal 
degeneration 
(Lane, 1963; Holme et 
al., 2002; Mburu et 
al., 2003; Yang et al., 
2010) 
USH3    
Ush3a    
Ush3a knockout Disruption and 
deletion of 
promoter and exon 
1  
Circling, head tossing, 
deafness 
(Geller et al., 2009) 
MYO7A: NP_032689, CDH23: NP_075859, PCDH15: NP_075604, SANS: NP_789817 
*: our unpublished data.  
Table 1. USH mutant mouse models 
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4. Cellular localization of USH proteins  
Defects in USH proteins result in Usher syndrome, nonsyndromic deafness, or retinitis 
pigmentosa, indicating that these proteins are essential in the inner ear and the retina. 
Therefore, extensive efforts have been put to investigate the cellular location of these 
proteins in these two tissues. The cellular localization of USH proteins in other tissues is 
relatively unclear, although some USH proteins are known to be present in the kidney, 
colon, brain, lung, olfactory neuron, ovary, oviduct, testes and intestine (el-Amraoui et al., 
1996; Hasson et al., 1997; Wolfrum et al., 1998; Kobayashi et al., 1999; Scanlan et al., 1999; 
Bhattacharya et al., 2002; Pearsall et al., 2002).  
 
Fig. 4. Schematic diagrams of a rod photoreceptor and a hair cell 
4.1 USH proteins in the inner ear 
The inner ear is composed of the cochlea and vestibular system for hearing and balance, 
respectively. In the vestibular system, hair cells exist in the maculae of the saccule and 
utricle and the cristae ampullares of the semicircular canals. In the cochlea, one row of inner 
hair cells and three rows of outer hair cells exist in the organ of Corti. The inner hair cells are 
responsible for mechanoelectric transduction, whereas the electromotile outer hair cells also 
perform an electromechanical transduction, thereby amplifying the sound-evoked 
vibrations of the entire sensory epithelium (Leibovici et al., 2008). All types of hair cells have 
stereocilia on their apical surfaces, which are modified microvilli filled with bundles of actin 
filaments. The stereocilia are well-organized into rows of different lengths and form a 
staircase-like hair bundle (Figure 4). Along with the hair bundle, there exists a real cilium, 
called kinocilium, which is filled with microtubules. Various links have been discovered 
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adulthood (Goodyear and Richardson, 1999; Goodyear and Richardson, 2003; Goodyear et 
al., 2005).  
The distribution of USH proteins in hair cells vary dramatically from the emergence of 
stereocilia to their maturation. All USH1 proteins are present either at the tip, the ankle 
links, the transient lateral links, or the kinociliary links of the stereocilia during the early 
stage of development. They are then restricted to the tip link and the accessory structures of 
the tip link, the upper (UTLD) and lower (LTLD) tip link densities, in mature hair cells 
(Figure 4) (Kussel-Andermann et al., 2000; Senften et al., 2006; Lefevre et al., 2008; Grillet et 
al., 2009; Bahloul et al., 2010; Caberlotto et al., 2011; Grati and Kachar, 2011). USH2 proteins 
are localized at the ankle links of the stereocilia (McGee et al., 2006; van Wijk et al., 2006; 
Michalski et al., 2007; Yang et al., 2010), which is a transient structure existing only during 
development (Goodyear et al., 2005). Whirlin is also present at the tip of stereocilia in the 
vestibular and cochlear hair cells all the time (Belyantseva et al., 2005; Delprat et al., 2005; 
Kikkawa et al., 2005). Clarin-1 was found at the stereocilia on postnatal day 0 (Zallocchi et 
al., 2009). Besides their location at the stereocilia, some USH proteins were found at the 
synaptic region of the outer and inner hair cells (Reiners et al., 2005b; van Wijk et al., 2006; 
Zallocchi et al., 2009), the cell body of the spinal ganglia (Alagramam et al., 2001b; Adato et 
al., 2002; van Wijk et al., 2006), the supporting cells (Alagramam et al., 2001b; Adato et al., 
2005a; Adato et al., 2005b), various nervous fibers (van Wijk et al., 2006), and Reissner’s 
membrane (Wilson et al., 2001; Lagziel et al., 2005). However, these distributions of USH 
proteins need to be further verified, because the specificity of antibodies used in the studies 
were not confirmed in their corresponding mutant mice. 
4.2 USH proteins in the retina 
In the retina, USH proteins are mainly localized in the photoreceptors (Kremer et al., 2006; 
Reiners et al., 2006; van Wijk et al., 2006; Liu et al., 2007; Maerker et al., 2008; Yang et al., 
2010). The photoreceptor is a highly polarized sensory neuron converting light signals to 
electrical impulses. It consists of the outer segment, connecting cilium, inner segment, cell 
body, and synaptic terminus (Figure 4). It contacts Muller cells at the adherens junction (the 
outer limiting membrane in the retina). Its outer segment is immediately next to the retinal 
pigment epithelium (RPE) cells. 
Compared with the studies in the inner ear, the cellular location of USH proteins is less well 
defined in the retina. All the USH proteins were once localized in the synaptic ends of 
photoreceptors (Reiners et al., 2005a; Reiners et al., 2005b; Maerker et al., 2008). However, 
these results are not conclusive (Williams, 2008; Saihan et al., 2009). They are not supported 
by the phenotypic analyses in USH mutant mice and the symptom manifestation in USH 
patients. For instance, ultrastructural abnormalities were not found at the synaptic terminus 
of photoreceptors in USH mice by electron microscopy (Self et al., 1998; Williams et al., 2009; 
Yang et al., 2010). No defective ERG waveforms typically resulting from abnormal 
photoreceptor synaptic transmission have been detected in USH mutant mice (Libby and 
Steel, 2001; Ball et al., 2003; Libby et al., 2003; Haywood-Watson et al., 2006; McGee et al., 
2006; Liu et al., 2007; Yang et al., 2010) or in USH patients.  
In addition to the synaptic distribution, MYO7A and SANS were shown to be present 
around the connecting cilium, harmonin at the outer segment, CDH23 in the inner segment, 
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and PCDH15 at the base of the outer segment by one research group (Ahmed et al., 2003; 
Reiners et al., 2005a; Maerker et al., 2008). However, other research groups did not find 
harmonin in the outer segment (Williams et al., 2009), and MYO7A was demonstrated to be 
predominantly expressed in the RPE cells (Hasson et al., 1995; el-Amraoui et al., 1996; Lopes 
et al., 2011). USH2 proteins were initially localized to the inner segment, adherens junction, 
connecting cilium, basal bodies, and synaptic terminus in photoreceptors (Figure 4) (Kremer 
et al., 2006; Reiners et al., 2006; van Wijk et al., 2006; Maerker et al., 2008; Lagziel et al., 2009). 
With the antibodies whose specificities have been confirmed in their respective mutant 
mice, the three USH2 proteins were recently localized to the periciliary membrane complex 
(PMC) around the connecting cilium (Figure 4) (Liu et al., 2007; Yang et al., 2010; Yang et al., 
2011; Zou et al., 2011). Finally, the distribution of clarin-1 in the retina is controversial. One 
report shows that it is present around the connecting cilium in photoreceptors (Zallocchi et 
al., 2009), while the other indicates that clarin-1 is restricted to the Muller cells but not 
photoreceptors (Geller et al., 2009).  
The calycal processes in photoreceptors are thought as an analogous structure to the 
stereocilia in hair cells (Goodyear and Richardson, 1999). They are well developed in 
humans, frogs and other species. In mice, only cone photoreceptors have obvious calycal 
processes (Cohen, 1965; Fetter and Corless, 1987; Rana and Taraszka, 1991). GPR98 and 
CDH23 are localized at the calycal processes in mouse cone photoreceptors, while whirlin is 
not evident at this structure in frog photoreceptors (Goodyear and Richardson, 1999; Yang et 
al., 2010). 
5. The USH protein complexes  
The indistinguishable symptoms within the same USH clinical type and the similar 
symptoms across different USH clinical types indicate that various USH proteins probably 
participate in the same cellular pathway in a broad sense. Among the USH proteins, 
harmonin, whirlin and SANS possess multiple protein-protein interaction domains and are 
proposed to be scaffold proteins in multi-protein complexes. Biochemical assays have 
indeed revealed the existence of their self-interactions and interactions with most of other 
USH proteins in vitro (Table 2). Interestingly, the in vitro interactions among different USH1 
and/or USH2 proteins exist extensively (Table 2). One USH protein is generally able to 
interact with at least three other USH proteins. In most cases, different regions of the same 
protein are involved in its binding to different USH proteins (Table 2). Although these 
interactions have not been individually confirmed in vivo, harmonin, MYO7A, and CDH23 
were recently reported to form a ternary complex in hair cells (Bahloul et al., 2010). Based on 
these findings, it has been hypothesized that USH proteins form an interacting network, an 
interactome, in both hair cells and photoreceptors (Richardson et al.; Kremer et al., 2006; 
Reiners et al., 2006; Saihan et al., 2009; Millan et al., 2011).   
The above hypothesis is supported by the facts that ablation of one USH protein in mice 
causes mislocation and/or disappearance of at least one other USH protein in hair cells 
(Table 3). This phenomenon occurs across USH1 and USH2 proteins. Normal distribution of 
the three USH2 proteins depends on MYO7A and the distribution of some CDH23 isoform 
at the tip of the stereocilia relies on GPR98 (Table 3). However, the USH1 and USH2 proteins 
are present at the different interstereociliary links in hair cells during development. 
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photoreceptors, the PMC and the synapse. Due to these different cellular locations of USH 
proteins, it is reasonable to propose that more than one USH protein complex exist and they 
play different but highly related roles in a broad cellular process (Williams, 2008; Yang et al., 
2011).  
Proteins/domains Interacting proteins/domains References 
MYO7A   
MyTH4-FERM Harmonin/PDZ1 (Boeda et al., 2002) 
Tail CDH23/not determined (Bahloul et al., 2010) 
SH2 PCDH15 (Senften et al., 2006) 
MyTH4-FERM SANS/cen (Wu et al., 2011; Adato et al., 2005b) 
MyTH4-FERM USH2A/cytoplasmic region (Michalski et al., 2007) 
MyTH4-FERM GPR98/cytoplasmic region (Michalski et al., 2007) 
Not determined Whirlin/not determined (Delprat et al., 2005) 
Harmonin   
PDZ1 MYO7A/MyTH4-FERM (Boeda et al., 2002) 
N-terminus, 
PDZ1/2 CDH23/PBMs 
(Boeda et al., 2002; Siemens et al., 
2002; Grillet et al., 2009; Pan et al., 
2009; Bahloul et al., 2010) 
PDZ2 PCDH15/CD1 PBM (Adato et al., 2005b; Reiners et al., 2005b; Senften et al., 2006) 
PDZ1/3 SANS/SAM, PBM (Adato et al., 2005b; Yan et al., 2010) 
PDZ1 USH2A/PBM (Reiners et al., 2005b) 
PDZ1 GPR98/PBM  (Reiners et al., 2005b) 
PDZ1/2, CC2 Harmonin/PBM, CC2 (Siemens et al., 2002; Adato et al., 2005b) 
CDH23   
not determined MYO7A/tail (Bahloul et al., 2010) 
2 PBMs Harmonin/N-terminus, PDZ1, PDZ2 
(Boeda et al., 2002; Siemens et al., 
2002; Grillet et al., 2009; Pan et al., 
2009; Bahloul et al., 2010) 
EC1-3 PCDH15/EC1 (Kazmierczak et al., 2007) 
Cytoplasmic 
region SANS/not determined (Caberlotto et al., 2011) 
ECs CDH23/ECs (Siemens et al., 2004; Kazmierczak et al., 2007) 
PCDH15   
Cytoplasmic 
region MYO7A/SH2 (Senften et al., 2006) 
CD1 PBM Harmonin/PDZ2 (Adato et al., 2005b; Reiners et al., 2005b; Senften et al., 2006) 
EC1 CDH23/EC1-3 (Kazmierczak et al., 2007) 
CD2/CD3 SANS/not determined (Caberlotto et al., 2011) 
ECs PCDH15/ECs (Kazmierczak et al., 2007) 
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Proteins/domains Interacting proteins/domains References 
SANS   
cen MYO7A/MyTH4-FERM (Wu et al, 2011.; Adato et al., 2005b) 
SAM, PBM Harmonin/PDZ1 (Weil et al., 2003; Yan et al., 2010) 
Not determined CDH23/cytoplasmic region (Caberlotto et al., 2011) 
Not determined PCDH15/CD2, CD3 (Caberlotto et al., 2011) 
PBM Whirlin/PDZ1-PDZ2 (Maerker et al., 2008) 
cen SANS/cen (Adato et al., 2005b) 
USH2A   
Cytoplasmic 
region MYO7A/MyTH4-FERM (Michalski et al., 2007) 
PBM Harmonin/PDZ1 (Reiners et al., 2005b) 
PBM Whirlin/PDZ1-PDZ2 (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
GPR98   
Cytoplasmic 
region MYO7A/MyTH4-FERM (Michalski et al., 2007) 
PBM Harmonin/PDZ1 (Reiners et al., 2005b) 
PBM Whirlin/PDZ1-PDZ2 (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
Whirlin   
Not determined MYO7A/not determined (Delprat et al., 2005) 
PDZ1-PDZ2 SANS/PBM (Maerker et al., 2008) 
PDZ1-PDZ2 USH2A/PBM (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
PDZ1-PDZ2 GPR98/PBM (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
PDZ1-PDZ2, PR-
PDZ3 Whirlin/PDZ1-PDZ2, PR-PDZ3 
(Delprat et al., 2005; Yang et al., 
2010) 
Table 2. Interactions among USH proteins 
In hair cells, the normal cellular localization of harmonin requires the presence of all other 
USH1 proteins, and loss of harmonin seems not to affect the localization of other USH1 
proteins (Table 3), indicating that harmonin is dispensable for locating these USH1 proteins to 
their normal position in cells. In contrast, CDH23 is relatively independent on other USH1 
proteins, and its loss results in mislocalization of the two putative scaffold proteins, harmonin 
and SANS (Table 3). Therefore, CDH23 may play a crucial role in anchoring/tethering USH1 
proteins. Harmonin and SANS may help hold the USH1 proteins in the complex. 
Besides the known USH proteins, many other putative components in the USH complexes 
has been identified. These components are able to interact with at least one of the USH 
proteins as shown by biochemical assays. For the currently known USH2-interacting 
proteins, please see the review (Yang et al., 2011). However, additional experiments are 
necessary to verify the existence of these putative components in the USH complexes in vivo 





photoreceptors, the PMC and the synapse. Due to these different cellular locations of USH 
proteins, it is reasonable to propose that more than one USH protein complex exist and they 
play different but highly related roles in a broad cellular process (Williams, 2008; Yang et al., 
2011).  
Proteins/domains Interacting proteins/domains References 
MYO7A   
MyTH4-FERM Harmonin/PDZ1 (Boeda et al., 2002) 
Tail CDH23/not determined (Bahloul et al., 2010) 
SH2 PCDH15 (Senften et al., 2006) 
MyTH4-FERM SANS/cen (Wu et al., 2011; Adato et al., 2005b) 
MyTH4-FERM USH2A/cytoplasmic region (Michalski et al., 2007) 
MyTH4-FERM GPR98/cytoplasmic region (Michalski et al., 2007) 
Not determined Whirlin/not determined (Delprat et al., 2005) 
Harmonin   
PDZ1 MYO7A/MyTH4-FERM (Boeda et al., 2002) 
N-terminus, 
PDZ1/2 CDH23/PBMs 
(Boeda et al., 2002; Siemens et al., 
2002; Grillet et al., 2009; Pan et al., 
2009; Bahloul et al., 2010) 
PDZ2 PCDH15/CD1 PBM (Adato et al., 2005b; Reiners et al., 2005b; Senften et al., 2006) 
PDZ1/3 SANS/SAM, PBM (Adato et al., 2005b; Yan et al., 2010) 
PDZ1 USH2A/PBM (Reiners et al., 2005b) 
PDZ1 GPR98/PBM  (Reiners et al., 2005b) 
PDZ1/2, CC2 Harmonin/PBM, CC2 (Siemens et al., 2002; Adato et al., 2005b) 
CDH23   
not determined MYO7A/tail (Bahloul et al., 2010) 
2 PBMs Harmonin/N-terminus, PDZ1, PDZ2 
(Boeda et al., 2002; Siemens et al., 
2002; Grillet et al., 2009; Pan et al., 
2009; Bahloul et al., 2010) 
EC1-3 PCDH15/EC1 (Kazmierczak et al., 2007) 
Cytoplasmic 
region SANS/not determined (Caberlotto et al., 2011) 
ECs CDH23/ECs (Siemens et al., 2004; Kazmierczak et al., 2007) 
PCDH15   
Cytoplasmic 
region MYO7A/SH2 (Senften et al., 2006) 
CD1 PBM Harmonin/PDZ2 (Adato et al., 2005b; Reiners et al., 2005b; Senften et al., 2006) 
EC1 CDH23/EC1-3 (Kazmierczak et al., 2007) 
CD2/CD3 SANS/not determined (Caberlotto et al., 2011) 
ECs PCDH15/ECs (Kazmierczak et al., 2007) 
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Proteins/domains Interacting proteins/domains References 
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cen MYO7A/MyTH4-FERM (Wu et al, 2011.; Adato et al., 2005b) 
SAM, PBM Harmonin/PDZ1 (Weil et al., 2003; Yan et al., 2010) 
Not determined CDH23/cytoplasmic region (Caberlotto et al., 2011) 
Not determined PCDH15/CD2, CD3 (Caberlotto et al., 2011) 
PBM Whirlin/PDZ1-PDZ2 (Maerker et al., 2008) 
cen SANS/cen (Adato et al., 2005b) 
USH2A   
Cytoplasmic 
region MYO7A/MyTH4-FERM (Michalski et al., 2007) 
PBM Harmonin/PDZ1 (Reiners et al., 2005b) 
PBM Whirlin/PDZ1-PDZ2 (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
GPR98   
Cytoplasmic 
region MYO7A/MyTH4-FERM (Michalski et al., 2007) 
PBM Harmonin/PDZ1 (Reiners et al., 2005b) 
PBM Whirlin/PDZ1-PDZ2 (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
Whirlin   
Not determined MYO7A/not determined (Delprat et al., 2005) 
PDZ1-PDZ2 SANS/PBM (Maerker et al., 2008) 
PDZ1-PDZ2 USH2A/PBM (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
PDZ1-PDZ2 GPR98/PBM (Adato et al., 2005a; van Wijk et al., 2006; Yang et al., 2010) 
PDZ1-PDZ2, PR-
PDZ3 Whirlin/PDZ1-PDZ2, PR-PDZ3 
(Delprat et al., 2005; Yang et al., 
2010) 
Table 2. Interactions among USH proteins 
In hair cells, the normal cellular localization of harmonin requires the presence of all other 
USH1 proteins, and loss of harmonin seems not to affect the localization of other USH1 
proteins (Table 3), indicating that harmonin is dispensable for locating these USH1 proteins to 
their normal position in cells. In contrast, CDH23 is relatively independent on other USH1 
proteins, and its loss results in mislocalization of the two putative scaffold proteins, harmonin 
and SANS (Table 3). Therefore, CDH23 may play a crucial role in anchoring/tethering USH1 
proteins. Harmonin and SANS may help hold the USH1 proteins in the complex. 
Besides the known USH proteins, many other putative components in the USH complexes 
has been identified. These components are able to interact with at least one of the USH 
proteins as shown by biochemical assays. For the currently known USH2-interacting 
proteins, please see the review (Yang et al., 2011). However, additional experiments are 
necessary to verify the existence of these putative components in the USH complexes in vivo 






+: existence of mislocalization, -: normal localization, +/-, contradictory results 
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6. Functions of the USH complexes  
The severe and early-onset hearing phenotypes in various USH1 and USH2 mouse models 
make it relatively easier to decipher the functions of USH complexes in the inner ear than in 
the retina. The following will focus on the three main cellular processes generally believed 
to involve the USH complexes. Disruption of these USH functions is thought to be the 
molecular mechanisms underlying USH. 
6.1 Hair bundle cohesion 
During development, at the apex of hair cells, microvilli grow into stereocilia by recruiting 
more actin filaments. These stereocilia are bundled with transient lateral links and are 
connected with the kinocilium through kinociliary links. Following the establishment of the 
planar cell polarity, the kinocilium moves from the center to the periphery of the cell, and 
the stereocilia elongate differentially. The staircase-shape hair bundle is eventually formed. 
At the same time, the transient lateral links are gradually substituted by two distinct sets of 
interstereociliary links. They are the horizontal top connectors and the ankle links, close to 
the tip and base of the hair bundle, respectively (Figure 4). The tip links emerge, which are 
fibrous connections between the tip of medium and low stereocilia and the side of the 
neighboring taller stereocilia (Figure 4). Finally, the stereocilia grow both in length and in 
width and reach their mature size. In rodent mature cochlear hair cells, the ankle links and 
the kinociliary links disappear with the regression of the kinocilium (Frolenkov et al., 2004; 
Goodyear et al., 2005; Nayak et al., 2007).  
CDH23 (Siemens et al., 2004; Lagziel et al., 2005; Michel et al., 2005; Rzadzinska et al., 2005; 
Lefevre et al., 2008) and PCDH15 (Goodyear et al., 2010; Webb et al., 2011; Lefevre et al., 
2008) are localized at the transient lateral links and kinociliary links during early 
development of hair cells. In their mutant mice, hair bundles are usually splayed into 
several clumps; kinocilium is mispositioned and disconnected with the hair bundle (Lefevre 
et al., 2008), indicating that CDH23 and PCDH15, as components of the interstereociliary 
links, are important for hair bundle cohesion and that loss of the connection between the 
stereocilia and kinocilium causes the misorientation of the hair bundle. Interestingly, the 
mutant mouse models of all five USH1 genes share such similar phenotypes.  This could be 
explained by the idea that the five USH1 proteins coordinate in this function. The PST 
domain of harmonin b binds to and bundles actin filaments (Boeda et al., 2002). MYO7A is a 
high duty ratio motor, which binds to actin filament strongly. Therefore, these two actin-
binding proteins may anchor their interacting partners, CDH23 and PCDH15, to the actin 
bundle in the stereocilia of hair cells (Table 2). In Ush1g-/- mice, cohesion of stereocilia is 
disrupted. In Ush1gfl/flMyo7a-cre+/- mice, whose expression of SANS is disturbed only after 
birth, the stereocilia stay cohesive (Caberlotto et al., 2011). Therefore, SANS plays a role in 
stereocilia cohesion during the prenatal period. It may be involved in the organization of 
other USH1 proteins through directly interacting with them (Table 2).  
All three USH2 proteins, USH2A, GPR98, and whirlin, are positioned at the ankle links of 
hair cells. Among these proteins, USH2A and GPR98 probably interact with each other or 
with some unidentified cell adhesion proteins to form the ankle links. Whirlin interacts with 
USH2A and GPR98 through the PDZ domain-mediated binding to anchor them at the base 
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6. Functions of the USH complexes  
The severe and early-onset hearing phenotypes in various USH1 and USH2 mouse models 
make it relatively easier to decipher the functions of USH complexes in the inner ear than in 
the retina. The following will focus on the three main cellular processes generally believed 
to involve the USH complexes. Disruption of these USH functions is thought to be the 
molecular mechanisms underlying USH. 
6.1 Hair bundle cohesion 
During development, at the apex of hair cells, microvilli grow into stereocilia by recruiting 
more actin filaments. These stereocilia are bundled with transient lateral links and are 
connected with the kinocilium through kinociliary links. Following the establishment of the 
planar cell polarity, the kinocilium moves from the center to the periphery of the cell, and 
the stereocilia elongate differentially. The staircase-shape hair bundle is eventually formed. 
At the same time, the transient lateral links are gradually substituted by two distinct sets of 
interstereociliary links. They are the horizontal top connectors and the ankle links, close to 
the tip and base of the hair bundle, respectively (Figure 4). The tip links emerge, which are 
fibrous connections between the tip of medium and low stereocilia and the side of the 
neighboring taller stereocilia (Figure 4). Finally, the stereocilia grow both in length and in 
width and reach their mature size. In rodent mature cochlear hair cells, the ankle links and 
the kinociliary links disappear with the regression of the kinocilium (Frolenkov et al., 2004; 
Goodyear et al., 2005; Nayak et al., 2007).  
CDH23 (Siemens et al., 2004; Lagziel et al., 2005; Michel et al., 2005; Rzadzinska et al., 2005; 
Lefevre et al., 2008) and PCDH15 (Goodyear et al., 2010; Webb et al., 2011; Lefevre et al., 
2008) are localized at the transient lateral links and kinociliary links during early 
development of hair cells. In their mutant mice, hair bundles are usually splayed into 
several clumps; kinocilium is mispositioned and disconnected with the hair bundle (Lefevre 
et al., 2008), indicating that CDH23 and PCDH15, as components of the interstereociliary 
links, are important for hair bundle cohesion and that loss of the connection between the 
stereocilia and kinocilium causes the misorientation of the hair bundle. Interestingly, the 
mutant mouse models of all five USH1 genes share such similar phenotypes.  This could be 
explained by the idea that the five USH1 proteins coordinate in this function. The PST 
domain of harmonin b binds to and bundles actin filaments (Boeda et al., 2002). MYO7A is a 
high duty ratio motor, which binds to actin filament strongly. Therefore, these two actin-
binding proteins may anchor their interacting partners, CDH23 and PCDH15, to the actin 
bundle in the stereocilia of hair cells (Table 2). In Ush1g-/- mice, cohesion of stereocilia is 
disrupted. In Ush1gfl/flMyo7a-cre+/- mice, whose expression of SANS is disturbed only after 
birth, the stereocilia stay cohesive (Caberlotto et al., 2011). Therefore, SANS plays a role in 
stereocilia cohesion during the prenatal period. It may be involved in the organization of 
other USH1 proteins through directly interacting with them (Table 2).  
All three USH2 proteins, USH2A, GPR98, and whirlin, are positioned at the ankle links of 
hair cells. Among these proteins, USH2A and GPR98 probably interact with each other or 
with some unidentified cell adhesion proteins to form the ankle links. Whirlin interacts with 
USH2A and GPR98 through the PDZ domain-mediated binding to anchor them at the base 





dependence of the ankle links on USH2A and whirlin has not been examined. In the wild-
type mouse, the stereocilia of outer hair cells are organized into a V-shaped staircase-like 
hair bundle. However, in all three Ush2 mutant mice, the outer hair cells show various 
disorganized stereocilia and abnormal U-shape hair bundles (Mburu et al., 2003; McGee et 
al., 2006; Liu et al., 2007; Michalski et al., 2007; Yang et al., 2010). Accordingly, as 
components of the ankle links, the three USH2 proteins probably contribute to hair bundle 
cohesion as well. 
6.2 Mechanotransduction 
The stereocilia of hair cells are the cellular organelle conducting mechanotransduction. The 
vibration of the basilar membrane and tectorial membrane or the motion of endolymphatic 
fluid induces the hair bundle deflection. When the deflection is toward the longest 
stereocilia (the positive or excitatory direction), the transduction channels are open. The 
influx of Ca2+ and K+ through the channels elicits changes of the membrane potential and 
glutamate release at the ribbon synapse in hair cells. When the hair bundle moves away 
from the longest stereocilia (the negative or inhibitory direction), the transduction channels 
close, and the membrane potential and transmitter release resume their resting statuses. 
Although the molecular machinery of mechanotransduction is not well understood, the 
‘gating spring’ model is popular in the field. In this model, the tip link, whose axis is parallel 
to the direction of the mechanical sensitivity of the hair bundle, is thought as a sensor to the 
stretch of the hair bundle. Alternatively, an unknown structure attached to the tip link 
fulfills this function (Vollrath et al., 2007; Gillespie and Muller, 2009). The transduction 
channel was recently localized to the plasma membrane at the lower end of the tip link in 
the stereocilia (Beurg et al., 2008).  
In mature hair cells, CDH23 (Siemens et al., 2004; Sollner et al., 2004) and PCDH15 (Ahmed 
et al., 2006) were found associated with the tip links. CDH23 is mainly at the upper part and 
PCDH15 at the lower part of the links (Kazmierczak et al., 2007; Alagramam et al., 2011). In 
Cdh23V-2J and Pcdh15aw-6J mice, the tip links are missing. Additionally, the response of the 
mechanotransduction is reduced. In the absence of stimulus, a fraction of transduction 
channels keep open in the wild-type hair cells, due to the resting tension of the tip links. 
However, the transduction channels in these two mutants do not open or take up the styryl 
dye FM1-43 at rest (Senften et al., 2006; Alagramam et al., 2011). Therefore, CDH23 and 
PCDH15 are believed to be components of the tip links and to participate in 
mechanotransduction in mature hair cells. 
At the two ends of the tip link immediately beneath the stereocilia plasma membrane, there 
are electron-dense complexes, the UTLD and LTLD (Figure 4). Harmonin and MYO7A are 
present at the UTLD (Grillet et al., 2009; Michalski et al., 2009; Caberlotto et al., 2011; Grati 
and Kachar, 2011). In Myo7a6J, Myo7a4626SB, Ush1cdfcr, and Ush1cdfcr-2J mice, the adaptation of 
mechanotransduction, a process for the hair cells to recover their sensitivity under sustained 
mechanical stimulation, was found consistently abnormal, while the amplitude of 
mechanotransduction responses is sometimes normal (Kros et al., 2002; Grillet et al., 2009; 
Michalski et al., 2009). These results suggest that harmonin and MYO7A are involved in the 
transduction adaptation. SANS may exist at both the LTLD and UTLD (Caberlotto et al., 
2011; Grati and Kachar, 2011). Its loss in hair cells (Ush1g-/-) causes elimination of the tip 
links and reduction in both the amplitude and sensitivity of the transduction currents 
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(Caberlotto et al., 2011). In Ush1gfl/fl Myo7a-cre+/- mice, whose hair bundle morphology is 
intact, only the amplitude of transduction is affected. This finding indicates that SANS is 
implicated in mechanotransduction and plays a different role from harmonin or MYO7A. 
Gpr98 knockout and Gpr98del7TM mice also show defects in mechanotransduction, though 
there are some discrepancies between them (McGee et al., 2006; Michalski et al., 2007). In 
general, the sensitivity to the stimulation direction is changed in both outer and inner hair 
cells. The amplitude and sensitivity of the transduction current decrease in the outer hair 
cells, but are normal in the inner hair cells and the utricular hair cells. It is suggested that the 
misorganization of hair bundles in Gpr98 mutant mice accounts of the abnormal sensitivity 
direction. Alternatively, GPR98 could be indirectly related with the cellular process of 
mechanotransduction. 
6.3 Protein and organelle transport 
In photoreceptors, the outer segment is a large specialized cilium filled with many flat 
membrane disks, where phototransduction occurs (Figure 4). This cellular compartment 
undergoes continuous and rapid renewal (Young, 1967; LaVail, 1976; Young, 1976; Besharse 
and Hollyfield, 1979), which requires a large amount of proteins and membrane lipids to be 
synthesized in the inner segment and to be quickly transported to the base of the outer 
segment through the connecting cilium (Figure 4). The removal of the old outer segment is 
achieved through phagocytosis by RPE cells.  In addition, in both photoreceptors and RPE 
cells, several proteins, involved in phototransduction and retinoid cycle, translocate 
between two different cellular compartments in response to light (Artemyev, 2008; Slepak 
and Hurley, 2008; Lopes et al., 2011).  
Among USH proteins, MYO7A is an actin-based motor. In the retina, it is expressed in both 
RPE cells and photoreceptors. In RPE cells, MYO7A is essential for the transport of 
phagosomes to their degradation apparatus (Gibbs et al., 2003), tethering melanosomes 
during their movement (Gibbs et al., 2004), and the translocation of RPE65 responding to 
light exposure (Lopes et al., 2011). In photoreceptors, MYO7A is present along the 
connecting cilium. Loss of MYO7A was found to delay the transport of opsin from the inner 
to the outer segment (Liu et al., 1999) and the transducin translocation from the outer to the 
inner segment after light exposure (Peng et al., 2011). In hair cells, without MYO7A, all 
USH2 proteins are mislocalized from the ankle links (Table 3), suggesting that MYO7A may 
transport the USH2 proteins. These lines of evidence establish the notion that MYO7A may 
function in protein and organelle transport in various cells in the retina and the inner ear. 
USH2 proteins are positioned at the PMC in mammalian photoreceptors, which is an 
analogous structure to the periciliary ridge complex (PRC) in frogs (Peters et al., 1983). The 
PRC is a morphologically-specialized structure with a symmetrical array of 9 ridges and 9 
grooves. It has been proposed, based on immunocytochemistry and freeze-fracture electron 
microscopy, as the membrane fusion site for post-Golgi vesicles carrying opsin and 
docosahexaenoyl (DHA)-phospholipids before these cargos are transported from the inner 
to the outer segment (Peters et al., 1983; Papermaster et al., 1986; Rodriguez de Turco et al., 
1997; Papermaster, 2002). Additionally, Rab8, rac1, Sec8, moesin, syntaxin 3 and SNAP-25 
have been localized around the PRC in frog photoreceptors (Deretic et al., 2004; Mazelova et 
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PCDH15 at the lower part of the links (Kazmierczak et al., 2007; Alagramam et al., 2011). In 
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(Caberlotto et al., 2011). In Ush1gfl/fl Myo7a-cre+/- mice, whose hair bundle morphology is 
intact, only the amplitude of transduction is affected. This finding indicates that SANS is 
implicated in mechanotransduction and plays a different role from harmonin or MYO7A. 
Gpr98 knockout and Gpr98del7TM mice also show defects in mechanotransduction, though 
there are some discrepancies between them (McGee et al., 2006; Michalski et al., 2007). In 
general, the sensitivity to the stimulation direction is changed in both outer and inner hair 
cells. The amplitude and sensitivity of the transduction current decrease in the outer hair 
cells, but are normal in the inner hair cells and the utricular hair cells. It is suggested that the 
misorganization of hair bundles in Gpr98 mutant mice accounts of the abnormal sensitivity 
direction. Alternatively, GPR98 could be indirectly related with the cellular process of 
mechanotransduction. 
6.3 Protein and organelle transport 
In photoreceptors, the outer segment is a large specialized cilium filled with many flat 
membrane disks, where phototransduction occurs (Figure 4). This cellular compartment 
undergoes continuous and rapid renewal (Young, 1967; LaVail, 1976; Young, 1976; Besharse 
and Hollyfield, 1979), which requires a large amount of proteins and membrane lipids to be 
synthesized in the inner segment and to be quickly transported to the base of the outer 
segment through the connecting cilium (Figure 4). The removal of the old outer segment is 
achieved through phagocytosis by RPE cells.  In addition, in both photoreceptors and RPE 
cells, several proteins, involved in phototransduction and retinoid cycle, translocate 
between two different cellular compartments in response to light (Artemyev, 2008; Slepak 
and Hurley, 2008; Lopes et al., 2011).  
Among USH proteins, MYO7A is an actin-based motor. In the retina, it is expressed in both 
RPE cells and photoreceptors. In RPE cells, MYO7A is essential for the transport of 
phagosomes to their degradation apparatus (Gibbs et al., 2003), tethering melanosomes 
during their movement (Gibbs et al., 2004), and the translocation of RPE65 responding to 
light exposure (Lopes et al., 2011). In photoreceptors, MYO7A is present along the 
connecting cilium. Loss of MYO7A was found to delay the transport of opsin from the inner 
to the outer segment (Liu et al., 1999) and the transducin translocation from the outer to the 
inner segment after light exposure (Peng et al., 2011). In hair cells, without MYO7A, all 
USH2 proteins are mislocalized from the ankle links (Table 3), suggesting that MYO7A may 
transport the USH2 proteins. These lines of evidence establish the notion that MYO7A may 
function in protein and organelle transport in various cells in the retina and the inner ear. 
USH2 proteins are positioned at the PMC in mammalian photoreceptors, which is an 
analogous structure to the periciliary ridge complex (PRC) in frogs (Peters et al., 1983). The 
PRC is a morphologically-specialized structure with a symmetrical array of 9 ridges and 9 
grooves. It has been proposed, based on immunocytochemistry and freeze-fracture electron 
microscopy, as the membrane fusion site for post-Golgi vesicles carrying opsin and 
docosahexaenoyl (DHA)-phospholipids before these cargos are transported from the inner 
to the outer segment (Peters et al., 1983; Papermaster et al., 1986; Rodriguez de Turco et al., 
1997; Papermaster, 2002). Additionally, Rab8, rac1, Sec8, moesin, syntaxin 3 and SNAP-25 
have been localized around the PRC in frog photoreceptors (Deretic et al., 2004; Mazelova et 





participate in and/or regulate the docking and membrane fusion of post-Golgi vesicles to 
the plasma membrane at the PRC. Therefore, the USH2 complex at the PMC might play 
either a direct or indirect role in the docking between the post-Golgi vesicles and plasma 
membrane at the base of the connecting cilium (Roepman and Wolfrum, 2007; Maerker et 
al., 2008). This proposed function can also be applied in hair cells. The ankle-links exist 
when stereocilia grow and differentiate from small microvilli. At this time, many vesicles 
are at the base of stereocilia (Forge et al., 1997; Hasson et al., 1997), which could be the post-
Golgi vesicles carrying proteins and membrane lipids from the cell body to the growing 
stereocilia. Supportively, the Gpr98 knockout mouse shows delocalization of some CDH23 
long isoforms at the tip of the stereocilia and, possibly, loss of some apical links between the 
stereocilia (Michalski et al., 2007). However, solid evidence supporting this putative 
function of the USH2 complex is still scarce. For instance, obvious mislocalization of 
rhodopsin has not been observed in whirlin knockout and Ush2a knockout mice (Liu et al., 
2007; Yang et al., 2010), and vesicles fused with the plasma membrane have not been 
demonstrated at the ankle links. 
7. Therapeutic studies  
Because of the widespread clinical application of the well-developed cochlear implant for 
hearing loss (Pennings et al., 2006; Liu et al., 2008), more attention is focused on seeking 
effective treatments for retinitis pigmentosa in USH. Next, I will address the current 
progress in studies on gene therapy, drug application, cell transplantation, and nutritional 
supplements (Yang et al., 2011). 
Human neural progenitor cells from the post mortem fetal cortical brain have been tested in 
the Ush2a knockout mouse (Lu et al., 2009). The progenitor cells were transplanted between 
photoreceptors and RPE cells. There, they delayed the cellular changes in photoreceptors 
and alleviated retinal functional deterioration. However, due to the short follow-up time 
after the treatment, the study did not examine whether the treatment can rescue 
photoreceptor loss in this animal model.  
Compared to the cell-based therapy, replacement of the mutant gene in the retina is 
straightforward. The efficiency and efficacy of a lentivirus-mediated gene replacement of 
MYO7A have been studied in the Myo7a4626SB mouse (Hashimoto et al., 2007). Although the 
delivery of MYO7A into photoreceptors and RPE cells is not quite efficient, the treated 
mutant retina does show correction of the histological phenotypes in these two cells. In 
addition, our laboratory utilized a combination of AAV and a photoreceptor-specific 
promoter to efficiently target the USH2D gene, whirlin, into both rod and cone 
photoreceptors. The transgenic whirlin was found to restore the changes of USH2A and 
GPR98 expression in the whirlin knockout retina (Zou et al., 2011). These encouraging 
progresses in the USH1B and USH2D mouse models lay a solid foundation for a further and 
detailed exploration of gene therapy for these and other USH subtypes. 
Aminoglycosides and their derivatives can induce a read-through of nonsense mutations by 
inserting an amino acid at the stop codon. These drugs have been tested in vitro, in cell 
cultures and in retinal explants to suppress the nonsense mutations found in USH1F 
(PCDH15) and USH1C (harmonin) patients (Rebibo-Sabbah et al., 2007; Nudelman et al., 
2009; Goldmann et al., 2010; Nudelman et al., 2010). However, the high cellular toxicity of 
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these drugs and the low efficiency of their read-through activities set a hindrance for their 
further application to patients. A recent report has shown that PTC124, a drug unrelated to 
aminoglycosides, has a relatively low cellular toxicity and high read-through efficacy 
(Goldmann et al., 2011). 
The nutritional supplementation, daily intakes of vitamin A at a dose of 15,000 international 
units (IU) and vitamin E less than 400 IU, is thought to be a potential effective therapy for 
retinitis pigmentosa (Berson et al., 1993; Berson, 2000). Although it has already been applied 
to patients, this vitamin A supplement therapy is still under debate and its underlying 
mechanism is unknown. 
8. Summary and perspective 
The research on USH has made tremendous progress since the discovery of its first 
causative gene, MYO7A, in 1995. Currently, nine genes have been identified responsible for 
this genetic disease. From the functional domain analysis, these genes have been proposed 
to participate in trafficking, scaffolding, cell adhesion, and signaling in cells. Many 
spontaneous and transgenic mouse, rat, and zebrafish models are available now. The 
majority of these animal models reproduce the hearing and balance problems in USH 
patients. However, not many of them manifest retinal degeneration, which is one of the 
typical symptoms in USH patients. The reason for this discrepancy is not clear. But lack of 
retinal phenotypes in these animal models hinders our studies on retinitis pigmentosa in 
USH patients. A large body of evidence from biochemical and cellular localization studies 
demonstrate that USH proteins are organized into multi-component complexes mainly in 
hair cells and photoreceptors. They play a role in hair bundle cohesion, 
mechanotransduction, and, possibly, protein/organelle transport in vivo. USH is an 
incurable disease. Effective treatments using different approaches are still being sought and 
explored. 
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1. Introduction 
In 1980, the first child in the world was implanted with the single-channel House cochlear 
implant device (Eisenberg & House, 1982). Children who initially received cochlear implants 
during this first paediatric clinical trial were quite old compared to current ages (the average 
age in the first House clinical trial was 8 years, whereas children are now being implanted as 
young as 6 months of age), and the majority communicated using sign language (Eisenberg 
& Johnson, 2008). It is now known that implanting older children who do not communicate 
orally gives little chance of speech perception or spoken language development. In 1985, the 
first children received a multichannel cochlear implant in Australia (Clark et al., 1987). This 
clinical trial selected children who had a higher potential for success, including shorter 
duration of deafness and a commitment to oral communication both at home and in their 
educational programs. At this time, it was unknown whether the speech processing schemes 
used with adults who had lost their hearing after developing language (ie. post-lingually 
deafened) would be appropriate for facilitating the speech perception and language 
development of young children with immature auditory systems. It is important also to note 
that the desired outcomes for adults and children differed; while the goal for adults was to 
improve auditory skills and communication using previously acquired cognitive, spoken 
language, and social skills, the goal for children was to develop these skills using the 
auditory information provided by the cochlear implant, having had no useful auditory 
experience (and therefore presumably no neural development of their auditory system) until 
they received their cochlear implant. The implantation of children was also highly 
controversial. For many years, cochlear implantation in children was opposed by the Deaf 
Community, on the grounds that deafness in children should be considered as a cultural 
and linguistic difference rather than as a disability that could be remediated by a cochlear 
implant. Over time, this view has changed such that in 2000, a position paper of the 
National Association of the Deaf in the U.S. stated that “cochlear implantation is a 
technology that represents a tool to be used in some forms of communication, and not a cure 
for deafness” (National Association of the Deaf, 2000).  
It is now well documented that children with severe-profound hearing loss receive 
significant benefits from cochlear implants in terms of speech perception and language 
development (Blamey et al., 2006; Geers et al., 2008; Moog, 2002; Nicholas & Geers 2007). 
Cochlear implants are becoming the standard of care for children with severe-profound 
hearing loss, with increasing uptake of simultaneous bilateral implants over recent years. 
There is a large variation in implementation of cochlear implant technology around the 
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world, and also within regions in some countries. Bilateral implantation is becoming the 
standard of care for children in developed countries, such as Germany, England and the 
United States, while in developing countries it is very infrequent. In less developed 
countries, many children are still receiving unilateral single-channel cochlear implants, 
which are cheaper to manufacture, and many are not able to access the technology at all due 
to high cost. For example, of the estimated 1 million children with profound hearing loss in 
India, only approximately 5000 are reported to have cochlear implants. It is difficult to 
estimate how many children worldwide have received cochlear implants to date, as reports 
vary widely. However, in December 2010, the U.S. Food and Drug Administration (FDA) 
reported that approximately 219,000 people worldwide had received implants (National 
Institute on Deafness and other Communication Disorders, 2011). Despite variations in 
estimates, it is generally accepted that approximately half of the number of cochlear implant 
recipients are children. 
2. Suitability for a cochlear implant 
2.1 Criteria for candidature 
In the early days of cochlear implantation in children, children were only considered as 
suitable recipients for a cochlear implant when they had no useable aided hearing, and 
therefore had nothing to lose if the outcome were not good, as cochlear implantation 
damages the inner ear such that acoustic hearing is not usually possible post-operatively. As 
technological improvements in electrode design, speech processing strategies, 
receiver/stimulator design and programming have gradually facilitated improving 
outcomes with cochlear implants, the clinical perspective has changed.  
Determining suitability in children is a more complicated process than it is for post-lingually 
deafened adults, whose speech production and language skills are fully developed. Whereas 
for adults it can be assumed that the ability to perceive speech is limited by hearing ability 
alone, for children, speech perception is limited by language knowledge and speech 
production skills as well as by residual hearing quality and quantity (DesJardin et al., 2009; 
Sarant et al., 1997). Unsurprisingly, speech perception scores (obtained from measuring the 
number of sounds, words, or sentences perceived correctly on a test) in children are more 
highly correlated with spoken language abilities than with any other factor (Blamey et al., 
2001a), and are also influenced by speech production skills (Paatsch et al., 2004). Therefore, 
basing decisions about cochlear implant candidature for children on speech perception 
scores alone could risk implanting some children who have sufficient aided hearing to 
develop spoken language through hearing aids, but who are limited in their speech 
perception ability by their undeveloped spoken language skills. This risk has increased over 
time as the age at which children receive cochlear implants has decreased. Further, as 
speech perception results with cochlear implants have improved, the amount of hearing 
being risked in order to achieve the potential benefits of a cochlear implant has increased. 
Given this increasing risk, accurate prediction of a particular child’s potential to benefit from 
a cochlear implant has become even more important.  
Blamey and Sarant (2002) proposed a method of combining speech perception and language 
assessment scores to calculate an objective criterion for cochlear implant suitability, so that a 
child’s pre-operative aided speech perception performance is compared to a distribution of 
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speech perception scores for children with cochlear implants who are matched according to 
language ability (Blamey & Sarant, 2002). While this approach is helpful for older children 
with some language ability, it is not suitable for use with very young children whose speech 
perception, production and language skills are undeveloped, independent of their degree of 
hearing loss, and for whom, due to behavioural and cognitive developmental issues, it is 
very difficult to assess speech perception ability.  
Since the 1990’s, several researchers have proposed alternate methods of determining 
suitability for a cochlear implant in children. Osberger et al. (1991) classified children using 
hearing aids into ‘gold’, ‘silver’ and ‘bronze’ categories, based on their unaided pure tone 
thresholds (PTA) averaged across 0.5, 1, and 2 kHz. Initially, it was predicted that only 
children in the ‘bronze’ category (mean >110dbHL and >110dbHL at two of the three 
frequencies) were suitable candidates for a cochlear implant. These categories were revised 
when it became apparent that children with cochlear implants were outperforming not only 
hearing aid users in the bronze, but also in the silver (mean = 104dbHL and 101-110 dbHL at 
two of the three frequencies) and gold (mean = 94dbHL and 90-100 dbHL in two of the three 
frequencies) categories. A further methodology that compared speech perception results for 
children using hearing aids and cochlear implants in order to determine criteria for 
suitability used the concept of ‘equivalent hearing loss’ (EHL). Boothroyd and Eran (1994) 
compared the abilities of children using hearing aids with those using a cochlear implant on 
an imitative test of phonetic (speech sound) contrasts, and derived EHL by plotting speech 
perception results against the three-frequency unaided PTA for each ear. Linear regression 
statistical analysis was used to transform the speech perception scores of the children into 
EHL values. Although the EHL for the children using cochlear implants suggested that their 
potential for speech perception was similar to that of children with a severe hearing loss 
using hearing aids, there were still children using cochlear implants whose speech 
perception skills were no better than those of children with a profound hearing loss using 
hearing aids. In 1997, Boothroyd reported that children with cochlear implants who were 
educated mostly in oral communicative environments achieved speech perception scores 
equivalent to those of children using hearing aids with a hearing loss in the 70-89 dbHL 
(severe) range (Boothroyd, 1997). Similar results have been reported more recently 
(Davidson, 2006; Eisenberg et al., 2004).  
Throughout the current decade, several studies of large numbers of children with cochlear 
implants have reported speech perception results that are comparable to those achieved by 
post-lingually deafened adults using cochlear implants, and even to those achieved by 
children with a moderate hearing loss using hearing aids (Geers et al., 2003; Svirsky et al., 
2004; Tajudeen et al. 2010; Wie et al. 2007). In response to these achievements, the criteria for 
suitability have again changed such that even very young children with a severe to severe-
profound hearing loss are now deemed suitable recipients for cochlear implants, and 
children with significant, or useable, residual hearing are currently being implanted in 
centers not under the jurisdiction of the United States FDA (Geers & Moog, 1994; Leigh et 
al., 2011; Svirsky & Meyer, 1999; Zwolan et al., 1997). Currently, the more conservative 
FDA guidelines approve cochlear implantation in children aged 12-23 months with 
bilateral profound sensorineural hearing loss (>90dbHL) and in children aged 2 years and 
older with severe-profound hearing loss (greater than or equal to 90dBHL in the better 
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The introduction of neonatal hearing screening programs in developed countries over the 
past decade has meant that hearing loss is now identified in babies as young as a few days 
or months old, and there is earlier referral and diagnosis than ever before (Dalzell, 2000; 
White & Maxon, 1995; Yoshinaga-Itano, 2003a). Very young infants and toddlers now 
represent the majority of paediatric cochlear implant candidates in these countries, and for 
these children, decisions about candidacy must currently be based solely or primarily on 
audiometric information if cochlear implants are to be given early, as there are limited tools 
available to measure speech perception or language abilities in this age group. The 
audiometric information is usually objective data obtained from the transient evoked 
auditory brainstem response (ABR) used in hearing screening, otoacoustic emissions, or 
auditory steady state responses (ASSR). These results may be combined with behavioural 
data derived from testing conducted by audiologists, depending on the protocol of 
individual cochlear implant programs. Most recently, an “equivalent PTA” model was 
derived to be applied to audiometric data for very young children from a comparison of the 
open-set speech perception scores of preschool and elementary school-aged children using 
cochlear implants and hearing aids. The model gives equivalent PTA for a 75% through to 
95% chance of improvement in speech perception outcomes in 5% steps. Using a less 
conservative 75% chance of improvement criterion (as opposed to the 95% criterion that has 
until now been applied), the model recommends that children with bilateral profound 
hearing loss through to children with unaided pure tone average thresholds of 75 to 90 
dBHL are suitable recipients for cochlear implants, while children with lesser hearing loss 
than 75dbHL are encouraged to continue with hearing aid use (Leigh et al., 2011). 
2.2 Children with additional disabilities: Implications for candidacy  
It is well established that 30-40% of children with severe-profound hearing loss also have an 
additional physical and/or cognitive disability, such as visual impairment, cognitive 
impairment, learning disabilities, autistic spectrum disorders (ASD) or developmental delay 
(Archbold & O'Donoghue, 2009; Edwards, 2007; Holt et al., 2005). Often, the additional 
disability is related to the cause of deafness, and is part of a syndrome or other grouping of 
disabilities. Children with additional disabilities present a further challenge with regard to 
determining suitability for cochlear implants, because the degree of benefit derived by the 
‘average’ child with hearing loss is unlikely to be experienced by these children due to the 
effects of their additional disabilities. For this reason, children with additional disabilities 
were not considered suitable cochlear implant candidates for many years. Although 
excluded from FDA clinical trials in the past (Holt et al., 2005), small numbers of children 
with additional disabilities have received cochlear implants. Little is known about the 
degree of benefit children with hearing loss and additional disabilities derive from cochlear 
implants with regard to speech perception and spoken language development, for several 
reasons. Firstly, much of the research effort around cochlear implants has been directed at 
identifying outcomes and predictive factors for the majority of children with cochlear 
implants who do not have additional disabilities. Secondly, due to the fact that there are 
smaller numbers of children with additional disabilities, and many are unable to complete 
standardised assessment procedures, quantitative analysis of outcomes has been difficult. A 
further challenge is that there are a large number of additional disabilities spread across a 
relatively small population of children, therefore obtaining sufficient numbers to define the 
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aspects of each disability and its impact on communication development after implantation 
has been difficult. 
The few studies of children with cochlear implants and additional disabilities have generally 
reported poorer performance on speech perception, production and language assessments, 
particularly when higher level speech processing abilities are required. For example, in one 
of the first studies of these children, (Pyman et al., 2000) found that although 90% of 75 
children with motor and/or cognitive delays could discriminate consonants and vowels 
after four years of cochlear implant use, only around 60% of the children were able to use 
this information to perceive open-set sentences (those presented with no context), compared 
to over 80% of children without additional disabilities. Similarly, a further study of children 
with a variety of disabilities, such as attention-deficit disorder, cerebral palsy, central 
auditory processing disorder, dyspraxia and autism, showed some speech perception skill 
development at a slower rate than for the general population (Waltzman et al., 2000). 
Children whose additional disability is mild can derive significant benefit from cochlear 
implants, whereas children with more severe disabilities have much less favourable 
outcomes, with some showing almost no progress (Edwards, Frost & Witham, 2006;  Filipo 
et al.,  2004; Hamzavi et al., 2000; Holt & Kirk, 2005;  Meinzen-Derr et al., 2011; Vlahovic & 
Sindija, 2004). Most studies have highlighted that children with additional disabilities 
require longer periods of implant use before demonstrating any benefit, and as for children 
in the general cochlear implant population, variation in outcomes is wide for children with 
additional disabilities (Hamzavi et al., 2000; Waltzman et al., 2000). It was reported for some 
children that the assessment tasks were too difficult to complete (Donaldson et al., 2004; 
Waltzman et al., 2000), which is a factor that has added to the difficulty of determining 
outcomes for this population.  
Children with autistic spectrum disorders (ASD) have historically been considered poor 
cochlear implant candidates, but as the age at which children are being implanted has 
decreased, there are now a number of children who have been implanted before their 
diagnosis of ASD. The single published study of progress in a group of children with ASD 
reported that smaller gains on tests of speech perception and language had been made in 
comparison to those reported for the cochlear implant general population, but that parent 
reports suggested positive improvements in their children’s functioning and responsiveness 
(Donaldson et al., 2004).  
In summary, although the degree of benefit obtained from cochlear implants is often lower 
for children with additional disabilities, many children still receive measurable benefit from 
their devices, and this benefit adds to their quality of life. Some of the observed benefits 
cannot be quantified on standardised tests, and have been instead reported anecdotally, 
with observations of improvements in social interaction and responsiveness to the 
environment, behaviour, vocalization, self-help skills, motor skills and the ability to follow 
instructions (Donaldson et al., 2004; Filipo et al., 2004; Fukuda et al., 2003; Waltzman et al., 
2000; Wiley et al., 2005). There is still a need to determine the impact of additional 
disabilities on post-operative benefit with cochlear implants, and to define more clearly 
what benefits might reasonably be expected for children with different additional 
disabilities. The point at which a cochlear implant will not be beneficial also needs to be 
determined with regard to the degree of severity of additional disabilities, and the definition 
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aspects of each disability and its impact on communication development after implantation 
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maximum potential, and quality of life being taken into consideration in addition to 
quantitative outcomes on tests. 
2.3 Candidacy and selected aetiologies/pathologies of deafness 
A further group of children for whom candidacy issues are more complex are those with 
selected pathologies that not only cause severe-profound hearing loss but may also impact 
on outcomes with cochlear implants. Although there are many such pathologies, the most 
common of these will be discussed as examples of the impact aetiology, or cause of hearing 
loss, may have on post-implantation outcomes. 
In the 1990’s, auditory neuropathy (AN) was defined as a distinct type of hearing disorder 
that disrupts neural activity in the central and peripheral auditory pathways (Starr et al., 
1996). Auditory neuropathy is characterised by normal outer hair cell function in the cochlea 
(which enables many babies to pass newborn hearing screening if otoacoustic emission 
testing is used), and a retro cochlear lesion (dysfunction in the inner hair cells or auditory 
[eighth] nerve), which manifests as an absent or abnormal response to auditory brainstem 
response (ABR) testing. Features of this pathology include poorer than expected speech 
perception abilities in relation to degree of hearing loss in the majority of children, with 
some children who have only a mild hearing loss demonstrating a severely impaired ability 
to use their hearing for speech understanding (Rance et al., 2007). This pathology affects 
approximately 0.23% of at-risk children (Rance et al., 1999). Given the unusual pattern of 
perceptual deficits that characterises AN, much of the research in this area has focused on 
whether or not a cochlear implant can assist these children to understand speech through 
their hearing. The few published investigations on speech perception have varied widely, 
reporting no benefit (Miyamoto et al., 1999; Teagle et al., 2010) through to benefit 
comparable to that received by the general population of children with cochlear implants 
(Buss et al., 2002; Peterson et al., 2003; Rance & Barker, 2008; Trautwein et al., 2000). For the 
children who demonstrated significant benefit, it was noted that electrical stimulation via 
the cochlear implant elicited ABR responses, which suggests that the implant was able to 
enable greater neural synchrony and therefore to overcome the desynchronization thought 
to underlie AN. Studies of language and speech production outcomes for these children are 
again limited, and results are similar to those for speech perception, with wide variation in 
outcomes, but also with some children demonstrating the same level of development as the 
general population of children with cochlear implants (Jeong et al., 2007; Madden, 2002; 
Rance et al., 2007). For parents of children with this pathology, there is reasonable evidence 
to suggest that children may benefit from a cochlear implant, although expectations may 
need to be lower than for the general population of children with sensorineural hearing loss. 
Usher syndrome is the most common condition that affects both hearing and vision, and its 
major symptoms are congenital or progressive deafness resulting in severe-profound 
hearing loss, and progressive loss of vision due to retinitis pigmentosa, an eye disorder 
which causes night blindness and a loss of peripheral vision. Many children with Usher 
syndrome also have significant balance problems, which can delay walking in very young 
children. Approximately 6-12% of children with hearing loss, or 4 in every 100,000 births in 
the United States (Boughman et al., 1983) and 6 per 100,000 births in England (Hope et al., 
1997) have Usher Syndrome, which is a genetic condition. Once children have lost their 
vision, the auditory information provided by a cochlear implant is their only means of 
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connecting and communicating with the world, so it is very important that these children 
are diagnosed and receive their cochlear implants early in order to establish communication 
through audition prior to the loss of vision. Usher syndrome is one of the 20% of causes of 
deafness that involve abnormalities in cochlea-vestibular anatomy. These abnormalities 
increase the potential for surgical difficulties and complications, such as damage to the facial 
nerve and incomplete insertion of the implant electrode array in the cochlea (Bauer et al., 
2002; Chadha et al., 2009).  
Some other children with congenital deafness also have cochlear abnormalities, often due to 
a range of genetic causes, another of which is CHARGE syndrome. Children with this rare 
genetic syndrome have deafness, visual problems, and a variety of other physical 
abnormalities, including serious heart defects, colobomas (or holes) in one or both eyes, 
growth retardation, genital abnormalities and external and internal ear malformations. 
Anatomical abnormalities in the structure of the cochlea can also create difficulties for 
programming, with reduced dynamic ranges for children with more severe cochlear 
abnormalities (Papsin, 2005). For these reasons, malformation of the cochlea was considered a 
contra-indication to cochlear implant surgery in the early years of cochlear implantation in 
children, and it is still not possible to implant some of these children (Bamiou et al., 2001).  
Despite these difficulties, initial results for small numbers of children with cochlear anomalies 
have shown that implantation is possible, with some children achieving speech perception and 
language results similar to those without anatomical abnormalities (Chadha et al., 2009; 
Dettman et al., 2011). Children with a common cavity anomaly (a single cavity in the cochlea) 
and other more severe syndromic anomalies have achieved much poorer results (Bauer et al., 
2002; Chadha et al., 2009; Lanson et al., 2007; Loundon et al., 2003; Young et al., 1995).  
Children with viral causes of deafness such as rubella, cytomegalovirus (CMV), 
toxoplasmosis and meningitis also require special consideration, as these viruses can cause 
developmental neurological deficits, including learning and cognitive difficulties (Edwards, 
2007; Grimwood et al., 2000; Isaacson et al., 1996). A significant difference between children 
with deafness caused by meningitis and that caused by the other viruses is that while CMV, 
toxoplasmosis and rubella are contracted perinatally, children who have had meningitis will 
have experienced sound prior to infection and may have developed some spoken language 
skills. A further complication of meningitis is ossification (bone growth) within the cochlea, 
which is usually bilateral and can commence within four weeks of the illness (Durisin et al., 
2010). This makes it imperative that children who have had meningitis are diagnosed with 
hearing loss and receive cochlear implants as soon as possible, before ossification limits both 
the potential for a full insertion and for benefit. Again, limited reports of post-operative 
benefit for children with these causes of deafness show a wide range of speech perception 
skills, intelligibility and language outcomes, with some children doing well (Francis et al., 
2004; Lee et al., 2005) and others doing poorly (Isaacson et al., 1996; Ramirez Inscoe & 
Nikolopoulos, 2004; Wie et al., 2007). 
3. Benefits of unilateral cochlear implants 
3.1 Environmental awareness 
At the most basic level, cochlear implants provide children with an auditory awareness of 
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3.1 Environmental awareness 
At the most basic level, cochlear implants provide children with an auditory awareness of 





sounds that would not be audible to them through hearing aids. These include high 
frequency sounds such as water running, birds singing, the kettle whistling, the car 
indicators ticking and the phone ringing. Being able to hear what is going on in their 
environment gives children a feeling of connectedness with the world, and also provides 
them with a greater degree of safety, although localization of sound sources is usually not 
achieved by most children with only one cochlear implant. Children are more easily able to 
hear their name being called, to determine when someone is speaking to them, and even to 
enjoy music. In the early days of cochlear implantation, when only older children received 
implants, and before it was realised that children could use cochlear implants to develop 
spoken language, environmental awareness was a prime motivating factor in the decision to 
implant some children (Sarant et al., 1994). 
3.2 Speech perception 
The cochlear implant assists children to process spoken auditory information in their 
environment both as an aid to lip reading, which is particularly useful in noisy educational 
environments, and also as a source of auditory information that can be relied upon without 
lip reading in appropriate listening conditions. As briefly mentioned earlier, speech 
perception results for children have steadily improved over time with advances in device 
hardware and software, surgical techniques, and experience with programming speech 
processors and habilitation.  Initially, it was not expected that children with congenital 
hearing loss would be able to achieve the speech perception abilities shown by post-
lingually deafened adults, but many children have exceeded these levels of perceptual 
ability. By the mid 1990’s, 60 to 80% of children with unilateral implants achieved open-set 
word and sentence speech perception abilities comparable to those achieved by adults using 
audition only (Dowell et al., 1995; Dowell et al., 1997; Geers et al., 2003; Sarant et al., 2001). 
More recent studies of children implanted at younger ages and using more recent 
technologies report even better speech perception abilities. While it has been suggested for 
some time that children with cochlear implants perform at a level equivalent to that of a 
child with a severe hearing loss using hearing aids (Blamey et al., 2001a; Boothroyd, 1997; 
Svirsky & Meyer, 1999), it has recently been reported that very young children can perform 
on tests of speech recognition at a level equivalent to that of children with a moderate 
hearing loss using hearing aids (Leigh et al., 2008b).  Recent long-term studies have also 
shown that high proportions of children (79% and 60%) can use the telephone (Beadle et al., 
2005; Uziel et al., 2007). These are considerable achievements for children who have been 
profoundly deaf since birth, and who have developed their auditory processing abilities 
through the reduced and fragmented sound provided by cochlear implants. It is also worth 
noting that a meta-analysis of 1916 reports on speech perception performance in children 
with cochlear implants suggested that, rather than levelling out, speech perception benefits 
continue to increase as children grow older (Cheng et al., 1999). 
The assessment of speech perception abilities in adults and older children is relatively 
straightforward. It may involve an individual listening to a sound or word and pointing to a 
picture that best represents that sound or word (closed-set testing) or could involve the 
individual listening to and repeating a sound, word or sentence spoken by the assessor with 
no context (open-set testing). Children with age-appropriate cognitive abilities are able to 
complete these sorts of tasks from the age of around 3 to 4 years, when they have developed 
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the ability to label sounds, letters or words (Spencer et al., 2011). With the introduction of 
earlier diagnosis of hearing loss through newborn hearing screening, a need to assess very 
young children has developed in order to determine their suitability for cochlear implants. 
There are several methods of doing this, but these are less objective, and are much more 
reliant on the expertise and judgement of professionals in observing behavioural responses 
in very young children, and also on parent reports of responses to speech sounds and 
specific familiar words. Reports using these modified forms of speech perception testing in 
very young children have suggested that speech perception skills can develop rapidly 
within the first two years of cochlear implantation for children implanted before 4 years of 
age (Robbins et al., 2004a; Svirsky et al., 2004; Tajudeen et al., 2010; Wie et al., 2007). 
As previously mentioned, much of the improvement in speech perception scores is 
attributable to advancements in technology, and particularly to the development of more 
effective speech processing strategies for the three commercially available cochlear implant 
devices (the Nucleus/Cochlear device, the Clarion device, and the Med-El device). The 
development of speech processing technology in the Cochlear device, which retains a 
dominant international market share of around 70% (Patrick et al., 2006) will be discussed as 
an example of this progress.  In the early Nucleus 22-channel cochlear implant device, 
speech feature extraction schemes that presented only the fundamental frequency of speech 
and the first two formants (or bursts of energy) of speech (F0F2 and F0F1F2) were used 
(Clark et al., 1983). These strategies provided an aid to lip reading and very limited speech 
perception ability (Dowell et al., 1985). They had several disadvantages, such as not 
discriminating between speech and non-speech sounds, causing some environmental noises 
to sound quite unnatural, and providing no information above 3kHz, which made it 
impossible for users to perceive unvoiced information about consonants (such as ‘s’, ‘sh’, ‘f’,’ 
th’ etc.).  
In the early 1990’s, a new strategy, known as Multipeak (MPEAK), was introduced with the 
goal of improving consonant recognition scores. MPEAK still used feature extraction 
algorithms, but also provided information about high frequency sounds on three fixed 
bands of the implant electrode array. The MPEAK strategy represented an improvement in 
that it distinguished between voiced and unvoiced sounds, and some electrodes were 
allocated to the representation of high frequency consonant information, which is extremely 
important for speech perception. The additional information provided through this speech 
processing strategy led to improved speech perception scores, particularly for fricatives (eg. 
‘s’, ‘sh’), in both quiet and noise conditions (Clark, 1989; Dowell et al., 1991). Despite the 
improvements in benefit with MPEAK, an ongoing disadvantage of formant extraction 
strategies was that in background noise the speech processor made errors.  
By 1995, improvements in electronics technology had allowed a new approach to speech 
processing to be adopted, using bandpass filtering principles in order to provide more 
information about the speech spectrum. The Spectral (SPEAK) speech processing strategy 
used bandpass filters to select 6 to 10 of the largest spectral components in each analysis 
time period and assigned these to particular electrodes in the cochlea.  In this strategy, 
groups of electrodes, rather than single electrodes, were stimulated to represent particular 
speech features such as vowels, and stimulation occurred at a much higher rate than for 
previous strategies, which meant that more information could be presented more quickly. 
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the ability to label sounds, letters or words (Spencer et al., 2011). With the introduction of 
earlier diagnosis of hearing loss through newborn hearing screening, a need to assess very 
young children has developed in order to determine their suitability for cochlear implants. 
There are several methods of doing this, but these are less objective, and are much more 
reliant on the expertise and judgement of professionals in observing behavioural responses 
in very young children, and also on parent reports of responses to speech sounds and 
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used bandpass filters to select 6 to 10 of the largest spectral components in each analysis 
time period and assigned these to particular electrodes in the cochlea.  In this strategy, 
groups of electrodes, rather than single electrodes, were stimulated to represent particular 
speech features such as vowels, and stimulation occurred at a much higher rate than for 
previous strategies, which meant that more information could be presented more quickly. 





the most salient speech information, and of suppressing lower amplitude background noise. 
The SPEAK strategy resulted in large increases in speech perception benefit for children and 
adults, particularly in background noise (Cowan et al., 1995; McKay et al., 1991), and 
probably contributed to the largest increase in speech perception benefit of all the 
technological advancements made before or since that time. Other significant technological 
improvements in cochlear implants over the last decade have included new receiver-
stimulators, smaller, body-worn and behind-the-ear digital speech processors, and further 
high-rate speech processing strategies. These have facilitated further improvements in 
speech perception benefit, particularly in very young children who have had access to all of 
the recent technology. 
One of the most challenging findings of research on speech perception ability in children 
with cochlear implants is the enormous variation in performance between individuals 
(Cowan et al., 1997; Pyman et al., 2000; Sarant et al., 2001; Staller et al., 1991). While many 
reports describe ‘average’ performance, this concept minimises and perhaps even disguises 
the fact that while many children do reasonably well, and some do as well as their peers 
with normal hearing, there are still children who derive very little benefit from their 
cochlear implant. This variation in outcomes makes it difficult to predict how a particular 
child will perform after implantation, and therefore to determine which children are suitable 
for a cochlear implant, particularly when they risk losing useable residual hearing in order 
to have one. Several factors that have been identified as predictive of post-operative 
performance will be discussed in section 4 of this chapter. 
3.3 Speech production  
The development of speech production has always been a significant problem for children 
with severe-profound hearing loss, as they do not have the auditory capacity to monitor 
their own speech or to hear the speech of normal-hearing individuals. For many years, most 
children using hearing aids with this degree of hearing loss have been rated as 
unintelligible, or as having very low intelligibility, to adult listeners unfamiliar with the 
speech of children with hearing loss (Bamford & Saunders, 1992; Gold, 1980; Spencer et al., 
2011). Cochlear implants can provide children with auditory information that makes their 
own speech and that of others audible, so that they can learn from speakers with normal 
hearing, and self-monitor their own speech production. As with speech perception, children 
with cochlear implants show a wide range of speech production abilities, with many 
children performing at a very high level, and others showing low levels of performance 
(Connor et al., 2006; Spencer & Oleson, 2008; Tobey et al., 2003), but even children implanted 
at relatively late ages and with only a few years of implant use are generally rated as much 
more intelligible than their peers with a similar degree of hearing loss using hearing aids 
(Connor et al., 2006; Flipsen, 2008; Tobey & Hasenstab, 1991; Tye-Murray et al., 1995). 
Speech production outcomes have improved over time, as a result of longer periods of 
implant experience and improved hardware and speech processing strategies, although for 
many children they are still not equivalent to those of children with normal hearing (Chin et 
al., 2003; Peng et al., 2004). 
Speech production skills and speech intelligibility ratings equivalent to those of ‘gold’ 
hearing aid users have been reported after less than 3 years of implant use (Blamey et al., 
2001b; Svirsky et al., 2000). Children who are implanted at younger ages and use more 
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recent technology demonstrate the greatest achievements, with intelligibility ratings of 60-
75% and much higher rates of speech production accuracy reported for children implanted 
as preschoolers (Ertmer et al., 2007; Flipsen, 2008; Peng et al., 2004; Tobey et al., 2003). More 
recent reports of children followed for longer post-operative periods of up to ten years have 
reported speech intelligibility rates of 77%, 90%, and 67% respectively, and suggest that the 
development of intelligibility does not plateau after a few years, but increases over time 
with chronological age and increased length of cochlear implant use (Beadle et al., 2005; 
Blamey et al., 2001c; Chin et al., 2003; Uziel et al., 2007). Beadle and colleagues showed that 
although 48% of the children in their study had developed connected speech that was 
intelligible to the average listener after 5 years of cochlear implant use, after 10 years this 
figure had increased to 77% (Beadle et al. 2005). 
It was initially unknown whether children with cochlear implants would follow the same 
pattern of sound acquisition as their peers with normal hearing, or what their rate of 
progress would be compared to the former. In children with normal hearing, speech 
acquisition generally takes between 4 to 7 years (Chin et al., 2003). Studies of consonant and 
vowel acquisition in children with cochlear implants suggest that, on average, these children 
demonstrate a pattern of phoneme (or speech sound) acquisition similar to that of children 
with normal hearing (Ertmer et al., 2007; Serry et al., 1997), although their rate of 
development is often slower (Blamey et al., 2001b). This has meant that the speech 
acquisition process has still been incomplete at the age at which children with normal 
hearing have mastered speech production, but with little or no evidence that a plateau in 
development has been reached for children implanted between 2 and 5 years of age (Blamey 
et al., 2001c). Initial investigations of a small number of children implanted before the age of 
12 months have yielded conflicting results, with one study reporting that the rate of speech 
production development for children implanted under the age of 12 months matched that of 
children with normal hearing (Leigh et al., 2008c), and another finding that children 
implanted before age 12 months and those implanted between 12-24 months showed no 
difference in their speech production development (Holt & Svirsky, 2008). Future research 
will hopefully clarify the critical period during which children should receive cochlear 
implants in order to facilitate speech production outcomes that are similar to those of 
children with normal hearing. 
3.4 Language development 
Language development is generally measured using standardised assessments of 
vocabulary and grammatical knowledge. In the early 1990s, most reports on language were 
case studies demonstrating changes thought to be associated with cochlear implantation, 
but knowledge in this area has grown over time, and there is now solid evidence for large 
numbers of children regarding language outcomes. Initial research concentrated on whether 
children with cochlear implants developed language more quickly than their peers with 
hearing aids, or compared development to predictions based on pre-operative language 
development with hearing aids. One of the earlier studies compared language development 
in three groups of children with cochlear implants, hearing aids and tactile aids (body-worn 
aids that provide vibratory or electrical stimulation) over 3 years (Geers & Moog, 1994). On 
average, the language growth of children with cochlear implants in this study was equal to 
or exceeded that for the other groups of children, and even approached that of children with 
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implants were reported to be developing at a rate similar to that of children with a severe 
hearing loss of around 78dbHL (Blamey et al., 2001a), and it is now well established that on 
average, children with cochlear implants demonstrate significantly faster spoken language 
development than their peers with similar levels of hearing loss who use hearing aids 
(Connor et al., 2000; Miyamoto et al., 1999; Svirsky et al., 2000; Tomblin et al., 1999). Given 
these promising results, the focus changed to comparing the progress of children with 
cochlear implants to that of their normally-hearing peers.  
By the late 1990’s, although language outcomes for children with cochlear implants had 
improved compared to those for children with similar degrees of loss using hearing aids, on 
average, children with cochlear implants were still demonstrating language growth rates of 
only 50-60% of the rate of children with normal hearing (Blamey et al., 2001a; Davis & Hind, 
1999; Geers, 2002; Ramkalawan & Davis, 1992; Wake et al., 2004). Given the fact that these 
children were already delayed in their language development by the amount of time it had 
taken for diagnosis and implantation to occur, this slower rate of growth meant that by the 
time they were of school age, many children were delayed by at least 1 year, and 
approximately half had a severe language delay (ie. greater than 2 standard deviations 
below the mean for children with normal hearing). This rate of progress clearly has severe 
implications for academic achievement and functional literacy outcomes. 
Over the past decade, with a decreasing average age at implantation and improved cochlear 
implant speech processing technology and hardware, language outcomes have further 
improved for children with cochlear implants, such that some children now acquire spoken 
language as do children with mild to moderate hearing loss (Spencer et al., 2011). More 
recently, several studies have shown that children who have received their cochlear 
implants at very young ages (and have had several years of experience) can achieve spoken 
language development at similar rates to children with normal hearing (Connor et al., 2006; 
Duchesne et al., 2009; Geers, 2006b; Schorr et al., 2008; Svirsky et al., 2004; Tomblin et al., 
2005). For example, Dettman et al. 2008 reported that children implanted before the age of 
2.5 years showed an average vocabulary development rate of 85% of that of children with 
normal hearing. This means that the gap between chronological age and language age for 
these children remains more constant, and for some diminishes instead of growing, as has 
commonly been reported in the past.  
Greater proportions of children are showing age-appropriate development in receptive and 
expressive vocabulary (50% & 58%; Geers et al., 2009) and receptive and expressive 
language (47% & 39%; Nicholas & Geers, 2008) than previously. It has also been observed 
that some children with cochlear implants are even able to learn language more quickly than 
the average child with normal hearing and therefore ‘catch up’ some of the delay in 
language acquisition incurred before they received a cochlear implant, with reports of 
language development at age-appropriate levels between the ages of 4 and 7 years 
(Yoshinaga-Itano et al., 2010).  As with speech perception and speech production, there is 
still enormous variation in language skills between individuals and between different 
populations of children (Spencer et al., 2003), with recent reports still documenting many 
children with significant language delays (Ching, 2010; Connor et al., 2000; Nikolopoulos et 
al., 2004; Sarant et al., 2009; Young & Killen, 2002). 
The capacity for learning language in children with normal hearing is so great that they are 
not only able to develop fluency in their native language, but can also become fluent 
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speakers of more than three other languages without specific instruction. However, there 
have long been concerns that language delay in bilingual children is due to simultaneously 
learning two languages, due to the fact that learning a second language delays the learning 
process with the first language. It seemed logical that, for children with impaired auditory 
systems who are facing even greater challenges in language acquisition, learning two 
languages simultaneously would further delay the acquisition of the first language. More 
recently, it has been found that delays in vocabulary and slower progress in learning the 
second language dissipate in the early primary school years, and are likely to be due to the 
amount of exposure children have to each language (ie. the language that is used the most 
develops more quickly). It has also been demonstrated that language impairments found in 
bilingual children are due to individual children’s innate capacity to learn language, and are 
not caused by simultaneous language learning (Genesee, 2001). 
Despite the significant challenge inherent in mastering one spoken language with a cochlear 
implant, there is emerging evidence that it is also possible for children with cochlear 
implants to develop competence in a second spoken language. Robbins et al (2004b) 
reported on 12 children implanted before age 3 years, who not only demonstrated 
exceptional proficiency in their first language (almost all children had age-appropriate first 
language) but also solid progress in their second language over the 2 years during which 
they were followed. The children who were most proficient in their second language 
development had parents who spoke the second language at home, had opportunities to use 
the second language outside home, and had extensive cochlear implant experience. It was 
noted that, as a group, many of these children were ‘ideal’ cochlear implant recipients; half 
had hereditary deafness without additional disabilities, none had less than a full electrode 
array insertion, all had received intensive auditory-oral therapy prior to and after 
implantation, and none had meningitis-caused deafness. Two other studies have 
documented the ability of children with cochlear implants to develop competency in a 
second language. Of 18 children who received their cochlear implants by the age of 5 years 
and had a mean usage time of 4.5 years, the majority had achieved age-appropriate 
receptive and/or expressive language skills in their primary language, although their 
second language skills were still in the early stages of development (Waltzman et al., 2003). 
Uziel and colleagues (2007) also documented that some of the children in their study 
showed some ability to develop competency in a second language. 
3.5 Social and emotional development 
Children with profound hearing loss, including children with cochlear implants, are at 
increased risk for adverse life outcomes such as loneliness, poorer quality personal 
relationships, behaviour problems, drug and alcohol problems, and generally poorer quality 
of life than their normally hearing peers (Meadow, 1980; Watson et al., 1990). These 
problems can be attributed to a reduced ability to acquire many of the skills that underpin 
social functioning due to hearing loss (Marschark, 1993), despite their improved auditory 
capabilities. It is also important to note, however, that not all children with profound 
hearing loss and/or cochlear implants develop these problems. The impact of hearing loss 
on children’s social and emotional development  is also affected by several factors external 
to the children themselves, such as parental acceptance of and adaptation to their child’s 
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had hereditary deafness without additional disabilities, none had less than a full electrode 
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support, and resources (Calderon, 2000; Montanini-Manfredi, 1993). Of course, a child’s 
personality and method of interacting with their social environment also contributes 
significantly. The few studies that examine the psychosocial development of children with 
cochlear implants show mixed results (Martin et al., 2011). 
It has been reported that children with cochlear implants often have limited pragmatic 
skills, which can lead to poor social integration (Bat-Chava et al., 2005). Pragmatic skills 
include using language for different purposes (eg. greeting people, requesting information, 
demanding information), being able to change language according to the situation or 
listener (eg. speaking to an adult versus a toddler), and following conversational rules (eg. 
turn-taking in conversations, using facial expressions and eye contact, rephrasing when 
misunderstood). Children with poor pragmatic skills may say inappropriate things during 
conversations, may show little variety in the language they use, or may relate stories in a 
disorganised, illogical way. These behaviours often lead to a higher incidence of 
communication breakdown, and can lower social acceptance, as many children may choose 
to avoid having uncomfortable interactions with others who have pragmatic difficulties.   
Pragmatic problems are often related to delayed language development, which may include 
a limited vocabulary, and deficits in knowledge of grammar and age-appropriate slang. 
It is not uncommon for children with severe-profound deafness to demonstrate significantly 
reduced emotional development and social maturity (Bat-Chava et al., 2005; Hintermair, 
2006). These children also report loneliness, a lack of close friendships and other 
psychosocial difficulties more frequently than do their normally-hearing peers (Most, 2007; 
Stinson & Whitimire, 2000), and some studies show that this is the same for some children 
with cochlear implants (Boyd et al.,2000; Dammeyer, 2010; Leigh et al., 2009). Older children 
with cochlear implants (aged 9-14 years) are generally more affected by loneliness than 
younger children (aged 5-9 years), with children who receive their implants when older 
being most affected (Schorr, 2006). This may reflect the fact that social interaction becomes 
increasingly complex in adolescence, and peer group size tends to increase at this time, 
making communication more difficult due to increased acoustic and social challenges (Bat-
Chava & Deignan, 2001; Martin et al., 2011).  
Unsurprisingly, loneliness and psychosocial difficulties are greatest for children with 
additional disabilities, particularly those with low speech intelligibility and poor 
communication skills, as this increases communication breakdown and results in poorer 
peer attitudes towards children with these difficulties, who may be rejected or ignored by 
their peers (Dammeyer, 2010; Hintermair, 2007; Most, 2007; van Gent et al., 2007). 
Conversely, other studies have found no increased incidence of loneliness and psychosocial 
difficulties in children with cochlear implants compared to children with normal hearing 
(Percy-Smith et al., 2008a; Schorr, 2006), and children have been observed by parents to have 
improved communication skills and social relationships as a result of cochlear implantation 
(Archbold et al., 2008b; Bat-Chava & Deignan, 2001; Bat-Chava et al., 2005; Huber, 2005; 
Huttunen & Valimaa, 2010). Children with cochlear implants have been reported to be more 
likely to be acculturated to hearing society than those with a severe-profound hearing loss 
using hearing aids (Leigh et al., 2008a). 
A statistically significant association has also been found between the level of social well-
being in children with cochlear implants and their speech perception, production and 
 
Cochlear Implants in Children: A Review 
 
345 
language skills (Dammeyer, 2010; Percy-Smith et al., 2008b). Social development usually 
follows language skill development, and improvements in both have been observed to occur 
more quickly for children with cochlear implants than for children with severe-profound 
hearing loss using hearing aids (Bat-Chava et al., 2005). It has been suggested that improved 
spoken language and communication skills facilitate psychosocial development through an 
ability to communicate and a subsequent increase in confidence (Bat-Chava & Deignan, 
2001). Children with severe-profound deafness have historically been found to have lower 
levels of self-esteem than their peers with normal hearing (Nicholas & Geers, 2003), with the 
self-esteem of adolescents being lower than that of younger children (Schorr, 2006). It has 
been suggested that unless their language skills match those of their hearing peers, children 
with cochlear implants cannot fully integrate into the hearing community and develop 
positive self-esteem (Crouch, 1997; Lane & Grodin, 1997). However, as with many recent 
outcomes for children with cochlear implants, more recent research has shown equivalent 
levels of self esteem in children with cochlear implants and children with normal hearing 
(Loy et al., 2010; Martin et al., 2011; Sahli & Belgin, 2006).  
Recent studies have also used measures of health-related quality of life (QOL) to investigate 
psychosocial development in children with cochlear implants, using both parental and child 
reports. QOL is considered to be an assessment of well-being across various areas of life 
such as social interaction, school adjustment, friendships, communication, and listening 
ability. Although a potential limitation of QOL measures can be that although parents are 
well-informed of their children’s level of physical functioning, they have a tendency to 
underestimate their psychosocial functioning (Zaidman-Zait, 2011), QOL assessments are 
still regarded as a useful method of obtaining a more holistic measure of benefit. Loy and 
colleagues (2010) found no significant differences between overall reported QOL for 
children with cochlear implants compared to their peers with normal hearing, in either 
younger (8-11 years) or older (12-16 years) groups, although the younger group rated QOL 
more highly than did the adolescent group. Others have reported similar findings for 
children of various ages (Huber, 2005; Warner-Czyz et al., 2009). 
Several factors have been found to influence psychosocial development in children with 
cochlear implants.  Children who are implanted earlier and therefore have a longer duration 
of implant use are reported to be more socially competent (Leigh et al., 2008a; Martin et al., 
2011), with girls outperforming boys (Martin et al., 2011; Nicholas & Geers, 2003; Percy-
Smith et al., 2008b). As mentioned earlier, children implanted at older ages appear to be at 
greater risk of loneliness (Schorr, 2006), and it has been suggested that this may be due to 
the fact that they do not develop feelings of belonging and inclusion at a young age, as do 
children with normal hearing, due to their delayed language prior to implantation. It is also 
reported that children with cochlear implants in mainstream educational settings who are 
exposed to spoken, rather than signed, language at home have a higher level of social well-
being (Percy-Smith et al., 2008b; van Gent et al., 2007). This may be because children in these 
settings are more likely to have hearing parents, and therefore are continuing to speak their 
first language in these settings, rather than using sign language at home and spoken 
language at school, as would children of many deaf parents. There is also no evidence that 
children with cochlear implants in mainstream educational settings, where speech is used 
exclusively for communication, have an increased incidence of social or emotional 
difficulties compared to children in special educational settings (Filipo et al., 1999; Nicholas 
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Once again, there is enormous variability between individuals in their communication and 
social development after cochlear implantation, with some children progressing at, or even 
above, the average rate of children with normal hearing, and others who lag behind their 
peers. Although there appear to be no negative reports on social/emotional development of 
children as a result of cochlear implantation, a cochlear implant will not guarantee that the 
social difficulties experienced by many children with severe-profound hearing loss are 
avoided (Punch & Hyde, 2011). The research does offer hope, however, that an early 
cochlear implant may not only facilitate the development of speech and language skills, but 
can also give children the potential to develop a healthy and positive social identity and 
competent interactional skills. 
3.6 Literacy and academic outcomes 
With documented improvements in speech perception, production and language outcomes 
clearly attributable to the improved auditory access provided by cochlear implants, there 
has been an expectation that academic outcomes for children with cochlear implants would 
also improve, with implanted children showing significantly better performance than their 
peers with hearing aids. However, although the proportion of children with cochlear 
implants who are enrolled in mainstreamed education settings is increasing steadily (Geers 
& Brenner, 2003), the degree to which cochlear implants have impacted on academic 
outcomes in children with severe-profound hearing loss is not yet clear. Much of the 
research on children with hearing loss is limited mainly to studies of reading ability, and 
few children who have received cochlear implants at a young age are currently old enough 
for longer-term outcomes to be measured. 
Many children with severe-profound hearing loss, including those with cochlear implants, 
have 4 to 5 year delays in spoken language development by the time they enter secondary 
school (Blamey et al., 2001a; Dahl et al., 2003; Davis & Hind, 1999; Ramkalawan & Davis, 
1992; Sarant et al., 2009). Generally, the greater the degree of hearing loss, the larger the 
language delay (Boothroyd et al., 1991). It is well known that poor spoken language ability 
is a primary cause of difficulty in learning to read for children with normal hearing, and it is 
therefore unsurprising that literacy achievement for children with hearing loss has 
historically been low, with many children failing to progress in reading beyond the 
identification of a limited number of words, or the fourth grade level of primary school 
(Geers et al., 2008; Moeller et al., 2007). Reported rates of progress have varied from 1 to 6 
months for every year of education, with the delay in reading widening in adolescence 
(Geers et al., 2008; Thoutenhoofd, 2006). A significant proportion of graduating students 
with hearing loss are functionally illiterate (Helfand, 2001; Moeller et al., 2007; Traxler, 2000; 
Walker et al., 1998), having not even acquired mastery of spoken language, which is 
necessary not only for the development of literacy but also for the development of literate 
thought (Paul 1998). Low literacy achievement and low academic outcomes have seriously 
impacted on the ability of many children with hearing loss to obtain employment as adults, 
with resulting low skill employment and reduced income for some, and others simply not 
having sufficient literacy skills to succeed in the workplace at all. 
One of the key language skills required for learning to read is vocabulary, which is often 
limited in children with hearing loss due to phonetic and phonological delays (Connor &  
Zwolan, 2004; James et al., 2008; Johnson & Goswami, 2010; Moeller et al., 2007; Moores & 
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Sweet, 1990). Phonological processing occurs when a child analyses words into their 
constituent parts, repeats strings of syllables that form new words, or quickly names 
common words. These processing abilities enable word decoding to occur, which in turn 
facilitates word recognition and comprehension of word meaning. Delayed phonological 
awareness, and a subsequently delayed vocabulary, makes it difficult to learn to read. 
Further compounding this difficulty is the fact that reading is a skill that must be learned 
through explicit instruction, some of which may be ‘missed’ due to compromised perceptual 
abilities caused by hearing loss, and also through an inability to understand some of the 
instruction due to poorer language skills (Moeller et al., 2007). It has been shown, however, 
that vocabulary development accelerates after cochlear implantation (Connor et al., 2006; 
Dawson, 1995; Geers et al., 2007; Johnson & Goswami, 2010; Nicholas & Geers, 2008), 
although there are conflicting reports regarding whether vocabulary growth rates slow over 
time, particularly for children who received their cochlear implants at older ages (El-Hakim 
et al., 2001) or remain constant (James et al., 2007). There is wide variability in vocabulary 
development between children (Connor et al., 2000), and long-term follow up of some 
children in their teen or early adult years still documents many children not having attained 
age-appropriate vocabulary (Uziel et al., 2007). 
Reading outcomes to date for children with cochlear implants are promising, with evidence 
that children with cochlear implants are often achieving better reading outcomes at a faster 
rate than their peers with hearing loss who use hearing aids (Marschark et al., 2007), 
although many children are still significantly delayed. The number of children with cochlear 
implants who achieve age-appropriate reading skills is increasing (Geers, 2002; 2003). It has 
also been documented that almost 4 times as many children who have used a cochlear 
implant for at least 2 years have achieved a reading level beyond that of fourth grade 
compared to children with severe-profound hearing loss of similar ages using hearing aids 
(Spencer et al., 2003; Vermeulen et al., 2007). Higher levels of reading performance have 
been documented for girls than for boys (Moog & Geers, 2003), as has been observed in 
children with normal hearing. As with normally-hearing children, the factor that most 
affects reading outcome is language ability (Connor & Zwolan, 2004; Geers, 2003; Johnson & 
Goswami, 2010; Spencer et al., 2003), with children who are more competent in producing 
an oral narrative attaining better reading comprehension skills (Crosson & Geers, 2001). 
Cognitive ability (Geers & Hayes, 2011), speech intelligibility and speech perception ability 
have also been shown to be strong predictive factors of reading outcomes (Geers, 2003; 
Johnson & Goswami, 2010; Spencer & Oleson, 2008).  
There is increasing evidence that some children with cochlear implants can not only acquire 
better reading outcomes than their peers with hearing aids, but can even achieve similar 
outcomes to their peers with normal hearing (Archbold et al., 2008a; Spencer et al., 2003; 
Spencer & Oleson, 2008). James and colleagues (2008) reported that children implanted 
between the ages of 2 to 3.6 years achieved reading scores that were within one standard 
deviation of the hearing normative mean, scoring higher than children implanted between 
ages 5 and 7 years.  Geers and Hayes (2011) also documented 47-66% of adolescents who 
received their implants as pre-schoolers achieving reading abilities within the average range 
for their hearing peers. Other studies have reported similar results, with 70%, 61%, and 51% 
of children reading within age-appropriate levels (Moog, 2002; Geers, 2003, Johnson & 
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Other studies have shown that although early cochlear implantation facilitates improved 
reading outcomes in terms of both decoding and reading comprehension, a significant 
number of children are still not reading at the same level as their normally-hearing peers, 
and are falling behind over time (Archbold et al., 2008a; Connor & Zwolan, 2004). Geers and 
colleagues showed that only 44% of secondary school students showed age-appropriate 
reading performance, compared to 56% of the same group when in primary (elementary) 
school (Geers et al., 2008). Although the group of children was reading, on average, at an 
age-appropriate level when aged 8-9 years, the same children were delayed on average by 
almost 2 years in their reading by age 15-16 years. More recently, Geers and Hayes (2011) 
also reported that although 72% of the adolescents in the same sample had retained their 
reading standing in comparison with hearing peers since primary school, (demonstrating 
age-appropriate growth in reading skills over that time), 60% were still delayed overall. For 
many children, the reading gap between children with cochlear implants and their peers 
with normal hearing still widens as they grow older. Some studies still report that some 
children still do not make any progress at all (James et al., 2008).  
Studies of writing in children with hearing loss have evaluated syntax (or grammar), 
looking specifically at complexity, productivity and grammaticality. The writing of children 
with hearing loss has generally been found to be composed of shorter sentences than those 
used by their hearing peers (Kretchmer & Kretchmer, 1986), repetitive phrasing, and many 
subject-object-verb constructions (Lichtenstein, 1998; Wilbur, 1977). There are also many 
errors of omission, substitution and word addition (Myklebust, 1964), including the 
omission of articles, prepositions, copulas, pronouns and conjunctions (Crosson & Geers, 
2001). Lichtenstein also noted many errors of morphology such as plurality, verb agreement 
and tense in the writing of children with hearing loss. It has been concluded that children 
with hearing loss have even greater difficulties with writing than with learning to read 
(Paul, 1998).  
During the primary (or elementary) school years, early writing patterns appear to follow 
those of spoken language development (ie. children write as they would speak). As their 
writing skills develop, they use more sophisticated forms of language so that their writing 
becomes more “detached” from their spoken language (Spencer et al., 2003).  Children with 
cochlear implants are reported to persist in the documented pattern of immature writing 
skills, with shorter, less complex sentences containing more errors reported for a group of 9-
year-old children using cochlear implants (Spencer et al., 2003). In this study, correlations 
between language abilities and writing productivity suggested that the children had not yet 
‘detached’ their written from their spoken language. Geers and Hayes (2011) also 
documented the poor spelling and writing skills of children with cochlear implants 
compared to their peers with normal hearing. Children in this study continued to struggle 
with phonological processing tasks, and performed at delayed levels on measures of 
phonological awareness, expository writing, and spelling. 
Academic success relies on reading and writing abilities, and there is now a body of work 
focused on literacy in children with cochlear implants. However, information on overall 
academic performance of these children is scarce. Spencer and colleagues (2004) examined 
academic achievement in science, social studies and humanities in young adults with 
cochlear implants, finding that consistent users of cochlear implants performed comparably 
to their hearing peers, achieving an overall mean standard score of 103.88 on the relevant 
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subtests of the Woodcock-Johnson Tests of Achievement (the expected average score for 
children with normal hearing would be 100). This study is novel because it is the only report 
of fully comparable academic performance for children with cochlear implants. A more 
recent report on educational and employment achievements in France showed that although 
42-61% of the children had failed one grade (or year level) at school (a higher rate of failure 
than for children with normal hearing), over 60% of those aged 18 years and over either held 
a university degree and/or were employed at levels similar to those of their peers with 
normal hearing. These figures were reported as being very similar to those for the general 
population of France, where 53% of individuals have at least a high school diploma (Venail 
et al., 2010). A third study of Malaysian children reported that for children implanted 
relatively late (aged 3-4 years), 56% performed below the average level academically, with 
greatest achievement in mathematics rather than language (Mukari et al., 2007). 
As with other areas of development, wide variability in literacy and academic outcomes has 
been reported. As children are implanted at younger ages and enter school with better 
language skills, it is likely that future research will show a further narrowing of the gap in 
literacy and academic performance between children with cochlear implants and children 
with normal hearing. However, although many younger children are reported to be 
performing at age appropriate levels, some studies suggest that this level of performance is 
not sustained long-term by all children. Currently, the effect of cochlear implants on the 
long-term academic outcomes of children appears promising, but unclear.  
4. Factors affecting speech perception, production and language outcomes 
Despite the significant improvements made in cochlear implant technology, and the large 
body of clinical knowledge gained over time regarding likely benefits for children with 
cochlear implants, one of the remaining significant challenges is to identify predictors of 
post-implant outcomes, as there is great variation in benefits between individuals. Several 
factors have currently been identified as influential in children’s speech perception, speech 
production, language and academic development after implantation, and the most 
important of these are discussed below. 
4.1 Age at diagnosis 
With the establishment of newborn hearing screening in many developed countries around 
the world, the average age of diagnosis of hearing loss in these countries has dropped to 12-
25 months, with many babies identified as young as 3 months of age (Dalzell et al., 2000; 
Harrison et al., 2003; Watkin et al., 2007). As mentioned previously, the earlier identification 
of hearing loss has resulted in a rapid rise in the numbers of children receiving cochlear 
implants at younger ages (ASHA, 2004). It was estimated that the number of children 
receiving cochlear implants before the age of 2 years between 1991 and 2002 increased forty 
fold (Drinkwater, 2004), and it is likely that this growth rate has not declined. However, 
there are still many children in developed countries who are not receiving cochlear implants 
early in life. It is disappointing to note that despite earlier identification of hearing loss 
through newborn hearing screening programs, many families (and almost half of the 
families in the U.S. who are referred for further hearing assessment of their newborn babies) 
still do not receive early intervention services by the age of 6 months, as is recommended by 
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with phonological processing tasks, and performed at delayed levels on measures of 
phonological awareness, expository writing, and spelling. 
Academic success relies on reading and writing abilities, and there is now a body of work 
focused on literacy in children with cochlear implants. However, information on overall 
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population of France, where 53% of individuals have at least a high school diploma (Venail 
et al., 2010). A third study of Malaysian children reported that for children implanted 
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been reported. As children are implanted at younger ages and enter school with better 
language skills, it is likely that future research will show a further narrowing of the gap in 
literacy and academic performance between children with cochlear implants and children 
with normal hearing. However, although many younger children are reported to be 
performing at age appropriate levels, some studies suggest that this level of performance is 
not sustained long-term by all children. Currently, the effect of cochlear implants on the 
long-term academic outcomes of children appears promising, but unclear.  
4. Factors affecting speech perception, production and language outcomes 
Despite the significant improvements made in cochlear implant technology, and the large 
body of clinical knowledge gained over time regarding likely benefits for children with 
cochlear implants, one of the remaining significant challenges is to identify predictors of 
post-implant outcomes, as there is great variation in benefits between individuals. Several 
factors have currently been identified as influential in children’s speech perception, speech 
production, language and academic development after implantation, and the most 
important of these are discussed below. 
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With the establishment of newborn hearing screening in many developed countries around 
the world, the average age of diagnosis of hearing loss in these countries has dropped to 12-
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of hearing loss has resulted in a rapid rise in the numbers of children receiving cochlear 
implants at younger ages (ASHA, 2004). It was estimated that the number of children 
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through newborn hearing screening programs, many families (and almost half of the 
families in the U.S. who are referred for further hearing assessment of their newborn babies) 
still do not receive early intervention services by the age of 6 months, as is recommended by 





reasons for this are varied, and include a lack of understanding of the importance of early 
identification and intervention, problems with follow-up systems, lack of access to 
appropriate services and other issues related to babies’ health (Sass-Lehrer, 2011). It is also 
reported that around one third of pediatric implant recipients who passed the newborn 
hearing screening assessment subsequently become implant candidates through progressive 
hearing loss in the first years of life due to genetic causes such as the Connexin 26 mutation, 
Usher Syndrome, or to other causes such as auditory neuropathy or congenital 
Cytomegalovirus (CMV) (Young et al., 2011), and these children also receive cochlear 
implants when older. 
Although age at diagnosis has been reported by many studies to be an influential factor in 
outcomes for children with cochlear implants, some studies have not found this link (Geers 
et al., 2009; Geers, 2004; Harris & Terlektsi 2011; Sarant et al., 2009; Wake et al., 2005). Two of 
these studies included a greater proportion of children who were diagnosed late and were 
therefore implanted at older ages, reporting poorer performance than other studies of 
children whose hearing loss was identified earlier. Nicholas and Geers (2006) reported that 
age at diagnosis was not a significant predictive factor in language outcomes unless it led to 
children receiving a cochlear implant before 24 months of age. Evidence that age at 
diagnosis is an important factor has become stronger as children receive cochlear implants 
at younger ages. Several studies have reported excellent speech perception abilities and age-
appropriate language outcomes for many young children who were diagnosed with hearing 
loss in the first six months of life (Apuzzo, 1995; Yoshinaga-Itano, 2003b; Yoshinaga-Itano et 
al., 1998), and there is mounting evidence that early-diagnosed children are developing 
language at a faster rate than their later-diagnosed peers (Connor & Zwolan, 2004; Kennedy 
et al., 2006).  
4.2 Age at implant/duration of profound deafness 
Age at implantation is often quite close to time of diagnosis early in life due to newborn 
screening. For children with congenital hearing loss, ‘age at implant’ is equal to ‘duration of 
deafness’. Many human and animal studies of the development of the neurosensory 
pathways of the primary auditory cortex in the brain have suggested that the plasticity, or 
potential for development, of neural pathways is greatest during early development, and 
that there is therefore a ‘critical period’, during which auditory stimulation must occur in 
order for neural maturation to occur (Kral et al., 2001; Sharma et al., 2002). If stimulation 
does not occur within this timeframe, the auditory system degenerates (Kral et al., 2001; 
Shepherd, 1997). In humans with normal hearing, maturation of the central auditory system 
continues throughout childhood through to adolescence. Research with humans has shown 
that the central auditory system can retain its plasticity for some years without auditory 
input, and when stimulated by a cochlear implant will commence maturation at the same 
rate as for children with normal hearing, with the maturational sequence delayed by the 
period of sensory deprivation (Ponton et al., 1996). 
It has been found, however, that after long periods of deprivation, such as in children who 
have used a unilateral implant for several years and have then received a second, bilateral 
implant, that there were abnormalities in spatial patterns of cortical activity in the brain not 
observed in children who received a second cochlear implant after a shorter time (Gordon et 
al., 2010). Further physiological studies suggest that in the absence of normal auditory 
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stimulation there is a period of about 3.5 years during which the central auditory system 
retains its maximum plasticity. This can extend in some children up to the age of 
approximately 7 years, after which it is significantly reduced (Sharma et al., 2005; Sharma et 
al., 2002). Harrison and colleagues (2005), who examined the speech perception performance 
of children implanted at different ages, argue that the situation is not quite as simple as this. 
They hypothesize that although central auditory plasticity is limited for children implanted 
at older ages, there is no age at which there is a clear cut-off, but instead there is an age-
related plasticity effect that depends to some extent on the tests used to assess performance.  
Early research on cochlear implantation in children supported the biological plasticity 
theory, showing a strong negative relationship between duration of deafness (or age at 
implant) and speech perception outcomes (Apuzzo, 1995; Nikolopoulos et al., 1999; 
Osberger, 1991; Staller et al., 1991). Initially, speech perception results for children who were 
not congenitally deaf, received their cochlear implant relatively quickly, and therefore had a 
shorter period of deafness, were superior to those for children with congenital deafness and 
later implantation (Pisoni et al., 1999; Staller et al., 1991). As Marshark (2007) noted, children 
who have later onset hearing loss have usually developed better language skills prior to 
implantation, and therefore show better achievement afterwards (for example, Moog & 
Geers, 2003). For children with congenital deafness, a significant correlation between age at 
implantation and outcomes has also been documented in many recent studies. Children 
implanted earlier show faster growth of speech perception (Tajudeen et al., 2010; Uziel et al., 
2007), language (Connor et al., 2000; Nikolopoulos et al., 2004; Schorr et al., 2008; Tomblin et 
al., 2005) and reading abilities (Archbold et al., 2008a; Geers et al., 2008; James et al., 2008; 
Johnson & Goswami, 2010), and also have improved psychosocial outcomes (Schorr, 2006). 
Development of speech production is also associated with age at implantation, with slower 
rates of development shown by children who received their implants later (Flipsen, 2008; 
Peng et al., 2004; Tye-Murray et al., 1995). Interestingly, for children implanted very early, 
early age at implantation and speech production have been observed to have the opposite 
association, with one study documenting slower vocal development for children implanted 
when younger. Greater physical, cognitive, and social maturity were thought to provide 
children implanted at older ages with an advantage for early speech development (Ertmer et 
al., 2007). 
More recently, there have been reports of even better outcomes in children implanted 
around the age of 2 years or younger, with higher proportions of children achieving speech 
perception, language and reading skills commensurate with those of their hearing peers 
(Duchesne et al., 2009; Geers, 2004; Niparko et al,. 2010; Svirsky et al., 2004). These results 
have been observed to be “consistent with the existence of a ‘sensitive period’ for language 
development, and a gradual decline in language acquisition skills as a function of age” 
(Svirsky et al., 2004). Svirsky and colleagues qualify this observation by suggesting that the 
auditory information provided by a cochlear implant is significantly inferior to that received 
by children with normal hearing, and that it is possible that sensitive periods for speech and 
language development may exist for cochlear implant users and not for children with 
normal hearing because of the diminished auditory signal the former receive.   
Nicholas and Geers (2007) studied the language development of 76 children who had 
received a cochlear implant by their third birthday. They concluded that children who 
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stimulation there is a period of about 3.5 years during which the central auditory system 
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early age at implantation and speech production have been observed to have the opposite 
association, with one study documenting slower vocal development for children implanted 
when younger. Greater physical, cognitive, and social maturity were thought to provide 
children implanted at older ages with an advantage for early speech development (Ertmer et 
al., 2007). 
More recently, there have been reports of even better outcomes in children implanted 
around the age of 2 years or younger, with higher proportions of children achieving speech 
perception, language and reading skills commensurate with those of their hearing peers 
(Duchesne et al., 2009; Geers, 2004; Niparko et al,. 2010; Svirsky et al., 2004). These results 
have been observed to be “consistent with the existence of a ‘sensitive period’ for language 
development, and a gradual decline in language acquisition skills as a function of age” 
(Svirsky et al., 2004). Svirsky and colleagues qualify this observation by suggesting that the 
auditory information provided by a cochlear implant is significantly inferior to that received 
by children with normal hearing, and that it is possible that sensitive periods for speech and 
language development may exist for cochlear implant users and not for children with 
normal hearing because of the diminished auditory signal the former receive.   
Nicholas and Geers (2007) studied the language development of 76 children who had 
received a cochlear implant by their third birthday. They concluded that children who 





developed, were more likely to achieve age-appropriate spoken language. These children 
‘caught up’ with their hearing peers by 4.5 years of age, whereas children implanted after 24 
months of age did not. Both Nicholas and Geers (2007) and Tomblin and colleagues (2005) 
observed an early burst of language growth in children implanted before the age of 18 
months which was not seen in children implanted after this age. More recent studies suggest 
implanting children as early as before 12 months of age, with strong development of speech 
perception and language skills reported at age-appropriate rates for many or all of the 
children (Svirsky et al., 2004; Tajudeen et al., 2010; Waltzman & Roland, 2005; Wie, 2010). 
A review of recent studies concluded that the evidence suggests that cochlear implantation 
before the age of 2 years is more effective than after this time, but that it is not yet clear 
whether implantation of children under 12 months of age provides greater benefit (Ali & 
O'Connell, 2007). As implantation of children under the age of 2 years is a relatively recent 
practice, limited evidence has been obtained for short-term outcomes (only up to 
approximately 5-8 years post-implantation) and the effect of implantation at a very young 
age on longer-term outcomes is still unknown (Ali & O'Connell, 2007). It is also not yet 
known whether children implanted at older ages, who have been shown to develop more 
slowly, will eventually reach equivalent long-term milestones to those implanted earlier. 
Some more recent longer term studies support this view, showing that although age at 
implantation strongly influences outcomes in younger children, the effect of this factor 
appears to wane with increasing age and implant experience (Geers, 2004; Hay-McCutcheon 
et al., 2008; Moog & Geers, 2003). Finally, when considering these reports, it is also 
important to remember that children implanted at younger ages are more likely to use oral 
communication, a factor that has also been shown to improve speech perception and spoken 
language outcomes.  
4.3 Degree of hearing loss 
There is conflicting evidence regarding the influence of degree of hearing loss on outcomes 
for children with cochlear implants. This factor has been reported as highly predictive of 
outcomes for children with cochlear implants in many studies. Speech perception abilities, 
language development and reading in children with hearing loss and those with cochlear 
implants have been found to decrease with increasing severity of hearing loss (Boothroyd et 
al., 1991; El-Hakim et al., 2001; Holt & Svirsky, 2008; Wake et al., 2005; Zwolan et al., 1997). 
Nicholas and Geers (2007) observed that children with better hearing prior to implantation 
showed faster language growth with increasing implant experience than did children with 
less pre-implant hearing. Conversely, some other studies that included more children who 
were older when implanted and at testing have not found a significant correlation between 
degree of hearing loss and speech perception, vocabulary or speech production outcomes 
(Blamey et al. 2001a; Harris & Terlektsi, 2011). The majority of published evidence supports 
a significant influence of degree of hearing loss on outcomes. 
4.4 Cognitive ability 
Non-verbal cognitive ability has been identified as one of the most influential factors on 
language outcomes in preschool children with hearing loss. The influence of cognitive skills 
is no less important for outcomes in children with cochlear implants, and several studies 
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have reported it to be one of the most significant factors of all those examined, having much 
greater influence than other variables (Geers et al., 2009; Geers, 2003). Non-verbal IQ has 
been shown to have a significant effect on the development of vocabulary (Mayne, 2000), 
language (Geers et al., 2009; Geers et al., 2008; Sarant et al., 2009; Sarant, Hughes, & Blamey, 
2010), reading (Moog & Geers, 2003), and speech production (Tobey et al., 2003). Although, 
after adjusting for the effect of language, cognitive ability usually has no direct effect on 
speech perception performance, it does have an indirect effect on this outcome. This is 
because language is strongly influenced by cognitive ability, and is the medium through 
which speech perception assessments are conducted; children have to comprehend the 
language used in speech perception tests and respond using spoken language (Sarant et al., 
2010). Many studies have demonstrated a strong association between language and speech 
perception ability (for example, Blamey et al., 2001; Niparko et al., 2010). 
Cognitive delay has been associated with reduced development of speech perception and 
production skills in populations of children with diagnosed additional disabilities (Holt & 
Kirk, 2005; Pyman et al., 2000; Waltzman et al., 2000), but is also a predictive factor for 
children who are in the average range for non-verbal cognitive abilities (Moog & Geers, 
2003). Pisoni and colleagues emphasized the importance of cognitive factors such as 
memory, attention, and verbal rehearsal speed in determining outcomes after implantation 
(Pisoni & Cleary, 2003; Pisoni et al., 1999), and postulated that ‘central’ cognitive factors 
might explain some of the previously unexplained variance in outcomes for children with 
cochlear implants (Pisoni & Cleary, 2003; Pisoni et al., 1999). Geers and Sedey (2011) added 
credence to this theory with their recent observation that faster verbal rehearsal speed 
contributed to better language outcomes in children implanted between 2 and 5 years of age 
with more than 10 years of cochlear implant experience. In further support of Pisoni and 
colleagues’ theory, it has recently been reported that when compared to children of the 
same age and cognitive ability, children with cochlear implants still demonstrate language 
delays that are disproportionate to their cognitive potential (Meinzen-Derr et al., 2011). 
The cognitive processes underlying this performance-functional gap need to be 
investigated and understood in order to implement appropriate intervention strategies to 
close the gap and improve outcomes for a greater proportion of children with cochlear 
implants.  
4.5 Communication mode 
Communication mode, often dichotomized into oral communication and total 
communication (signing plus speaking), has long been investigated as a source of variance 
in outcomes for children with cochlear implants, with mixed results. Proponents of oral 
communication maintain that maximal auditory benefit from cochlear implants can only be 
gained if hearing and speech are the only media for communication. There are several 
reports of children attending oral communication programs achieving higher speech 
perception and language scores than children in total communication programs (Archbold 
et al., 2000; El-Hakim et al., 2001; Geers et al., 2003; Meyer et al., 1998; Moog & Geers, 2003).  
Similarly, speech production outcomes are reported to be better for children in oral 
education settings. Tobey et al (2003) found oral-aural communication and teaching 
methods that emphasized speaking and listening to be the most influential factors in 
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have reported it to be one of the most significant factors of all those examined, having much 
greater influence than other variables (Geers et al., 2009; Geers, 2003). Non-verbal IQ has 
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4.5 Communication mode 
Communication mode, often dichotomized into oral communication and total 
communication (signing plus speaking), has long been investigated as a source of variance 
in outcomes for children with cochlear implants, with mixed results. Proponents of oral 
communication maintain that maximal auditory benefit from cochlear implants can only be 
gained if hearing and speech are the only media for communication. There are several 
reports of children attending oral communication programs achieving higher speech 
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methods that emphasized speaking and listening to be the most influential factors in 





environments were found to enhance speech production development, regardless of 
whether the environment was a mainstream school or a special school, although children in 
mainstream environments outperformed those in special education environments.  
Proponents of the total communication approach maintain that children will obtain maximal 
information through the use of both speech and some form of manually coded English, as 
the latter will provide information that may be missed due to insufficient auditory abilities.  
Improved vocabulary development has been documented for children implanted early and 
enrolled in total communication educational programs over those in oral programs (Connor 
et al., 2000). There are also reports that mode of communication does not significantly 
influence some outcomes. Yoshinaga-Itano and Snyder (1996) found that mode of 
communication and learning did not significantly affect students' performance in the 
lexical/semantic characteristics of their written language. They hypothesized that written 
language is acquired in such a way that students need only one well-established language in 
order to acquire the written form of their language, and that both oral and signed 
communication methods may provide students with sufficient bases from which to learn 
written English. Similarly, several studies of speech perception, production, language, 
reading and later academic outcomes of children with cochlear implants have not found oral 
or total communication modes to be predictive of better results (Geers, 2003; Miyamoto et 
al., 1993; Niparko et al., 2010; Robbins et al., 1999; Uziel et al., 2007).  
The absence of overwhelming evidence of the superiority of one communication method 
over the other may be due to differences in the characteristics of the children studied. 
Children who are implanted at younger ages are more likely to use an oral communication 
method, and particular educational programs may also have selection biases towards 
children with characteristics such as greater preoperative residual hearing or higher 
cognitive ability (Geers, 2006a). Some non-government funded educational programs are 
not accessible to families of lower socioeconomic status, and in this way only children from 
families with greater financial means and likely higher educational achievements will be 
enrolled in particular programs.  When considering the effect of mode of communication, it 
is unclear in many cases whether children use oral communication after cochlear 
implantation because they are progressing well, or whether their rate of progress is due to 
their use of oral communication. 
4.6 Family characteristics  
Several family characteristics have been found to contribute to various outcomes for 
children with hearing loss, including those with cochlear implants. Family size has been 
observed to impact on speech production outcomes, with children from smaller families 
making faster progress (Moog & Geers, 2003; Tobey et al., 2003). This is presumably due to 
the fact that parents of smaller families may have more time and/or resources to devote to 
assisting their children’s communication development. Similarly, children from families of 
higher socioeconomic status have achieved better speech production, language and literacy 
outcomes (Connor & Zwolan, 2004; Dollaghan et al., 1999; Holt & Svirsky, 2008; Niparko et 
al., 2010; Tobey et al., 2003). Greater parental involvement in children’s intervention 
programs has also been associated with improved language development (Moeller, 2000; 
Sarant et al., 2009; Watkin et al., 2007). This is presumably due to increased follow-up and 
improved communication at home, as parents who become involved in intervention have 
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been shown to demonstrate better communication skills and make higher contributions to 
children’s progress than non-participating parents (Fallon & Harris, 1991).  
 Unsurprisingly, maternal communication skills are also a significant indicator for language 
development, early reading skills, and psychosocial development, with children of mothers 
who are better communicators developing better reading and language skills and having 
fewer behaviour problems (Calderon, 2000; Niparko et al., 2010). Children with a more 
highly educated parent caregiver have been reported to have better language, even in 
studies where the average educational level was relatively high (Geers et al., 2009; Sarant et 
al., 2009). It has been suggested that the relationship between socioeconomic status and 
language outcomes is actually mediated solely by properties of maternal speech that differ 
as a function of socioeconomic status (Hoff, 2003; Hoff & Tian, 2005).  Gender also 
contributes to the variation in outcomes between children, with females consistently 
achieving better results with regard to speech production (Tobey et al., 2003), reading (Moog 
& Geers, 2003) and language development (Geers et al., 2009).  
4.7 Other factors 
Cochlear implant and speech characteristics such as the number of active electrodes in the 
implant array, larger dynamic ranges in speech processor maps, greater growth of loudness 
and length of time using the latest speech processing strategies have been found to 
significantly influence speech production and language outcomes in children implanted by 
age 5 years (Connor et al., 2000; Moog & Geers, 2003; Peng et al., 2004; Tobey et al., 2003). 
The number of surviving nerves has also been postulated to contribute to outcomes (Pyman 
et al., 2000). 
5. Limitations in outcomes with unilateral cochlear implants 
Historically, the consequences of unilateral hearing loss (UHL) have been underestimated, 
both for children with normal hearing and those with a unilateral cochlear implant, as 
spoken language can still be developed with one hearing ear. Prior to the introduction of 
neonatal hearing screening, many children with UHL were undiagnosed until they attended 
school, where communication difficulties in noisy educational environments or failure to 
progress academically at the expected rate raised suspicions of hearing loss. Although there 
has been limited research on the effect of UHL on the development of spoken language, 
mild through to significant delays have been reported in several studies of children with 
UHL and normal hearing in the unimplanted ear, although there has been insufficient 
follow-up to determine whether the reported delays persisted through childhood (Cho Lieu, 
2004). A review of the literature in this area also found that school-aged children with UHL 
have increased rates of academic failure (22-35% rate of repeating at least one grade), 
additional needs for educational assistance (12-41%), and behavioural problems in the 
classroom (Cho Lieu, 2004).  
Despite the fact that many children with a unilateral implant demonstrate excellent speech 
perception abilities in the controlled testing environment of a sound proof booth (Cheng et 
al., 1999; Leigh et al. 2008c; Sarant et al., 2001), this performance does not represent their 
speech perception abilities in the real world. The difficulties experienced by children with 
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single cochlear implant and a severe-profound or profound hearing loss in the non-
implanted ear. These include difficulty understanding speech that is soft, or speech in noisy 
environments, such as the playground or classroom, and difficulty locating sound sources, 
such as their peers in a group conversation, or their teachers in the classroom. These 
auditory challenges can limit their ability to follow or take part in a group conversation, or 
to focus in the correct direction when the teacher begins to speak. The amount and quality of 
speech heard by children with one cochlear implant and a significant hearing loss in the 
other ear is greatly reduced and fragmented compared to what is heard by children with 
normal hearing. Further, understanding what they do hear is made difficult by their often 
delayed language skills. With poor language knowledge, many of these children are unable 
to piece together poorly heard or overheard information, and therefore to learn incidentally 
(without direct teaching), as do children with normal hearing. The inability to ‘overhear’ 
spoken conversations limits the access of these children to many avenues of incidental 
learning, and therefore restricts their acquisition of knowledge of language, social 
interaction, and how the world works, stifling their development in many areas. 
A unilateral cochlear implant does not guarantee the development of language, speech 
production, academic or social skills comparable to those of children with normal hearing. 
Although there are many children with a unilateral cochlear implant who are able to 
develop these skills at an age-appropriate rate, there also remain many who show delayed 
development in these areas, some of whom maintain or increase their delay through to 
adulthood. Given the difficulties of unilateral hearing loss, giving children bilateral cochlear 
implants could potentially improve outcomes.  
6. Bilateral cochlear implants 
A recent report on worldwide trends in bilateral cochlear implantation estimated that 59%of 
bilateral cochlear implant recipients in the U.S., and 78% of recipients in other countries are 
currently children (Peters et al., 2010). It was observed that by the end of 2007,  70% of all 
bilateral cochlear implants had been received by children, with children aged 3-10 years 
being most highly represented in this group (33% of all bilateral surgeries; Peters et al., 
2010). 70% of children received 2 cochlear implants in sequential operations (2 separate 
operations). Of the remaining 30%, children aged less than 3 years were the only group for 
whom the majority (58%) received bilateral cochlear implants simultaneously (during the 
same operation). Bilateral cochlear implantation in children is a growing trend worldwide; 
in 2010, implant manufacturers’ databases indicated that there were 4986 children with 
bilateral implants (Peters et al., 2010). 
6.1 
6.1.1 Decision making 
The decision to give a child one or two cochlear implants is a difficult one for parents, 
despite the growing trend toward implanting children at a young age with simultaneous 
bilateral cochlear implants. Until recently, there has been a lack of strong evidence to 
support bilateral implantation, particularly with regard to longer term outcomes (Hyde et 
al., 2010). For parents of children with no useable residual hearing, the decision is more 
straightforward, as binaural hearing offers significant benefits over monaural hearing. 
However, parents of children with useable aided residual hearing face a more difficult 
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decision, as loss of functional and useful hearing is being risked for a probable, but not 
guaranteed, benefit. Parents usually take into account their child’s degree of hearing loss in 
both ears (if the child has no cochlear implants) or in the non-implanted ear, professional 
recommendations, costs (typically between $US40,000 -$US60,000 (Papsin & Gordon, 2007), 
their own attitudes and desires for their child, and surgical/medical and other risks (see 
section 6.1.4). Parents of children who are deemed eligible by an implant team for bilateral 
cochlear implants may still choose to give their child a unilateral implant. Reasons for this 
decision have included a desire to see what the benefits of one implant are before 
proceeding with another, concerns about the appearance of children wearing two speech 
processors, saving an ear for future technological developments (see 6.1.3), and difficulty 
accepting children’s hearing loss. 
6.1.2 Physiological and functional arguments for bilateral cochlear implantation 
The arguments for bilateral cochlear implantation include stimulation of both auditory 
nerves to ensure that the better ear is stimulated, as the benefits of cochlear implantation are 
not necessarily symmetrical for each ear. As previously discussed, many factors influence 
outcomes, and although some factors will be the same for both ears in a particular 
individual (for example, communication mode, cognitive ability etc.), others may not. These 
could include the anatomical structure and physiology of the ears, effects of the pathology 
that caused the hearing loss, and in the case of children who receive two cochlear implants 
separated in time (sequential implantation), the duration of deafness will differ between the 
ears. A further reason for bilateral cochlear implantation is to prevent the neural 
degeneration that has been documented in humans and animal studies as a result of 
auditory deprivation (Hardie, 1998; Sharma et al., 2002; Shepherd, 1997). Bilateral 
implantation also ensures that children still have hearing in the case of speech processor or 
device failure in one ear, which can significantly reduce stress for children and their families 
if these events occur. Finally, having bilateral cochlear implants may facilitate binaural 
hearing, which requires the perception of auditory information in both ears. As discussed 
earlier, children with unilateral cochlear implants experience the difficulties associated with 
unilateral deafness, such as an inability to localize sounds, and difficulty perceiving speech 
in background noise. For the relatively small number of children who have sufficient 
hearing to use a hearing aid in their non-implanted (or contralateral) ear, the literature 
shows that binaural benefit is gained through use of the cochlear implant and hearing aid 
together (Frush Holt et al., 2005; Mok et al., 2007). However, for many children with a 
bilateral profound or severe-profound hearing loss, the use of a contralateral hearing aid in 
the non-implanted ear is not a viable option, due to a lack of residual hearing. For these 
children, bilateral cochlear implantation is the only means of providing binaural hearing. 
6.1.3 Access to future technology 
Arguments against bilateral implantation include ‘saving’ an ear for future technology while 
using a hearing aid with residual hearing (if there is sufficient residual hearing). Although it 
is known that changes in the cochlea occur after implantation, and that these are permanent, 
it is not known whether repeated re-implantation with cochlear implants or with other 
future technology is possible after many years of cochlear implant use (although re-
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when future technologies such as gene therapy or neural regeneration will become available 
for clinical use, and it is accepted that there is a critical time period for central auditory brain 
and language development, beyond which future technology may not be beneficial. Without 
knowing what form future technologies may take, it is not possible to predict how useful 
they may be for individuals who have ‘waited’ and not proceeded with the current cochlear 
implant technology. 
6.1.4 Risks  
Many parents have concerns about the risks of cochlear implant surgery, and some of these 
risks are increased with two separate implant operations, as is the case with sequential 
implant procedures. Simultaneous implant operations require less than double the surgery 
time and eliminate the need for, and risks of, two anaesthetics and recovery periods. 
Complications as a result of cochlear implant surgery can be categorised as major and 
minor, and most occur very close to the time of surgery, although some have been reported 
up to 14 years post-surgery, and can recur. Major complications include infections or skin 
flap breakdown in the area around the implant, extrusion of the end of the electrode array 
outside the cochlea, device failure (requiring explantation of the device), cholesteatoma, 
permanent facial nerve damage, persistent eardrum perforation, cerebrospinal fluid leak 
with subsequent meningitis, and magnet displacement. For children with anatomical 
deformities of the cochlea (such as Mondini deformity, in which there are less than the 
normal two and a half turns in the cochlea), the risk of facial nerve damage is greater. 
However, reported major complication rates are very low, ranging from 2 - 5% (Bhatia et al., 
2004; Cohen et al., 1989; Loundon et al., 2010).  
Minor complications are those which can be resolved without surgery, and include vertigo 
with or without nausea, persistent otitis media (middle ear infection), facial palsy, tinnitus, 
mild skin flap infection, flap swelling, hematoma (bruising), taste disturbance, and pain 
around the operation site. The incidence of minor complications is higher and more subject 
to variation between cochlear implant centers; studies of large numbers of patients ranging 
from 4% - 20% (Bhatia et al., 2004; Dutt et al., 2005; Loundon et al., 2010). Other risks include 
those of any surgical procedure, including the risks associated with an anaesthetic and 
blood loss. Some risks are increased for younger children, including an increased risk of 
anaesthetic complications. A further risk is due to the relatively small size of their skulls. 
Although their cochleae are adult-sized at birth, their small skull size increases the risk of 
displacement of the electrode array with subsequent significant skull growth. There is also a 
high prevalence of otitis media in this age group, which raises the risk of significant 
infection in the implant area as a result of infection spread from the middle ear. Due to these 
concerns, the FDA currently approves cochlear implantation in children only from the age 
of 2 years and older (ASHA, 2004). In summary, although there are several possible 
complications of cochlear implant surgery, the incidence of life-threatening complications is 
extremely low, and the rates of major and minor post-operative complications are also low, 
making cochlear implant surgery in children a reliable and safe procedure. 
Longer term risks of cochlear implantation include device failure. Although cochlear 
implants are designed to last for a lifetime, about 2% of devices do fail (ASHA, 2004). Device 
failure can result in a changed auditory percept or a total lack of function, and re-
implantation is the only solution. Fortunately, most re-implants function as well as, or better 
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than, the original implants, but the risks, costs, and inconvenience of surgery must be 
undertaken. Another longer-term risk is the increased risk of bacterial meningitis, due to the 
fact that the cochlear implant is a foreign body, and can act as a nidus for infection when 
there is a bacterial illness (ASHA, 2004). This risk is highest for children with malformed 
cochleae, those who contract meningitis prior to cochlear implantation, children aged less 
than five years, and children with otitis media or immunodeficiency. A further longer-term 
complication is facial nerve stimulation, which can occur at any time after cochlear 
implantation, but is rare. Children most at risk of this are those with malformed cochleae. 
Fortunately, it is a simple procedure for an audiologist to switch off the electrode/s causing 
the unwanted sensation. 
A final and important risk that is unique to sequential bilateral cochlear implantation is that 
some (usually older) children may not like the sound of their second cochlear implant, and 
will eventually become non-users. While many children, particularly those who have had 
one cochlear implant and have another after a significant period of time, may not initially 
like the sound of their second implant, most adapt to it over time with encouragement and 
support. However, some children never adapt, and show a pattern of inconsistent use over 
several years that culminates in rejection when they are older. There have been no reports in 
the literature to date about adaptation and non-user rates for either large groups of children 
with bilateral implants or for simultaneously implanted children. Factors thought to 
contribute to this outcome in children with a unilateral cochlear implant include older age at 
implantation, dislike of the auditory percept, facial nerve pain or twitching, peer pressure in 
secondary school, family issues, non-mainstream school settings, use of signed 
communication, lack of involvement in the decision-making process (older children), and 
poor speech intelligibility after several years of cochlear implant use (Archbold et al., 2009; 
Ray et al., 2006; Watson & Gregory, 2005).  
Published information on the current non-user rate for children with unilateral cochlear 
implants suggests the risk of rejection is low; the reported non-user rate is currently around 
3% (Archbold et al. 2009; Uziel et al. 2007). However, for children receiving a second, 
sequential cochlear implant, the situation is entirely different, as they must adapt to a 
second, different sound percept; one that may not compare favourably with that provided 
by their first cochlear implant. In the first study to be published on adaptation in children 
with bilateral implants, Galvin and Hughes (in press) noted that a higher proportion of 
children who were implanted simultaneously adapted to full-time use of their devices (95%) 
than those implanted sequentially (70%), and that adaptation to bilateral implant use was 
not easy for almost 20% of the 46 children studied. Both Galvin and colleagues, and 
Archbold (2009; in a study of long term use of unilateral cochlear implants in children) 
noted that children who eventually become non-users often first demonstrate a pattern of 
inconsistent use. Archbold also noted that children who became non-users usually had 
disabilities additional to their hearing loss. The possibility of this eventuality should be 
taken into account by parents, and also by children old enough to participate in the 
decision-making process. 
6.2 Benefits of bilateral cochlear implants 
When a person with normal hearing listens with two ears (rather than just one) sound 





when future technologies such as gene therapy or neural regeneration will become available 
for clinical use, and it is accepted that there is a critical time period for central auditory brain 
and language development, beyond which future technology may not be beneficial. Without 
knowing what form future technologies may take, it is not possible to predict how useful 
they may be for individuals who have ‘waited’ and not proceeded with the current cochlear 
implant technology. 
6.1.4 Risks  
Many parents have concerns about the risks of cochlear implant surgery, and some of these 
risks are increased with two separate implant operations, as is the case with sequential 
implant procedures. Simultaneous implant operations require less than double the surgery 
time and eliminate the need for, and risks of, two anaesthetics and recovery periods. 
Complications as a result of cochlear implant surgery can be categorised as major and 
minor, and most occur very close to the time of surgery, although some have been reported 
up to 14 years post-surgery, and can recur. Major complications include infections or skin 
flap breakdown in the area around the implant, extrusion of the end of the electrode array 
outside the cochlea, device failure (requiring explantation of the device), cholesteatoma, 
permanent facial nerve damage, persistent eardrum perforation, cerebrospinal fluid leak 
with subsequent meningitis, and magnet displacement. For children with anatomical 
deformities of the cochlea (such as Mondini deformity, in which there are less than the 
normal two and a half turns in the cochlea), the risk of facial nerve damage is greater. 
However, reported major complication rates are very low, ranging from 2 - 5% (Bhatia et al., 
2004; Cohen et al., 1989; Loundon et al., 2010).  
Minor complications are those which can be resolved without surgery, and include vertigo 
with or without nausea, persistent otitis media (middle ear infection), facial palsy, tinnitus, 
mild skin flap infection, flap swelling, hematoma (bruising), taste disturbance, and pain 
around the operation site. The incidence of minor complications is higher and more subject 
to variation between cochlear implant centers; studies of large numbers of patients ranging 
from 4% - 20% (Bhatia et al., 2004; Dutt et al., 2005; Loundon et al., 2010). Other risks include 
those of any surgical procedure, including the risks associated with an anaesthetic and 
blood loss. Some risks are increased for younger children, including an increased risk of 
anaesthetic complications. A further risk is due to the relatively small size of their skulls. 
Although their cochleae are adult-sized at birth, their small skull size increases the risk of 
displacement of the electrode array with subsequent significant skull growth. There is also a 
high prevalence of otitis media in this age group, which raises the risk of significant 
infection in the implant area as a result of infection spread from the middle ear. Due to these 
concerns, the FDA currently approves cochlear implantation in children only from the age 
of 2 years and older (ASHA, 2004). In summary, although there are several possible 
complications of cochlear implant surgery, the incidence of life-threatening complications is 
extremely low, and the rates of major and minor post-operative complications are also low, 
making cochlear implant surgery in children a reliable and safe procedure. 
Longer term risks of cochlear implantation include device failure. Although cochlear 
implants are designed to last for a lifetime, about 2% of devices do fail (ASHA, 2004). Device 
failure can result in a changed auditory percept or a total lack of function, and re-
implantation is the only solution. Fortunately, most re-implants function as well as, or better 
 
Cochlear Implants in Children: A Review 
 
359 
than, the original implants, but the risks, costs, and inconvenience of surgery must be 
undertaken. Another longer-term risk is the increased risk of bacterial meningitis, due to the 
fact that the cochlear implant is a foreign body, and can act as a nidus for infection when 
there is a bacterial illness (ASHA, 2004). This risk is highest for children with malformed 
cochleae, those who contract meningitis prior to cochlear implantation, children aged less 
than five years, and children with otitis media or immunodeficiency. A further longer-term 
complication is facial nerve stimulation, which can occur at any time after cochlear 
implantation, but is rare. Children most at risk of this are those with malformed cochleae. 
Fortunately, it is a simple procedure for an audiologist to switch off the electrode/s causing 
the unwanted sensation. 
A final and important risk that is unique to sequential bilateral cochlear implantation is that 
some (usually older) children may not like the sound of their second cochlear implant, and 
will eventually become non-users. While many children, particularly those who have had 
one cochlear implant and have another after a significant period of time, may not initially 
like the sound of their second implant, most adapt to it over time with encouragement and 
support. However, some children never adapt, and show a pattern of inconsistent use over 
several years that culminates in rejection when they are older. There have been no reports in 
the literature to date about adaptation and non-user rates for either large groups of children 
with bilateral implants or for simultaneously implanted children. Factors thought to 
contribute to this outcome in children with a unilateral cochlear implant include older age at 
implantation, dislike of the auditory percept, facial nerve pain or twitching, peer pressure in 
secondary school, family issues, non-mainstream school settings, use of signed 
communication, lack of involvement in the decision-making process (older children), and 
poor speech intelligibility after several years of cochlear implant use (Archbold et al., 2009; 
Ray et al., 2006; Watson & Gregory, 2005).  
Published information on the current non-user rate for children with unilateral cochlear 
implants suggests the risk of rejection is low; the reported non-user rate is currently around 
3% (Archbold et al. 2009; Uziel et al. 2007). However, for children receiving a second, 
sequential cochlear implant, the situation is entirely different, as they must adapt to a 
second, different sound percept; one that may not compare favourably with that provided 
by their first cochlear implant. In the first study to be published on adaptation in children 
with bilateral implants, Galvin and Hughes (in press) noted that a higher proportion of 
children who were implanted simultaneously adapted to full-time use of their devices (95%) 
than those implanted sequentially (70%), and that adaptation to bilateral implant use was 
not easy for almost 20% of the 46 children studied. Both Galvin and colleagues, and 
Archbold (2009; in a study of long term use of unilateral cochlear implants in children) 
noted that children who eventually become non-users often first demonstrate a pattern of 
inconsistent use. Archbold also noted that children who became non-users usually had 
disabilities additional to their hearing loss. The possibility of this eventuality should be 
taken into account by parents, and also by children old enough to participate in the 
decision-making process. 
6.2 Benefits of bilateral cochlear implants 
When a person with normal hearing listens with two ears (rather than just one) sound 





speech, particularly in background noise. The improved sound quality with two ears is 
commonly described as fuller, more spacious, and more natural. To locate sound sources, 
the listener primarily uses the differences in timing and level of sound arriving at each ear, 
with sound arriving later and being softer at the ear furthest from the sound source. This 
localization ability allows the listener to locate sounds in the environment, to find the 
speaker in a group conversation, and to be more aware of changes in their auditory 
environment.  Speech perception is improved with two ears because the brain has two 
opportunities to process the same signal (binaural redundancy), and because the combined 
signal is slightly louder (binaural summation). The benefits of two ears are particularly 
significant when speech and noise are coming from different directions. Firstly, due to the 
physical barrier of the head (the head-shadow effect), the noise level will be lower at the ear 
that is furthest from the noise source. Given that speech will usually be arriving from in 
front of the head, the level of the speech signal is equal at both ears. The listener is therefore 
better able to perceive speech by attending primarily to the ear at which the noise level is 
lower. Secondly, with speech and noise coming from different directions, each ear receives a 
different balance of speech and noise. The brain is able to compare these two different 
signals and reduce the impact of the noise to increase the salience of the speech signal 
(binaural unmasking). 
6.2.1 Speech perception 
The speech perception abilities of children with bilateral cochlear implants have been 
explored using both standardized measures and a variety of study-specific measures in 
quiet conditions and in various noise conditions (for example, Galvin et al., 2007a, b; Scherf 
et al., 2007; van Deun et al., 2010). A review of the research found that 11/13 of the studies 
reported significant improvement in children’s speech perception in noise abilities (Johnston 
et al., 2009). Some of these improvements were due simply to the head shadow effect, or to 
the ability to concentrate on the sound from one ear over another (Galvin et al., 2008a; 
Galvin et al., 2007a; Litovsky et al., 2006a). A recent study found that although they did not 
perform as well as children with normal hearing, bilaterally implanted children performed 
significantly better than unilaterally implanted children on tests of speech perception 
performance in noise (Lovett et al., 2010). As with outcomes for children with unilateral 
cochlear implants, the degree of improvement varies widely between individuals. Improved 
speech perception in noise has been associated with shorter periods of hearing loss in the 
second ear in some studies (Litovsky et al., 2004; Peters et al., 2007; Steffens et al., 2008), but 
not all have found this link (Kuhn-Inacker et al., 2004; Litovsky et al., 2006a; Wolfe et al., 
2007). Two studies that did not find improvements in speech perception in noise included 
children who had a long time period between their first and second cochlear implants. There 
have also been reports of improved speech perception performance in quiet conditions with 
bilateral implants (Scherf et al., 2007; Zeitler et al., 2008). 
6.2.2 Localization of sound 
Bilateral cochlear implantation has not yet shown a clear benefit for sound localization. In 
assessments of localization performance for long-term users to date, some children can 
localize sounds well (Litovsky et al., 2006b; Lovett et al., 2010). Bilateral implantation has 
been associated with increases of 18.5% in the accuracy of sound localization (Lovett et al., 
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2010). Other children are more limited in their localization ability; able to lateralize sounds 
from the left or right side of their heads confidently and with high accuracy, but unable to 
determine the direction of the sound source (as occurs with true binaural processing) as the 
stimulus is presented closer to the front and centre of their heads (Galvin et al., 2008b; 
Grieco-Calub & Litovsky, 2010). Many other bilaterally implanted children (particularly 
older children) have shown no ability at all to locate sound sources (Galvin et al., 2007a). Of 
the children who show some spatial awareness, many do not differ significantly in their 
ability to children with bimodal stimulation (a cochlear implant plus hearing aid), and none 
have the abilities of children with normal hearing (Sparreboom et al., 2010).  Although 
overall the best performers are younger, not all young children demonstrate an ability to 
locate sound sources (Galvin et al., 2010; Galvin et al., 2007a).  
6.2.3 Broader outcomes of bilateral implantation 
Most of the research on outcomes for children with bilateral cochlear implants has focused 
on speech perception in noise and sound localization abilities. There is little research to date 
comparing broader outcomes of children with unilateral versus bilateral cochlear implants, 
and at the time of writing, there were no reports of speech production or academic 
outcomes. An initial theoretical analysis of the cost effectiveness of bilateral implantation 
suggested that it “is possibly a cost-effective use of resources”, but that further data on the 
costs and benefits of bilateral implantation compared with unilateral implantation are 
required to reach a definitive conclusion (Summerfield et al., 2010). To date, two studies 
using standardized quality-of-life measures have attempted to determine whether bilateral 
implants facilitate improved quality of life in children, however neither reported a 
significant improvement for children with bilateral implants (Beijen, 2007; Lovett et al., 
2010).  
Information on the impact of bilateral cochlear implantation on language is currently 
limited. A recent study comparing the preverbal communication of children implanted 
before age 3 years (27 bilaterally; 42 unilaterally) reported that children with bilateral 
cochlear implants were significantly more likely to use vocalisation to communicate and to 
use hearing when interacting with an adult than were children with unilateral implants (Tait 
et al., 2010). After statistically controlling for the influence of age at implantation and length 
of deafness, it was found that bilateral implantation contributed to 51% of the variance in 
outcomes. A multi-center study of 91 children with unilateral (n=60) and bilateral (n=31) 
implants reported that bilateral implantation was not associated with improved expressive 
or receptive language development (Niparko et al., 2010). Similarly, Nittrouer & Chappman 
(2009) examined the vocabulary, receptive and expressive language abilities of 58 children 
tested at age 3.5 years and also found no differences in outcomes between 15 children with 
unilateral and 26 with bilateral cochlear implants. Both of these studies provide no support, 
in terms of language development, for providing young children with bilateral cochlear 
implants.  
However, recent initial results of another prospective, multicentre study comparing 
outcomes for children with unilateral and bilateral cochlear implants showed a significant 
advantage for bilaterally implanted children with regard to language development (Sarant 
et al., in press). The groups of unilaterally (n= 11) and bilaterally (n=17) implanted 5-year-
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parent involvement in intervention or parent stress levels, and children with bilateral 
cochlear implants achieved significantly higher expressive and total language scores than 
did children with unilateral cochlear implants. Initial results of a Belgian study of 25 
bilaterally implanted children matched for 10 factors with 25 unilaterally implanted children 
also reported significantly better receptive and expressive language outcomes for the 
bilaterally implanted children (Boons et al., in press).  
Considering other benefits of bilateral implants, Galvin and colleagues’ research and clinical 
experience with older children and young adults indicates that there are more general 
benefits, such as ease of listening, awareness of the auditory environment, and increased 
confidence in social situations, that are of great functional value to children with bilateral 
implants (Galvin & Hughes, in press). For this group, self-motivation and external support 
and encouragement were particularly important, as adapting to a second implant at a later 
age is a more difficult process. Parent questionnaire data from this study for 38 children and 
young adults showed that 79% of children were using two cochlear implants more than 60% 
of the time, and 68% reported using bilateral implants more than 90% of the time. Reports of 
perceived benefit in everyday life also indicated that there was no upper age limit beyond 
which additional benefit could not be gained from bilateral implants. When considering the 
risks, time and effort required to obtain bilateral implants versus any additional benefit 
gained, 79% of the families reported that the second cochlear implant was worthwhile, 16% 
were unsure, and only 5% felt that obtaining bilateral implants had not been worthwhile 
(Karyn Galvin, personal communication, August  16th, 2011).  
6.3 Timing of first and second cochlear implants; sequential and simultaneous 
implantation 
It is reasonable to assume that children who receive a second cochlear implant early in life 
will have greater neural plasticity of the central auditory system, and that the first implant 
will have dominated the auditory neural pathways for a shorter period of time also. 
Electrophysiological studies of auditory brainstem  responses in children with early onset of 
deafness support this view, showing prolonged wave latencies in the second implanted ear 
for children implanted sequentially compared to those implanted simultaneously (Gordon, 
2008; Gordon et al., 2010). Follow up of children has shown that wave latencies improve 
over time, particularly for children implanted under 3 years of age (Gordon et al., 2007), and 
that cortical evoked responses are fundamentally different for children implanted before 
and after age 3.5 years in terms of wave morphology and latency (Bauer et al., 2006; Sharma 
et al., 2005). These studies suggest that the shortest delay possible (ie. simultaneous bilateral 
implantation) will maximise the chance of developing true binaural auditory processing. 
The clinical evidence reported to date supports the electrophysiological findings. Children 
who receive bilateral implants sequentially when younger adapt more quickly (Dowell et 
al., 2011; Galvin & Hughes, in press; Scherf et al., 2009) and generally have better speech 
perception and sound localization outcomes than those implanted when older (Galvin et al., 
2007a).  
 There appears to be a consensus that children receiving a second implant over the age of 4 
years perform much more poorly on speech recognition and sound localization tasks, and 
do not show evidence of true binaural processing (for example, Galvin et al., 2007a; Johnston 
et al., 2009; Wolfe et al., 2007). Current evidence suggests that simultaneous bilateral 
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implantation is a safe surgical procedure, and may also offer advantages to ease of 
adaptation, although there may be greater challenges associated with programming and 
managing two devices in younger children (Ramsden et al., 2009). 
6.4 Factors affecting outcomes  
Outcomes with bilateral implants are influenced by many of the same interacting factors as 
with unilateral implants (see section 4). As with unilateral implants, factors such as age at 
time of first implant and amount of pre-operative auditory stimulation in the ear implanted 
second contribute to outcomes, with younger children and those with pre-implant hearing 
aid use achieving better results (Galvin et al., 2007a; Peters et al., 2007; Wolfe et al., 2007; 
Zeitler et al., 2008) . Consistency of device use also influences outcomes, with most children 
implanted at younger ages adapting more quickly and with greater ease to using bilateral 
implants, whether they are simultaneously or sequentially implanted (Galvin et al., 2008a; 
Scherf et al., 2009). Older sequentially implanted children and young adults (who are 
responsible for their own consistency of device use) must be highly self-motivated in order 
to persist with learning to use their second cochlear implant; this can be particularly difficult 
for children aged 7-12 years, especially if they have not been involved in the decision-
making process (Galvin et al., 2009). Children implanted at younger ages are also more 
likely to achieve similar listening abilities with either device, and appear to have greater 
potential for the development of localization abilities.  
For children implanted sequentially, greater improvements in speech perception and 
localization abilities are demonstrated when there is a shorter time period between the first 
and second implants (Galvin et al., 2008a; Schafer & Thibodeau, 2006).  Factors associated 
with poor outcomes include poorer than expected outcomes with the first implant, a long 
time delay between the first and second implants, and limited experience and/or 
habilitation using the second implant on its own (Dowell et al., 2011). Given the limited 
information about outcomes for bilaterally implanted children to date, it is not currently 
possible to accurately predict outcomes for individuals. 
6.5 Limitations in current knowledge of outcomes with bilateral implants 
The early literature is limited in showing what is possible for bilaterally implanted children. 
Many studies have included children with very little experience at the time of assessment 
(as low as 6-12 months for many studies; Sparreboom et al., 2010). We know from the 
experience of both adults and children with unilateral implants that speech perception and 
other skills can improve over a period of years, and from bilateral studies that localization 
skills also require time to develop, therefore it is reasonable to expect that results could 
improve over time. The evidence is also limited in terms of the number of children who 
have been followed. A review of paediatric bilateral implant research noted that over half of 
the published studies reviewed had only 10 or fewer participants (Johnston et al., 2009). 
Although there are no reports to date on outcomes for children who have received bilateral 
cochlear implants aged under one year, it would not be unreasonable to expect that very 
early bilateral implantation would also further optimize outcomes, given the 
electrophysiological and other evidence collected to date (Peters et al., 2010). There is also 
currently a lack of evidence regarding quality of life, language, literacy and academic 
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implantation is a safe surgical procedure, and may also offer advantages to ease of 
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Although there are no reports to date on outcomes for children who have received bilateral 
cochlear implants aged under one year, it would not be unreasonable to expect that very 
early bilateral implantation would also further optimize outcomes, given the 
electrophysiological and other evidence collected to date (Peters et al., 2010). There is also 
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receive bilateral implants, studies with larger numbers of participants observed over longer 
periods of time will be conducted, as has occurred with unilateral implants. These studies 
will no doubt provide further information on which the magnitude of the effect of bilateral 
implants on outcomes can be measured. 
7. Conclusion  
Enormous progress has been made over the past three decades in the development of 
cochlear implants. We have progressed from uncertainty and controversy around whether 
children could use the incomplete auditory information provided by a unilateral cochlear 
implant to develop spoken language, to documenting outstanding and life-transforming 
success for many children with unilateral or bilateral cochlear implants. Cochlear implants 
are now accepted as the standard of care for children with severe-profound hearing loss. 
They have allowed many children to attend regular schools, and to develop their language, 
social and academic skills to levels that exceed those for their peers with severe-profound 
hearing loss using hearing aids. For some children, cochlear implants have facilitated 
outcomes such as those their hearing peers achieve, including post-secondary school study, 
fulfilling employment, and rich social relationships in the hearing world. However, there 
are still a significant number of children with cochlear implants whose speech intelligibility, 
speech perception, spoken language, academic and social development are far below that of 
children with normal hearing. There remains enormous variation in outcomes between 
individuals with both unilateral and bilateral cochlear implants. Other influences related to 
neural maturation and development, and also to complex interactions between 
demographic variables, environmental factors, intervention and learning processes, are not 
yet understood. A challenge for the future will be to make progress in our understanding of 
these factors and processes in order to improve outcomes for a greater proportion of 
children with cochlear implants. Further follow-up of children with unilateral and bilateral 
cochlear implants is required in the future to determine what the best outcomes will be. 
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1. Introduction 
The application of drugs through the eardrum and into the middle ear to treat various 
otologic disorders, such as Meniere’s disease and sudden sensorineural hearing loss has 
recently gained widespread popularity. The intratympanic treatment modality can provide 
also a chemoprotection strategy for exposure to noise (1) cisplatin (2), and aminoglycosides 
(3). 
Inflammatory processes may play a role in the etiology of various inner ear pathologies of 
which the pathogenesis is poorly understood. Intratymapanic corticosteroid may be a 
promising therapy for several ear disorders.  
Neurosensorial hearing loss therapy to date has consisted mostly of the systemic 
administration of steroids and has been limited by their side effects and low therapeutic 
concentrations within the fluids and tissues of the inner ear. It has been shown in animals 
and humans that systemically applied glucocorticoids reach only low drug concentrations in 
the perilymph. The local application of drugs to treat inner ear diseases is expected to 
provide advantages as compared with systemic treatments, namely: 1) bypassing the blood-
labyrinthine barrier, 2) resulting in higher concentrations in the inner ear fluids 3) avoiding 
major unwanted effects of systemically administered medications. 
Despite some successes, the local medical treatment of inner ear conditions, is often 
frustrating to patients and physicians. We review the status of the intratympanic 
corticosteroids treatment. 
2. History  
The delivery of medications to the inner ear through the transtympanic route dates back to 
1935, when Barany (4) used intratympanic lidocaine for treatment of tinnitus. Since then, 
other molecules have been used and the indications have expanded. In 1948, streptomycin 
was used to treat patients with unilateral Meniere’s disease specifically on the basis of its 
vestibulotoxic effects (5). It was Harold Schuknecht who proposed the use of streptomycin 
as an alternative to surgical unilateral labyrinthine ablation (6). Francis Bauer, in 1969 and 
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vestibulotoxic effects (5). It was Harold Schuknecht who proposed the use of streptomycin 
as an alternative to surgical unilateral labyrinthine ablation (6). Francis Bauer, in 1969 and 





interesting application of intratympanic medication was reported by Bryan in 1973, when he 
described the use of intratympanic steroids in a patient with facial paralysis (8). Itoh (9), in 
1991, used steroids for Meniere’s disease. Silverstein (10) in 1996, used steroids for 
Sensorineural Hearing Loss. 
3. Anatomy 
The cochlea can be thought of as a long coiled tube looking much like a snail shell (11). It is 
composed of three compartments. The middle compartment is the scala media, which is 
filled with endolymph. The lower and upper fluid compartments respectively are the scala 
tympani and scala vestibuli, both of which are filled with perilymph. These two 
compartments communicate with each other at the apex of the cochlea through the 
helicotrema. The round window is a membranous opening in the bone within the scala 
tympani. It sits at the base of the scala tympani and is very compliant, capable of bulging 
into the middle ear. It separates perilymph from the middle ear space. The oval window, in 
the scala vestibuli, contains the footplate of the stapes, one of the middle ear bones, that 
transmits acoustic vibrations from eardrum to the inner ear. 
4. Physiology 
Most of the structures of the cochlea are protected from the systemic circulation by the 
presence of a blood-cochlear barrier (or blood-labyrinthine barrier), similar to the blood-
brain barrier. There is exchange between the different compartments of the inner ear: 
between tympanic perilymph and vestibular perilymph and between endolymph and 
perilymph. But also between the inner ear fluids and cerebrospinal fluid and between the 
inner ear fluid and plasma (12) (13). Exchanges between endolymph and plasma are 
through the stria vascularis and between perilymph and plasma through the capillaries 
perilymphatic. At this level makes a pass filtering products: blood-labyrinthine barrier 
(13). 
This blood–inner ear barrier consist of tight junctions and other mechanisms that limit 
access of molecules to inner ear targets. In fact the endothelial cells are connected with tight 
junctions and without fenestrations (14). This network of tightly coupled endothelial cells is 
the dominant component of the blood-cochlear barrier which make this solid barrier 
impermeable to macromolecules.  In addition to this physical barrier, there is a chemical 
barrier between blood and endolymph/perilymph wich has a selectivity to electrolytes and 
water-soluble molecules  (15).  
In the fluid of the inner ear, there are other obstacles to the spread of drugs administered 
systemically: Because the scala media has a relatively high positive charge due to the 
endocochlear potential, the charge the drug carries will be a significant factor in its ability to 
enter the scala media, with positively charged drugs at a disadvantage (13).  
The relatively high protein content of perilymph will tend to bind drugs (16). Protein 
interactions with drugs are as important in the perilymph as in blood. Albumin levels are 
high and can bind acidic drugs, and acid glycoproteins can bind basic drugs (16). Partition 
coefficients of drugs with these proteins will determine free concentration of the drug. The 
free fraction of the drug binds to the sensory cells and exerts its effect (13). 
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The cochlea is surrounded by the petrous bone. It was shown that there is a direct exchange 
between the extracellular space of the petrous bone and perilymph through the lacuna 
canaliculi which are canals or holes in the bone in free communication with the scala 
tympani (17). 
5. Pharmacokinetics and pharmacodynamics 
Treatment given by intratympanic will diffuse in liquid of the inner ear. There are 3 practical 
entry points: 1) through round window membrane RWM (at the base of the cochlea on the 
scala tympani side), 2) through or near the oval window (at the base of the cochlea on the 
scala vestibuli side), 3) through the bone of the cochlea via application in the middle ear. 
This infusion is mainly through the round window.  
The RWM has three layers (18): an outer epithelial layer on the middle ear side, a middle 
fibrous layer, and another epithelial layer facing the inner ear. The outer epithelial layer 
contains some microvilli and abundant mitochondria, suggesting that it may be able to 
absorb substances and carry out metabolic activities. The inner epithelial layer has areas of 
discontinuous basement membrane that may provide space for substances to traverse the 
membrane. 
Plontke (19), and colleagues have extensively modeled the distribution of drugs applied at 
the RWM. They suggest that in addition to diffusion along the length of the cochlea, 
diffusion through the tissue of the cochlea from one scala to another must be considered as 
well. 
Some factors facilitate the passage of molecules through the round window membrane: low 
molecular weight, water-soluble nature, the ionic charge, histamine, prostaglandins, 
leukotrienes, endotoxin of E. coli, Staphylococcus exotoxins (20). The contact time with the 
round window membrane has the most important effect. Wang (21) demonstrates that the 
inner ear pharmacokinetic profile of steroids administered intratympanically is dependent 
upon the nature of the vehicle as well as the physicochemical properties of the steroid drug 
itself. In fact the degree of aqueous solubility of the drug has a major impact on its residence 
time and exposure in the inner ear (21). 
Glucocorticoid receptors have been identified in the inner ear and are more abundant in the 
cochlea (22). The presence of glucocorticoid receptors in the inner ear provides a cellular 
means by which circulating glucocorticoids can directly affect the inner ear physiology. 
Corticosteroids have been used extensively for inner ear disease because of their anti-
inflammatory effects but also affect the vascularity of the inner ear. Corticosteroids have 
many effects : they prevent a decrease in cochlear blood flow, reduce degeneration of the 
stria vascularis  and have an antioxidant effect (23). 
6. Choice of drug 
Two corticosteroids are used by the majority of the researchers: dexamethasone and 
methylprednisolone. The concentration is varied between 4 mg/ ml and 25 mg/ml for 
dexamethasone and between 32 mg/ ml and 62,5 mg/ml for methylprednisolone. 
Parnes in pharmacokinetic animal study compared intracochlear levels of three 
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(24). When correcting for the lower Dexa concentration (4 mg/mL) compared to MP (40 
mg/mL) in their study and for the higher potency, dexamethasone is expected to reach 
higher effective levels in perilymph after application to the round window membrane. In 
addition, contrary to Dexa, MP solution is not stable but hydrolyzed after some days in the 
pump cartridge (19) (25). 
7. Intratympanic delivery methods 
There is no standard protocol for IT corticosteroid injections; the frequency of injections, 
concentration and type of corticosteroid. Method of injection is determined by the 
individual surgeon.  
Multiple intratympanic delivery methods are descripted:        
Syringe delivery is a simple method. However, direct injections do not allow for prolonged 
delivery. We can anesthetize the tympanic membrane with 10 percent Xylocaine. A drop of 
phenol on the ear drum is one method. Another is a topical anesthetic such as "Emla" cream. 
The drug is injected, left in the middle ear for 30 minutes.  
The myringotomy is placed in the most superior and anterior location to allow maximal 
filling of the middle ear space with the corticosteroid solution while the patient is supine. 
Placement of the tube eliminates the need for a new myringotomy for each subsequent 
injection. For injection, we use a 25-gauge spinal needle attached to a 1-mL tuberculin-type 
syringe. To equalize pressure, two needle punctures were made in the anterior superior 
quadrant of the tympanic membrane, the first for injection and the second (superior) for air 
escap. The initial injection was followed by a second injection about 15 minutes later for a 
total volume of approximately 0.5 mL. The patient remained supine for 30 to 40 minutes, 
with the head turned to the side and the injected ear upright, and was instructed to swallow 
as little as possible to help maintain the fluid in the middle ear space for longer duration. 
Microwick is the polyvinyl acetate wick (1 mm diameter by 9 mm length). It absorbs 
medication and transports it directly to the RWM. It’s placed through a tube, at the round 
window niche. It allows instillation by the patient himself at home. The MicroWick should 
be removed or replaced after 4 weeks of treatment to prevent it from becoming adherent to 
the mucosa of the round window  (26). 
Microcatheter is composed of two tubes: one for injection and the other for the return of 
excess liquid. It ends with a bulge that is placed at the round window niche under general 
anesthesia. Some researchers propose to link the catheter to a pump. This would allow 
continuous irrigation and delivery of the product constantly at the round window. 
8. Indications 
Corticosteroids are indicated in several types of sensorineural affects. Indications are : 
sudden deafness, autoimmune Deafness, Deafness and Dizziness related to Meniere's 
disease and Tinnitus.  
They are also available for otoprotection against physical and chemical aggressions of the 
inner ear. It seems that corticosteroids will respond to inner ear hair cells and nerve cells. 
They may prevent, limit and recover the damage caused by noise trauma (27).  They may be 
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given in anticipation of ototoxicity that could be associated with systemic aminoglycoside 
antibiotic or cisplatinum and other chemotherapeutic agents. They can also be used after 
injuries (28). 
9. Results 
Intratympanic corticosteroids for sudden hearing loss and Meniere’s disease has been the 
subject of retrospective, uncontrolled studies and a few controlled studies with small 
numbers of subjects. Hamid in 2001 with a single injection of high concentration of 
Dexamethasone (24mg/ml) for patients with Meniere’s disease, was able to get control of 
vertigo in 90% of cases with an improvement of hearing threshold, the percentage of 
discrimination and sensation of fullness (29) (26). In his study, 90% of patients had vertigo 
control, 90% had improved speech discrimination, and 90% had decreased aural pressure. 
Garduno (30), compared intra tympanic Dexamethasone versus placebo in Meniere disease. 
He obtained full control of vertigo in 82% of cases against 57% with placebo with significant 
differences. He also noted a reduction of tinnitus in 48% of cases and hearing improvement 
in 35% of cases. 
In sudden deafness, Ahn (31) compared two groups: systemic corticosteroids alone versus 
intratympanic corticosteroids associated with systemic treatment. He found no significant 
difference in overall response, but noted a significant improvement on the low frequencies 
in intratympanic treatment group. HONG (32) compared intratympanic corticosteroids 
alone versus systemic corticosteroids alone also found no difference, but noted a significant 
improvement over the low frequencies. Alatas (33) concluded that intratympanic 
dexamethasone is an effective therapy for low frequency hearing loss. Hunchaisri (34) 
concluded that it may have benefits for patients with sudden sensorineural hearing loss who 
failed systemic steroid therapy. 
In diabetic patients with sudden sensorineural hearing loss, intratympanic corticoid 
injection is as effective as systemic steroid treatment and it can avoid undesirable side effects 
(35). Han studied three groups of diabetics and compared prednisolone administered by 
oral, intravenous and intra tympanic Dexamethasone. He noted a better outcome with 
intratympanic treatment without significant difference. However, systemic treatment was 
discontinued in 6 patients due to problems of hyperglycemia.  This disadvantage is not 
observed with the intratympanic treatment. 
Many studies concluded that using the continuous intratympanic dexamethasone by 
MicroWick is effective, safe and efficient for treatment of sudden idiopathic sensorineural 
hearing loss (26) (19). 
There is an increasing number of series evaluating intratympanic (IT) steroids as first line or 
salvage therapy in ISSHL with some studies presenting control groups and randomized 
controlled trials (Table 1). 
The effect of intratympanic corticosteroids on tinnitus is difficult to assess due to limited 
work. Shulman (37) treated tinnitus with intratympanic dexamethasone and obtained 
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injection. For injection, we use a 25-gauge spinal needle attached to a 1-mL tuberculin-type 
syringe. To equalize pressure, two needle punctures were made in the anterior superior 
quadrant of the tympanic membrane, the first for injection and the second (superior) for air 
escap. The initial injection was followed by a second injection about 15 minutes later for a 
total volume of approximately 0.5 mL. The patient remained supine for 30 to 40 minutes, 
with the head turned to the side and the injected ear upright, and was instructed to swallow 
as little as possible to help maintain the fluid in the middle ear space for longer duration. 
Microwick is the polyvinyl acetate wick (1 mm diameter by 9 mm length). It absorbs 
medication and transports it directly to the RWM. It’s placed through a tube, at the round 
window niche. It allows instillation by the patient himself at home. The MicroWick should 
be removed or replaced after 4 weeks of treatment to prevent it from becoming adherent to 
the mucosa of the round window  (26). 
Microcatheter is composed of two tubes: one for injection and the other for the return of 
excess liquid. It ends with a bulge that is placed at the round window niche under general 
anesthesia. Some researchers propose to link the catheter to a pump. This would allow 
continuous irrigation and delivery of the product constantly at the round window. 
8. Indications 
Corticosteroids are indicated in several types of sensorineural affects. Indications are : 
sudden deafness, autoimmune Deafness, Deafness and Dizziness related to Meniere's 
disease and Tinnitus.  
They are also available for otoprotection against physical and chemical aggressions of the 
inner ear. It seems that corticosteroids will respond to inner ear hair cells and nerve cells. 
They may prevent, limit and recover the damage caused by noise trauma (27).  They may be 
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given in anticipation of ototoxicity that could be associated with systemic aminoglycoside 
antibiotic or cisplatinum and other chemotherapeutic agents. They can also be used after 
injuries (28). 
9. Results 
Intratympanic corticosteroids for sudden hearing loss and Meniere’s disease has been the 
subject of retrospective, uncontrolled studies and a few controlled studies with small 
numbers of subjects. Hamid in 2001 with a single injection of high concentration of 
Dexamethasone (24mg/ml) for patients with Meniere’s disease, was able to get control of 
vertigo in 90% of cases with an improvement of hearing threshold, the percentage of 
discrimination and sensation of fullness (29) (26). In his study, 90% of patients had vertigo 
control, 90% had improved speech discrimination, and 90% had decreased aural pressure. 
Garduno (30), compared intra tympanic Dexamethasone versus placebo in Meniere disease. 
He obtained full control of vertigo in 82% of cases against 57% with placebo with significant 
differences. He also noted a reduction of tinnitus in 48% of cases and hearing improvement 
in 35% of cases. 
In sudden deafness, Ahn (31) compared two groups: systemic corticosteroids alone versus 
intratympanic corticosteroids associated with systemic treatment. He found no significant 
difference in overall response, but noted a significant improvement on the low frequencies 
in intratympanic treatment group. HONG (32) compared intratympanic corticosteroids 
alone versus systemic corticosteroids alone also found no difference, but noted a significant 
improvement over the low frequencies. Alatas (33) concluded that intratympanic 
dexamethasone is an effective therapy for low frequency hearing loss. Hunchaisri (34) 
concluded that it may have benefits for patients with sudden sensorineural hearing loss who 
failed systemic steroid therapy. 
In diabetic patients with sudden sensorineural hearing loss, intratympanic corticoid 
injection is as effective as systemic steroid treatment and it can avoid undesirable side effects 
(35). Han studied three groups of diabetics and compared prednisolone administered by 
oral, intravenous and intra tympanic Dexamethasone. He noted a better outcome with 
intratympanic treatment without significant difference. However, systemic treatment was 
discontinued in 6 patients due to problems of hyperglycemia.  This disadvantage is not 
observed with the intratympanic treatment. 
Many studies concluded that using the continuous intratympanic dexamethasone by 
MicroWick is effective, safe and efficient for treatment of sudden idiopathic sensorineural 
hearing loss (26) (19). 
There is an increasing number of series evaluating intratympanic (IT) steroids as first line or 
salvage therapy in ISSHL with some studies presenting control groups and randomized 
controlled trials (Table 1). 
The effect of intratympanic corticosteroids on tinnitus is difficult to assess due to limited 
work. Shulman (37) treated tinnitus with intratympanic dexamethasone and obtained 
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Author Type of study Steroid used Protocol Results 
Kara 
(52) 
Prospective control Dexamethasone 5 intratympanic 
injections with 
the dose of 4 
mg/ml, 
Intratympanic 
steroids gave better 
hearing results than 
systemic steroids 









Dexamethasone 4 mg/ml 
continuously 
applied for 14 
days 
better hearing 
improvement in the 
treatment group 
absence of serious 
adverse events 
Table 1. Review of Literature on Intratympanic steroid Therapy for sudden neurosensorial 
hearing loss 
The effectiveness of steroids in reducing noise induced hearing loss has been inconclusive 
(13). Many types of steroids, antioxidants and growth factors have been studied to protect 
the ear from trauma or to minimize or reverse damage (38) (39). Some researchers have used 
antioxidants such as D-methionine and N-acetylcysteine to prevent noise induced hearing 
loss (40). A variety of growth factors and peptides, are being introduced to combat the 
effects of Noise induced hearing loss :  Insulin-like growth factor-1 (IGF-1), neurotrophic 
factor-3 (NT-3) , AM-111 and D-JNKI-1 peptides (41) (42) (40). 
Steroids have also been tested for their otoprotective attributes during antibiotic treatment. 
The intracochlear infusion of dexamethasone before and after kanamycin delivery protected 
hearing (43). Hill (44) concluded that IT dexamethasone may be a safe, simple and effective 
intervention that minimizes cisplatin ototoxicity without interfering with the 
chemotherapeutic actions of cisplatin. 
A sudden or progressive hearing loss can occur during radiation treatment of head and neck 
tumors (45). Patients are commonly given steroids to reduce inflammation, but their local 
delivery would reduce the side effects associated with systemic steroid treatment (13). 
Inflammation often results from inner ear surgical trauma, as well (46). 
10. Complications 
Complications of intratympanic injections of corticosteroids are uncommon and banal (19). 
Those most often reported in the literature are: 1) some individuals experience intense pain 
during injection, 2) vertigo and tinnitus, 3) Other complications are rare and include acute 
otitis media and mastoiditis. 
Patients who undergone trans-tympanic aerator to avoid multiple injections or to put in the 
microwick have an increasing risk of persistent eardrum perforation (47). In fact, 20% of 
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The intratympanic treatment has several advantages. It is an effective procedure for the 
control of cochleovestibular disorders such as sudden deafness and Ménière's disease. Up 
till now, there is no consensus on the IT protocol. Future studies will define the best 
prtocole. The perspective is the development of the gene therapy and the intracochlear 
treatment. 
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prognostic factors affecting the improvement of ISSHL using feature selection analysis and 
decision tree model. 
2. Materials and methods 
2.1 Patients and eligibility 
We reviewed the medical records of ISSHL patients who visited ‘Tinnitus & Hearing loss 
clinic’ in Kyung Hee Oriental Medical Hospital, Seoul, Korea from June 2006 to February 
2011. Patients who met the definition of ISSHL, which is defined as an abrupt or rapidly 
progressing hearing loss of at least 25 dB in 3 contiguous frequencies over a period of no 
more than 3 days, were eligible to participate in this study. We excluded patients with 
sensorineural hearing loss caused by trauma, noise, tumors, otitis media or Meniere’s 
disease. Additionally, patients were ineligible if they have hearing loss in both ears.  
Of a total 117 patients, ten had Meniere’s disease, two had senile progressive hearing loss, 
four had hearing loss in both ears, one had otitis media and twenty-eight failed to undergo a 
follow up audiogram. Therefore, 72 patients (40 males, 32 females) were enrolled in this 
study (Fig. 1). This study was approved by the Institutional Review Board of Kyung Hee 
Oriental Medical Hospital (KOMCIRB-2011-09). 
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2.2 Audiological assessment 
All patients underwent a full physical exam as well as a routine audiological evaluation and 
otolaryngologic history was also recorded. Magnetic resonance images were acquired if 
necessary. Pure tone audiograms were conducted using a GSI 61 audiogram (Grason-Stadler, 
Inc., WI, USA) on the day of the initial visit and the day of the follow-up measurement, 
which was usually after 10 rounds (1st follow-up) and 20 rounds (2nd follow-up) of AT. 
However, the follow-up measurement was performed before 10 or 20 rounds of 
acupuncture for some patients who request an earlier audiogram because they felt clear 
improvement. If partial improvement in the audiogram was observed at the time of the first 
follow-up measurement, AT was continued until the second follow-up measurement. The 
hearing results were evaluated based on the pure tone average (PTA) of 4 frequencies (250, 
500, 1000, 2000 Hz). A clear improvement of hearing was defined as a final hearing level less 
than 25 dB and a partial improvement of hearing was defined as a final hearing level not 
less than 25dB but decreased in PTA of 10 dB or more. 
2.3 Acupuncture treatment 
All patients received the same method of AT from one TCM doctor. It was typically 
performed two times a week and the frequency was increased or decreased as necessary. 
The sterile acupuncture needles (length: 40 mm and diameter: 0.25 mm, Dondbang Co. 
Korea) were inserted to a depth of 10 - 30 mm until the patient felt the characteristic 
needling sensation of soreness, numbness or distension around the acupuncture point. 
Stimulated acupuncture points included GV14, GV15, GV16, GB20, GB21, BL10, SI4, SI15 
and additional local points (TE21, TE22, SI19, GB2, ST7, BL2, LI20, GV20, EX-HN3) as 
necessary in the prone position, right after the 1st stimulated acupuncture were removed, 
and the liver tonification formula of Saam acupuncture theory (KI10, LR8, LU8 and LR4) 
(Yin CS et al., 2007) which were combined with contralateral LI4, LR3, and ST36 in the 
supine position. The needles were retained at each position for 10 minutes. Most patients 
were also administered herbal medicine individually to improve their body condition.  
2.4 Statistical analysis 
All continuous variables represented in this study were expressed as the means ± the 
standard deviation and all categorical variables were expressed as patient number and 
percentage (%). The differences between improvement and no improvement groups were 
analyzed by the independent-samples T test for all continuous variables if the distribution 
was normal. If the distribution was abnormal, the differences between groups were 
analyzed by the Mann-Whitney U test. In addition, categorical variables were analyzed 
using a Chi-square test or Fisher’s exact test. These statistical analyses were conducted using 
SPSS 17.0 statistical software for windows.  
We also analyzed our data using the feature selection model to classify the important 
variables. Then, based on these important variables, we analyzed our data using a decision 
tree model to identify and rank prognostic factors affecting the improvement of ISSHL by 
AT. These calculations were performed using SPSS Clementine version 12.0 statistical 
software for windows.  
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3.1 Patient population 
Seventy-two patient charts were reviewed (40 males, 32 females). The average age of the 
patients was 49.4 years (range, 8 to 76) and the average time interval from the onset of 
hearing loss to the start of AT was 109.1 days (range, 1 to 1460). 
3.2 PTA changes before and after acupuncture treatment 
Before acupuncture, mean PTA scores of improvement and no improvement groups were 
63.92 ± 22.82 dB and 63.78 ± 17.99 dB, respectively and there was no statistical difference 
between groups (P = 0.977). After AT, mean PTA of improvement and no improvement 
groups were 39.55 ± 21.77 dB and 62.64 ± 18.23 dB, respectively and a significant difference 
between groups was evident (P = 0.000) (Fig. 2). 
 
* : Statistically significant difference, P<0.05 using independent-samples T test 
Fig. 2. Mean PTA before and after AT between Improvement and No Improvement Groups 
3.3 Overall improvement rate  
Overall, after completing the treatment, 36 patients (50.0%) showed improvement including 
a clear (14 patients, 19.4%) and partial (22 patients, 30.6%) improvement. In improvement 
group, the average age was 51.2 years (range, 19 to 76), the average time interval from the 
onset of hearing loss to the start of AT was 51.06 ± 69.39 days (range, 1 to 330) and the 
average improvement in PTA was 24.47 ± 14.85 dB (range, 9 to 63) including two cases 
which the average improvement in PTA was less than 10dB, but PTA was within 25dB. 
3.4 Gender, age, location of lesion, vertigo, hypertension and diabetes mellitus 
There was no significant difference in the gender distribution between improvement and no 
improvement groups. Also, no significant difference between groups was observed in 
regards to the occurrence of vertigo, the location of lesion, presence of hypertension and 
diabetes mellitus (Table 1). 
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 improvement   
    P* 
 Yes No Total  
Gender     
Male 20 (27.8%) 20 (27.8%) 40 (55.6%)  
Female 16 (22.2%) 16 (22.2%) 32 (44.4%) 1.000 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
Age     
≤60 27 (37.5%) 31 (43.1%) 58 (80.6%)  
>60 9 (12.5%) 5 (6.9%) 14 (19.4%) 0.234 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
Location of lesion     
Left 22 (30.6%) 24 (33.3%) 46 (63.9%)  
Right 14 (19.4%) 12 (16.7%) 27 (36.1%) 0.624 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
Vertigo     
Yes 9 (12.5%) 7 (9.7%) 16 (22.2%)  
No 27 (37.5%) 29 (40.3%) 56 (77.8%) 0.571 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
Hypertension     
Yes 11 (15.3%) 10 (13.9%) 21 (29.2%)  
No 25 (34.7%) 26 (36.1%) 51 (70.8%) 0.795 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
Diabetes Mellitus     
Yes 0 (0%) 1 (1.4%) 1 (1.4%)  
No 36 (50.0%) 35 (48.6%) 73(98.6%) 1.000 
Total 36 (50.0%) 36 (50.0%) 72 (100%)  
* Statistically significant difference, P<0.05 using χ2 test or Fisher’s Exact test 
Table 1. Relationship of Character of Patients and Improvement of ISSHL  
3.5 Time interval from the onset of hearing loss to the start of acupuncture treatment 
The time intervals from the onset of hearing loss to the start of AT for improvement and no 
improvement groups were 51.06 days (±69.39 SD) and 167.22 days (±265.01 SD), 
respectively, which differed significantly (P=0.013) (Table 2). 
 
 Improvement  
   P* 
 Yes No  
Time interval from the onset of hearing 
loss to the start of acupuncture treatment 
 
51.06 ± 69.39 
 
167.22 ± 265.01 
 
0.013* 
* Statistically significant difference, P<0.05 using independent-samples T test 
Table 2. Differences in the Time Interval from the Onset of Hearing Loss to the Start of 
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To analyze the relationship between ISSHL improvement and the time interval, we divided 
72 patients into four groups (within 2 weeks, 2 – 6 weeks, 6 weeks – 6 months and over 6 
months groups). In this analysis, 9 of 10 patients (90%) and 15 of 25 patients (60%) showed 
improvement with the time interval within 2 weeks and 2 - 6 weeks, respectively. Only 10 of 
26 patients (38.5%) and 2 of 11 patients (18.2%)  showed improvement with the time interval 
of 6 weeks – 6 months and greater than 6 months, respectively (Table 3).  
 
Time interval ISSHL improvement 
 
  
 Yes No  P 
 Clear Partial  Total  
Within 2 weeks 
 















6 weeks – 6 months 4 (5.6%) 6 (8.3%) 16 (22.2%) 26 (36.1%) 0.004* 
6months or more 1 (1.4%) 1 (1.4%) 9 (12.5%) 11 (15.3%)  
Total 14 (19.4%) 22 (30.6%) 36 (50.0%) 72 (100%)  
* Statistically significant difference, P<0.05 using χ2 test 
Table 3. Relationship between the Time Interval and ISSHL Improvement 
3.6 Severity of hearing loss on the day of initial visit as a prognostic factor 
As mentioned earlier, there was no difference in mean PTA before and after AT between 
improvement and no improvement groups (Fig. 2). 
To evaluate the co-relationship between severity of hearing loss and time interval with 
improvement, we divided patients with 2 groups; within 6 weeks and over 6 weeks. Within 
6 weeks, there was no difference of severity of hearing loss on the day of initial between 
improvement and no improvement groups (P = 0.145). On the other hand, over 6 weeks, 
severity of hearing loss on the day of initial in no improvement group was higher than in 
improvement group. However, there was no statistical significance (P = 0.055) (Table 4). 
 
 
Time interval from the onset 





 Yes No  
Within 6 weeks 69.74 ± 22.03 (n = 24) 59.20 ± 18.36 (n = 11) 0.145 
Over 6 weeks 52.29 ± 20.52 (n =12) 65.60 ± 17.82 (n = 25) 0.055 
* Statistically significant difference, P<0.05 using Mann-Whitney U test 
Table 4. Severity of Hearing Loss on the Day of Initial Visit as a Prognostic Factor 
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3.7 Important variables for ISSHL improvement  
In the feature selection analysis to classify the most important variables to the improvement 
of ISSHL by AT, pure tone at each frequency (250, 500, 1000, 2000 Hz), PTA on the day of the 
initial visit and time interval (categorical variable) were determined to be important 
variables (Table 5). 
 
Rank Field Importance Value 
1 pure tone at 500Hz (middle-low frequency 
range) on the day of the initial visit 
Important 1.0 
2 pure tone average on the day of the initial visit Important 1.0 
3 pure tone at 1000Hz (middle-high frequency 
range) on the day of the initial visit 
Important 1.0 
4 pure tone at 250Hz (low frequency range) on 
the day of the initial visit 
Important 1.0 
5 pure tone at 2000Hz (high frequency range) on 
the day of the initial visit 
Important 0.993 
6 time interval from the onset of hearing loss to 
the start of acupuncture treatment (categorical) 
Important 0.988 
7 age Unimportant 0.727 
8 presence of vertigo Unimportant 0.217 
9 location of lesion (right / left) Unimportant 0.18 
10 presence of hypertension Unimportant 0.166 
11 Gender Unimportant 0.133 
* 1 screened field: presence of diabetes mellitus 
Table 5. Results of Feature Selection of Important Variables Contributing to the 
Improvement of ISSHL  
3.8 Prognosis factors for ISSHL improvement  
Based on the results of feature selection model, we identified the prognosis factors that affect 
ISSHL improvement by AT using a decision tree model. In patients who started AT within 2 
weeks and over 6 months, the improvement was not affected by PTA on the day of the initial 
visit. Otherwise, in patients who started treatment 6 weeks - 6 months PTA on the day of the 
initial visit were found to be important variables to the prognosis for ISSHL improvement. 
Especially, in patients who started treatment between 2 and 6 weeks, pure tones at 500Hz 
(middle-low frequency range) were found to be important variables to the prognosis for ISSHL 
improvement (Fig. 3). 
4. Discussion 
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Table 4. Severity of Hearing Loss on the Day of Initial Visit as a Prognostic Factor 
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3.7 Important variables for ISSHL improvement  
In the feature selection analysis to classify the most important variables to the improvement 
of ISSHL by AT, pure tone at each frequency (250, 500, 1000, 2000 Hz), PTA on the day of the 
initial visit and time interval (categorical variable) were determined to be important 
variables (Table 5). 
 
Rank Field Importance Value 
1 pure tone at 500Hz (middle-low frequency 
range) on the day of the initial visit 
Important 1.0 
2 pure tone average on the day of the initial visit Important 1.0 
3 pure tone at 1000Hz (middle-high frequency 
range) on the day of the initial visit 
Important 1.0 
4 pure tone at 250Hz (low frequency range) on 
the day of the initial visit 
Important 1.0 
5 pure tone at 2000Hz (high frequency range) on 
the day of the initial visit 
Important 0.993 
6 time interval from the onset of hearing loss to 
the start of acupuncture treatment (categorical) 
Important 0.988 
7 age Unimportant 0.727 
8 presence of vertigo Unimportant 0.217 
9 location of lesion (right / left) Unimportant 0.18 
10 presence of hypertension Unimportant 0.166 
11 Gender Unimportant 0.133 
* 1 screened field: presence of diabetes mellitus 
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Abbreviation: PTA500=pure tone at 500 Hz on the day of the initial visit; PTA before AT=pure tone 
audiogram before acupuncture treatment 
Fig. 3. Decision Tree Model of Important Variables as Prognosis Factors of ISSHL  
Although there have been several studies about AT, it has not been fully explained how 
acupuncture works. Since gate-control theory, basic scientific research has focused on 
acupuncture theory from a neurobiologic perspective. Therefore, several studies have 
reported the effect of acupuncture on neurologic diseases, like seizure, cerebrovascular 
disorders, Parkinson’s disease, etc. According to these studies, there is no evidence which is 
conclusive to support the use of acupuncture for a range of neurological disorders. (Lee H et 
al., 2007). The other study suggested that acupuncture have some effect on psychosomatic 
diseases, like pain, headache and smoking (Vincent CA., 1987). 
Even though there was no strong scientific and clinical evidence, people have tried AT on 
the diseases which have unknown causes, for example, ISSHL. 
There have been several studies to evaluate the effects of AT on ISSHL (Abel SM et al., 1976; 
Madell JR, 1975; Zhang CY & Wang Y, 2006; Zhang XZ et al., 2009; Yin CS et al., 2010; Yoon 
HS et al., 2003; Ha MK & Choi IH, 2003). Some studies have demonstrated that AT did not 
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produce significant shifts in hearing compared with sham groups (Abel SM et al., 1976) or 
there were no clinically important differences during and post treatment (Madell JR, 1975). 
However, other studies have reported that AT was effective to patients with ISSHL (Yin CS 
et al., 2010; Yoon HS et al., 2003; Ha MK & Choi IH, 2003).  
In spite of these results, the efficacy of AT on ISSHL is still unknown, because these studies 
often lacked definite diagnostic standards. Therefore, we excluded patients who had 
sensorineural hearing loss not from ISSHL but from other diseases even if the patients had a 
good response to make strict diagnostic standards.    
The acupuncture points, methods and depth of acupuncture methods and the depth of 
acupuncture are regarded as important things for the better effect.  
On SSHL including ISSHL, common acupuncture points are as follows; GB20, TE21, SI19, 
GB2, TE17, LI4, GB43, TE3, GB20, GV23, GV20, EX-HN 1, TE5, KI1 and so on ( Zhang CY & 
Wang Y, 2006; Zhang XZ et al., 2009; Yin CS et al., 2010; Yoon HS et al., 2003; Ha MK & Choi 
IH, 2003). Especially, TE21, SI19 and GB2 are main points on ISSHL. We combined with 
these acupuncture points with Samm acupuncture points. Saam acupuncture is a traditional 
Korean acupuncture theory that originated in the 17th century. This acupuncture system 
applies a five-phase theory in which each of five transport points in 12 meridians 
correspond to one of the five phases. Saam acupuncture also simultaneously modulates 
other relative channels, which are selected based on the theory of nourishing or suppressing 
cycle relationships, to ensure whole-body balance (Hwang DS et al., 2011; Yin CS et al., 
2007).  
Some studies revealed that deep needling is more significantly effective than shallow 
needling at TE21, SI19 and GB2 combined with body acupuncture (Zhang CY & Wang Y, 
2006). According to these studies, acupuncture needles in our trial were inserted to a deep 
depth of 20-30 mm at TE21, SI19 and GB2 until the patient felt the characteristic needling 
sensation of soreness, numbness or distension around the acupuncture points.  
ISSHL is one of the tough problems in ear diseases area because there is no definite answer 
for this disease. There is not even universally acceptable standard definition of ISSHL. 
Although many studies define ISSHL as loss of at least 30 dB in 3 contiguous frequencies 
over a period of 3 days (Shemirani et al., 2009, Xenellis J., 2006, etc), some studies defined as 
a >20 dB (Haberkamp & Tanyeri, 1999), and others defined ISSHL as a >25 dB loss. (BYL 
FM, 1984). We defined ISSHL as hearing loss of at least 25 dB in 3 contiguous frequencies 
over a period of no more than 3 days, because there were some patients who complained 
hearing disturbance even if they had PTA lower than 30 dB.     
ISSHL is thought to be the clinical manifestation of diverse pathologic processes: viral 
infection, circulatory disorders, labyrinthine membrane rupture, and autoimmune reactions 
have been suggested to be possible causative factors (Eisenman D & Arts HA, 2000). Because 
of the multifactorial etiopathology, a number or different regimens have been used as 
therapy, including vasodilators, anticoagulants, corticosteroids, vitamins, plasma expander, 
histamine, antiviral agents, batroxobin, contrast media, stellate ganglion block, hyperbaric 
oxygen, and carbogen (Suzuki H et al., 2011).  
Antiviral was selected because ISSHL is regarded as one of the viral infection diseases. 
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(Shaikh JA & Roehm PC, 2011). Vasodilators which widen blood vessels and thus improve 
blood flow were selected because it has been frequently considered that ISSHL may have a 
vascular origin. However, the effectiveness of vasodilators in the treatment of ISSHL could 
not be proven (Agarwal L & Pothier DD, 2010). Usually, early use of high-dose systemic 
steroid therapy improves hearing recovery. However, persistent hearing losses after 2 weeks 
of oral treatment with steroids have a poorer prognosis (Ito et al., 2002). There have been 
several reports regarding the benefits of intratympanic steroids for the treatment of 
refractory ISSHL, but the efficacy of intratympanic steroids is still controversial (Haynes et 
al., 2007). 
On the one hand, the controversial results for various therapies would be reasonable 
because the rate of spontaneous recovery of ISSHL is 45 to 65 percent (Mattox & Simmons, 
1977; Eisenman D., 2000). On the other, the lack of universally accepted standard criterion of 
effect would make this controversial result. The standard criterion is very important factor 
for study, because the results on effectiveness and prognostic factors could be changed by 
this. Unfortunately, each study of ISSHL used different criterion of effect. 
We decided the criterion valuation basis for effectiveness at least 10 dB decrease in PTA of 
contiguous 4 frequencies (250, 500, 1000, 2000 Hz) because most of patients visited our clinic 
after they failed to conventional therapies, so we considered that 10 dB was reasonable 
comparing other studies (Xenellis J et al., 2006; Rauch SD et al., 2011; Wu HP et al., 2011)   
After completing the AT, 50% patients (36/72) showed clear or partial improvement. If the 
10 patients within 2 weeks from the onset were excluded to eliminate the effect from nature 
spontaneous recovery, 43.5% patients (27/62) showed clear or partial improvement. These 
results were similar to or higher than average recovery rate of other studies especially 
considering the time interval from onset of ISSHL to start treatment( Xenellis J et al., 2006; 
Haynes DS et al., 2007; Raymundo IT et al., 2010; Wu HP et al., 2011; Rauch SD et al., 2011; 
Park MK et al., 2011).  
Commonly, the time interval from onset to treatment was regarded as the most important 
factor for improvement of ISSHL. Therefore, most of studies of ISSHL were conducted with 
the patients within 2 weeks from onset. Even the studies that conducted with patients who 
failed to conventional therapy, the periods of ISSHL were only a few months. Haynes et al. 
(Haynes DS et al., 2007) conducted a retrospective review of 40 SSHL patients who failed 
systemic therapy and underwent intratympanic dexamethasone. They found that 27.5 % (11 
patients) patients recovered (criteria for improvement: 20 -dB PTA or 20 % improvement in 
SDS), and that the average duration from onset of symptoms to intratympanic therapy was 
40 days with a range of 7 days to 310 days. However, even in this study, no patient receiving 
intratympanic corticosteroids after 36 days recovered their hearing. Psifidis AD et al. 
(Psifidis AD et al., 2006) conducted a review of 15-year retrospective series of 80 patients 
diagnosed with SSHL and they concluded that any additional treatment after 2 months 
should not affect the outcome of the hearing.   
In our study, 37 out of 72 (51.3%) patients started AT 6 weeks after onset of ISSHL, and 13 
patients (35.1%) showed improvement, even 5 patients showed complete recovery. Yeo SW 
et al (Yeo SW et al., 2007) conducted retrospective study of 156 SSHL patients who were 
treated by 10-day course of admission therapy and followed for at least months. They 
concluded that delayed recovery occurred later than 1 month after discharge. The result of 
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this study is very interesting because this study was conducted in Korea, also. Almost of 
patients in our study visited our clinic after they had failed conventional therapies. Even 
though, Yeo SW et al hypothesized that conventional therapies for ISSHL might have long 
term effects, they didn’t check if their patients had oriental medicine as the 2nd treatment or 
not. So, we hypothesized cautiously that the reason of delayed recovery in Yeo’s study 
might be Oriental medicine, including acupuncture. Of course, we admit that our 
hypothesis is too much jump because there is no other study like Yeo’s. From now, further 
studies were necessary to certify our hypothesis. 
There have been several studies reported about the prognostic factors of ISSHL. Several 
factors, including gender, age, presence of vertigo, time interval from the onset to the start of 
treatment, severity of hearing loss, etc. have been suggested. Some studies have reported 
that the female gender was suggested to be poor prognostic factor for recovery of hearing loss 
(Ceylan et al., 2007) and male gender was related to better hearing outcomes (Xenellis J et al., 
2006). In our study, correlation between gender and prognosis for recovery of hearing loss was 
not evident.  
Standard age of prognosis on ISSHL is different according to each study. Wang L et al 
(Wang L et al., 2009) reported that the prognosis of patients under the age of 55 was better 
and Lee HN & Ban JH (Lee HN & Ban JH, 2010) proposed that the prognosis of patients 
under the age of 60 was better. In our finding, age was not a prognostic factor for recovery 
of hearing loss. 
Location of lesion is regarded as an important factor in TCM. According to the TCM theory, 
the left side is controlled by Blood-Liver and the right side is controlled by Qi-Lung. From this 
theory, TCM doctors usually consider that the main reason of disease in left side is the stress 
and in right side is the deficiency of body-energy. However, location of lesion was not a 
prognostic factor for recovery of ISSHL in our study. 
The presence of vertigo is one of important prognostic factors for recovery of hearing loss 
which many studies recommended (Kang D & Wan L, 2005; Suzuki H et al., 2011; Cvorović 
L et al., 2008). Some studies reported that BPPV in patients with SSHL, representing 
definitive vestibular damage, was closely related to poor prognosis (Lee NH & Ban JH, 
2010). Other study revealed that the presence of vertigo was found to be significantly 
correlated with the lack of improvement in hearing, but only at the 8-kHz frequency (Ben- 
David J et al., 2002). But, our findings showed that the presence of vestibular damage such 
as vertigo or tinnitus was not related to improvement of ISSHL. These results were 
consistent with Wang L et al (Wang L et al., 2009). 
Luo Y et al (Luo Y et al., 2010) reported that diabetes, hypertension, hyperlipidemia, high 
blood viscosity, cerebral blood supply insufficiency and liver disease were the risk factors of 
sudden hearing loss. Our findings showed that diabetes and hypertension was not related to 
recovery rate of hearing loss in accordance with some studies (Wang L et al., 2009; Kang D & 
Wan L, 2005). 
Some studies have reported that the prognosis for recovery from hearing loss was better 
when the patients begin treatment within 2 weeks (Shikowitz, 1991; Byl, 1984; Wang L et al., 
2009). In consistent with these findings, the most important prognosis variable in our study 
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patients (90%) who started treatment for ISSHL within 2 weeks showed clear or partial 
improvement. 
Many studies regarded the severity of hearing loss is one of the important prognostic factors 
for improvement of ISSHL(Byl FM., 1984; Fetterman BL et al., 1999; Psifidis AD et al, 2006; 
Cvorovic L et al., 2008; Ceylan A et al., 2007) However, the standard of severity which could 
affect the prognosis, was different in each study Moreover, some studies have reported that 
the initial hearing level had no statistical point on prognosis (Suzuki H et al., 2011; Wang L 
et al., 2009). In our study, there was no difference in severity of hearing loss between 
improvement and no improvement groups. However, in patients who started AT after 6 
weeks of onset, no improvement group showed higher severity of hearing loss on the day of 
initial than improvement group. Even if there was no statistical significance, the difference 
was considerably high (P=0.055). Moreover, in feature selection analysis, PTA on the day of 
initial visit was one of the important variables contributing the improvement of ISSHL by 
AT.    
Several studies reported that an upward-sloping audiogram pattern was related to better 
hearing outcomes (Xenellis J et al., 2006; Wu J et al, 2011). Wu J et al suggested that concave 
audiogram pattern as well as upward-sloping may be a favorable prognostic factor (Wu J et 
al, 2011). Cvorović L et al demonstrated that flat audometric curves had worse prognosis. To 
analysis of audiogram patterns, we divided frequency into low (250 Hz), middle-low (500 
Hz), middle-high (1000 Hz), high (2000 Hz) frequency and analyzed each pure tone level 
according to each frequency. In patients who started treatment within 2 weeks, the 
improvement rate was not related to PTA on the day of the initial visit. Otherwise, in 
patients who started acupuncture treatment after 2 weeks, pure tones at 500Hz (middle-low 
frequency range) were found to be important variables to the prognosis for ISSHL 
improvement. These findings are very unique and our analysis method is the first trial 
combined to the time interval from the onset of hearing loss and audiogram.  
In conclusion, our findings indicate that AT have some effects on ISSHL even for the 
patients who failed to respond to conventional therapies. It also demonstrated that favorable 
prognosis was directly related to the time interval from the onset of hearing loss to the start 
of AT. The severity of hearing loss, especially at middle-low frequency was also 
considerable as an important factor.  
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prognosis was directly related to the time interval from the onset of hearing loss to the start 
of AT. The severity of hearing loss, especially at middle-low frequency was also 
considerable as an important factor.  
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